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Abstract 
 
Aim 
To develop a list of red flag clinical indicators for possible serious pathology 
masquerading as, or presenting alongside, neck related musculoskeletal disorders 
in the adult population. 
 
Background 
Musculoskeletal physiotherapists provide assessment and treatment for pain and 
functional impairments relating to musculoskeletal disorders, such as back and neck 
pain.  In order to apply safe and effective treatment to these conditions it is vitally 
important that any underlying serious complaints have been excluded.  Clinical 
indicators known as ‘red flags’ have been developed for diagnostic triage in back 
pain to help identify serious underlying conditions, such as cancer and infection. 
Red flags for serious pathology in neck pain or neck related pathology has not 
received the same level of attention as red flags in back pain. A literature review 
identified inconsistent evidence for clinical tests and clinical indicators for serious 
pathology in neck related musculoskeletal disorders.  This presents a serious clinical 
challenge for musculoskeletal physiotherapists. 
 
Method 
A mixed method study design was developed involving: a) Qualitative descriptive 
method through Physiotherapy focus group; and, b) Three round Delphi survey 
method involving consultant neurologists and consultant neurosurgeons.  The 
Delphi method involves combined qualitative and quantitative data phases. 
Thematic content analysis was used to analyse the qualitative data. A combined 
descriptive and inferential (non-parametric) statistical analysis was used to analyse 
the quantitative data.  Kendall’s W (Kendall’s coefficient of concordance) was used 
to evaluate the level of consensus across all participants for the quantitative phase 
of the Delphi method. 
 
Findings 
A list of neck related red flag clinical indicators within five specific categories were 
developed:  1. progressive pain; 2. cancer, infection, trauma; 3. neurological deficit 
(spinal cord compromise); 4. headache (associated with neck pain/stiffness); 5. 
brainstem, cervical arterial and cranial nerve dysfunctions.  An increase in Kendall’s 
W was demonstrated between Rounds 2 and 3 in four out of five categories, 
indicating an increase in consensus levels between participants. This process 
highlights the complexity of interpreting clinical features within musculoskeletal 
presentations. 
 
Key words 
Cervical spine red flags; neck pain red flags; cervical arterial dissection; cervical 
arterial dysfunction; cervical spondylotic myelopathy; cord compression; serious 
spinal pathology.  
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Chapter 1. Introduction 
 
Musculoskeletal physiotherapists provide assessment and treatment for pain and 
functional impairments relating to the musculoskeletal system, for example back and 
neck pain.  In order to apply safe and effective treatment to these conditions it is 
vitally important that any underlying serious complaints have been excluded.  
Clinical indicators or danger signs known as ‘red flags’ have been developed as a 
diagnostic triage or screening tool to help identify any possible serious underlying 
condition, such as cancer.  This process helps reduce the risk of physiotherapy 
treatment causing further harm and improve the chance of early detection of more 
serious conditions presenting as a musculoskeletal problem. 
 
Whilst red flags for musculoskeletal back pain have been developed (e.g. Clinical 
Standards Advisory Group - CSAG 1994) and widely accepted, a change in 
provision of a Scottish-based regional musculoskeletal spinal service (adult 
population) has given rise for  the need  to include more specific red flag indicators 
or diagnostic screening for neck  related pain or functional impairment.   
 
Development of local clinical guidelines that included neck or cervical spine red flag 
screening focused around Coman’s (1986) 5Ds framework (dizziness, diplopia, 
dysarthria, dysphagia and drop attacks).  These clinical indicators are frequently 
quoted in physiotherapy literature regarding screening for signs and symptoms of 
vascular insufficiency, which have potential to develop as an adverse event, such as 
transient ischemic attack (TIA), stroke, or potentially death following treatment to the 
cervical spine.  Although such events are a rare occurrence, the outcome for both 
patient and carer are catastrophic. 
 
Discussions with a medical advisor (consultant neurologist) regarding the 
development of the regional guidelines identified that the 5Ds were not reliable 
indicators of serious cervical vascular pathology.  On reviewing the evidence base 
used to inform these discussions it became apparent that the information was 
extracted from physiotherapy-based literature. This literature was limited to clinical 
commentary or masterclass type publications (e.g. Kerry and Taylor 2006), which do 
however, use medical-based literature to inform their recommendations, and single 
case reports (e.g. Taylor and Kerry 2005).   
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Indeed, the medical advisor’s opinion on the limitations of the 5Ds framework is 
supported by a commissioned report (Kerry et al 2007).  However, this framework 
continues to be used within the physiotherapy evidence base, albeit with 
progressive development since its initial introduction following the publication of 
Coman (1986).   This process now includes additional clinical features (ataxia, 
nausea, numbness, and nystagmus) to form an extended framework known as the 
‘5Ds And 3Ns’.  
 
A literature review designed to investigate this framework and other neck related 
serious pathologies, such as cord compression, is explored in chapter 2.  This 
review identifies that a number of limitations and significant inconsistencies exist 
within the evidence base. 
 
Kerry and Taylor’s (2006; 2008) physiotherapy masterclass type publications 
demonstrate that improvements have been made within recent years by the 
physiotherapy profession to better understand serious pathology related to the 
cervical spine.  However, there appears to be a lack of high level observational 
evidence originating from the musculoskeletal physiotherapy-based journals to 
suitably inform physiotherapy practice.  In addition, no systematic reviews were 
identified that specifically examines cervical spine red flags for serious pathology. 
 
Therefore, this suggests that a knowledge gap remains in physiotherapy screening 
methods for musculoskeletal neck related problems with specific reference to local 
neurological and neurovascular pathology.  This presents a serious clinical problem 
where physiotherapists administering therapeutic intervention may be faced with 
patients presenting with early signs of stroke or who may be at risk of developing 
stroke through the presence of benign arterial pathology.  This scenario requires a 
high level of knowledge to detect potential serious pathology and prevent 
progression to an adverse event (Kerry and Taylor 2006; 2008). 
 
As stated earlier, red flags for back pain have been developed (CSAG 1994) and 
widely accepted, as exemplified through integration in more recent guidelines for low 
back pain (van Tulder et al 2006; NICE 2009).  Although the red flag list developed 
by CSAG (1994) contains components that apply to the whole spine, such as cancer 
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or infection, the uncertainty that exists for the cervical spine emphasises a need to 
review and develop the physiotherapy knowledge base for neck related red flag 
indicators.  
 
Aim 
The aim of this study is to develop an evidence based list of red flag indicators for 
neck related problems that would equate to, or complement, the list of red flags for 
back pain.  This screening process for early recognition of potentially serious 
neurological and neurovascular pathology could enhance safe application of 
treatment to meet quality ambitions, such as NHS Scotland’s (Scottish Government 
2010) quality strategy to deliver safe, effective and person centred care.  The key 
ambition behind this study is summarised in the following overarching research 
question to be addressed within this thesis: 
 
What pathologies, including their signs and symptoms and risk factors, should be 
considered as red flags when screening for serious pathology in neck related 
musculoskeletal disorders? 
 
This study is designed to combine a literature review with engagement from expert 
physiotherapists and medical consultants to develop a process that addresses the 
knowledge gap within this overarching research question.  
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Chapter 2. Literature Review 
 
2.1 Literature review methodology 
The Scottish Intercollegiate Guideline Network (SIGN) 
(http://www.sign.ac.uk/guidelines/fullt/50/index.html) methodology for conducting a 
literature review was adapted for use by a single reviewer.  Key question(s) are 
defined followed by a systematic review process involving a literature search for 
existing evidence based guidelines, systematic reviews and meta-analyses.  
Literature is graded according to the SIGN levels of evidence (section 2.1.1).  If 
sufficient evidence is not available to answer the specific question(s), then the 
literature search is expanded to include studies of quality as detailed within the 
inclusion criteria point 1 (Section 2.1.3). 
 
2.1.1 SIGN Guidelines: Levels of evidence    
(http://www.sign.ac.uk/pdf/sign50.pdf) 
1++ High quality meta-analyses, systematic reviews of Randomised Controlled 
Trials (RCTs), or RCTs with a very low risk of bias 
1+ Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of 
bias 
1 - Meta-analyses, systematic reviews, or RCTs with a high risk of bias 
2++ High quality systematic reviews of case control or cohort studies 
High quality case control or cohort studies with a very low risk of confounding or bias 
and a high probability that the relationship is causal 
2+ Well conducted case control or cohort studies with a low risk of confounding or 
bias and a moderate probability that the relationship is causal 
2 - Case control or cohort studies with a high risk of confounding or bias and a 
significant risk that the relationship is not causal 
3 Non-analytic studies e.g. case reports, case series 
4 Expert opinion 
 
2.1.2 Literature review search strategy 
The databases searched were EBSCO CINAHL, MEDLINE, and the Cochrane 
Library.  Searches were performed using a combination of key words (Refer to 
Appendix A for detailed search strategy and summary of selected studies used to 
inform the main literature review).  The search was reduced to include peer-
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reviewed articles with abstracts available and published in English from January 
2002 to October 2012.  In addition, the initial searches were supplemented by 
manually searching the reference sections in those studies retrieved from the initial 
search. 
 
Studies were selected to inform three phases of this project (Refer to chapter 3 for 
full details of phases).  The main function of the literature review within these three 
phases was for use in preparatory work for the following: 
 
a. Focus group information pack (within phase 1).  This included summaries of key 
studies used to inform the focus group discussion.  
b. To inform construction of a draft clinical chart (within phase 2) that would 
provide context of the clinical scenario for Delphi survey participants. 
c. To inform construction of the Delphi survey (within phase 3). 
 
(This work is discussed in chapter 3 alongside signposting to relevant appendices). 
 
Studies were selected on the basis of the inclusion/exclusion criteria as outlined in 
section 2.1.3, below. 
 
2.1.3 Inclusion criteria were as follows: 
1. Literature selected in  the following hierarchical order (Adapted from SIGN: 
http://www.sign.ac.uk/pdf/sign50.pdf): 
A: Guidelines, meta-analyses, systematic reviews. If evidence is not sufficient to 
address the questions under consideration, progress to B. 
B: Randomised control trials. If evidence is not sufficient to address the questions 
under consideration, progress to C and D. 
C: Case control or cohort studies. 
D: Non-analytic studies: Case series reporting 5 or more cases (Haneline and 
Lewkovich 2004).  
2. Studies describing signs, symptoms, clinical tests and/or risk factors for 
pathologies included in the research questions. 
3. Adults (≥16 years). 
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2.1.4 Exclusion criteria were as follows: 
1. Literature graded as lower level of quality: 
A: Case series of less than 5 cases (Haneline and Lewkovich 2004).  
B: Single case studies. 
C. Expert opinion. 
Note: Exclusions A-C may be used to provide supplementary statements within the 
literature review or to support areas within the clinical chart where studies meeting 
the inclusion criteria are considered to have limited supporting evidence.   
2. Literature not describing signs, symptoms, clinical tests and/or risk factors to 
answer the specific questions informing the literature search strategy. 
3. Paediatric (infants, children or adolescent <16 years) based studies. 
 
2.2 Literature review introduction 
In order to make a valid risk assessment prior to therapeutic intervention, knowledge 
development of haemodynamic principles, pathophysiology, risk factors and clinical 
signs of Cervical Arterial Dissection (CAD) are considered essential (Kerry and 
Taylor 2006; 2008). This presents a significant clinical challenge to clinicians as 
demonstrated by Rubinstein et al’s (2006) attempt to aid understanding and clinical 
reasoning of the pathogenesis of CAD through their theoretical model outlining 
major risk categories.  Although CAD can present initially with benign clinical signs 
and symptoms it is a major cause of stroke in young to middle age adults (35-50 
years of age), therefore, early recognition and appropriate management is of 
paramount importance (Leys et al 2002; Debette and Leys 2009).  This has added 
importance as there is a tendency for clinicians to believe that more gentle manual 
treatment techniques in neck pain are relatively risk free (Sweeney and Doody 
2010). This appears as a reasonable assumption; however, there is no empirical 
data to support this statement. 
 
Similarly, serious neurological conditions, such as cervical myelopathy (spinal cord 
compression) that may result from cervical spondylosis (degenerative spine) may 
present only after delayed diagnosis and operations for misdiagnosis e.g. carpal 
tunnel syndrome (Meyer et al 2008).  Cervical degenerative changes are the most 
likely cause of cervical myelopathy, however other considerations for differential 
diagnosis may include intracranial pathology, intradural tumour or syrinx, multiple 
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sclerosis, amyotrophic lateral sclerosis or Guillain Barre syndrome (Edwards et al 
2003).  Unfortunately, a delayed diagnosis could have a detrimental effect on an 
individual’s functional recovery e.g. gait, bladder control and hand function if not 
detected at an early stage (Meyer et al 2008).  Screening tests, therefore, are 
utilised to achieve early exclusion of selected diagnosis or impairments.  These 
should be cheap, relatively accurate and not cause further complications during their 
application (Cook et al 2007).   
 
The range of neurological and neurovascular presentations are too numerous to 
discuss in this review.  This literature review will rather briefly outline the 
epidemiology and pathogenesis of neurological and neurovascular complications or 
masqueraders linked with Coman’s (1986) 5D’s, as a screen for cervical arterial 
pathology, and other clinical presentations that create challenging differential 
diagnosis scenarios in musculoskeletal physiotherapy practice. Examples of such 
additional challenges are cervical myelopathy, headaches and dizziness 
presentations.  As stated in Chapter 1, dizziness forms part of the 5Ds.  Headaches 
and dizziness are included as they may feature as patient symptoms, but have 
multiple causes of onset, such as CAD or upper cervical spine dysfunction.  In 
addition, adverse events associated with clinical practice will be considered to 
provide context for this review.  Together, these highlight the significant clinical 
challenge of differential diagnosis and the requirement to consider a list of clinical 
features that would be considered as red flags for serious pathology. 
 
The review will examine two key areas; cervical arterial dysfunction and cervical 
myelopathy.  The review will specifically consider cardinal signs and symptoms, 
main risk factors (where applicable), including theoretical modelling that may 
contribute to the screening process, and relevant screening tests with an objective 
to identify any inconsistencies or gaps in the current knowledge base.  The findings 
will direct this research project, which has an overarching aim to support clinical 
decision making skills through developing appropriate screening methods for 
potential neurological and neurovascular conditions or complications presenting as, 
or parallel to, cervical spine musculoskeletal disorders.  
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2.3 Cervical arterial dysfunction (includes dizziness and headaches)  
2.3.1 Epidemiology and pathogenesis 
The cervical arteries are more vulnerable to injury compared to vessels of similar 
size as they are more mobile in the cervical spine (Schievink 2001). Spontaneous 
CAD (sCAD), which may involve the internal carotid artery (ICA) and/or vertebral 
artery (VA) can affect all age groups, but mainly affects young and middle-aged 
adults between the ages of 35-50 years (Schievink et al 1994; Schievink 2001). 
Community based studies in the USA and France have reported the annual 
incidence of spontaneous ICA dissection (sICAD) as 2.5 per 100,000 and 3 per 
100,000 per year (Schievink et al 1993; Giroud et al 1994).  The annual incidence of 
VA dissection (VAD) has been estimated to be 1-1.5 per 100,000 per year 
(Schievink 2001).  These ranges of incidence are probably an underestimation of 
CAD as cases with reduced clinical signs may remain undiagnosed (Debette and 
Leys 2009).   
 
A combination of an underlying arteriopathy and an additional factor, such as minor 
trauma is a probable mechanism of CAD onset (Schievink and Debette 2011). 
Thanvi et al’s (2005) review paper of CAD, however, questions the theory of an 
underlying arteriopathy as it does not explain specific sites of dissections, low 
recurrence rates, and rare cases of familial history of CAD.  Case control studies 
involving biopsies of CAD patients compared to patients free of vascular disease 
e.g. accident victims, identified signs of tissue weakening along the Tunica Media 
(middle layer) and Tunica Adventitia (outer layer) junction of the artery in all of the 
spontaneous CAD patients, but not in any of the control samples.  These findings 
suggest a generalised arteriopathy leading to haematoma formation.  This formation 
can be a source of somatic head/neck pain and can further cause arterial wall 
instability in sCAD patients, which can lead to dissection (tearing) (Volker et al 2005; 
2011). It is this mechanism that can result in stroke onset, which may be 
accompanied by additional symptoms, such as dizziness.  There are several 
limitations to Volker et al’s (2005; 2011) studies with low numbers, non-blinded 
investigators and the use of the superficial temporal artery as a surrogate (vessel 
representing a similar function) for the cervical arteries (Schievink and Debette 
2011).  In addition, these studies use autopsy samples used as controls (e.g. 
accident victims free of vascular disease) obtained from a separate European 
country.  This is acknowledged by the authors. 
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This presents a clinical problem of how to identify patients with an arteriopathy if 
they present to musculoskeletal clinics complaining of head and/or neck pain with or 
without associated symptoms, such as dizziness. Dizziness accounts for 
approximately 5% of reasons for attendance at primary care clinics and can be 
difficult to differentially diagnose from other conditions as the symptoms are 
frequently non-specific (Post and Dickerson 2010).  Therefore, a high level of clinical 
awareness is required to detect a potential CAD (Thanvi et al 2005; Greenhalgh and 
Selfe 2006; Kerry and Taylor 2006, 2008). 
 
2.3.2 Clinical presentation (cervical arterial dysfunction) – Background 
problem of ‘Classical’ cardinal symptoms and signs 
 
Rivett et al (2006 p.3) recommends: 
 “In every patient presenting with upper quadrant dysfunction, questioning is 
specifically directed to determine the presence of dizziness which is the most 
common presenting symptom of VBI. If dizziness is present, other symptoms 
associated with VBI should be sought…” 
 
No references are provided to support the cardinal signs and symptoms provided in 
Rivett et al (2006), which is a similar list referred to by Kerry and Taylor (2006 p.244-
245) as “Classically, signs and symptoms related to hindbrain ischaemia are 
considered as the “5 Ds And 3Ns” of Coman (Coman 1986)”.  This list is Dizziness 
(vertigo, giddiness, light-headedness), Drop attacks, Diplopia, Dysarthria, Dysphagia 
(+ hoarseness/hiccups), Ataxia, Nausea, Nystagmus, Numbness (unilateral).  
Coman’s (1986) list of cardinal signs and symptoms is not referenced.  Kerry and 
Taylor (2006), however, advise that unreasoned adherence to this list may result in 
an incomplete understanding of the patient’s presentation, and in a commissioned 
report, Kerry et al (2007) state there is no support for Coman’s 5 Ds. 
 
Table 2.1 summarises literature findings that questions the suitability of the 5D And 
3N framework as an appropriate screening aid in neck pain/headache presenting at 
physiotherapy musculoskeletal clinics. This further supports the medical advisor’s 
opinion as outlined in Chapter 1 (Introduction).     Kerry and Taylor (2006, 2008) and 
Kerry et al (2007), are the only authors to question the 5Ds And 3Ns framework 
through a literature review approach. 
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Table 2.1: Summary of background problem of ‘Classical’ cardinal symptoms and signs 
Reference Symptoms and signs Study authors’ 
comments 
Researcher comments 
Coman (1986) 5Ds  Book chapter. No 
supporting references. 
Grant (1994) 5Ds (Coman) plus 
visual disturbances, 
visceral and vasomotor 
disturbances (e.g., 
nausea, faintness, light-
headedness), perioral 
sensory changes 
Cite Coman 
(1986) and 
Williams and 
Wilson (1962). 
Book chapter. Williams and 
Wilson (1962) not 
available, but is reported as 
a review of 20 major and 
65 minor cases of basilar 
insufficiency. 
Magarey et al 
(2004) 
Vertigo (may be initial 
symptom), visual 
disturbances, diplopia, 
nausea/vomiting, 
dysarthria, dysphagia, 
hemiparesis/hemiplegia, 
drop attacks, ataxia 
Cite Grad and 
Baloh (1989 
cited by 
Clendaniel 
2000).   
Magarey et al (2004) is a 
physiotherapy masterclass 
type publication.  
Thiel and Rix 
(2005) 
5Ds And 3Ns 
framework.  
State ‘adapted 
from 
Sturzenegger 
(1993), Saeed et 
al (2000). 
Papers cited are small 
studies with patients 
presenting at neurological 
units with stroke. Mainly 
formed part of presenting 
features i.e. at 
development of stroke 
rather than early warning 
signs. 
Rivett et al 
(2006) 
Similar to 5Ds And 3Ns.  Clinical guidelines. No 
references for these signs 
and symptoms. 
Kerry and 
Taylor (2006) 
5Ds And 3Ns - Unreasoned 
adherence may 
result in an 
incomplete 
understanding  
Masterclass type 
publication. 
Greenhalgh 
and Selfe 
(2006) 
Variation of the above. Cite Magarey et 
al (2004) and 
Grant (1994). 
Greenhalgh and Selfe 
(2006) is a guide book for 
physiotherapists on serious 
spinal pathology. 
Kerry et al 
(2007) 
Coman’s 5Ds. No support for 
5Ds. 
Commissioned review. 
Conclusion: It is therefore questionable whether the 5D And 3N framework is an appropriate 
screening aid in neck pain/headache presenting at a physiotherapy musculoskeletal clinical setting. 
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Furthermore, Debette, Grond-Ginsbach et al’s (2011) large multicentre prospective 
study presents differential features of carotid and vertebral artery dissections.  
Unfortunately, this report does not offer specific detail on aspects of pain 
presentation or ischemic signs that may aid musculoskeletal physiotherapists in their 
identification of such pathologies.  In addition to the uncertainties suggested above 
with regards to the 5Ds And 3Ns framework, this recent study highlights the difficulty 
in establishing patterns of presenting features to assist physiotherapy clinical 
decision making.   
 
2.3.3 Clinical presentation (cervical arterial dysfunction) – Literature review for 
‘Classical’ cardinal symptoms and signs 
A systematic review process was used to investigate the signs and symptoms 
relative to the 5D And 3Ns framework and ascertain if this framework is a 
reasonable clinical approach for identifying possible serious neurovascular 
pathology.  To enhance clarity of discussion the local symptoms of neck pain, 
headache, and tinnitus are addressed separately in section 2.3.5. 
 
In addition to headache and neck pain, Thomas et al’s (2011) retrospective case 
control study of a younger patient group (<55-years) comparing cervical arterial 
dissection cases with non-dissection causes of stroke identified the following 
symptoms and signs: 
 
“Symptoms: Dizziness, visual disturbance, paraesthesia (face, upper and 
lower limb). 
 
Signs: Unsteadiness/ataxia, weakness upper and lower limb; 
dysphasia/dysarthria/aphasia, facial palsy, ptosis (Horners sign), 
nausea/vomiting, dysphagia, drowsiness, confusion, and loss of 
consciousness” Thomas et al (2011 p.355). 
 
In general, visual disturbances were reported, however, observations of nystagmus 
was rarely recorded.  Ataxia or balance problems were quite frequent in the VBAD 
group (18:67%) and in less than half of ICAD cases (9:45%). 
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This study was designed for the purpose of informing clinical practice of manual 
therapists e.g. physiotherapists, therefore it is useful to have symptoms and signs 
separated.  As a retrospective study, it is however, vulnerable to bias.  The authors 
acknowledge that medical records are not always detailed and that negative 
responses to questions in the history may not always be recorded.  Thomas et al 
(2011) also observed that details of blood results and radiological imaging were 
sometimes limited. 
 
Vertebrobasilar ischemia typically presents with a collection of symptoms and signs, 
such as motor or oculomotor signs, and rarely causes only one symptom (Savitz 
and Caplan 2005).  Savitz and Caplan’s (2005) review paper is linked to Caplan et 
al’s (2004) large prospective study (n=407) in which <1% of patients with 
vertebrobasilar ischemia had only one presenting symptom or sign.  Frequent 
symptoms of vertebrobasilar-artery occlusive disease are dizziness, vertigo, 
headache, vomiting, double vision, loss of vision, ataxia, numbness, and weakness 
with bilateral body structure involvement (Savitz and Caplan 2005).  These features 
support Thomas et al’s (2011) retrospective observations.  Savitz and Caplan 
(2005), however, also state that dizziness and drop attacks are often incorrectly 
apportioned to posterior-circulation (vertebral artery) ischemia.   Pelkonen et al 
(2004) in reporting on pulsatile tinnitus also reported that dysgeusia (taste 
disturbance) was observed in two cases (from 16 pulsatile tinnitus cases).  
Dysgeusia is not mentioned by Thomas et al (2011) or Savitz and Caplan (2005). 
 
Bassi et al’s (2003) prospective study (n=49) of arterial dissections mainly 
spontaneous in nature, reported local neurological manifestations were present in 
15 patients (30.6%): this represents less than one-third of patients.  The majority of 
patients (41:83.6%) had ischemic cerebral symptoms.  No specific detail is provided 
on the latter.  Eighty per cent of strokes are ischemic with one-quarter of ischemic 
events being apportioned to posterior (vertebrobasilar) circulation (Savitz and 
Caplan 2005).   
 
Debette, Grond-Ginsbach et al’s (2011) large multi-centred prospective study sub-
divides cerebral ischemia into four components:  a. Ischemic stroke;   b. TIA;   c. 
transient monocular blindness; and, d. Subarachnoid haemorrhage. Ischemic 
cerebral symptoms are reported as the main presenting complaint in a number of 
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patient-centred studies of varying levels of quality (Chaves et al 2002; Dziewas et al 
2003; Arnold, Bousser et al 2006; Lee et al 2006; Chandra et al 2007; Huang et al 
2009; Gui et al 2010). The nature of these ischemic components suggests that the 
majority of patients presented with more severe signs and symptoms that are very 
unlikely to present at musculoskeletal clinics. 
 
Drop attack also forms part of the 5Ds.  Savitz and Caplan (2005) reporting on 
Caplan et al (2004) identified that no episodes of drop attack occurred in isolation 
within this large study (n=407).  Savitz and Caplan (2005) consider that weakness of 
the legs is more likely to be persistent if caused by brain-stem ischemia with its 
affect on corticospinal tracts and motor control of the legs. This questions the 
rationale behind drop attacks being included within the 5Ds And 3Ns framework for 
identifying vertebrobasilar insufficiency.  Similarly, loss of consciousness is more 
likely related to seizures and syncope (a faint) than cerebrovascular disease. 
 
Thomas et al (2011) additionally reported the signs of ptosis (Horner’s 
sign/syndrome), facial palsy and upper and lower limb weakness were the most 
common signs in ICAD (anterior circulation system).  This supports Baumgartner et 
al (2001) who identified the main significant local signs in ICAD without ischemic 
development (n=55) was Horner’s syndrome and lower cranial nerve palsies.  Ptosis 
or Horners sign/symptom or oculosympathetic palsy was reported in approximately 
25-30% of cases (Bassi et al 2003; Dziewas et al 2003; Lee et al 2006).  Ptosis or 
Horners sign and facial palsy, however, are not included in the 5Ds And 3Ns 
framework.  Within the literature there appears to be an interchangeable use of the 
terms ptosis, Horner’s syndrome and Horner’s sign (drooping eyelid).  
 
2.3.4 Dizziness 
Dizziness is a symptom within the 5Ds And 3Ns framework.  The term ’dizziness’ 
may also encompass light headedness, a lack of mental clarity or frank vertigo, and 
is reported to be a frequent symptom of vertebro-basilar-artery occlusive disease 
(Savitz and Caplan 2005).  Tarnutzer et al (2011) similarly use the term dizziness to 
encompass vertigo, presyncope, unsteadiness, and other non-specific forms of 
dizziness.  However, of note, is Bhattacharyya et al’s (2008) interchangeable use of 
the terms dizziness and vertigo, and may mention light-headedness alongside these 
terms within their clinical practice guideline for Benign Paroxysmal Positional Vertigo 
(BPPV). This inconsistency in use of terminology highlights a further potential 
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source of confusion for physiotherapists in attempting to improve their differential 
diagnosis knowledge of peripheral and central causes of dizziness. 
 
Savitz and Caplan (2005) consider that vertigo indicates dysfunction of the 
peripheral vestibular or central vestibulocerebellar system.  This is significant as 
Tarnutzer et al’s (2011) systematic review reports that vertebrobasilar ischaemic 
stroke may closely mimic peripheral vestibular disorders, with obvious focal 
neurologic signs absent in greater than half of patients presenting with acute 
vestibular syndrome due to stroke.  
Furthermore, Thomas et al (2011) identify that dizziness is often emphasised as a 
primary clinical indicator of vertebrobasilar flow insufficiency (e.g. Rivett et al 2006; 
Maitland 2005 in Thomas et al 2011). However, Thomas et al’s (2011) retrospective 
case control study revealed that dizziness presented in only 32% (15) of total 
dissection cases versus 7% (3) of non-dissection cases.  This study is based within 
a specialty setting.  Bhattacharyya et al’s (2008) clinical guidelines reports that 
evaluation of patients presenting with vertigo in a non-specialty setting found that  
BPPV and vestibular neuritis, accounted for most of the cases with 42% and 41%, 
respectively.  The remaining causes were apportioned to Ménière’s disease (10%), 
vascular causes (3%), and other causes (3%). 
Missed diagnosis of stroke at first medical contact within emergency departments is 
often linked to dizziness with 35% of cerebrovascular events in patients with any 
dizziness and 44% in those with isolated dizziness reported to be have been missed 
at this stage (Tarnzutzer et al 2011).  The authors add that available data suggests 
that patients with misdiagnosis are at particularly high risk of poor outcomes.  This 
emphasises the requirement for accurate screening for potentially serious pathology 
that may present at musculoskeletal physiotherapy clinics.   
Vertebral-artery disease can cause transient attacks of vertigo; however, this is 
usually accompanied by other brain-stem or cerebellar symptoms. Light-
headedness typically indicates presyncope related to circulatory, systemic, or 
cardiac disease rather than vertebral artery disease (Savitz and Caplan 2005).  
Savitz and Caplan’s (2005) review following Caplan et al’s (2004) posterior 
circulation registry  (n=407) observed that isolated episodes of vertigo continuing for 
more than three weeks was almost never caused by vertebrobasilar disease, and 
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that only 7% (of n=407) described light-headedness.  No patients presented with 
light-headedness as an isolated symptom.  This type of information may help guide 
differential diagnosis at first point of contact.  These relatively low numbers 
questions the accuracy of using the symptom of dizziness as a primary indicator of 
cervical arterial pathology and perhaps the focus should be on a combination of 
symptoms/signs.  Caution, however, should be exercised if focusing on a 
combination of symptoms/signs as demonstrated by the earlier report of Tarnutzer 
et al’s (2011) systematic review identifying that missed diagnosis of stroke at first 
medical contact within emergency departments is often linked to dizziness.   
 
As previously mentioned, Savitz and Caplan (2005) consider that vertigo indicates 
dysfunction of the peripheral vestibular or central vestibulocerebellar system.  BPPV 
is a peripheral vestibular dysfunction.  Clinical practice guidelines have been 
developed for BPPV that include guidance on diagnosing and differentiating 
peripheral and potential central neurological causes for dizziness (e.g. migraine-
associated vertigo, vertebrobasilar insufficiency, and intracranial tumors), as central 
causes may have more serious medical implications.  This presents a significant 
clinical challenge for differential diagnosis (Bhattacharyya et al 2008).  
Bhattacharyya et al (2008) outline other less serious or self limiting causes for 
differential diagnosis are; otological (e.g. Meniere’s disease, vestibular neuritis or 
labyrinthitis), and other entities (e.g. Anxiety or panic disorders, cervicogenic vertigo, 
medication side effects, and postural hypotention).  
 
Two systematic reviews were identified that considered differential diagnosis of 
peripheral and central causes of dizziness (Dros et al 2010; Tarnutzer et al 2011).   
 
Dros et al (2010) conducted a systematic review with a clearly defined question and 
methodology to investigate tests used to evaluate dizziness in primary care to 
determine differentiation between self limiting conditions and serious conditions 
requiring referral or immediate treatment.  Most musculoskeletal physiotherapy 
clinics, including those sited within hospitals, are likely to operate in a primary care 
format e.g. accepting General Practitioner or self-referrals in addition to those 
generated from medical consultant sources.  Therefore these systems require 
careful consideration to their clinical ability to diagnose dizziness within primary care 
settings. 
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Dros et al (2010) report four tests for neuro-otologic conditions that were evaluated 
in more than one study: a. Dix-Hallpike manoeuvre; b. Head-shaking nystagmus 
test; c. Head impulse test; and d. Vibration-induced nystagmus test. This review 
concluded the following: 
 
1. “Studies on diagnosing dizziness have been conducted in highly selected 
homogeneous groups of patients only e.g. within secondary care.  
Secondary care settings are likely to have higher prevalence rates and 
severity of conditions compared to primary care due to it receiving specific 
conditions” (p.E621); 
 
2. “Evidence to support the diagnostic process in primary care is scarce” 
p.E621). Studies were not diagnostic or of poor methodological quality, and; 
 
3. Two tests (head-shaking nystagmus and head impulse tests) however, 
differed to this report.  Dros et al (2010 p.E630) report that these two tests 
demonstrated a similar prevalence of peripheral vestibular dysfunction in 
primary care based patients complaining of dizziness when compared to 
other target groups.  
 
Tarnutzer et al’s (2011) systematic review similarly considered the differential 
diagnosis of an acute peripheral vestibular syndrome and stroke. 
 
“A three-component bedside oculomotor examination – HINTS (horizontal 
head impulse test, nystagmus and test of skew) is reported to identify stroke 
with high sensitivity and specificity in patients with acute vestibular syndrome 
and rules out stroke more effectively than early diffusion-weighted MRI in the 
acute phase” (Tarnutzer et al’s 2011 p.1025). 
 
These findings are encouraging.  However, clinicians also need to consider if these 
tests are appropriate for non-medical musculoskeletal clinical settings. 
 
Dros et al (2010) provide web-links to the tests covered in their study.  On review, 
clinical experience suggests that these tests (head-shaking nystagmus and head 
impulse tests) are too aggressive to perform on a patient complaining of neck pain.  
  17 
Furthermore, if from a musculoskeletal screening perspective the aim is to exclude 
potentially serious pathology then the application of vigorous tests has potential to 
prematurely progress a dissecting artery.  Tarnutzer et al (2011) recommends that 
no provocative tests, including the gentler Dix-Hall pike test, should be applied in an 
acute setting.   
Tarnutzer et al’s (2011) systematic review is primarily aimed at establishing 
differential diagnosis of acute vestibular syndrome of peripheral cause from a central 
cause.  Acute vestibular syndrome typically presents with dizziness onset of 24-48 
hours, rather than the shorter transient dizziness as seen in other conditions e.g. 
TIA, BPPV.   
Tarnutzer et al (2011 p.1031) conclude: 
“Red flags for stroke probably include a history of multiple transient 
prodromal episodes of dizziness over weeks or months; auditory symptoms; 
and headache, neck pain or recent trauma. Best evidence suggest that 
nearly two-thirds of patients with stroke lack focal neurologic signs that would 
be readily apparent to a non-neurologist and one-third lack signs that would 
be readily apparent to a neurologist”. 
It is highly unlikely that acute vestibular patients may present at a physiotherapy 
department.  However, as it aims to differentiate from a central cause, the 
information on the central type presentations has potential for extraction for clinical 
use by non-medical musculoskeletal clinicians.   
 
2.3.5 Pain (Background problem and cervicogenic headache) 
Cervicogenic headache is considered a disorder that is manageable by the physical 
therapies (Jull 1997). This disorder has been recognised by the International 
Headache Society (IHS 2004).  Part of the criteria referred to by the IHS is pain 
referred from a source in the neck and felt in one or more regions of the head and/or 
face.  Differential diagnosis of cervicogenic headache, however, can be difficult to 
separate from other causes of headache unless additional features are presented. 
Some physiotherapy studies have attempted to address this differential diagnosis 
problem by comparing examination findings in headache groups of cervicogenic and 
migraine with aura, and asymptomatic controls and have identified upper cervical 
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spine mechanical dysfunction (Zito et al 2006; Ogince et al 2007).  The most crucial 
differential diagnosis is headache from CAD due to the heightened risk of adverse 
events with potentially near fatal consequences following manipulation (Bogduk and 
Govind 2009).   
 
An additional problem with headache differentiation is that neurologists differ in their 
agreement of cervicogenic headache as having a nosological identity making the 
concept of cervicogenic headache controversial (Leone et al 1998; Zhou 2008; 
Bogduk and Govind 2009).  This adds greater complexity to clinicians navigating 
their clinical reasoning processes when a patient presents complaining of neck pain 
and headache.   
 
2.3.5.1 Pain (Overview - Cervical arterial dysfunction)  
Neck pain and/or headache symptoms are the most frequent local symptoms of 
CAD (Silbert et al 1995; Savitz and Caplan 2005; Taylor and Kerry 2005;  Arnold, 
Cumurciuc et al 2006; Kerry and Taylor 2006; Chandra et al 2007; Hardmeier, 
Gobbi et al 2007; Morelli et al 2008; Rigamonti et al 2008; Tobin and Flitman 2008; 
Thomas et al 2011), and additionally, can be the only presenting symptoms 
(Biousse et al 1992; Biousse et al 1994; Guillon et al 1998; Arnold, Cumurciuc et al 
2006).  Furthermore, VAD has also been reported as presenting as a fifth cervical 
nerve root (C5) radiculopathy (Arnold, Bousser et al 2006; Hardmeier, Haller et al 
2007).  Note, Rivett et al (2006) stated that dizziness was the most frequent 
symptom.   However, they also advise to check for presence of neck pain or 
headache.  Savitz and Caplan (2005) state that the cardinal symptom in patients 
with vertebral dissections is occipital or posterior neck pain with diffuse headache 
also occurring; however, no supporting data is presented.  Savitz and Caplan’s 
(2005) review paper is linked to Caplan et al’s (2004) large prospective study (stroke 
registry). 
 
For VBI, Rivett et al (2006 p.3) cite Haldeman et al (2002) and Krespi et al (2002) to 
add that pain is “Specifically, sudden, severe, sharp pain located in the ipsilateral 
postero-superior region of the neck and occiput and for which there is no past 
history should be regarded as suspicious”.  This does not include ICAD. Kerry and 
Taylor (2006) describe acute onset neck pain/headache as “unlike any other”, but 
are these patterns and distributions definitive in CAD? 
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In considering clinical recommendations (e.g. Rivett et al 2006; Kerry et al 2007), 
Thomas et al (2011) noted that headache was not always present or severe in either 
VBAD or ICAD subjects.  However, headache was more prevalent in VBAD (85%) 
and ICAD (75%) subjects when compared to an age-matched control group of non-
dissection stroke patients (51%).  This latter point differs to Debette et al (2011) who 
reported that headache was more prevalent in ICAD > VAD, which supports 
Chandra et al’s (2007) small retrospective study (n=20) reported the most common 
symptom on presentation in both SCD and SVD patients was headache (83% SCD, 
78% SVD). 
 
Thomas et al (2011) and Debette, Gronsbach et al (2011), however, both reported 
that neck pain was more likely in VBAD than ICAD subjects.  Neck pain and 
headache are symptoms that can present at musculoskeletal clinics without prior 
attendance at a medical practitioner, or could be the reason for referral from the 
medical practitioner.  Therefore, more specific detail of description and pattern of 
such pain presentations may assist in the differential diagnosis of more serious 
causes. 
 
2.3.5.2 Neck pain and headache in cervical arterial dysfunction (patterns and 
characteristics) 
Arnold, Cumurciuc et al (2006) examined cases of sCAD that presented with pain 
only (without additional neurologic manifestations).  By using a hospital-based 
registry 20 from 245 patients (8%) mean age 39-years (±8) were identified. Six 
patients presented with headache only, 2 with neck pain only, and 12 with both.  
Twelve had VAD, 3 had ICAD and 5 had multiple dissections.  There was no clear 
pattern of headache and neck pain characteristics. This supports Silbert et al (1995) 
and Biousse et al (1994) who considered varying descriptors of pain: distribution, 
mode of onset, quality and evolution (constant or intermittent). 
 
Silbert et al (1995) specifically studied the characteristics of headache in 161 
consecutive patients presenting at the same location.  The mean age of ICAD 
patients (n=135) and VAD (n=26) was 47 years and 40.7 years, respectively.  
Biousse et al (1994) investigated pain in non-traumatic ICAD patients (n=65 mean 
age: 43-years range 14-67) headache was the presenting symptom in 38 (58.5%) 
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and present at any point throughout the duration in 48 patients (74%).  Facial pain 
and neck pain also presented independently as the initial symptom and a 
combination of all three was present in 17% of patients (Biousse et al 1994).   No 
clear pattern was demonstrated in CAD related head and neck pain. 
 
Chaves et al’s (2002) report on 10 cases identified that 9 had a stroke (1 had an 
associated subarachnoid hemorrhage), whereas 1 patient had only transient 
ischemic attacks. Severe headache (usually retro-orbital, frontal and/or temporal) 
followed by contralateral hemiparesis was the most common initial clinical 
symptoms (80%). Although this pain was severe in all cases, the distribution is not 
specific.  Bassi et al (2003) reported headache and neck pain occurred in 32 
patients (65.3%), and Lee et al (2006) retrospective study (n=48) reported the 
occurrence of neck pain in 13 (27%) and headache in 33 (69%).  Unfortunately, no 
information on pattern, distribution or temporal components is provided. 
 
In contrast, Huang et al’s (2009) retrospective study (n=73) identified 22 (55%) had 
accompanying headache and/or neck pain lateralized to the dissection side. This is 
supported by a small case series (3 male/4 female age range 35-79 mean +/- 16.2 
years: 6VAD, 1 ICAD) that reported all except one had a unilateral distribution of 
headache or neck pain only (Maruyama et al 2012).  Huang et al (2009) also 
describe pain in patients presenting with sub-arachnoid haemorrhage (SAH) as 
intense and lateralized to the dissection side.  Gui et al’s (2010) prospective study 
over a 6 year period reported serious parieto-occipital pain with symptoms of 
posterior-circulation ischemia were the most common manifestations in 10 cases 
(63%).  Headache was the initial symptom in 8 patients (53%).  One patient had 
SAH.  However, patients with SAH and acute unilateral hemiparesis are highly 
unlikely to present at musculoskeletal clinics. 
 
Silbert et al (1995) reported  65 of ICAD patients considered their headache as 
’unique’ but 45 did not consider a significance difference to previous experience of 
headache.  This does not support Kerry and Taylor’s (2006) statement as having 
headache “unlike any other”.   Cases of CAD presenting with pain only may be 
under-diagnosed, particularly if it presents similar to previous episodes of pain 
(Biousse et al 1992; Mirza et al 1998; Arnold, Cumurciuc et al 2006).  Silbert et al 
(1995) also reported that 132 from 135 ICAD patients had accompanying focal 
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neurological manifestations. Only three had headache only, with/without neck or 
facial pain. Additionally, Silbert et al (1995) report from 135 ICAD patients, 35 (26%) 
had neck pain at time of dissection with gradual onset in 25 patients and sudden in 
7.  Neck pain was the first symptom in only 9 patients. 
 
These studies suggest there is no clear pattern of headache or neck pain that may 
occur in either VAD or ICAD and demonstrates inconsistency in literature reporting 
pain presentations related to CAD.   These studies typically use a retrospective 
and/or prospective methodology.  For example, Biousse et al (1994) utilises a 
combined methodological approach with retrospective recording to 1988 followed by 
a prospective method to 1990.  Silbert et al (1995) specifically studied the 
characteristics of headache in CAD and provide a sound description of a follow-up 
direct interview with patients, unless a detailed history of the headache according to 
diagnostic criteria set by the International Headache Society (1988) was recorded by 
the neurologist. 
 
The study by Debette, Grond-Ginsbach et al (2011) is a high quality large 
prospective study that reports presenting differential features of carotid and vertebral 
artery dissections.  No specific detail on pattern, distribution or temporal aspect of 
pain presentation is provided. This study highlights the difficulty for physiotherapists 
in establishing patterns of presenting features to assist clinical decision making 
processes.  In addition, patients are recruited through large neurological centres that 
are unlikely to receive patients with local signs, or mild cerebral or retinal ischemia, 
the type of clinical picture which is more likely to present at a musculoskeletal 
physiotherapy clinic.   
 
Furthermore, the literature suggests if clinicians focus solely on either the anterior or 
posterior circulatory system, rather than consider the cervical arteries as a group 
e.g. Rivett et al’s (2006) guidelines (refer to section 2.3.2) highlighting occipital or 
posterior neck pain with VBI (posterior circulation), then there is a possibility that an 
ICAD could be undetected if the patient presents with pain in other regions, such as 
temporal or retro-orbital pain. 
 
As previously stated, Debette, Grond-Ginsbach et al (2011) and Thomas et al 
(2011) report neck pain is more likely in VAD, but both reports differed with regards 
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to headache.   However, from a physiotherapy clinical perspective it is questionable 
if this information is relevant to musculoskeletal clinical decision making.  Clinical 
experience suggests that it would be too difficult for a physiotherapist to be able to 
differentiate between these two arteries, unless additional advanced practice 
training was received.  It may therefore be a reasonable suggestion that 
physiotherapists should focus solely on whether the presence of a serious arterial 
pathology exists, rather than trying to further complicate the examination by 
attempting to ascertain which of the cervical arteries is in a dysfunctional state. This 
additional information is unlikely to alter the clinician’s subsequent management i.e. 
refer on to a medical specialist.  One counter argument to this suggestion is that this 
additional information may assist the specific targeting of any further investigations 
e.g. Duplex ultrasound.   
 
2.3.5.3 Headache – red flags 
The Scottish Intercollegiate Guideline Network (SIGN) Guideline 107 Diagnosis and 
management of headache in adults is a national (NHS Scotland) clinical guideline.   
Guideline 107 states that secondary headache (i.e. headache caused by another 
condition other than a primary cause) should be considered in patients presenting 
with new onset headache or headache that differs from their usual headache. 
 
In addition, observational studies have highlighted the following warning signs or red 
flags for potential secondary headache which requires further investigation: 
 
Red flag features (SIGN Guideline 107): 
 “new onset or change in headache in patients who are aged over 50 
 thunderclap: rapid time to peak headache intensity (seconds to 5 mins) 
 focal neurological symptoms (e.g. limb weakness, aura <5 min or >1 hr) 
 non-focal neurological symptoms (e.g. cognitive disturbance) 
 change in headache frequency, characteristics or associated symptoms 
 abnormal neurological examination 
 headache that changes with posture 
 headache wakening the patient up (NB migraine is the most frequent cause 
of morning headache) 
 headache precipitated by physical exertion or valsalva manoeuvre (e.g. 
coughing, laughing, straining) 
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 patients with risk factors for cerebral venous sinus thrombosis 
 jaw claudication or visual disturbance 
 neck stiffness 
 fever 
 new onset headache in a patient with a history of human immunodeficiency 
virus (HIV), infection 
 new onset headache in a patient with a history of cancer” (SIGN 107 p.9). 
 
SIGN guideline 107 outlines what clinical evaluation should take place e.g. 
neurological testing including cranial nerve testing and fundoscopy.  Cranial nerve 
testing is advocated by a small number of physiotherapy based publications (Taylor 
and Kerry 2010; Thomas et al 2011). Unfortunately, clinical observation suggests 
that cranial nerve testing is not routinely utilised within physiotherapy and 
fundoscopy is a medical based skill.  Therefore, physiotherapists would benefit from 
additional medical guidance as to what specific features should be considered as 
being a potential indicator of serious pathology, relative to a musculoskeletal clinic 
setting.  For example, thunderclap type headache is a medical emergency that will 
not typically present at a musculoskeletal clinic.   
 
2.3.5.4 Pulsatile tinnitus 
Pulsatlie tinnitus is almost exclusively related to the sound of non-laminar blood flow 
transmitted to the inner ear occurring from alteration in haemodynamics e.g. arterial 
dissection, systemic disease, or local disorders within or in close proximity to the 
petrous bone (Pelkonen et al 2004).   Pulsatile tinnitus presented as a symptom in 
16 patients within a prospective study (n=136; Pelkonen et al 2004).  Ten cases 
presented with subjective (only heard by the patient), 5 with objective tinnitus 
(audible to auscultation) and 1 case of it being the only presenting symptom. In one 
additional case reported within this study, pulsatile tinnitus in a patient with bilateral 
ICAD was reported to have occurred 3-months after initial symptoms occurred 
(Pelkonen et al 2004). Pelkonen et al (2004) also reported that 12 patients had 
headache, 1 with headache and neck ache, and 1 patient with neck ache.  Arnold, 
Bousser et al (2006) and Dziewas et al (2003) also reported tinnitus occurring in a 
small number of patients 7 (5%) and 8 (6%), respectively.   This symptom is not 
included within the 5Ds And 3Ns framework. 
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2.4 Temporal aspects 
One additional consideration should be given to the temporal aspect of pain onset to 
additional manifestations in CAD, which could significantly aid physiotherapists’ 
clinical decision making knowledge.  This has been reported as a mean 8.8 days 
delay in ICAD patients and mean 12-day delay in VAD patients (Silbert et al 1995) 
and from several minutes to 1-month (Mas et al 1987; Biousse et al 1995).  Biousse 
et al (1995) reported ≤7 days in 82% of cases.  Gui et al (2010) reported neurologic 
deficits with the onset of sVAD, and symptoms of posterior-circulation ischemia were 
apparent within 4 days of onset of headache (n=14, 88%).  Dziewas et al (2003) 
reported that 75 (78 %) of patients with stroke reported preceding warning 
symptoms with 54 patients (56 %) recognising symptoms only minutes prior to the 
onset of stroke, whereas 42 patients (44 %) noticed between 12 hours and 14 days 
(median 3 days) before the onset of stroke.  Similarly, Chaves et al (2002) reported 
that neurological signs occurred in most patients (9: 90%) immediately after severe 
headache (usually retro-orbital, frontal and/or temporal). 
 
With regards to pain duration, Biousse et al (1994) reported  all pain had resolved in 
less than 30 days: Headache had a duration of 90-minutes to 30-days (mean 5.4 
days ± 7.5); neck pain duration from 1-13 days (mean 5.9 ± 4.3); and facial pain 
lasted 2-hours-15-days (mean 5.3 ± 5.8-dyas). Arnold, Cumurciuc et al (2006) 
reported all pain resolved within 3-months.   
 
The publications in section 2.3-2.4 referring to signs and symptoms, such the ‘5Ds 
And 3Ns framework’, including dizziness and headache presentations highlights the 
difficulty physiotherapists face in clinic when considering differential diagnosis.  This 
creates the question of what subjective (questioning) and objective procedures e.g. 
cranial nerve testing, should musculoskeletal practitioners use to support awareness 
of detecting more subtle aspects of neurological change in order to prevent 
occurrences of an adverse event?  
 
2.5 Adverse events (AE) associated with physical therapies 
Identifying AE associated with treatment of neck pain in adults has been problematic 
due to low quality data in clinical trials and lack of agreement on standardised AE 
terminology (Carlesso et al 2010).  Ernst’s (2007) systematic review, however, 
concluded that spinal manipulation was frequently associated with mild-moderate 
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AE and can result in more serious events such as VAD. This is highlighted by Lee et 
al (1995) who surveyed California, USA based neurologists to gain an estimation of 
adverse neurological complications following chiropractic manipulation over a 2-year 
period. From 177 (29%) responses: 55 strokes (1 death), 16 myelopathies and 30 
radiculopathies were reported, most of which involved the cervical spine.  Despite 
limitations to this survey, such as it being questionnaire based without validation of 
the clinical details provided by the respondents, it nonetheless highlights the serious 
nature of such events.  However, defining AE in the physical therapies to enable 
consistent reporting has proven difficult without context and detail (Carnes et al 
2010). 
 
More recently, Sweeney and Doody’s (2010) postal-survey of Manipulative 
Physiotherapists (n=127) in Ireland to determine the use of cervical spine manual 
treatment and to describe adverse events associated with these interventions 
reported the most serious adverse events were associated with more gentle non-
manipulation techniques.  These included one TIA, one fainting, and one drop 
attack.  There was moderate use of vertebro-basilar insufficiency (VBI) functional 
screening tests as outlined by Rivett et al (2006). However, of the 26% (n=33) of 
respondents that experienced an adverse event, 24% (n=8) had conducted VBI 
testing, whilst 58% (n=19) did not conduct testing.  This questions the validity of 
functional screening tests (section 2.6) as outlined by Rivett et al (2006). 
 
2.6 Clinical tests, functional screening tests, and blood flow studies 
Rivett et al (2006) published evidence-based guidelines for assessment of VBI prior 
to the application of manipulation and mobilisation of the cervical spine, which 
include provocative testing for patients who report symptoms associated with VBI 
(e.g. dizziness) during the subjective examination (refer to sections 2.3.3-2.3.4).  It is 
hypothesised that a mechanically induced stress on the VA causing altered blood 
flow with decreased perfusion to the brainstem will initiate VBI signs and symptoms 
(Westaway et al 2003). Thiel and Rix (2005) question the continued use of 
functional pre-manipulation testing of the cervical spine as it could cause added 
arterial compromise to an underlying vascular pathology resulting in an AE.  As 
stated earlier, screening tests should not cause further harm (Cook et al 2007). 
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Provocative functional testing, as outlined by Rivett et al (2006), consists of end-of-
range cervical/neck rotation held for a minimum 10 seconds, simultaneously 
examining the eyes for nystagmus and checking for any additional symptoms.  
Rivett et al (2006) further suggest that symptoms of dizziness provoked by cervical 
spine causes can be differentiated from a vestibular cause by trunk rotation 
sustained and moving, whilst keeping the head steady.  Also, from a physician’s 
perspective, Post and Dickerson (2010) report that differential diagnosis of dizziness 
can be narrowed down with clinical tests, such as evaluating for nystagmus, Dix-
Hallpike manoeuvre (a positional test for the vestibular system) and orthostatic 
blood pressure testing, but 20% of cases will remain undiagnosed beyond these 
tests.  Bhattacharyya et al (2008) suggests several clinical features may suggest a 
central cause of vertigo rather than BPPV, one of which is nystagmus.   Nystagmus 
may occur in both peripheral and central causes of vertigo.  The latter is more 
strongly suggested if; down-beating nystagmus on the Dix-Hallpike manoeuvre, 
direction-changing nystagmus occurring without changes in head position (i.e. 
periodic alternating nystagmus), or baseline nystagmus manifesting without 
provocative manoeuvres 
 
These tests could be used by physiotherapists, with the Dix-Hall pike manoeuvre in 
particular being utilised by clinicians specialising in managing dizziness caused by 
vestibular dysfunction. Evaluation of nystagmus, however, requires a high level of 
interpretative skills (Patten 1998).   Patten (1998) states that “the importance of 
testing nystagmus correctly and recording the quality, direction and other features is 
not sufficiently appreciated……can demonstrate poor clinical technique and a failure 
to distinguish this from a true physical sign” (p.103). 
 
Additionally, Rivett et al’s (2006) statement oversimplifies the clinical scenario of 
differential diagnosis for causes of dizziness when compared to Newman-Tolker et 
al’s (2008) cross sectional analysis investigating the spectrum of dizziness visits to 
United States Emergency Departments.  A total of 9472 dizziness cases over a 13-
year period were grouped into the following diagnostic categories of dizziness: 
otologic/vestibular (32.9%), cardiovascular (21.1%), respiratory (11.5%), neurologic 
(11.2% including cerebrovascular/stroke), injury/poisoning (10.6%), psychiatric 
(7.2%), digestive (7.0%), genitourinary (5.1%), and infectious (2.9%).  Although 
these were acute onset cases it highlights the complexities presented to 
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physiotherapists when attempting to address dizziness as part of a patient’s 
complaint and should also be considered alongside the current evidence base on 
cervical artery blood flow studies 
 
A number of blood flow studies investigating the effects of provocative testing on the 
arterial flow have produced inconsistent results (Kerry and Taylor 2008).  
 
Several studies have reported reduced blood flow in functional testing positions 
(Rivett et al 1999; Mitchell et al 2003, 2004; Arnold et al 2004).  Mitchell et al (2003) 
reported reduced contra-lateral blood flow in the intracranial VA on full rotation and 
in a later study Mitchell et al (2004) reported reduced intracranial VA blood flow in 
healthy participants, but no VBI signs and symptoms. Despite using healthy 
participants and recreating no signs and symptoms, Mitchell et al (2004) stated that 
their study supports the use of the VBI test.  This is difficult to accept as the reduced 
blood flow does not correlate with a reproduction of signs or symptoms. 
 
In contrast, several studies have reported no change in flow (Thiel et al 1994; Zaina 
et al 2003; Bowler et al 2011).  Bowler et al (2011) considered both the ICA and VA 
blood flow in the simulated manipulation position and reported no reduced blood 
flow in healthy participants.  The authors are currently developing this study on 
patients with signs and symptoms of vascular pathology on pre-manipulative testing.  
However, blood flow studies of this nature cannot factor in the effect of a 
manipulative thrust or repeated less forceful manual mobilisations on a potentially 
dissecting artery.   
 
These examples provide an indication of the inconsistency in blood flow studies and 
neurological clinical tests. Therefore clinicians also need to enhance awareness of 
neurological and neurovascular pathology through other methods, such as 
identifying risk factors.  
 
2.7 Risk factors (Vascular pathology) 
2.7.1 Theoretical modelling 
Thomas et al (2011) consider that a consensus has not been achieved on definitive 
risk factors for CAD.  Additionally, there is inconsistent evidence between studies 
investigating risk factors for CAD (Kerry et al 2008; Thomas et al 2011). 
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Kerry and Taylor (2006) consider CAD to be intrinsically linked to two inter-related 
principles of an underlying pathology (including atherosclerosis) and mechanical 
forces. Other features linking to underlying pathology or risk have been suggested 
as: genetic (e.g. connective tissue disorders, fibromuscular dysplasia (non-
inflammatory disease of medium sized arteries), or family history) and environmental 
origins (e.g. major and minor trauma, infections, smoking, hypertension, oral 
contraceptives, iatrogenic causes such as, surgery or medical intervention) are also 
considered a risk (Thanvi et al 2005; Debette and Leys 2009;). 
 
In an attempt to aid understanding and clinical reasoning of the pathogenesis of 
CAD Rubinstein et al (2006) present a theoretical model that outline four major risk 
categories of CAD: 1) genetic predisposition/underlying familial disorder; 2) 
environmental exposure e.g. infection, oral contraceptive; 3) trivial trauma e.g. 
normal neck movements, sports injury, neck manipulation; and 4) common risk 
factors associated with atherosclerosis.  Rubinstein et al (2006) propose that a 
genetic predisposition must be present, plus an additional necessary trigger for a 
CAD event to occur.  They argue that a CAD is highly unlikely in an otherwise 
healthy individual free from this combination of factors.  In a thorough review 
focusing on sCAD Debette and Leys (2009) concluded that studies on genetic 
association with CAD have been underpowered.   
 
Rubinstein et al (2006) acknowledge that based on poor methodological processes 
identified in a systematic review (Rubinstein et al 2005), the true risk of CAD to the 
population remains unknown. Therefore, if manipulation could be a contributing 
factor, as opposed to a principal cause of CAD, the problem of identifying a 
young/middle aged person at risk from CAD still remains.  This provides a 
challenging problem to clinicians in how to identify these patients.   
 
2.7.2 Manual therapies and minor trauma 
Haldeman et al (2002) concluded after reviewing 64-medicoloegal (medical related 
compensation claims) cases that risk factors could not be identified and that 
dissection was an unpredictable event.  Manipulation of the neck, however, is 
considered as having a strong association as a risk factor for CAD (Rubenstein et al 
2005; Ernst 2007).  In addition to Sweeney and Doody (2010) and Lee et al (1995) 
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(section 2.4), Volker et al (2005) and Mas et al (1987) report cases of VAD following 
manipulation. Thomas et al (2011) found a statistically significant association 
between minor mechanical trauma and CAD. The minor trauma included manual 
therapy (chiropractic, osteopathy, physiotherapy, massage) to the neck; however, 
what type and extent of therapy was not recorded.  Similarly, Kerry and Taylor 
(2006) consider that altered mechanical forces, such as movement or positions can 
influence the blood flow.   
 
2.7.3 Cardiovascular system 
Kerry and Taylor (2006) recommend undertaking a systems based approach to 
identify those at risk of CAD.  This system includes assessing for cardiovascular risk 
factors.  A number of studies have considered cardiovascular risk factors relative to 
CAD, which question this recommendation (e.g. Arnold et al 2008; Thomas et al 
2011), although all cardiovascular components cannot be excluded at this time (e.g. 
Baumgartner et al 2001). 
 
Arnold et al (2008) conducted a case control study to examine vascular risk factors 
in 239 CAD patients (ICAD 150:63%; sVAD 71:30%; and 18:7% with both) 
compared with 516 age and sex matched healthy controls.  There was no significant 
difference in other cardiovascular factors previously considered as a risk for 
vascular pathology: frequency of hypertension, diabetes, current smoking, past 
smoking and hypercholesterolemia.  This supports Thomas et al (2011) who 
reported that cardiovascular risk factors were not considered significant in a CAD 
group compared with age (<55-years) and sex matched controls of patients with 
stroke from other causes, and Biousse et al (1994) who reported no difference 
between 65 ICAD patients with (48) or without pain (17).  Hypercholesterolemia, 
however, was reported as a significant risk factor (p<0.05) in sICAD patients with 
ischaemic events compared to patients without such developments (Baumgartner et 
al 2001).  Similarly, Arnold, Bousser et al (2006) reported a higher rate of 
hypercholesterolemia in a prospective study of 165 VAD patients compared to other 
studies.  The authors considered that although no control groups were used, this 
feature could not be dismissed as a significant risk factor in VAD. 
 
In a further report Arnold et al (2010) compared the characteristics of consecutive 
patients with sVAD with cerebral ischemia (n=165) versus patients with local signs 
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and symptoms only (head/neck pain, cervical spine radiculopathy; n=21) and 
concluded that older patients (mean 43.6 ±9.9 v’s 38.6±9 years) and smokers were 
more likely to develop cerebral ischemia.  Arnold et al (2010) hypothesise that this 
age finding may be related to an increase in inflammation and vulnerability to 
thrombosis with increasing age, which is a recognised risk factor for ischemic stroke.   
The patient group from Arnold, Bousser et al (2006) was also included this paper.   
Arnold et al (2008) concluded that sCAD patients tended to be taller and have a 
lower body weight than the control group. These features were previously 
unreported in other studies, however, the measurements were self reported, which 
exposes the data to personal bias e.g. inserting a lower weight.  Nevertheless, it is 
an interesting aspect as general health knowledge informs us that obesity causes 
further risk to cardiovascular complications. 
 
Thomas et al’s (2011) control group (n=43 age 43.6 years ± 7.3) and Debette, 
Metso et al’s (2011) control group (n=556 44.7±10.5 years; 39.9% women) of non-
CAD ischemic stroke, had stroke from causes other than dissection.  Therefore, 
from an initial screening perspective, this questions the process of trying to separate 
potential symptoms caused by a dissection from other causes, if stroke from non-
dissection causes can also occur in the younger population (<55 years).  Thomas et 
al’s (2011) control group had considerably more cardiovascular risk factors and 
other co-morbidities (average 3.23, SD 1.6) compared to the dissection group (1.4, 
SD 1.3).   Clinically, this is too difficult to differentiate; therefore, it is a potential risk 
focusing on dissection pathology alone.  This opinion supports the recommendation 
to consider cardiovascular risk factors (e.g. Taylor and Kerry 2010). 
 
2.7.4. Migraine 
Migraine is defined by the International Classification of Headache Disorders (2004). 
Debette, Grond-Ginsbach et al’s (2011) large observational study (2004-2009, 20 
centres in 9 countries) reported migraine in 221 (36.3%) ICAD and 123 (38.1%) 
VAD patients with no significant difference in frequency between the two dissection 
sites (p=0.6 odds ratio (OR) (95% CI) = 1.09 (0.81-1.47).  Silbert et al (1995) 
investigated characteristics of headaches in CAD and reported a history of migraine 
was present in 24 (8%) ICAD and 6 (23%) VAD cases.  Rist et al (2011) conducted 
a systematic review and meta-analysis to evaluate the association between 
migraine or migraine subtypes (e.g. with aura) and CAD. Five case control studies 
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were included that were published through 2010. A pooled analysis revealed that 
migraine doubled the risk of CAD (pooled OR = 2.06, 95% CI 1.33-3.19).  Migraine 
with aura showed slightly weaker association compared to without aura; however, 
there was no evidence that aura status modifies association between migraine and 
CAD (met-regression on aura status p=0.58).  Arnold, Cumuric et al (2006) 
investigated characteristics of pain as the only symptom of CAD. Twenty from 245 
consecutive cases diagnosed with sCAD were included, of which 50% had a history 
of migraine (8 without and 2 with aura). 
 
2.7.5 Oral contraceptives 
Thomas et al (2011) observed use of oral contraceptives in 5 (14%) of CAD patients 
and 4 (9%) of control subjects (<55 years stroke of non-dissection cause). 
Unfortunately, the statistical analysis is between the groups, rather than considering 
this as an isolated risk of stroke. Caplan’s (1985) uncontrolled 5-case series 
reported one patient was also using oral contraceptives. Oral contraceptives were 
not considered in Debette, Metso et al’s (2011) large multi-centred observational 
study.  Guillon et al (2003) reported 58.3% of n=47 CAD and 40% of n=52 control 
subject with cerebral ischemic event unrelated to CAD had baseline characteristics 
of oral contraceptives. Unfortunately, there is no mention if this was current or past 
use. There appears to be weak evidence to support inclusion of oral contraceptive 
use as a risk factor for stroke, but not specifically dissection. 
 
2.7.6 Infection 
Recent infection is considered as a risk factor that could be a trigger for sCAD 
(Guillon et al 2003; Debette, Grond-Ginsbach et al 2011).  Both studies provide 
definitions of infection, however, Debette, Grond-Ginsbach et al (2011) consider 
their results, ICAD n=131 (21.7%), VAD n=47(14.6%) p=0.009 OR (95% CI) 1.59 
(1.09-2.31), are possibly an over-estimation of infection within the previous week as 
their definition is broadly defined i.e. “….one typical feature of infection combined 
with fever (≥38 degrees) or one typical symptom with corresponding investigative 
findings indicating infection or two typical symptoms indicating infection” (p.1175).  
Guillon et al’s (2003) case control study investigating infection occurring within the 
previous 4-weeks as risk factor of sCAD (n=47) compared to a control group (n=52) 
with cerebral ischemic event unrelated to SCAD  reported that infection was present 
in 31.9% sCAD and 13.5% control subjects (crude OR 3.0 (95% CI) 1.1-8.2 
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p=0.032).  Clinical staff were not blinded to the patient groups; however, a 
structured questionnaire was used in the diagnosis of infection. 
 
2.7.7 Genetic 
Genetic risk factors are thought to play a role in the aetiology of sCAD; however, 
familial CAD is rare (Grond-Ginsbach et al 2012).  Debette and Markus (2009) 
conducted a thorough systematic review of all published data from 1966-2008 on 
genetic factors for CAD and performed a meta-analysis of association studies with a 
polymorphism report.  Debette and Markus (2009) concluded that studies on genetic 
association with CAD have been underpowered and that monogenic connective 
tissue disease is rarely associated with CAD (Debette and Markus 2009).  Ehlors 
Danlos syndrome is the main connective tissue disease.  However, Debette and 
Markus (2009) report that there are several arguments for association of “sporadic” 
CAD with connective tissue abnormalities as part of a multifactorial predisposition.  
A meta-analysis identified an overall significant association of the MTHFR 677TT 
genotype and CAD (OR1.67 (95% CI) 1.21 – 22.31).  This genotype is associated 
with elevated homocysteine levels (refer to 2.7.8), which could contribute to arterial 
wall damage (Debette and Markus 2009). Unfortunately, identifying a MTHFR 
677TT genotype is not conducted within a musculoskeletal clinic.  This review is 
performed by the study lead of the Cervical Artery Dissection and Ischemic Stroke 
Patients (CADISP) study, a large multi-centred prospective study involving 9 
countries and 20 centres, which is an indication of the methodological quality.    
 
Martin et al (2006) examined 7 families (n=15, 9 female) with 15 dissections to 
establish if any specific features existed and identified that familial CAD families are 
young at first dissection (mean age 36.2 years, median age 32 years, range 18-59).  
This younger age group of first onset familial CAD is supported by Grond-Ginsbach 
et al (2012) reporting a mean age of 38.4 years (± 13.3, n=32).  Grond-Ginsbach et 
al (2012) suggest that a specific predisposition for familial history does exist; 
however, the age of onset and site of dissection differs between families making the 
familial CAD profile heterogeneous.   
 
2.7.8 Hyperhomocysteinemia 
Mild Hyperhomocysteinemia has been reported as a risk factor for both arterial 
dissection and ischemic stroke without dissection (e.g. case-control studies of 
Pezzini et al 2002; Arauz et al 2007; Benninger et al 2009).  However the underlying 
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mechanism behind this risk factor remains unclear and requires additional 
investigation (Benninger et al 2009).  Additionally, the practicalities of assessing this 
risk factor are not feasible within musculoskeletal clinics.  Arauz et al (2007) 
however, reported that high plasma concentrations of homocysteine and low plasma 
levels of folate were associated with an increased risk of CAD and concluded that in 
a Mexican population that deficiencies in nutritional status may contribute to the 
relatively high incidence of CAD in Mexico.  This feature has potential consideration 
during assessment e.g. in poor socioeconomic areas. 
 
2.7.9 Styloid process length 
Raser et al (2011) conducted a single centre retrospective (2001-2009) case control 
study of patients with cervical carotid artery dissection (n=38, male=18, age 50.6 
years, ±11.5, range 21-77 years) with an equal no. of age and sex matched controls 
to investigate a potential association between length of styloid process and CAD.  
The styloid process of the temporal bone is variable in length, angulation and 
proximity to the carotid artery. This study revealed no significant difference in 
angulation, however, there was a significant difference for styloid process being 
longer ipsilateral to the dissection than in control subjects (30.3mm v 26.6mm, 
p=0.33).  Dissection was associated with increasing styloid length with OR 1.08/mm 
(95% CI 1.002 to 1.17, p=0.04).  
 
Eagle syndrome involves an elongated styloid process that produces a range of 
cervical related symptoms (Das et al 2008; Piagkou et al 2009 in Raser et al 2011), 
including potential compromise of the carotid arteries (Piagkou et al 2009 in Raser 
et al 2011).  Figure 2.1 displays elongated styloid processes through ossification of 
the stylohyoid ligament.  
 
 
 
 
 
 
 
 
 
  34 
Figure 2.1: Radiographs of the cervical vertebral spine: anterior-posterior (left) and lateral view (right) 
showing bilateral ossification of the stylohyoid ligament indicated by the red arrows. 
 
 
 Adapted from Kirchhoff et al (2006). 
 
Raser et al (2011) concluded that CAD is associated with a longer styloid process 
suggesting that mechanical injury from the styloid may contribute to the 
pathogenesis of CAD.  Although the study is retrospective, with potential bias to 
recall of information, the methodology is detailed and measurements were recorded 
by blinded observers with high inter-observer correlation coefficients for all 
measures (0.88 for length and proximity, 0.91 for proximal angulation, and 0.89 for 
caudal angulation).  All subjects had CT angiogram that allows evaluation of both 
bone and vascular tissue.  Unfortunately, in the absence of radiological investigation 
an elongated styloid process is likely to go undetected if the clinician does not 
possess a high level of palpation skills and increased awareness to suspect its 
presence. 
 
2.7.10 Post-partum 
Cervicocephalic artery dissection in mothers following childbirth is considered rare.  
Arnold et al (2008) conducted a case control study to determine differences between 
post-partum (childbirth within 6-weeks previous) and non-postpartum CAD.  A total 
of 102 women <50 years (6 post-partum, 96 non-postpartum) from 245 female 
patients held on single centre CAD register (1997–2005) were identified.  Arnold et 
al (2008) concluded that post-partum CAD patients and associated conditions 
should be considered in women with unusual headache after childbirth.  All post-
partum CAD patients had neck and or headache as the first symptom onset ranging 
from 7 days to 18 days after delivery.  There was a mixture of risk factors present 
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and 3 had ischemic events following pain onset (2 TIA and 1 cerebral infarction). 
One also had Horner’s syndrome.  There was no significant explanation behind the 
underlying mechanisms.  In addition to this study there are a number of single case 
reports on natural post-partum CAD. 
 
2.7.11 Seasonal variability 
Seasonal variability has been reported in CAD.  Paciaroni et al (2006) examined 
seasonal variability in a prospective study of 352 patients with 380 spontaneous 
CAD (361 symptomatic; 305 carotid and 75 vertebral artery dissections) admitted to 
2 Swiss hospitals (1985 – 2004).   Most patients presented with ischemic stroke 
(241 / 63%), followed by TIA in 40 (11%), retinal ischemia in 7 (2%), and non-
ischemic in 73 (19%).  Nineteen (5%) were asymptomatic spontaneous CAD.  A 
higher frequency of CAD was observed in winter (31.3%; 95% CI; 26.5 to 36.4; 
p=0.021) compared to spring (25.5% (95% CI) 21.1 to 30.3), and summer (23.5% 
(95% CI) 19.3 to 28.3), and autumn (19.7% (95% CI) 15.7 to 24.1).  Although a 
seasonal pattern is reported this does not appear to be constant i.e. spring and 
summer displays a greater prevalence than autumn.  Paciaroni et al (2006) report 
that the cause of dissection in winter is unclear with possible increased contribution 
from winter peaks of infection, hypertension, and aortic dissection.  There was no 
additional data to support this hypothesis other than observing season variation.  
Therefore, it would appear that further evidence is required to accept seasonal 
variation as a risk factor for CAD. 
 
2.7.12 Risk factors - conclusion 
Knowledge of potential risk factors associated with CAD may help early detection of 
an underlying serious pathology occurring.  Similarly, this information may help 
guide physiotherapeutic management if serious pathology is not imminently 
suspected.  It would appear that some risk factors discussed in section 2.7 have 
either weak or inconclusive evidence to support routine inclusion as risk factors.  In 
addition, some risk factors, such as length of styloid process, mild 
hyperhomocysteinemia, and MTHFR 677TT genotype would be very difficult if not 
impossible to detect within a musculoskeletal clinic setting.  However, the presence 
of cardiovascular risk factors, infection, history of migraine, use of oral 
contraceptives, awareness of family history of previous cervical arterial pathology or 
stroke, and headache onset soon after childbirth accompanied by symptoms and 
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signs of CAD as discussed within this review should raise the index of suspicion for 
the presence of an underlying serious pathology.  
 
2.8 Cervical myelopathy 
2.8.1 Cervical myelopathy - pathogenesis 
Cervical myelopathy (CM) is a clinical diagnosis arising from compression of the 
spinal cord at cervical spine level.  Myelopathy can also occur at the thoracic and 
lumbar spine sections.  The most common cause is degenerative changes related to 
progressive spondylosis that narrows the spinal canal (disc degeneration/protrusion, 
osteophyte formation, thickening of the ligamentum flavum, and facet joint 
hypertrophy) (Meyer et al 2008).   The subsequent cord compression can result in a 
range of neurological signs and symptoms that makes differential diagnosis a 
challenge.  The cord compression can cause functional dysfunction and pain that 
may require urgent surgical intervention. 
 
Cervical myelopathy is reported to peak between the ages of 50 and 60-years; 
however, the incidence of progression from spondylosis to cord compression 
myelopathy is unknown (Cook et al 2007; Meyer et al 2008).  Chiles et al (1999) 
retrospectively examined patterns of neurological deficit and recovery following 
anterior cervical decompression resulting from cervical spondylotic myelopathy 
(n=76. Male 47:62%) and identified a mean age of 56-years (range 29-87).  This 
was further sub-grouped to myelopathy primarily due to soft disc herniation (mean 
age 51.3-years, range 29-77) and spondylitic ridges (57.6-years, range 33-87).  No 
additional statistical analysis is provided to identity any significant age related 
difference between disc and spondylotic changes. 
 
2.8.2 Cervical myelopathy – clinical challenge 
The clinical features of myelopathy can overlap with a radiculopathy problem, which 
is generally compression of a single nerve root as it exits the spinal canal.  This is 
not a medical emergency and is more responsive to conservative management.   
Furthermore, spinal cord pathologies, such as cervical myelopathy, multiple 
sclerosis and amyotrophic lateral sclerosis may have similar presenting signs and 
symptoms that may include upper and lower motor neuron signs, pain, 
paraesthesia, functional impairment (Cook et al 2007).  This presents a significant 
challenge to practitioners to ensure correct differential diagnosis is obtained with 
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subsequent selection of safe management strategies.  This challenge is exemplified 
by the findings of Heffez et al (2004) and Rhee et al (2009).  
 
Twenty-one per cent (8) of 39 patients in a prospective controlled study with MRI 
confirmed cervical myelopathy and subsequent progression to surgery did not 
demonstrate a single myelopathic sign at their initial presentation (Rhee et al 2009).  
Rhee et al (2009) was included in Cook et al’s (2011) systematic review described in 
section 2.8.4.  This achieved a score of 6 using the Quality Assessment of 
Diagnostic Accuracy Studies (QUADAS) tool (score 0-14). 
 
Heffez et al (2004) demonstrated clinical evidence for cervical myelopathy due to 
Chiari 1 malformation (cerebellar tonsillar herniation; 20%) and clinically significant 
spinal canal stenosis with mild extension (46%) in n=270 patients (female (86%), 
mean age 44 years; SD=11 years) who had previously received a diagnosis of 
fibromyalgia.  This initial diagnosis was made by external medical practitioners 
(Rheumatologist (in 66% of cases), neurologist, or primary care physician).   Some 
patients had previous MRI investigation identifying a degree of stenosis and/or 
cerebellar tonsillar ectopia, however, this was not considered significant at that time.  
There is no mention of timeframe or comparison of previous imaging and the most 
recent MRI confirming cervical myelopathy.   Heffez et al (2004) acknowledge that 
patients were not randomly selected from fibromyalgia sufferers i.e. patients had self 
referred in this study; therefore, the prevalence of cervical myelopathy Chiari 1 
malformation and spinal stenosis within fibromyalgic patients remains unknown.  As 
similar signs and symptoms may exist in these conditions Heffez et al (2004) 
recommend that a detailed neurological evaluation should be conducted in patients 
diagnosed with fibromyalgia to exclude cervical myelopathy resulting from cord 
compression.   
 
2.8.3 Myelopathy – symptoms and signs 
2.8.3.1 Multiple level involvements 
As previously reported the most common cause of cervical myelopathy is 
degenerative changes that narrow the spinal canal (Meyer et al 2008).  The nature 
of degenerative changes suggests that pathology may not be restricted to one 
specific level of the cervical spine; therefore, clinicians should exercise caution when 
interpreting presenting symptoms and signs.  
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Vyas et al (2004) prospectively studied the C3-4 level in cervical spondylotic 
myelopathy (n=14, all male, mean age 50.6 years, range 24-77, identified from 137 
CM patients).  This study focused on the C3/4 level due to infrequent reporting of 
involvement at this level and its compromise reportedly being generally in an older 
patient age group.  This mean age (50.6 years) is considered by the authors as 
younger than previously reported.  As an age comparison, Taylor et al (1991) 
retrospectively observed surgical treatment of cervical spondylotic myelopathy in 
elderly patients (n=17; Female = 6), where a mean age 71 years (range 65-82) was 
recorded and additionally observed that coexisting medical conditions (ischemic 
heart disease (5), significant RA/OA (5, 4 of which with arthroplasties) were common 
in elderly patients.  This is a small sample size and Taylor et al (1991) considered 
that presenting signs and symptoms (not co-morbidities) were similar to those in 
younger patients, but no comparison or control group is used to support this.  Vyas 
et al (2004) is also a small sample size due to the focus on a specific level and was 
restricted to an Indian population, therefore this aspect may not transfer to a broader 
population.  Although anterio-posterior cord compression ratio showed significant 
compression compared to lower cervical levels and all patients demonstrated 
pyramidal signs, this study is unable to state if these features are related to the C3/4 
level.   The presenting symptoms and signs lack specific detail.  
 
Eleven from 14 patients also had lower cervical level involvement (Vyas et al 2004) 
and Kim et al’s (2007) retrospective study (n=26; male =20, mean age 44.8 years 
range 23-61) reports the most frequent level as C5/6 with 4 patients having more 
than 2 levels of involvement.   Vyas et al (2004) consider the effect of lower cervical 
spine level involvement predisposes upper cervical levels to increased mobility and 
spondylotic change.  Therefore, these studies suggest that physiotherapists should 
exercise caution in interpreting a patient’s presentation as multiple level involvement 
may be occurring with potential to contribute to an array of signs and symptoms.    
 
2.8.3.2 Sphincter (bladder/bowel) and sexual dysfunction 
Bladder and/or bowel dysfunction and erectile/sexual dysfunction are signs that may 
indicate potential spinal cord compromise e.g. compression through cervical 
myelopathy (e.g. Bednarik et al 1999; Vyas et al 2004) or malignancy (Greenhalgh 
and Selfe 2003; 2009).   Personal experience and clinical observations suggests 
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that specific detail of these features may be poorly understood by physiotherapists, 
unless advanced level or specialist training has been undertaken.  Similar to the 5Ds 
discussed earlier, in presentations that may include bladder dysfunction the 
clinician’s level of questioning may be limited to enquire solely on bladder 
dysfunction or disturbance without any clarification beyond this.  Unfortunately, there 
is no empirical data to support this observation. However, there are examples within 
the evidence base that may contribute to this observation. 
 
Studies, in the main, reporting on cervical myelopathy tend to use generic terms 
such as, bladder or sphincter dysfunction when reporting such changes (e.g. 
Bednarik et al 1999; Vyas et al 2004). These terms lack specific detail to suitably 
inform clinicians as part of their decision making processes.  This lack of specific 
detail may result in delayed diagnosis (Cook et al 2007; Meyer et al 2008).  
Therefore, if physiotherapists become consistently more aware of the range of 
features that may appear within sphincter dysfunction this may help earlier decision 
making.  
 
One study, however, does provide such specific detail.  Sakakibaraet al (1995) 
studied the location of the paths subserving micturition in patients with cervical 
myelopathy through a prospective design (n=95 identified from 128 cervical 
myelopathy patients).  Micturitional symptoms were classified as either: irritative 
(diurnal or nocturnal urinary frequency; sensation of urgency or incontinence) n=61, 
or; obstructive (urinary hesitation, prolongation, difficulty of voiding and urinary 
retention) n=71.  Urinary incontinence was found in 25 patients and urinary retention 
in 22 patients. 
Urodynamic studies (residual volume, water cystometry and simultaneous sphincter 
EMG) were undertaken alongside neurological examination (disturbed deep 
sensation of lower extremities (position and vibration; n=55), disturbed superficial 
sensation of lower body including perineal area (pin prick; n=63) and pyramidal 
signs (weakness and hyperreflexia of lower extremities, and Babinski sign; n=96).  
Uninhibited contraction was more common with all 3 pyramidal signs (p<0.05). 
Bladder capacity was smaller in patients with pyramidal signs, and with Babinski 
sign (p<0.05). 
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All participants referred for assessment of micturitional state were included in this 
study.  From a clinical perspective, this study may be useful to highlight patterns of 
micturition disturbance. As most studies tend to use the generic terms such as, 
bladder or sphincter dysfunction, this study could inform clinical practice by 
highlighting the micturitional sub-groups of irritative and obstructive features.  No 
specific studies on bowel dysfunction were identified during the search. 
 
He et al (2006) examined improvement of sexual function in male patients (average 
age 56.3-years; range 43-72) treated surgically for cervical spondylotic myelopathy 
through prospective follow-up. Symptoms of sexual dysfunction were reported with 
difficulty in penile erection or ejaculation.  Twenty-two subjects (plus 2 unable to 
attend follow-up) were identified from 753 patients diagnosed with cervical 
myelopathy.  All participants reported normal function 6-months pre-surgery.  The 
dysfunctions were classified as either reflexogenic erection (n=4) or psychogenic 
erection (n=18).  Post surgery: 20 from 22 (91%) improvement was measured in 
International Index of Erectile Function.  This study highlights the low frequency of 
sexual dysfunction, which is more likely to be psychogenic compared to 
reflexogenic.  This supports Chiles et al (1999) in commenting that sphincter and 
sexual dysfunction were relatively infrequent and usually in far-advanced 
myelopathy after they identified the incidence of bowel dysfunction (4: 5.3%), 
bladder dysfunction (8: 10.5%), and sexual dysfunction (5: 6.6% men only). 
 
Therefore, this low rate may indicate that routine questioning in relation to sphincter 
or sexual dysfunction may not need to occur; however, questioning for these 
dysfunctions may be utilised in advanced level questioning should more information 
be required. This could be combined with awareness of duration of this dysfunction.  
All patients with sexual dysfunction reported normal function 6-months pre-surgery 
(He et al 2006).   
 
2.8.3.3 Gait 
Similar to generic terms used in clinical practice for bladder or sexual dysfunction, 
personal clinical observation suggests that gait disturbances are also a broad term 
used for checking for such dysfunctions with specific detail lacking on the 
components of gait disturbance.  Although there is no empirical data to support this 
observation this is frequently used within the evidence base (e.g. Bednarik et al 
  41 
1999; Chiles et al 1999; Kim et al 2007). Kim et al (2007) report patients (20:77%) 
with myelopathy caused by soft cervical disc herniation had difficulty with walking, 
Bednarik et al (1999) reported 56 from 60-patients in a prospective case control 
study, and Chiles et al (1999) reported gait disturbance in 61 (80.3%) patients with 
cervical myelopathy.  These studies do not provide specific detail, such as kinematic 
and linear parameters, for these dysfunctions.   
 
A number of studies, however, have investigated spatiotemporal or linear 
parameters and kinematic parameters for specific gait disturbances within this 
pathology (Kuhtz-Buschbeck et al 1999; Kim et al 2010; Lee et al 2011). Three 
dimensional gait analysis, which provides a quantitative measurement was included 
in all three studies.    
 
Spatiotemporal or linear parameters comprised of; step width, gait velocity, cadence 
(step rate per minute), step length, stride length (distance between both feet), step 
length (distance between contact point same foot), stance time (single foot), and 
double support time (both feet).  Kinematic data comprised of pelvic or hip, knee and 
ankle joint range of movement (ROM) (Kuhtz-Buschbeck et al 1999; Kim et al 2010; 
Lee et al 2011).  Consistent findings (disturbances) were reported between these 
studies:   
 
Disturbances of linear parameters include: 
o Slow gait. 
o Decreased step/stride length  
o Increased step width and double support. 
o Decreased single limb support. 
Disturbances in kinematic parameters include: 
o Decreased maximal knee flexion (swing phase). 
o Increased ankle dorsi-flexion (swing phase). 
o Decreased plantar-flexion at push-off. 
 
These kinematics features are indicative of spasticity (Kim et al 2010).  Furthermore, 
Lee et al’s (2011) prospective case control study (n=38 (control=36); male (21), age 
56.2-years ± 15.2, mean duration of symptoms 4.3 months ± 4.2 months) identified 
an increase in leg muscle tone (1 to 1+ Ashworth scale) in all CM patients.  This 
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supports Kim et al (2010) who also identified mild-moderate spasticity within their 
study and state that decreased knee joint flexion during swing phases and ankle 
joint motion during stance phase are indicative of a spastic gait pattern.  Gait 
deviations in cervical myelopathy patients with mild spasticity are considered to 
mainly result from instability caused by impairment of afferent proprioceptive signal 
delivered by the dorsal column. Decreasing gait velocity and step length and 
increasing step width and double support time were identified as compensatory 
strategies to stabilise dynamic balance (Lee et al 2011). 
 
Kuhtz-Buschbeck et al (1999), Kim et al (2010) and Lee et al (2011) do not provide 
specific detail of the selection process; however, detailed information on gait 
analysis procedures is provided and although MRI films were reviewed 
independently by one radiologist in Lee et al (2011), this practitioner was blinded to 
clinical information before grading levels of compression.  Kim et al’s (2010) study 
used two radiologists to sub-group subjects into 3 groups (0, 1 and 2): Group 0, No 
Increased Signal Intensity (ISI) (n=13, age 54.5 ± 9.6-years); Group 1, Faint ISI 
(n=14, age 58.6 ± 8.3-years); or, Group 2, Intense ISI (n=9, age 62.9-years ± 7.3) to 
evaluate the relationship between increased signal intensity (ISI) on magnetic 
resonance imaging (MRI) and gait function in cervical spondylotic myelopathy 
(n=36, Male=26).  This is a retrospective analysis therefore risks recall bias and the 
authors acknowledge limitations in statistical analysis e.g. limited statistical power 
from a small sample size; however, sub-grouping into levels of ISI and correlated 
with gait analysis using Spearman rank correlation coefficient is detailed.  
 
Patients with ISI on MRI compared to those without ISI had significantly slower gait 
speed, longer step time, decreased single limb support time, increased double-limb 
support time, and reduced  knee flexion in swing phase and increased ankle DF 
ROM, which the authors report as being indicative of spasticity.  
 
Kuhtz-Buschbeck et al’s (1999) cervical myelopathy group (n=12, age 49 ± 5-years), 
within a case control study demonstrated significant 2-month post-surgical 
improvement in spatiotemporal parameters.  Velocity was increased (mean 10%) in 
all patients, except one (p<0.01).  This is a small sample, however an age and 
anthromorphically matched healthy control group (n=14) is utilised.   Pre-post 
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surgical gait analysis helps support the findings that the gait disturbances are 
related to myelopathic pathology.   
 
The three gait analysis studies described above are useful studies to help inform 
clinical practice to identify specific aspects of gait, rather than simply considering 
generic difficulties with gait.  More defined detail would enable clinicians to guide 
subjective questioning for any changes reported by patients and to objectively 
observe with greater knowledge. 
 
2.8.3.4 Upper motor neuron (spasticity) signs 
In addition to gait analysis, Kim et al (2010) also checked for presence of: neck pain, 
increased tendon reflex, ankle clonus, Babinski sign (upgoing plantar response), 
paraesthesia, sensory changes, bowel/bladder symptoms.  Regression tree analysis 
observed upper motor neuron signs, such as ankle clonus and Babinski sign were 
important in classification of ISI groups.  These signs, in addition to other pathologic 
reflexes, such as Hoffman sign, and inverted radial reflex are pyramidal or long tract 
signs consistent with cord compression (Edwards et al 2003).  Upper motor neuron 
findings (spasticity) may occur in both upper and lower limbs. Cranial nerve 
dysfunctions or hyperactive jaw reflexes may indicate brainstem or intracranial 
lesions (Edwards et al 2003).   
 
Other examples of varying quality of studies reporting these signs of spasticity are 
displayed in Table 2.2: 
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Table 2.2: Additional examples of studies reporting signs of spasticity in cervical myelopathy 
Study n Study information / clinical features 
Taylor et al (1991)  17 Reflex changes in both upper and lower (generally hyperreflexia in 
lower limbs, with brisk or diminished upper limb depending on level 
of lesion), lower limb weakness associated with spasticity (13)  
Bednarik et al (1999)  60 Gait disturbances (56), spasticity and/or weakness of the lower 
and/or upper extremities (55). 
Chiles et al (1999) 76 Spastic gait (52: 68.4%), ankle clonus (25: 32.9%), Babinski reflex 
(31: 40.8%), hyperreflexia (58: 76.3%). 
Heffez et al (2004)  270 Hyperreflexia (64%), inverted radial reflex (57%), Hoffman sign 
(26%), Clonus (25%), weakness in ≥1 limb (22%). 
Kim et al (2007)  
 
26 Reported walking difficulty (20: 77%), spasticity (15:58%) and 
central cord syndrome (4:15%) without providing any additional 
specific information. 
 
Kim et al (2007) is a retrospective study, therefore potential recall bias may occur.  
The primary aim of this study was to establish clinical characteristics, radiological 
findings, and improvement post surgery for CM caused by soft cervical disc 
herniation. Twenty-six myelopathy patients due to soft cervical disc herniation were 
selected from n=456 undergoing surgery during a 7-year period, with n=111 
identified as being soft disc herniation during this period.  However, no specific detail 
is provided on how the signs/symptoms of the study group differed from the n=111, 
also with soft disc herniation.   
 
Heffez et al (2004) provide details on their standard pre-assessment conducted by a 
neurologist and/or neurosurgeon (n=138 assessed by both). However, a statistically 
significant difference (p=0.02) was noted between the two specialists with the 
neurologist recording a higher prevalence of findings in hyperreflexia, Hoffman sign, 
Romberg sign, and impaired tandem walking.   Heffez et al’s (2004) analysis of this 
difference was a higher threshold required by the neurosurgeon as they were 
required to consider surgery.   Bednarik et al’s (1999) prospective case control (n= 
60; Male (43), Female (17); mean age 52.6 ± 8.1-years range 32-76) provides 
details on the selection process and control group (probable vascular cerebral 
involvement), however, they simply state this group did not show signs of CM.   
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2.8.3.5 Motor deficit 
Chiles et al (1999) reported motor deficit in 152 muscle groups from n=76 patients.   
Motor deficit in the upper limbs typically occurred in the hands and triceps first; Hand 
intrinsics (86: 56.6%), triceps (44: 28.9%), biceps (18: 11.8%), and deltoid (16: 
10.5%).  Motor deficit in the lower limb was recorded more frequently in the hip 
flexor and knee extensor muscle groups; iliopsoas (59: 38.8%), quadriceps (40: 
26.3%), dorsiflexion (28: 18.4%), plantarflexion (24: 15.8%). Heffez et al (2004; 
n=270) reported weakness in ≥1 limb (22%). Weakness in the hands may also be 
described as clumsy or useless (Bednarik et al 1999; Taylor et al 1991).  Bednarik et 
al (1999; n=60) reported weakness of the hands/upper limbs (14) and lower limb 
weakness associated with spasticity (13). 
 
The work of Taylor et al (1991) is a retrospective analysis, and therefore vulnerable 
to potential recall bias. The small sample is specific to elderly population.  Taylor et 
al (1991) state the presenting features are similar to younger patients, but no direct 
comparison group is provided.  Objective functional improvement was recorded in 
58% upper limb and 71 % lower limb post-surgical intervention.  Taylor et al (1999) 
devised their own functional grading system for upper and lower limb and allocated 
a score to each patient after obtaining information from patient notes.  No 
information on validity/reliability of this system is provided.  
 
It is hypothesised that motor deficit occurs from anterior horn cell loss, rather than 
nerve root compression, resulting from spondylotic obstruction of spinal cord venous 
drainage (Chiles et al 1999).  There is no mention of a standardised subjective 
screening process or the method of individual muscle testing. The same surgeon 
performed surgery, but it is not clear if this surgeon also conducted assessment of 
all patients.  However, validated functional measures are used pre/post surgery.  
There is no comparison for the presenting signs/symptoms e.g. against a control 
group of cervical radiculopathy, but significant post-surgery improvement helps 
support pre-operative test findings. 
 
2.8.3.6 Sensory deficit 
Sensory deficit is a common finding in cervical myelopathy (e.g. Chiles et al 1999; 
Bednarik et al 1999).  Chiles et al (1999; n=76) reported upper limb sensory 
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complaints (sensory loss, dysaesthesias, paraesthesias) occurred in 63 (82.9%) 
patients, and lower limb sensory complaints 34 (44.7%). 
 
Chiles et al (1999) observed that upper limb symptoms usually occurred slightly 
before the onset of gait difficulties, and in all (except 6) patients the upper limb 
sensory complaints or difficulties typically started distally in the finger tips, thus 
affecting fine movements, and then progressed proximally with time.  Unfortunately, 
no timelines are provided.  These symptoms rarely had a radicular distribution.   The 
primary aim of Chiles et al’s (1999) study was to establish patterns of neurological 
deficit and recovery post surgery for CM.  Although this study used a retrospective 
analysis of presenting signs and symptoms, with potential recall bias, the 
information regarding upper limb dysfunction occurring pre-gait dysfunction as early 
signs, and most experiencing difficulty with fine hand movements before progressing 
proximally could be particularly helpful from a clinical perspective when 
differentiating from other possible diagnoses. 
 
Taylor et al’s (1991) retrospective study involving elderly patients (n=17) reported 
paraesthesiae in hands and upper limbs, often with asymmetrical distribution (16), 
impairment of pin prick sensation in hands and upper limb (12), lower limb (10), 
severe proprioceptive loss in legs (1).   Bednarik et al’s (1999) prospective case 
control (n= 60. Male (43), female (17); mean age 52.6 ± 8.1 range 32-76) reported 
sensory disturbance corresponding to cervical spinal cord involvement (n=37).  The 
primary aim of study was to investigate presence of median nerve mononeuropathy 
in CM. 
 
2.8.3.7 Pain  
Neck, and upper and lower limb pain has been reported to occur in cervical 
myelopathy (e.g. Bednarik et al 1999; Chiles et al 1999; Kim et al 2007; 2010).  
Edwards et al’s (2003) clinical review type publication advises that myelopathy may 
occur simultaneously to radiculopathy as a result of progressive cervical spondylosis 
causing foraminal stenosis.   However, specific aspects of pain in studies on cervical 
myelopathy were generally poorly reported.  Chiles et al (1999 n=76) reported the 
occurrence of; neck pain (21:27.6%), upper extremity pain (18: 23.7%), and lower 
extremity pain (7:9.2%).   Taylor et al (1991) also reported neck pain (5 from 17).  
Radicular pain was reported by Kim et al (2007; 9:35%) and Kuhtz-Buschbeck et 
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al’s (1999) in upper limbs (9) without specific detail provided.   Bednarik et al (1999) 
reported Lhermitte sign (n=9), an electric shock type phenomenon occurring down 
the spine or limbs on neck flexion.   
 
2.8.3.8 Cervical myelopathy - Mean duration of symptoms and signs 
The studies reviewed in this section had reported a large variation of duration of 
symptoms that suggest a largely chronic and progressive presentation; however, 
caution should be reserved for acute or rapid deterioration of clinical features.  
Examples of these variations in mean duration or time-range of features are: Vyas et 
al (2004) ranged from 1 to 36-months pre-spinal surgery; Lee et al (2011) 4.3 
months ± 4.2 months; Kuhtz-Buschbeck et al (1999) 10-months ± 3-months;   Heffez 
et al (2004) 8-years (SD=6.3-years); Taylor et al (1991) symptoms duration 1 to 18 
months (mean 9).   
 
2.8.3.9 Summary of cervical myelopathy presenting features 
The following is a summary of the presenting features for cervical myelopathy: 
 
UMN - Pyramidal signs (corticospinal tracts - motor) 
o Spasticity e.g. limbs / gait / reflexes (hyper) 
o Weakness  
o Upper Limb (UL): intrinsics>triceps are 1st onset 
 Grip, fine motor skills 
o Lower Limb (LL): Hip flexor>knee Extensors (quads) are 1st 
o Hyperreflexia 
o LL / UL 
 
LMN - Sensory deficit 
o Hyporeflexia 
o UL at level of compression 
o UL/LL numbness/paraesthesia/dysaesthesia 
o UL usually begin in digits and move up  
o Proprioception, balance, fine motor e.g. fastening buttons 
o Pain: May have concomitant radiculopathy therefore mixed picture. 
Pain not always present. 
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2.8.4 Cervical myelopathy - Clinical tests for screening and diagnosis   
A range of clinical tests are used to screen for neurological conditions, such as 
cervical myelopathy (cord compression).  However, some neurological clinical tests 
(e.g. finger escape sign and clonus) have not been investigated for diagnostic 
accuracy, whilst others (e.g. the Hoffman sign, Lhermitte sign, and plantar response) 
have been investigated, but with inconsistent levels of methodological quality that 
affects their diagnostic accuracy values (Cook et al 2007 p.1237). 
Cook et al’s (2011) systematic review of 12 studies followed Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to examine 
clinical tests for screening and diagnosis of cervical spine myelopathy.   
 
All studies were assessed using Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS) tool.  No RCTs were included within this review and the authors 
acknowledge that not many studies met their inclusion criteria, which are outlined.  
This appears appropriate; therefore, the process relied heavily on hand searches. 
All studies were double assessed and no authors assessed any of their own 
previous work. 
 
This review is a comprehensive collection of the clinical tests commonly used for 
screening for CM and highlights the generally low-moderate quality of studies 
assessing the clinical utility of such testing.  These tests demonstrated high levels of 
specificity and low levels of sensitivity (see additional comments below). 
 
The authors have sub-divided the tests into 3 categories of tests: 
 
  1. Those associated with gait or balance analysis; 
 
  2. Those associated with upper motor neuron or “pathological” signs; and, 
 
  3. Those associated with deep tendon reflexes. 
 
Cook et al’s (2011) tables 1-4 and descriptions/positive findings summary is 
presented (with permission) in Appendix A.  The authors recommend further 
evaluation of these tests and exploration of clustered findings. Tests with low 
sensitivity are unlikely to identify the condition early in the examination (cannot rule it 
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out) and may result in a false negative. Thus clinicians may apply treatment 
techniques under false assumptions of safety, which may further compromise the 
spinal cord. 
One further test identified that is not included in Cook et al’s (2011) review is the foot 
tapping test (FTT; Refer to Appendix A for description) as a simple quantitative 
objective assessment of cervical myelopathy (Numasawa et al 2012;).  The FTT 
strongly correlated with Japanese Orthopaedic Association Lower Extremity, a 
reliable functional scale (r=0.696, p<0.0001) and correlated with a reference test, 
grip /release test (r=0.571, p<0.0001). 
Numasawa et al (2012) consider this test as an easily applied quantitative test for 
patients with cervical myelopathy, especially those with limited walking ability.  
However, on review, easy replication may be counteracted with difficulty to achieve 
a meaningful clinical interpretation unless a comparative quantitative base measure 
is used e.g. <30 repetitions derived as a base comparative measure that may be 
developed following additional testing, including healthy volunteers. This is because 
both lower limbs may be affected making it difficult to compare limb to limb.  In 
addition, Numasawa et al (2012) identify that the test is not specific to cervical 
myelopathy, but rather is a test for UMN diseases and may not be readily 
differentiated from LMN disorders such as, peroneal palsy or lumbar spinal stenosis.  
This test, however, appears suitable for non-ambulatory patients, where gait 
disturbances are difficult to assess (Numasawa et al 2012). 
 
2.9 Literature review conclusion 
This literature review identifies that there is a risk of neurological/neurovascular 
pathology, such as cervical arterial dissection and cervical myelopathy, presenting 
as neck and/or head pain or functional impairment at musculoskeletal clinics. 
Currently, the extent of adverse events related to such presentations is unknown.  
Although the problem is not considered common, there is limited evidence to 
support this assumption.  Therefore, clinical decision making processes should be 
sufficiently robust to establish a correct early diagnosis or to identify those patients 
at risk of developing an adverse event following manual treatment.  Failure to 
identify such cases may have catastrophic consequences for the individual and 
carer through complications, such as permanent gait or bladder dysfunctions, stroke 
or potentially, death. 
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The literature review identifies limitations and inconsistent evidence for current 
functional provocative testing and clinical tests, risk factors, and, cardinal signs and 
symptoms traditionally used as a screening process by musculoskeletal 
physiotherapists to differentially diagnose serious neurological and neurovascular 
pathology from musculoskeletal disorders.  Additionally, the review highlights the 
difficulties in differentiating neck and head pain from non-musculoskeletal causes.  
This presents a serious challenge for physiotherapists and requires a high level of 
awareness to suspect such pathology (Thanvi et al 2005; Greenhalgh and Selfe 
2006; Kerry and Taylor 2006, 2008).  Therefore, an improved process aimed at 
detecting serious neurological and neurovascular pathology of the cervical spine 
would be of clinical value. 
 
It is of paramount importance that physiotherapists attain the required evidence 
based knowledge that may be applied to their musculoskeletal clinical practice.  This 
includes correct interpretation of the medical literature and engagement with medical 
professionals to achieve high quality information and clinical credibility in any 
screening process.  In order to develop an improved red flag screening process for 
serious pathology related to the cervical spine the following research aim and 
questions have been developed to achieve this process. Chapter 3 describes the 
methodological processes developed to address the research aim and questions. 
 
2.10 Research aim  
The overarching aim of this study is to develop a list of red flag clinical indicators of 
possible serious cervical spine related pathology presenting as a musculoskeletal 
disorder.   
 
2.11 Research questions (RQ) 
RQ1. “What pathologies including their signs and symptoms and risk factors should 
be considered as red flags when screening for serious pathology in neck related 
musculoskeletal disorders in the adult population?” 
 
a) “What risk factors and signs and symptoms may indicate the presence of 
Cervical Arterial Dysfunction (CAD)?”   
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b) “What features of headache and/or neck pain are likely to indicate the 
presence of serious pathology e.g. CAD?” 
 
c) “What features of dizziness and what clinical tests would aid MSK 
physiotherapists’ differential diagnosis of a peripheral versus central cause of 
dizziness?” 
 
d) “What clinical tests, signs and symptoms of cervical myelopathy (CM) have 
been identified in this presentation that should be used to screen for this 
pathology?” 
 
.
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Chapter 3. Methodology 
 
3.1 Development of the research methodology 
One method of contributing to the knowledge base is to seek a consensus of the 
medical profession on key issues regarding screening and differentiation of 
conditions, such as cervical arterial dysfunction and cervical myelopathy. The Delphi 
technique and Nominal Group Techniques are consensus methods. The latter uses 
a highly structured meeting to gain information from experts.  This method was not 
considered practical for this study due to the anticipated difficulties and complexities 
involved in recruiting and convening a group of specialist medical consultants. 
Therefore, this option was rejected. The Delphi technique, however, was considered 
as a suitable method, which is designed to gain a consensus where there is 
incomplete knowledge or uncertainty in clinical issues (Jones and Hunter 1995; 
Powell 2003; Skulmoski et al 2007; Hung et al 2008).  An example is Smart et al’s 
(2010) Delphi approach using expert clinicians to achieve a consensus in 
establishing clinical indicators of pain mechanisms in musculoskeletal disorders.  
 
The Delphi technique is an iterative survey process used to collate expert opinion 
over a series of sequential rounds, which are interspersed by feedback from the 
previous round (Powell 2003; Skulmoski et al 2007; Hung et al 2008).  However, 
immediate progression to a Delphi survey approach would be making an 
assumption that there was indeed a problem with red flag screening for serious 
pathology in neck pain or neck related disorders.  As the literature review was 
conducted by a single researcher, additional input was considered appropriate to 
gain opinions from physiotherapists on three key components before progressing to 
a Delphi survey (The Delphi technique is discussed in section 3.3).  Therefore, a 
subset of aims was constructed specifically for the focus group.  This subset is listed 
in 3.1.1: 
 
3.1.1 Subset of aims specific to focus group 
1) Gain additional opinions on the researcher’s suggestion that a knowledge 
gap exists for red flag screening of serious pathology in neck pain or neck 
related disorders. 
2) Seek opinion on relevant key sub-topics within this red flag screening 
process. 
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3) Seek opinion on a format for which to present these key sub-topics that will 
aid clinical decision making. 
4) Seek opinion to establish if gaining input from medical experts would be 
considered beneficial to addressing areas of incomplete knowledge or 
uncertainty in clinical areas. This could help support the literature review 
findings. 
 
3.1.2 Mixed methodology research design 
A mixed qualitative and quantitative methodological design was considered 
appropriate to address the research questions within this study, as listed in section 
2.11.   
 
The study’s aim to inform clinical practice by developing a clinical screening list of 
red flag clinical indicators of possible serious cervical spine related pathology 
presenting as a musculoskeletal disorder would be created through a 3-phase 
process that followed the literature review: 
 
Phase 1 – Expert physiotherapists focus group that informs phase 2 and 3 
 
Phase 2 - Develop draft clinical chart based on information gained through 
focus group discussion and findings established from literature review.  The 
aim of the clinical chart is to present pathology related clinical symptoms and 
signs within one accessible resource that supports clinical decision making 
for physiotherapists.  This clinical information will provide context and detail 
to support the final list of red flag features established through phase 3 
 
Phase 3 – 3-round Delphi survey of medical experts (including pilot for 1st 
round). 
 
The research design, including phases 1-3, is displayed in Figure 3.1: 
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Figure 3.1: Research design 
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detection of red flag neurological and neurovascular pathologies presenting as, or 
alongside, a musculoskeletal disorder.  Strengths in the qualitative aspect of this 
research design are; it allows flexibility that enables the researcher to adjust their 
focus on data collection processes, and it allows the researcher to be close to the 
data and research material, which can be tested in subsequent quantitative studies 
if required (Bowling 2010 p.380). 
 
Within a qualitative approach researchers using a Qualitative Description (QD) 
method are considered to be closer to their data compared to researchers 
conducting grounded theory, phenomenologic, ethnographic or narrative studies 
(Sandelowski 2000; Neergaard et al 2009). Sandelowski (2000) considers that QD 
involves reporting the facts of the event or situation in the everyday language of 
these occurrences, whereas other qualitative approaches (e.g. grounded theory, 
phenomenologic, ethnographic or narrative studies) require the researcher to have a 
reflective or interpretive interplay on their observations, thus reporting or 
representing such events in different terms (Sandelowski 2000; Neergaard et al 
2009).  Qualitative description is not free from interpretation. However, less 
inference is generated and the results are likely to achieve a consensus from 
researchers (Sandelowski 2000). A low level of inference could be construed as a 
limitation of QD as it reduces the depth of discussion in general terms (Neergaard et 
al 2009).  Additionally, the QD approach remains flexible and may be utilised with 
aspects of other qualitative approaches (e.g. grounded theory, phenomenologic, 
ethnographic or narrative) integrated into the study design, dependent on its 
objectives (Sandelowski 2000; Neergaard et al 2009). 
 
QD is the least theoretical of the qualitative approaches; however, it is founded on 
existing knowledge or evidence base with thoughtful conduits to such work and 
experience of the research group (Neergaard et al 2009).  This is a valuable 
component of this research design, which aims to inform clinical practice through 
several stages of interactions with two professional groups; Physiotherapists and 
medical consultants, where opinions and recommendations on clinical practice and 
clinical indicators would be received.  However, flexibility should not be sought at the 
expense of sacrificing methodological organisation and rigour (Bowling 2010 p.379). 
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The results of a QD study offer great potential in the provision of information to 
develop service delivery, which is a reason for increasing use of this methodological 
approach by clinical expert nurses (Sullivan-Bolyai et al 2005).  However, Sullivan-
Bolyai et al’s (2005) study used a QD approach to develop and refine interventions 
in persons with health disparities, whereas this study aims to use this approach with 
service providers to develop construction of a questionnaire. The QD design 
provides a method whereby participants’ constructive suggestions may be identified 
and utilised to inform development of clinical practice (Sullivan-Bolyai et al 2005). 
 
QD is the method of choice if data is not generated or interpreted from the existing 
evidence base.  However, the subsequent descriptive summaries for example, the 
findings from focus groups, can be used to generate future theory-based research 
(Sandelowski 2000; Neergaard et al 2009).  Reporting in QD describes the 
experiences or opinions in a language similar to the informants or participants.  This 
study’s participants are senior clinicians, therefore lending itself to the inclusion of 
technical descriptions within the summaries, if considered appropriate.  This creates 
added potential for development of the third phase (Delphi method) of this project.  
QD methodology is an appropriate form of qualitative enquiry in a mixed method 
design prior to questionnaire development (Sandelowski 2000; Sullivan-Bolyai et al 
2005; Neergaard et al 2009; Peerman et al 2013). 
 
3.2. Focus groups 
Focus groups are a method used to collect qualitative data from a focused 
discussion that is both inductive and naturalistic.  This method can be used for 
constructing questionnaires (Krueger and Casey 2000 p. 18-19) or as a Delphi study 
first round to generate qualitative comments (Keeney 2000 in Keeney et al 2006; 
Hasson and Keeney 2011).  Focus groups are useful if a range of views or opinions 
are needed on a specific issue.  For example, they have been used to good effect 
before designing a questionnaire for patients’ priorities regarding outpatient 
physiotherapy care (Peerman et al 2013).    Pagé et al’s (2012) qualitative approach 
to investigate psychosocial services associated with congenital heart disease 
combined a focus group and survey method with the same participants. Geller and 
Holtzman (1995) used focus group methodology in a medical context with 
physicians to gain their perceptions on genetic testing then subsequently 
summarised these perceptions.   
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3.2.1 Focus group construction 
A focus group method involves a group interview, typically consisting of 6-10 
participants and lasting between 1-2 hours duration (Petty et al 2012).  Stewart et al 
(2000 p.37) also report that focus groups may consist of 8-12 participants.  
Whereas, Krueger and Casey (2000) consider the ideal group size to be between 6-
8 participants in non-commercial topics, and observe that smaller numbers of 4-6 
are becoming more popular due to easier to recruit and to host.  However, fewer 
than 6 participants may be considered not ideal for optimal discussion (Stewart et al 
2007 p.58).  Participants may be a homogeneous group with similar backgrounds or 
a heterogeneous group with different backgrounds or experiences (Petty et al 2012).  
The focus group is usually audio or video-recorded for subsequent analysis.   
 
Focus group methodology typically consists of 3-4 groups with any one type of 
participant (Krueger and Casey 2000 p. 26) or 4-12 groups (Litoselliti 2003) to 
achieve a point of “saturation”.  Saturation is a term used to describe the point 
where no new data or ideas have been generated (Krueger and Casey 2000 p.26).  
However, 1-2 focus groups may be appropriate dependent on the purpose of the 
study and where the focus group sits within the research agenda to which they are 
applied.  The key aspect of successful integration of a focus group is ensuring that it 
is consistent with the objectives and purpose of the study (Stewart et al 2000 p.39). 
 
The inconsistencies in reporting the number of focus group discussions conducted 
within individual studies was addressed in a methodological study of sample size 
reporting in focus group studies (Carlsen and Glenton 2011).  Carlsen and Glenton 
(2011) identified 220 papers involving focus group methodology in various forms 
and considered there was poor reporting of sample sizes.  The number of focus 
groups conducted within these papers varied considerably (mean 8.4, median 5, 
range 1 to 96).  Eleven studies used one focus group and typically involved 
questionnaire design. Carlsen and Glenton (2011) conclude that further evidence 
based guidance is required to assist in deciding on sample size.  The authors also 
considered that ”saturation” point was inconsistent or unconvincing reports of the 
iterative process in reaching this point, although there were several examples of 
adequate reporting.  In relation to this red flag project, it is important to consider 
Stewart et al’s (2000 p.39) considerations that successful integration of a focus 
group is ensuring that it is consistent with the objectives and purpose of the study.  
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Stewart et al (2000 p.40) cites Krippendorf (2004) to describe two types of data: 
emic and etic.  Emic data arises in a natural or indigenous form, whereas etic data 
represents a researcher’s imposed view.  Focus group interviews are likely to be 
closer to the emic end of the continuum, whereas a survey design is closer to the 
etic end of the spectrum.  This concept helps consider how focus groups may be 
used for both exploration and confirmation purposes if questioned against the choice 
of other research tools, such as a questionnaire design.  An exploratory purpose is 
typically used at the early phase of a research project (Stewart et al 2000 p.40).  A 
focus group approach in this study is utilised in an exploratory context to gain 
opinion on particular clinical issues within physiotherapy practice.   
 
3.2.2 Focus group bias 
Researchers should be cautious of introducing bias into the focus group approach 
(Krueger and Casey 2000; Stewart et al 2000).  Selection bias may develop in ways 
that are not obvious which has potential to reduce the quality of the study.  To 
counteract this, Krueger and Casey’s (2000 p.80-81) recommendation is that all of 
the target population has an equal chance of selection and that randomisation is 
only effective if prospective participants meet the selection criteria.   
 
Stewart et al (2000) also advise caution on introducing moderator bias; however, 
there is no single most effective style or type of moderator to lead a focus group.  
This role should be adapted in order that the strategy and moderator suit the 
function of the group.  Kennedy (1976 in Stewart et al 2007 p.85) identifies three 
different sources of moderator bias that may potentially affect moderator objectivity: 
 
 Personal bias; reinforcing points of view commensurate with the moderator’s 
own perspectives.  This was considered as a risk within this study. 
 Unconscious needs to “please” the client; reinforcing points of view 
commensurate with the moderator’s own perspectives.  This was not 
considered as a risk of bias within this study. 
 The need for consistency; the predisposition to reinforcing points of view that 
are internally consistent.  This was considered as a risk within this study. 
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3.2.3 Focus group analysis – How much? 
The extent of focus group analysis varies with the purpose of the research, 
complexity of research design and the extent of which how efficiently the researcher 
may reach conclusions’ based on simple analyses (Stewart et al 2007 p.109).  This 
range of analyses may vary from requiring no formal documentation due to quickly 
ascertained obvious conclusions to more detailed reports, such as to inform product 
design or service delivery.  Therefore, the depth of analysis and level of rigour will 
be dependent on the purpose of the research project combined with the cost-benefit 
of carrying out analysis at a given level (Stewart et al 2007 p.110). Refer to section 
3.6.2.5 for a more detailed discussion on focus group analysis. 
 
3.3 Delphi technique 
As previously stated, the Delphi technique is an iterative survey process used to 
collate expert opinion over a series of sequential rounds, which are interspersed by 
feedback derived from previous responses (Powell 2003; Skulmoski et al 2007; 
Hung et al 2008).   
 
The Delphi method is considered as an effective method for this systematic 
collection and aggregation of informed judgement e.g. achieving a consensus or to 
forecast future events, by a group of experts on specific questions and issues (Hung 
et al 2008; Reid 1988 in Hasson and Keeney 2011 p. 7).  An example of such issues 
or situations is where frequent clinical or practical judgements may be encountered 
in the presence of incomplete empirical evidence to support evidence-based 
decision making (Cook et al 2005). 
 
There are various forms of Delphi technique, such as ‘modified Delphi’ where 
panellists are presented with pre-selected items; the ‘policy Delphi’ designed to 
inform policy decision-makers; ‘Technological Delphi’ with the aims varying 
dependent on research design, such as predicting future events; and the ‘classical 
Delphi’ designed to elicit opinion and gain consensus (Keeney et al 2006; Hasson 
and Keeney 2011). This study is interested in the ‘classical Delphi’, however, 
Hasson and Keeney (2011) consider that whichever approach is taken the generic 
aim is to determine, predict and explore group attitudes, needs and priorities. 
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3.3.1 Delphi technique critique 
The variations in design are likely to have different characteristics with different aims 
that are reflective of the situation, target participants and administrative 
requirements (Hasson and Keeney 2011).   For example the number of rounds, level 
of anonymity and feedback provided, inclusion criteria, methods of sampling and 
analysis.  These differing methods will also have accompanying variances in quality 
of outcomes.  This combination has contributed to considerable criticism of this 
technique with regards to its ability to achieve acceptable levels of reliability and 
validity (Powell 2003; Hasson and Keeney 2011).  Hasson and Keeney (2011) also 
identify the Delphi technique to contain other challenges, such as defining a 
consensus level, the expert level, and the number of Delphi method variations that 
are available.   
 
Strengths and weaknesses of the Delphi method have been discussed in a number 
of studies (e.g. Jones and Hunter 1995; Kennedy 2003; Powell 2003; Hung et al 
2008; Hasson and Keeney 2011).  These are highlighted below: 
 
3.3.1.1 Delphi weaknesses / criticisms 
 Anonymity could lead to a lack of accountability of views or perhaps expressing 
opinions without full thought; however, this critique could also be applied to any 
type of questionnaire design e.g. postal, and the engagement of participants 
over sequential rounds is likely to negate this critique. 
  Consensus approach may lead to a diluted version of best opinion. 
  Concerns over administration and analyses involved over three rounds. 
 A consensus does not equate to achieving the correct answer nor is the method 
a replacement for rigorous scientific reviews. 
 Criticised as a method that forces a consensus with no scope for experts to 
elaborate on responses.  Therefore, this study included multiple opportunities for 
comment after each section.  This helped keep comments fresh and relevant to 
thought process at this time.   
 Criticised in relation to its reliability and validity.  
 Feedback mechanism may lead to conformity rather than consensus. Possible 
problems in developing initial questionnaire. 
  No accepted guidelines for establishing consensus, sample size or sampling 
techniques; 
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  Time delays between rounds (data collection process); requires time/participant 
commitment, particularly over typical 3-rounds. 
 
3.3.1.2 Delphi strengths 
 Anonymity counteracts dominant character effect as may be observed in 
meetings and avoids direct confrontation. 
 Possibly motivational and educational for participants e.g. an opportunity to 
compare their opinions to peers without judgement.  
 Focused, avoiding distraction and combines a collective opinion. Allows 
thoughtful consideration, particularly compared to a meeting setting.  
 Validity – content is driven by the panel. Applicable where clinical uncertainty 
exists and for informing on planning future studies 
 The Delphi technique enables contact with a group of relevant experts without 
geographical restriction and high costs. However, low costs benefits may be 
counter-argued with the extensive time commitment required to administer a 
Delphi method. 
 
3.3.1.3 Delphi technique methodological rigour 
The criticism of the Delphi method in relation to its reliability and validity may be 
levelled at any qualitative research method (Keeney et al 2001). Hasson and 
Keeney (2011) explore the rigour of the Delphi technique with consideration to the 
“holy grail” of research is establishing methodological rigour as the researcher’s 
responsibility to ensure procedures are conducted to produce dependable results.  
Hasson and Keeney (2011) provide a useful deconstruction of the methodological 
rigour for quantitative methods and how this transfers to qualitative studies.  Within 
quantitative studies this involves reliability and validity, whereas in qualitative 
studies, methodological rigour is measured by applying components of 
trustworthiness.  This consists of credibility (comparable to internal validity), 
dependability (in lieu of reliability referring to stability of data), confirmability 
(conveying neutrality) and transferability (external validity and application to other 
settings) (Hasson and Keeney 2011).   
 
Hasson and Keeney (2011) report key methodological and contextual challenges to 
establishing rigour in a Delphi study with measurement and continuing modifications 
being key examples. Reliability and validity are aligned with a positivist or scientific 
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approach (seeking prediction); whereas trustworthiness is more aligned with an 
interpretive perspective (exploring and understanding situations). Thus, “transferring 
such measurements between paradigms is problematic, since both are based on 
different underlying philosophies” (Hasson and Keeney 2011 p.1696). In addition, 
Hasson and Keeney (2011) consider that the frequent variations of modifications of 
this method create challenges to testing rigour.  Methodological rigour is explored 
further in section 3.5.3. 
 
3.4 Ethics  
A change in NHS ethics policy was implemented in September 2011, which states 
that NHS ethics approval is not required for questionnaires/surveys involving NHS 
staff.  However, the NHS ethics policy officer (Scotland) recommends submitting the 
research proposal to the ethics office, where a letter of confirmation will be issued. 
This was obtained (Appendix B).  In addition, the Researcher’s host NHS health 
board’s Research and Development (R&D) office was informed in accordance with 
local procedures. The study was assessed as not requiring R&D Management 
approval.  However, it had been noted by the Research Governance Committee 
(Appendix C). 
 
The host university’s Divisional Research Ethics Committee (DivREC) procedures 
were followed (Appendix D) with consent achieved (Appendix E).  The Researcher 
made minor amendments to the study’s original recruitment strategy and 
subsequently informed DivREC as per local policy (Appendices F and G). These 
changes were accepted (Appendix H).  
 
3.5. Objectives 
Following the detailed literature review used to develop materials for a focus group, 
the objectives for each phase of this study are: 
 
Phase 1: 
 1. Facilitate a focus group (physiotherapists) that will prioritise the research 
literature and review main findings (from a musculoskeletal physiotherapy 
perspective) for inclusion in a red flag clinical chart. This will also reveal areas of 
consensus and lack of consensus in preparation for presenting material in the 
Delphi process. 
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Phase 2: 
2. Construct a draft clinical chart to provide physiotherapists with an initial list of red 
flags indicators for possible serious pathology in neck pain or neck related disorders. 
The chart additionally aims to provide information from the literature review to inform 
clinical decision making that underpins these red flag features.   
 
Phase 3: 
3. Conduct a Delphi process with medical experts where iterative exploration of the 
findings formulated from 1 and 2 will allow these to be refined.   
 
Final outcome: 
4. Formulate a list of red flags that may be applied to clinical practice to help detect 
early indicators of serious pathology presenting as, or alongside, cervical spine 
musculoskeletal disorders. This list may be presented in a final version of the clinical 
chart (point 2.) 
 
3.6 Application of the study design 
3.6.1 Study design overview 
The objectives outlined in section 3.5 will be achieved by the study design displayed 
in Figure 3.1 (section 3.1.2) and detailed below for phases 1-3. 
 
3.6.2. Phase 1: Focus group 
3.6.2.1 Participants:  Inclusion criteria 
Inclusion criteria for focus group participants were detailed as follows: 
 
1. UK based physiotherapists: 
 National Health Service (NHS) clinical consultant / senior grade or private 
practitioner with 5-years post-graduate clinical experience; or university 
physiotherapy lecturer with publications in relevant areas; or lecturer in 
spinal component of post-graduate Master of Science (MSc) degree in 
Neuromusculoskeletal Physiotherapy/Manual Therapy; 
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(An NHS physiotherapy senior grade will typically complete 2-3 years post-graduate 
rotational work in a junior physiotherapy role before being considered suitable for 
selection to a senior physiotherapy position). 
 
And; 
 
2. Members of the Musculoskeletal Association of Chartered Physiotherapists 
(MACP). 
The MACP is a clinical sub-group of the Chartered Society of Physiotherapy.  In 
addition to their undergraduate training, MACP members undertake extensive 
postgraduate study to reach a recognised standard of excellence in 
neuromusculoskeletal physiotherapy (http://www.macpweb.org).   
3.6.2.2 Participants:  exclusion criteria 
Exclusion criteria for focus group participants were detailed as follows: 
 
1.  Non-UK based physiotherapists, or 
 
2. UK based physiotherapists not meeting professional experience detailed in 
inclusion criteria point 1, or 
 
3. Non-members of the MACP. 
 
3.6.2.3 Recruitment 
A purposive sampling method was used as the recruitment strategy.  Permission 
was gained from the MACP to contact their membership. The MACP circulated the 
focus group recruitment call (Appendix I) to its membership. Interested members 
were requested to contact the researcher directly for additional information 
(Appendix J). 
 
Twenty-nine prospective participants contacted the researcher to request additional 
information or to acknowledge the research call for participants.  This number 
progressively reduced due to logistical issues, such as unable to attend for 
geographical reasons or other prior commitments.  In addition, a number of 
interested participants did not have access to video-link.  Three did not re-contact 
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following receipt of the information sheet.  The final number of prospective 
participants reduced naturally to seven confirmed participants.  Therefore, no 
additional selection process was required. Table 3.1 summarises the prospective 
participants’ responses with final status of participation or non-participation 
alongside reasons cited for this outcome:  
 
Table 3.1: Prospective participants’ responses with final status of participation or non-participation with 
reasons cited for this outcome 
Prospective 
participant no’s 
Participated or Reasons cited for non- participation 
7 Participated 
1 Withdrawal without reason pre-focus group 
9 Distance too far to focus group location (Edinburgh) and unable 
to establish video-link facilities 
9 Acknowledged research call for participants expressing best 
wishes with project, but cited unavailable due to various 
reasons; work/course commitments, work part-time only, based 
outwith UK (USA), specialist interests had developed in other 
areas. 
3 No follow-up 
 
 
All prospective participants were based within the National Health Service except;  
 4 were employed as university physiotherapy lecturers,  
 2 worked within independent healthcare,  
 1 worked in private physiotherapy practice, and 
 1 was based overseas (on career break, but maintaining specialist 
knowledge) 
 
Figure 3.2 outlines the focus group recruitment process. 
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Figure 3.2: Focus group participant recruitment process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2 displays the focus group participants’ demographic information.  These 
positions are all classed as consultant or senior positions.  
Focus group participant recruitment process 
Forward research call (Appendix I) for participants to 
administrator of the clinical interest group 
Musculoskeletal Association of Chartered 
Physiotherapists (MACP)  
Prospective participant contacts researcher to register 
their interest / request more information 
Ensure information sheet provided (Appendix J), plus 
oral explanation if requested 
 
 
Consent form issued (Appendix K) 
Participant formally recruited  
Consent form returned via personalised work email 
(includes participant having gained any relevant 
permissions to participate).  
 
Participant confirms intention to participate 
MACP administrator circulates research call to 
members  
Inclusion criteria:  
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Table 3.2: Focus group participants’ demographic information 
 
Identifier 
 
Experience 
 
Years 
qualified 
 
Education 
level 
 
Geographic 
location 
 
Participation 
 Method 
 
1 Clinical (Lead 
MSK 
Physiotherapist) 
>10 PhD South East 
Scotland 
Attendance 
2 Clinical 
(Extended 
scope 
practitioner – 
ESP)  
>10 PhD North 
England 
Attendance 
3 Clinical 
(Consultant) 
>10 MSc West 
Scotland 
Attendance 
4 Clinical 
(Combined 
manager and 
clinical role) 
>10 MSc North 
England 
Video-link 
5 Clinical (Senior) >10 Post-graduate 
diploma 
North 
England 
Video-link 
6 Clinical 
(Principal 
Physiotherapist) 
>10 MSc South East 
England 
Video-link 
7 Clinical (ESP) >10 MSc South West 
England 
Video-link 
 
 
3.6.2.4 Focus group procedure 
Focus group participants may be asked to prepare for the group discussion (Krueger 
and Casey 2000 p.55).   An information pack was prepared and circulated to 
participants to assist in their preparations for discussion.   This pack, which is part-
displayed in Appendix L, outlined the background problems, research questions, 
summaries of research findings relative to these questions, and a format for the 
discussion. 
 
 
 
  68 
The aims of the focus group were to: 
 
 1) Identify priority areas for inclusion in a clinical screening chart; 
 2) Discuss any inconsistencies’ in the literature; and, 
 3) Discuss the potential structure of the clinical chart (Figure 3.3 is the initial 
clinical chart design provided within the information pack and presented on 
screen during the focus group discussion). 
 
 
 
Figure 3.3: Initial clinical chart design presented to focus group for discussion 
 
Keeney et al (2006) report several studies with their personal involvement that used 
the literature to inform the basis of their interviews or focus groups as part of a 
Delphi process.  Although Keeney et al (2006) provided opportunity to raise new 
issues or ideas, they do however, note caution on introducing bias with participants 
feeling psychologically pressured in not altering their opinions against peer-reviewed 
literature.   
 
The focus group was conducted through a combination of attendance for those 
participants able to attend and video link for participants based further afield.  Three 
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participants attended the host venue and four participants engaged through three-
video-links in England.  The discussion was facilitated by the researcher as a single 
moderator. 
 
Videoconference (VC) facility was provided through the host university. Connections 
were established using Integrated Services Digital Network (ISDN) or via the JANET 
Videoconferencing Service (JVCS), dependent on participants’ VC facility.  A VC 
test was conducted 5-days before the focus group discussion to ensure quality of 
visual and video connections.  Following testing, two support audio-links were 
established as reserve in the event of loss of VC connection.  
 
The information pack was discussed alongside contributions of participants’ 
experiential knowledge and opinions (Bohnsack 2004).  The focus group discussion 
was recorded through audio and video means.  The video-recording was 
downloaded whilst logged onto the secure JANET server and transferred to an 
encrypted information systems device.  The audio recording was transferred to the 
same encrypted system before file deletion from the recording device. 
 
3.6.2.5 Focus group data analysis 
Analysing the obtained data is considered as the most difficult phase of focus group 
research.  This requires decisions on who will perform the analysis, what method will 
be used and to what extent of analysis will be conducted (Litoselliti 2003).  Various 
methods of analysis may be chosen dependent on the anticipated outcomes of the 
project or guided by time or budget constraints (Krueger and Casey 2000 p. 130-
131; Litoselliti 2003)  
 
Qualitative content analysis is the strategy of choice in Qualitative Descriptive (QD) 
design (Sandelowski 2000).  Although content analysis is a specific research tool, it 
is composed of features similar to other types of research, such as data making, 
reduction, analysis and validation (Stewart et al 2007 p.120).  This type of analysis 
takes a dynamic form that is shaped to summarise the informational content of the 
data.  Codes or themes are generated from data, which differs to quantitative 
content analysis where the researcher systematically applies a pre-existing set of 
codes to the data (Sandelowski 2000).  However, in qualitative content analysis the 
researcher may also start with pre-existing codes. This coding system may be fluid 
or undergo change throughout the analysis e.g. dependent on how the information 
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best represents its source (Sandelowksi 2000).  This was particularly relevant to this 
study.  The focus group information (literature) pack containing formulated questions 
with sub-categories of literature with flow of pathologies and associated symptoms 
served as pre-existing codes. The content and organisation of this information is 
considered as the least interpretive of the qualitative analysis processes; however, it 
is presented in a way that best suits the data as it is from its own source 
(Sandelowki 2000).   
 
A transcript-based analysis may involve an unabridged (full) transcript or it may use 
abridged transcripts.  The researcher will typically read the full transcript and make 
notes, code sections or develop categories of the group discussion (Krueger and 
Casey 2000 p. 130-131; Litoselliti 2003).  However, unitising all of the discussion is 
generally not practical or is a regular requirement (Stewart et al 2007 p. 122).  An 
abridged transcript should be used by a member of the research team with a 
thorough understanding of the purpose of the project as this involves constructing a 
transcript of the relevant and useful portions of the discussion to form a condensed 
version (Krueger and Casey 2000).   This method allows for removal of irrelevant 
components of the discussion. 
 
A notes based method is based on the researcher’s field notes or observations, but 
may use the audio or video recording as back-up for clarification.  The advantage of 
this method is speed (Krueger and Casey 2000).  However, as a single researcher 
the notes based method was not considered robust as the degree of note taking 
was limited due to performing the function of moderator.  This reduced the capacity 
to record detailed notes.  The researcher may have a number of functions in the 
focus group: moderator, listener, observer, and analyst using an inductive process 
to foster an understanding of the topic for discussion, as opposed to testing a 
hypothesis (Krueger and Casey 2000 pp.11-12).  Krueger and Casey (2000) also 
describe a memory based approach, which requires considerable skill and 
experience in this methodology; and a long table approach involving the laying-out 
and cutting of the transcript and compiled into themes.  This low-technology method 
was considered too laborious for the purpose of this phase. 
 
The method selected, therefore, was a combined approach incorporating a full 
transcript compiled of the group discussion followed by an abridged version.  As a 
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single researcher this provided an additional check with each version constructed 
from the audio and/or video-recording.   
 
Litoselliti (2003) recommends the analyst works closely with the transcriber to be 
closer to the data and to read the transcript for general impression before focusing 
on the substantive aspects of the transcript related to the research questions.  
However, Litoselliti (2003) also outlines the advantage of the researcher analysing 
their own focus group data.  This creates an opportunity to think about the material 
as it is collected and processed.  The latter method of the researcher processing the 
data was used in this project to facilitate a thorough analysis and recollection of 
observations to occur at an early stage.   Reading the transcript for an initial 
impression enabled a seamless extension of early analysis as the researcher 
transcribed this discussion.    
 
A final stage of data making is recording data in a way to ensure reliability and 
meaningfulness (Stewart et al 2007). A thematic content was established as 
described above from the formulated questions with sub-categories of literature to 
prioritise clinical sections for inclusion in a clinical screening chart and identify a 
potential suitable format for presentation.  Thematic content is a method frequently 
used in focus group analyses and provides a framework for a more systematic 
analysis of this data type.  This method of analysis should be led by the focus of the 
research and the researcher’s ability to achieve reliability in the coding system 
(Stewart et al 2007 p.120).   The condensed version / summary of the discussion 
was circulated to the group participants.  This served a dual purpose of providing 
feedback to participants with the opportunity to respond should any discrepancies 
be identified, and to enhance the trustworthiness of the data through providing this 
feedback mechanism. 
 
The outcomes from the focus group discussion were used to inform construction of 
phases two (development of draft clinical chart) and three (Delphi survey) of this 
study.  
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3.6.3 Phase 2: Development of draft clinical chart 
As outlined in sections 3.1.2 and 3.5, phase 2 involves development of a draft 
clinical chart designed to provide physiotherapists (or other non-medical 
practitioners) with pathology related clinical symptoms and signs within one 
accessible resource that supports clinical decision making.  This clinical information 
will provide context and detail to support the final list of red flag features produced 
as an outcome of phase 3 (Delphi survey). 
 
An initial chart design (Figure 3.3 section 3.6.2.4) was presented to the focus group 
participants for their opinion regarding its potential for development as a tool to 
support clinical decision making.  This draft clinical chart was developed using 
Mindjet Manager Version 9 for Windows (http://www.mindjet.com) to include 
information obtained through literature review.  The original file was saved and 
converted to an interactive pdf. format (Appendix M – electronic version has 
embedded pdf.  Hard copy - refer to CD attachment inside rear cover for full view) 
for distribution to the expert panel.  Examples of images extracted from this clinical 
chart are displayed in Figures 3.4 and 3.5.  Figure 3.4 is displayed to a size that 
provides readability of the core features, whilst Figure 3.5 is reduced to demonstrate 
the drop-down feature within the main chart.  The draft clinical chart was forwarded 
to Delphi participants as preparation for phase 3.  The final version of the full clinical 
chart will be progressed outwith this study to identify the red flag features through 
phase 3. 
 
 
 
 
  
 
 
 
 Figure 3.4: Image of draft clinical chart showing quick reference red flag section with main sub-topics below
 Figure 3.5: Image of draft clinical chart showing a drop-down feature of a main clinical sub-topic 
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3.6.4 Phase 3: Delphi survey 
3.6.4.1 Delphi survey overview 
As previously stated the Delphi technique is typically a 3-round process considered 
as a suitable method to gain a consensus where there is incomplete knowledge or 
uncertainty in clinical issues (Jones and Hunter 1995; Powell 2003; Skulmoski et al 
2007; Hung et al 2008).  This ‘classic’ approach involves presenting a questionnaire 
to a panel of experts or informed individuals within a specific field to gain a 
consensus (Keeney et al 2006).  Questionnaires are returned, analysed and 2nd 
round questionnaire developed from responses.  This is forwarded to the same 
participants for completion. The second-round responses are analysed and used to 
construct the third-round questionnaire.  This is forwarded to participants with group 
feedback returned to provide participants’ with the opportunity to reconsider their 
responses relative to the group response (Jones and Hunter 1995; Powell 2003; 
Keeney et al 2006; Skulmoski et al 2007; Hung et al 2008).  Keeney et al (2006) 
suggest that individual responses are returned with group responses to participants 
for the first and second rounds.  However, this first round return method was not 
employed by Rushton and Moore (2010) and Smart et al (2010).  In addition, the 
anonymity provided to participants through the web-based survey method in this 
study does not provide individual identities for this to occur.  Feedback is 
recommended in the form of summary statistics e.g. histograms or graphical 
representations.  This enables participants to consider their rankings relative to 
other participants (Jones and Hunter 1995).   
 
3.6.4.2 Participants – selection and numbers required 
3.6.4.2.1 Participants: Delphi inclusion criteria 
Inclusion criteria for Delphi survey participants were detailed as follows: 
 
1. Consultant neurosurgeon or neurologist 
2. Currently practising within respective specialty 
3. Based within the UK or Ireland 
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3.6.4.2.2 Participants: Delphi exclusion criteria 
Exclusion criteria for Delhi survey participants were detailed as follows: 
 
1. Neurology or neurosurgical grades below consultant level e.g. specialist 
registrar  
2. Non-practising consultants e.g. retired 
3. Based out with the UK or Ireland 
 
The selection of qualified participants is critical to a successful Delphi.  Participants 
or ‘experts’ should be selected for their knowledge within a chosen field and 
commitment to a group process.  Clinicians within a specific clinical field may be 
considered as experts and considered appropriate for this selection process 
(Gordon 1994; Powell 2003; Skulmoski et al 2007; Hung et al 2008).  Selection bias 
should be avoided, such as selection on the basis of acquaintance (Powell 2003; 
Mitchell 1991 in Hung et al 2008 p.192;).  Skulmoski et al (2007 p.4) identifies four 
requirements for “expertise”:  
 
1. Knowledge and experience with the issues under investigation; 
2. Capacity and willingness to participate; 
3. Sufficient time to participate in the Delphi; and 
4. Effective communication skills (p.4). 
 
Consultant neurologists and consultant neurosurgeons are medical specialists in the 
relevant areas of this study (e.g. CAD and cervical myelopathy) and form part of a 
group of medical specialists within the ‘clinical neurosciences’.  Consultant 
neurologists provide non-surgical management for central nervous problems. 
Consultant neurosurgeons may provide surgical or non-surgical management for 
central nervous system problems.  Both consultant specialties are appropriate 
medical experts relevant to this study. 
 
3.6.4.2.2 Participants: numbers required 
The numbers required to make up an expert panel vary significantly (Gordon 1994; 
Powell 2003; Keeney et al 2006; Skulmoski et al 2007; Hung et al 2008).  The scope 
of the problem and available resources may influence the number of participants in 
a Delphi (Powell 2003). In homogeneous groups a sample number between ten to 
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fifteen participants is considered appropriate (Skulmoski et al 2007).  A group of 
experts selected from within the clinical neurosciences was considered as a 
homogenous sample for the purpose of this study.  Therefore, this number (10-15) 
was used as guide to form an expert panel of medical consultants for this study.   
 
3.6.4.3 Participants – recruitment strategy 
A purposeful sampling strategy was utilised to recruit this group of medical experts, 
consisting of consultant neurologists and neurosurgeons (Skulmoski et al 2007).  
Skulmoski et al (2007) advise on the challenges around recruitment of prospective 
participants who are true experts in their respective fields due their busy schedules. 
Therefore clear communication and concise questions should be used.  
 
Participants were recruited via two methods; 
 
 1) Email distribution direct to two professional organisations’ members of their 
respective society (Smart et al 2010).  The following organisations agreed to 
circulate a research call (Appendix N) to their respective neurologist and/or 
neurosurgeon members: 
 
a) The Scottish Association of Neurological Sciences (SANS) 
(http://www.dcn.ed.ac.uk/sans/). Membership includes neurologists, 
neurosurgeons, neuropathologists and clinical neurophysiologists 
working in Scotland, trainees as well as consultants.  SANS aim is to 
improve the care of patients with neurological problems in Scotland, to 
enhance the training and education of everyone involved in that care, 
and to promote research. 
b) The Society of British Neurological Surgeons (SBNS) 
(http://www.sbns.org.uk/). The purpose of the Society is the study and 
advancement of Neurosurgery; and 
 2) Email distribution direct to consultant neurologists and neurosurgeons (Gordon 
1994).  This strategy, however, was restricted to Scotland due to limitations in 
identifying suitable prospective participants.   Skulmoski et al (2007) also suggest a 
“snowball” sampling technique to generate additional participants after an initial 
group of experts has been identified.  This was achieved through requesting a 
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consultant to share the information with their consultant colleagues if considered 
appropriate.  
 
Figure 3.6 outlines the Delphi recruitment process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Delphi study participant recruitment process 
 
Delphi study participant recruitment process  
Forward research call (Appendix N) for participants to 
specialist organisations (SANS and SBNS). 
 
 Administrator circulates research call to members  
 
Prospective participant contacts researcher to register 
their interest / request more information 
Ensure information sheet provided (Appendix O), plus 
oral explanation if requested 
 
Draft clinical chart circulated plus issued with final 
instruction to access web-based Delphi study 1
st
 round 
(Consent form contained in page 1 Delphi 1
st
 round) 
Participant formally recruited  
Informed consent (Appendix P) considered as gained 
when participant clicks web-link to Delphi study 1
st
 
round - a method used in a published Delphi study 
 
 
Participant confirms intention to participate 
Direct email contact with consultant identified within 
areas of clinical interest.  
Inclusion criteria 
checked. 
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The participants’ demographic information is detailed in Table 3.3. 
 
Table 3.3: Delphi participants’ demographic information 
 
Identifier 
 
Consultant 
 
Years 
qualified 
 
Geographic 
location 
 
Main 
professional 
setting  
 
Other 
1 Neurologist 5-9 South East 
Scotland 
NHS Academia, 
Research 
2 Neurosurgeon 10-19 North West 
England 
NHS  
3 Neurologist <5 North East 
Scotland 
NHS  
4 Neurosurgeon 10-19 South East 
Scotland 
NHS Independent 
healthcare 
5 Neurosurgeon >20 London NHS Independent 
healthcare, 
Military 
6 Neurologist >20 South East 
Scotland 
NHS Research 
7 Neurologist 10-19 West 
Scotland 
NHS Independent 
healthcare, 
Academia, 
Research 
8 Neurosurgeon <5 North West 
England 
NHS Independent 
healthcare 
9 Neurologist 10-19 South East 
Scotland 
NHS  
10 Neurologist 10-19 South East 
Scotland 
NHS  
11 Neurologist <5 South East 
Scotland 
NHS  
12 Neurosurgeon 10-19 North East 
England 
NHS  
 
 
3.6.4.4 Pilot Delphi  
A Delphi pilot is not an obligatory part of the Delphi process.  However, it may be 
applied to test and adjust the Delphi questionnaire to improve comprehension and 
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address any procedural issues or ambiguities (Powel 2003; Skulmoski et al 2007).  
A pilot Delphi method was adopted to test these purposes.  Three senior medical 
consultants within the host health board agreed to participate in this process; 
Consultant Physician, Consultant Radiologist, and General Practitioner.  The pilot 
Delphi recruitment process is outlined in Figure 3.7.  Circulation of draft clinical chart 
and informed consent followed the same process as outlined in main Delphi study.  
 
Figure 3.7 Pilot Delphi study - participant recruitment process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gain permission from NHS Borders to undertake the 
following process  
Circulate pilot study research call via poster/email or 
verbal for sample of convenience to NHS Borders 
medical practitioners  
Prospective participant contacts researcher to register 
their interest / request more information 
Ensure information sheet provided, plus oral 
explanation if requested 
 
Draft clinical chart issued with final instruction to 
access web-based Delphi study 1
st
 round  
Participant formally recruited  
Informed consent considered as gained when 
participant clicks web-link to Delphi study 1
st
 round – a 
method used in a published Delphi study 
 
Participant confirms intention to participate 
Pilot Delphi study participant recruitment process  
Inclusion criteria:   
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3.6.4.5 Main Delphi Procedure  
Delphi participants within the main study were forwarded the draft clinical chart as 
discussed in section 3.6.3. Consultants were advised that comments on the chart 
would be requested during the Delphi 1st round survey (Appendix Q).  
 
To assist reliability or consistency in the interpretation of the questions, a parallel-
form testing method was adapted as a pilot process.  Parallel-form testing is a 
process that is recommended to improve stability or reliability of the Delphi 
technique (Hasson and Keeney 2011). In this study the 1st round questions were 
submitted to three medical practitioners of consultant or experienced General 
Practitioner level to explore respondents’ interpretations of the questions (Gordon 
1994; Hasson and Keeney 2011).   
 
There is no clear guidance for undertaking pilot tests before implementation; for 
example, if this should take place before each round or before the first round 
(Keeney et al 2001).  Due to anticipated recruitment and retention challenges 
associated with busy medical staff it was decided to perform one such pilot test 
before round one.  This was considered as the most appropriate position as round 
one is related to open questions required to obtain suitable information to inform the 
construction of questionnaire contained within round two.  In addition, achieving a 
high quality and clear opening round was considered important to enhance 
retention. 
 
A small number of consultants opted to provide initial feedback through email 
correspondence.  This early feedback was combined with the pilot Delphi feedback 
to inform development of the main Delphi study.  With consideration to cautions 
outlined by several authors (e.g. Powell 2003; Skulmoski et al 2007; Hung et al 
2008) regarding the difficulties of recruitment and retention of experts the researcher 
opted to remain flexible to these methods of receiving feedback; however, all 
feedback from email communication was incorporated with the Delphi survey 
comments for analysis.   
 
An internet based system ‘Bristol Online Surveys’ (https://www.survey.bris.ac.uk/) 
was used as the data collection system over three rounds.   
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Round one consisted of three initial short questions to obtain participant 
demographic data (Table 3.2), followed by a number of questions based on 
presented information obtained from the literature review and focus group.   
Appendix Q contains the web-based version of this questionnaire.  As consultants 
had committed time to viewing the clinical chart, the 1st round survey was 
constructed with a simple strategy to request: chart feedback; consultant’s thought 
on red flag list with associated conditions that these features may indicate; plus an 
additional information section if required.  This allowed for any narrative around the 
features 
 
Open ended questions are considered to enhance the content of the data collected, 
which will then undergo qualitative analysis, and subsequently used to inform the 
structure of the questionnaire in round two (Powell 2003).  The third and final round 
questionnaire was a repeat of round two with minor modifications applied for clarity.  
These minor changes were based on additional comments received from round two 
responses.  A reminder scenario (Appendix R) was provided alongside the final 
round.  Appendix S contains the web-based version of this final round questionnaire.  
 
3.6.4.6 Delphi data analysis 
A mixed method (qualitative and quantitative) approach is utilised within the Delphi 
method.  The first round is a qualitative design using a thematic content analysis 
approach to identify key themes (Carlesso et al 2011).  A similar approach to the 
focus group analysis was employed with the coding system developed from the data 
source.  However, the Delphi first round responses were developed and assessed 
for inter- and intra-coder reliability in the analysis of the 1st round responses.  Inter-
coder reliability was checked by the researcher and one research supervisor coding 
the same response data from 3 randomly selected transcripts (Smart et al 2010). 
Intra-coder reliability was checked by the researcher coding 3 randomly selected 
transcripts on two separate occasions with a minimum of 2-days a part (Smart et al 
2010). 
 
Rounds 2 and 3 utilised a quantitative approach based on responses from round 1.   
This comprised of a set of questions/statements designed by the researcher.  The 
responses followed a five- point likert scale format (5 = strongly agree, 4 = agree, 3 
= no preference, 2= disagree, 1 = strongly disagree) and subsequently analysed 
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using descriptive and non-parametric statistics.  Kendall’s W (Kendall’s coefficient of 
concordance) was used to evaluate the level of consensus across all participants’. 
This method has been used in previous Delphi studies (Rushton and Moore 2010; 
Smart et al 2010).  Round 2 format will also allow for optional additional comments.  
As round 2 is formulated from thematic content analysis of round 1 data response, 
this enhances validity of the researcher’s interpretations by providing a facility to 
respond to any discrepancies identified by participants.  Hasson and Keeney (2011) 
recommend providing the expert panel with the opportunity to perform a check on 
the 1st round interpretation to improve construct validity. This allows for any 
necessary amendments by the researcher to occur for round three, if considered 
appropriate.  Round three contained feedback to the participants in the form of 
graph representation of the highlighting the percentage distribution of participants’ 
responses (Gordon 1994). 
 
3.6.4.7 Consensus level and non respondents 
There are no recognised guidelines for setting a consensus level (Powell 2003; 
Keeney et al 2006).  However, Keeney et al’s (2006) paper to inform research using 
the Delphi technique recommends a minimum 75%.  Therefore, this level was 
selected for gauging the consensus point.  Consensus information gained from open 
questions was compared with existing literature as a method to help gauge 
generalisability (external validity) or transferability of the findings (Hasson and 
Keeney 2011) and provides further guidance to clinicians specialising in 
musculoskeletal clinics. However, caution should be exercised in interpretation of 
Delphi outcomes as consensus does not necessarily mean that the correct answers 
have been found. 
 
Keeney et al (2001) and Hung et al (2008) report poor response rates are 
characteristic of the iterative process, with Keeney et al (2006) specifying the Delphi 
final round being susceptible to participant drop-out. Therefore, email reminders 
were sent on two occasions during each round post-initial circulation as a reminder 
to non-respondents (Smart et al 2010).  This was performed at the two and three 
week stages. 
 
Hung et al (2008) identify that motivating panellists is one method to address this 
issue with quick turnaround times in data collection recommended. A one-week 
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turnaround time was implemented from the closure of round two to the distribution of 
the final round. The time between the first and second round required an extended 
period to allow for the qualitative analysis and construction of the second round 
survey to occur.  Keeney et al (2006) suggest that it is critical for the panel to feel 
they are partners in the study. Engagement in the clinical chart from the outset and 
incorporating a ‘reminder’ scenario (Appendix R) at the beginning of round three 
communications were strategies that helped maintain interest.  Although this was a 
small study, a non-response was observed in one case only with no follow through 
to round 2 from round 1.  Opportunistic communication with this consultant reported 
this reason be due to time pressures.  Powell (2003) and Skulmoski et al (2007) 
note the difficulties in recruitment and retention of experts due to their busy 
demands from the very nature of their expertise in demand elsewhere. 
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4. Results 
 
4.1 Introduction 
Inconsistencies and limitations within the existing evidence base on the main clinical 
indicators for potential serious pathology presenting as, or alongside, cervical spine 
musculoskeletal disorders has been discussed in chapter 2. Chapter 3 subsequently 
outlined a study design aiming to contribute to this evidence base to improve 
musculoskeletal physiotherapy screening for serious pathology. 
 
The main findings from two phases within this study design are presented in this 
chapter: phase 1 focus group with experienced physiotherapists, and phase 3 Delphi 
survey (3-round method) involving medical consultants.  Phase 2 involved the draft 
clinical chart, which linked phases 1 and 3.  The progression of this chart was 
presented in chapter 3 (methodology). Figure 3.3 (section 3.6.2.4) is the initial chart 
design presented to the physiotherapy focus group with Figures 3.4 and 3.5 displaying 
examples of the chart content presented to the Delphi participants in preparation for the 
Delphi survey method.  This may be viewed in Appendix M (electronic version has 
embedded pdf.  Hard copy - refer to CD attachment inserted inside rear cover).  
 
Table 4.1 provides an overview of the main themes presented in this chapter. These 
themes were identified and explored through phases 1 and 3. The prevalent findings 
that have emerged from these themes will be identified throughout this chapter.  The 
relationship of these findings to the current evidence base with implications for clinical 
practice will be discussed in chapter 5. 
 
This chapter contains a number of sections of literature presented as direct quotes or 
summaries by the researcher in order to facilitate or prompt discussion.  These sections 
are indented to assist clarity in this presentation and to differentiate this information 
from additional commentary provided by the researcher.  Similarly, all discussion based 
comments / responses are indented and coded by respective speaker for clarity 
(Researcher or Focus Group participants 1-7 [FG1-7]).  An exception to this indentation 
method is the presentation of any subsequent sub-questions or specific statements 
generated by the researcher through discussion on the main problems.  These 
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questions or statements are presented in a contemporaneous order with standard 
alignment and pre-fixed with ‘Q’ to denote a question or statement.   
 
Table 4.1: Overview of the main themes identified and explored during phase 1 (focus group) and phase 3 
(Delphi surveys) 
Main themes 
Phase 1: Focus group - Physiotherapists 
 
 Current status on red flags 
 Cervical arterial dysfunction 
 Clinical features 
 Balance and cranial nerve testing 
 
 Drop attacks 
 Neck pain/headache 
 Dizziness 
 Nystagmus 
 Cervical myelopathy 
 Draft clinical chart 
Phase 3: Delphi Surveys - Medical consultants 
 
 Feedback on draft clinical chart  
 Red flag clinical features, which were sub-grouped into:   
o Progressive pain 
o Cancer etc. 
o Neurological 
o Headache 
o Brainstem, vascular, cranial nerve dysfunction 
 
 
4.2 Phase 1: Focus group 
4.2.1 Current status on red flags 
The researcher summarised the current status on red flags within clinical practice and 
the existing evidence base. This primarily included the Clinical Standards Advisory 
Group list of red flags for low back pain alongside locally developed departmental 
screening forms incorporating other comorbidities, such as Diabetes Mellitus, cardiac 
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and respiratory problems.  In addition, local departments may adapt variations of the 
5Ds And 3Ns framework as discussed in chapter 2. 
With reference to specific red flags for the cervical spine, the health information website 
Patient.co.uk is a resource supplying evidence based information to patients and health 
professionals and provides a list of red flags for neck pain.  A section on ‘cervical 
radiculopathy’ cites the Clinical Knowledge Summaries (2009) as its source.   CKS was 
a National Institute for Health and Clinical Excellence supported website provide 
information to support clinical practice. CKS provides a number of references with 
Binder (2007) found to be the most relevant reference provided.  Binder (2007) provides 
a list of red flags, which is poorly referenced.  This work has been adapted for use by 
Patient.co.uk.   This website describes itself as 
“…one of the most trusted medical resources in the UK, supplying evidence 
based information on a wide range of medical and health topics to patients and 
health professionals” (www.Patient.co.uk). 
Patient.co.uk provides the following red flag list: 
 
“Red flags for neck pain 
A serious underlying cause is more likely in people presenting with 
Red flags suggesting possible malignancy, infection or inflammation 
Red flags suggesting myelopathy (compression of the spinal cord) 
Red flags suggesting severe trauma/skeletal injury 
Red flags suggesting vascular insufficiency” (www.Patient.co.uk). 
 
The low back pain red flags are integrated within specific cervical red flag information. 
However, due to limited supporting evidence, questions remain on the selection of the 
clinical indicators and tests as being reliable or of sufficient detail to inform clinical 
practice. 
The researcher, however, suggested this list appears reasonable, but has potential for 
improvement. For example, this list could be developed. Alternatively, if the list is not 
amended then the process of providing a list resulting from a more robust supporting 
structure could provide clinicians’ with enhanced confidence in the red flag information. 
One such example are red flags suggesting vascular insufficiency include: 
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 Dizziness and blackouts (restriction of vertebral artery) on movement, especially 
on extension of the neck with upward gaze 
 Dizziness, drop attacks 
These clinical indicators form part of the 5Ds And 3Ns framework discussed in chapter 
2, which outlined limitations with this framework.  This highlights a lack of clear 
information on cervical spine red flags. 
The researcher asked the group the following question: 
Q: Do you have any thoughts or opinions on how to use this current information, 
for example, do we list the CSAG low back pain red flag list then ask a series of 
specific questions for the cervical spine or should we integrate the information 
as in patient.co.uk? 
 
There were four responses received during this phase of discussion indicating that it 
was better to have specific groups of pathologies that encouraged clinicians to consider 
such conditions within their clinical decision making or screening process. There were 
no signs or expressions from the remaining participants indicating disagreement to 
these comments.  The responses were: 
 
I would certainly think that it would be more useful to be thinking about specific 
pathologies and problems when you are going through your risk factors [FG2]. 
 
The researcher sought further clarification by asking: 
Q: Do we include the low back pain list? 
 
Depends on what the use is. If you are thinking of a screening questionnaire for 
your average MSK department I think you make them do everything, then it is 
covered from a managers point of view on a clinical governance, but perhaps 
from an ESP clinic then you will have reasoned that if it is a neck that you will 
pick out the questions that you need to cover.  So I think it depends on the 
context [FG1]. 
 
I like the way that it is separated out into different pathologies. Perhaps having it 
set out separately will make the clinicians think more carefully as to why they 
are actually asking these questions, rather than having a tick box screening tool. 
It makes them think more about why they are asking the questions [FG6]. 
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A back clinic and neck clinic will depend on the patient you have in front of you. 
There will be some overlap of questions. For example  infection is applicable to 
both low back and neck pain, where for example bladder and bowel problems 
will always be asked in low back presentation, but only in neck if suspecting a 
cervical myelopathy presentation  in neck pain. Similarly, wouldn’t be thinking 
about headache as red flag for low back pain [FG7]. 
 
These comments suggest that grouping pathologies would better inform clinical 
decision making.  However, these should be specific to each situation. 
 
4.2.2 Clinical problems 
A series of clinical problems (sections 4.2.2.1 – 4.2.2.5) were read by the researcher 
and discussed within this group.  These problems were provided in advance to 
participants within the focus group information pack alongside relevant literature 
(Appendix L) to inform this discussion.  The findings identified during this discussion are 
presented in the remainder of this section (4.2.2).  As stated in 4.1 additional 
researcher-led sub-questions and statements evolved from discussions on the main 
problems and are presented in a contemporaneous order. These are pre-fixed with ‘Q’.  
 
4.2.2.1 Problem 1: What signs and symptoms indicate the presence of 
CADysfunction?  Studies appear to be based in neurological centres; therefore it 
is questionable as to how relevant the findings are to MSK clinics?  Admission to 
neurological centres indicates significant progression of an arterial event. Taylor 
and Kerry (2010 masterclass) provide excellent information on CADy from a 
manual therapy perspective.  However, the following studies highlight the 
difficulty in identifying features relevant to MSK clinics. Other than single case 
reports, there are no identifiable studies within MSK settings (excluding adverse 
events based reports). 
 
4.2.2.1.1 The presence of pain and/or stiffness 
The researcher cited Thomas et al (2011) in reporting that headache, neck pain and 
dizziness was not always present in patients within their retrospective study of cervical 
arterial dissections.  Therefore, the researcher proposed the following to the group: 
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Q: For the purpose of musculoskeletal clinics, it is reasonable to assume that 
neck pain, headache and/ or upper limb dysfunction would feature, otherwise the 
patient may not present at a musculoskeletal clinic. 
 
A participant responded to this: 
 
Well, do people sometimes come into clinic with stiffness rather than pain as 
their main complaint? May be unusual, but neck stiffness is possible rather than 
pain [FG6]. 
 
There were three to four general agreements to this comment indicated through head 
nodding actions with one additional comment received that also agreed this was 
reasonable to accept that stiffness may feature as a complaint without the presence of 
pain.   
 
 Yes, stiffness is possible [FG3]. 
 
There were no signs or expressions of disagreement to this comment. 
 
The researcher added that it is important to consider what other local symptoms and 
signs may be present. Therefore, the researcher  provided a summary of literature 
provided for this section that was contained within the focus group information pack 
(Appendix L).  This summary included symptoms and signs from Thomas et al (2011): 
 
“Symptoms: Pain, dizziness, Visual disturbances, paraesthesia face/UL/LL 
 
Signs: unsteadiness/ataxia, weakness (UL/LL), dysphasia/dysarthria/aphasia, 
facial palsy, nausea/vomiting, dysphagia, drowsiness, confusion, loss of 
consciousness” Thomas et al (2011 p.355) [Researcher]. 
 
And in addition, Chandra et al 2007: 
 
“Other associated symptoms such as amaurosis (loss of vision 1 eye), 
anisocoria (unequal pupil size), ipsilateral facial droop, partial ipsilateral Horner's 
syndrome, and neck pain were seen to occur in one-third or fewer patients in 
each group” (Chandra et al 2007 p.180) [Researcher]. 
 
There were no additional comments received to this prompt. 
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4.2.2.1.2 Balance testing in neck pain, headache or dizziness 
The researcher reported that Kerry and Taylor (2010) and Thomas et al (2011) 
recommend incorporating balance and cranial nerve testing (CNT) into the routine 
musculoskeletal examination to detect potential symptoms and signs of cervical arterial 
dysfunction.  Therefore the researcher asked the following question: 
 
Q: Do you or your departmental colleagues currently consider balance testing in 
neck pain or headache? 
 
Approximately three initial responses indicated that this was not used routinely, unless 
dizziness or falls were identified during the subjective assessment as part of the 
presentation.  Thereafter, balance or an alternative e.g. Romberg’s test is incorporated 
into the assessment.  Testing for balance, however, was also reported as being very 
variable between staff members and locations, typically dependent on level of training 
or location of specific staff e.g. with vestibular rehabilitation experience being more 
likely to perform balance testing. 
 
I could say that we don’t use it routinely, but if dizziness was part of the picture 
then we would use it. It would depend on the context of the patient’s subjective 
[FG3]. 
 
The researcher explored this further with a scenario: 
 
Q: If a patient complained of neck pain or headache and dizziness featured, you 
would test balance? 
 
Yes [FG3]. 
 
Approximately four other participants agreed with this statement through “yes” and head 
nodding actions. There was one additional comment stating that Romberg’s test would 
be included for people with dizziness. 
 
Yes, we do that for people suffering from dizziness. We do Romberg’s usually 
[FG4]. 
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Other comments on integrating balance into neck assessment were provided: 
 
We do all sorts of things. I brought along a comprehensive chart…, but it 
includes the sort of things that you are probably going to bring up [FG1]. 
 
This was confirmed as a document specifically developed for this participant’s local 
department use, which included testing for balance in this scenario. 
 
Testing for balance is very very patchy here (video-link participant) depending 
on the kind of in-service training or external courses the physios have been on.  
I mean I have worked with physios who have been on loads of extra courses on 
vestibular problems and they always incorporate it into their tests and they will 
obviously get other people doing it as well, but that is very patchy and only 
occurs in some places [FG6]. 
 
The researcher clarified this phase of discussion did not relate to a patient referred in 
with a specific complaint of dizziness or for vestibular rehabilitation, but rather a 
musculoskeletal setting in which the person complained of dizziness you would test for 
balance? 
 
Four responses were noted to indicate agreement to this through stating “Yes” or head 
nodding action, that balance would be tested in this scenario.  One additional extended 
comment was received: 
 
But if they didn’t complain of dizziness, no, unless there was some other 
indication like falls that would send you that way, but then it would be a routine 
[FG1]. 
 
The researcher clarified this situation that if clinical reasoning or decision making in the 
scenario indicated a need for testing, then this would be incorporated. 
 
Yes [FG1]. 
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4.2.2.1.3 Cranial nerve testing 
The researcher reported that Thomas et al (2011) recommend cranial nerve testing 
(CNT) due to ICAD findings in their retrospective study.  However, symptoms and signs 
referred to were also present in VAD.  In addition, the physiotherapists’ Taylor and 
Kerry’s (2010) masterclass type paper published in an osteopathic journal also 
recommend conducting a simple eye exam and CNT.  This paper was omitted from the 
information pack due to it not containing patient observations. 
 
The group was asked the following question on CNT: 
 
Q: Do you or your departmental colleagues currently do cranial nerve testing in 
neck pain/headache presentations? 
 
Four  “No” responses were received plus two participants reported their respective 
locations had received training in cranial nerve testing (including crib sheet) but this was 
not performed frequently (estimated ≤ 3 times per year).  One location was in an 
Extended Scope Practitioner (ESP) role, while all musculoskeletal staff within the 2nd 
location were trained in performing CNT. However, this was rarely used.  Comments 
also suggested that there may be a confidence issue if not performing the test on 
regular basis. 
 
In my ESP clinic I have been taught to do cranial nerve testing and I do have a 
little crib sheet to help do it if I need to, and I think that is quite appropriate in 
that setting, but I probably wouldn’t expect the rest of the physio dept unless I 
have gone through that with them to be very adept at doing it, but I don’t feel 
very confident at doing it myself unless you are doing it all the time, and a lot of 
time you only need to do it when you need to clinically, so that is very rare 
actually [FG7]. 
 
The researcher prompted expansion on this response through further enquiry: 
 
Q: How often was this type of examination conducted over the past twelve 
months? 
 
Probably about 2 or 3 times in the past year [FG7]. 
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We had ………(name deleted) here doing a training session with all members of 
the physio staff and I would say that nobody uses it on a routine basis at all and 
it is very rare for some to find the sheet that tells us how to do it . I would say 
less than three times a year [FG4]. 
 
There were no additional comments received for this phase of the discussion. 
 
4.2.2.1.4 Temporal component 
Q: Another component identified in literature is the temporal or time factor i.e.  A 
time period that exists from preceding warning symptoms to the onset of more 
serious development. Do you think that is an important aspect that could help 
guide our clinical reasoning process?  A clinical example is a patient reporting 
the presence of dizziness alongside neck pain/headache or stiffness.  Is the 
duration or length of time that dizziness has been present of relevance to you? 
 
There were four responses indicating (head nodding action) and/or stating: 
Yes  
The researcher asked participants about the relevance of what this information would 
provide you with. 
Q:  What else would it add? 
 
Well it would depend if the onset of dizziness coincided with the onset of their 
problem or if they have always been dizzy. You have to clarify, don’t you? [FG5]. 
 
Approximately four “Yes” or head nodding actions indicating agreement were received 
with extended comments detailed as follows: 
 
If it was progressive then you would take action. The majority of people that 
come to see us may have actually had dizziness for a long time before they 
actually see us. It is about the onset [FG5]. 
 
Participant added: 
 
Reading through some of the literature there was such variance from the 
literature from minutes to days to weeks that it was very difficult that it might be 
useful to know and ask the question by episode or by how long they have had a 
continual headache and did it coincide with their other symptoms. But you would 
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need to be quite clear back to the literature on what parameters you were going 
to use because it was so varied that I think that would be quite difficult to pin 
down [FG3]. 
 
The other thing to consider is that if they have got a severe headache  they will 
be taking medication  and the effects of the medication, whether that is actually 
giving them a headache and giving them dizziness because they will be taking 
presumably opiates or something to do with that [FG5]. 
 
 
To invite additional comments the researcher suggested that: 
Q: It would appear the temporal component is of relevance with potential to add 
value to physiotherapy clinical decision making processes. 
 
 A further response was received: 
 
Can I say that it only adds to our reasoning process only if we know what 
proportion go on to develop a serious adverse event at that stage [FG2]. 
 
 
The researcher added:  
This aspect was not evident from the literature review.  One potential problem in 
ascertaining this information is the likelihood of quick medical intervention 
should symptoms be detected at an early stage by appropriate clinical staff 
[Researcher]. 
 
There were no additional comments received for this phase of the discussion. 
 
 
4.2.2.1.5 Presenting symptoms and signs and their relevance within current 
physiotherapy screening methods 
The researcher summarised Savitz and Caplan (2005), which is based on findings from 
New England Medical Centre Posterior Circulation Registry.  This is cited within 
physiotherapy based literature (e.g. Kerry and Taylor 2008) and was provided in the 
focus group information pack (Appendix L and summarised in Appendix A).  This 
information was provided as a prompt for discussion on aspects such as, symptoms 
and signs presenting in isolation versus likely to be accompanied by other features, and 
the relevance of any of the following features within current physiotherapy screening 
methods: 
 
  
 
96 
4.2.2.1.5.1 Atherosclerotic stenosis and occlusion (The researcher read the 
following) 
“Near the origin of a vertebral artery in the neck…..often presents as brief TIAs 
(Transient Ischemic Attacks), consisting of dizziness, difficulty focusing visually, 
and loss of balance” Savitz and Caplan (2005 p.2619) [Researcher]. 
 
No comments were received. Therefore, the researcher added the following question: 
 
Q: Regarding TIA, does it always have these three components present or just 
part of it? 
 
The Group were unable to provide further clarification. 
 
The researcher continued with the summary from Savitz and Caplan (2005): 
 
“Intracranial vertebral artery…..most often causes symptoms and common signs 
referred to as the Wallenberg, or lateral medullary syndrome” (Savitz and 
Caplan 2005 p.2619-2620) [Researcher]. 
 
Researcher added: 
 
Serious pathology of this level or full stroke is highly unlikely to present in MSK 
clinics.  This is acknowledged by Taylor and Kerry (2010) who state that it is 
unlikely full stage will present to manual therapist, but subtle retinal ischemia 
might [Researcher]. 
 
Three nodding actions were noted indicating agreement to this. There were no signs or 
expressions indicating disagreement. 
 
4.2.2.1.5.2 Arterial dissection (The researcher read the following) 
“The cardinal symptom in patients with vertebral dissections is pain, most often 
in the posterior part of the neck or occiput, spreading into the shoulder.  Diffuse, 
mostly occipital, headache also occurs” (Savitz and Caplan 2005 p.2620) 
[Researcher] 
 
Researcher added: 
 
No supporting data is presented for this within this particular paper 
[Researcher]. 
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“Dizziness, diplopia, and signs of lateral medullary or cerebellar infarction can 
ensue from embolism or extension of the dissection to the intracranial vertebral 
artery” (Savitz and Caplan 2005 p.2620) [Researcher]. 
 
Researcher added: 
 
This may suggest a later presentation, yet the literature also suggests that a TIA 
(consisting of dizziness) may be early. This potentially creates confusion for 
clinicians.  Therefore, dizziness could be considered as possibly presenting 
early or later [Researcher]. 
 
The group were invited for any comments or opinions on these components.  No 
additional comments were received at this stage. 
 
4.2.2.1.5.3 Drop attacks (The researcher read the following) 
“Drop attacks have inappropriately been attributed to transient ischemia of the 
posterior circulation. Not a single patient in the NEMC-PCR had a drop attack as 
the only symptom” (Savitz and Caplan 2005 p.2621) [Researcher]. 
 
Researcher added: 
 
Q: Therefore, if asking this question, are we screening for another reason?  For 
example, cardiovascular rather than a cervical arterial dysfunction problem. 
 
No additional comments were received at this stage. The following question was then 
asked: 
 
Q: Does this call into question the inclusion of drop attacks within the 5Ds And 
3Ns framework when considering cervical arterial dysfunction? 
 
Well I would ask, what are people asking when they ask about drop attacks. 
Within the department there is a huge range of what people will actually say to 
the patient from “have you ever collapsed?” to “have you ever found yourself on 
the floor unconscious and not knowing why?” You know, it depends on how they 
establish what people say to establish that their drop attack has occurred. I don’t 
know if everyone else has had this experience with their staff or not. And 
certainly I would say there is a huge range or variation in what people are 
actually saying or asking [FG4]. 
 
I sometimes think the understanding of what a drop attack is not always 
accurate, which is in the type of questions that are asked [FG6]. 
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It would therefore appear that the issue of drop attacks and loss of consciousness lacks 
clarity. No additional comments were received at this stage. 
 
4.2.2.1.5.4 Differentiating ICAD and VAD sites of pathology 
The researcher reported that physiotherapy literature suggests a clinical reasoning 
approach to identify if the arterial problem is ICAD or VAD in origin (e.g. Taylor and 
Kerry 2010).  Taylor and Kerry (2010) recommend use of palpation skills for the carotid 
artery in times of suspicion as one method to assist differential diagnosis.  Therefore, 
the researcher asked the following question: 
 
Q: From the perspective of screening for potential red flags in cervical arterial 
dysfunction is there clinical value in trying to reason out if it is ICAD or VAD, 
versus grouping the two together? 
 
 
I just don’t think that it is appropriate for us to try and do this……we just need to 
consider if there is some serious pathology. That is not for us [FG5]. 
 
I think at the end of the day, what we are looking at when we are assessing a 
patient is we are looking towards what we can do for that patient and what that 
treatment is going to look like and how safe is that treatment going to be. So I 
don’t think it is that relevant to know what artery it is that we are looking at 
[FG3]. 
 
Q: Do you think that palpating the artery will add anything more as a 
physiotherapist? 
 
I don’t think that is a skill that is relevant to us and I think we would be laughed 
off the podium by our medical colleagues if we were trying to diagnose from that 
[FG3]. 
 
Two additional comments agreed with this through “yes” and/or head nodding action, 
with one additional participant offering an alternative perspective: 
 
I was just going to say we do palpate for abdominal aortic aneurysm so we do 
have a history in saying that we are able to do that and we can use that in our 
diagnostic process, so I am afraid that I don’t know if there is something that we 
could palpate in a carotid artery that would give us any information that would be 
useful, but if there was something we could do, then I would not be averse to 
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learning how to do it.  So I don’t think it is outside our scope of practice because 
we have got a precedent with abdominal aortic aneurysms [FG4]. 
 
This point identifies that there could be a training issue present.  However, there are 
reservations regarding the profession’s credibility on palpating the carotid artery for 
diagnostic purposes.  Participants were asked any additional opinions on separating the 
internal carotid and vertebral artery from a musculoskeletal perspective? 
 
Personally, I can’t see the value in that. I think as said, as musculoskeletal 
physiotherapists we are looking to see is there anything we can do to add to that 
person’s journey and if it is not a musculoskeletal problem then we can pass 
them onto a professional who can deal with them.   So it is just about being able 
to identify, from an extended scope capacity, which professional would be of use 
to them.  So that is why we need the information. So for me, I don’t think that we 
need to differentiate the two [FG4]. 
 
I agree with…(deleted name inserted FG4) and I was thinking as well that with 
some physiotherapists using the ultrasound scan that they would be appropriate 
to them to be able to scan the artery, but for the majority of people it is not  
[FG7]. 
 
This phase of the discussion highlights inconsistencies and uncertainties  in the 
information interpreted from the symptoms, signs and diagnostic skills on identifying 
arterial dysfunction and what aspects are relevant to physiotherapists.  This suggests 
there is potential benefit seeking direction from the medical profession. 
4.2.2.2 Pain 
Pain is a symptom that has been mentioned previously.  Therefore the following 
problem was read to the group by the researcher: 
Problem 2: Neck pain and/or headache symptoms are reported as the most 
frequent local symptoms of cervical arterial dissection.  There are suggestions 
that onset of headache is described as “unlike any other”, that pain associated 
with vertebral artery dissection (VAD) is typically posterior neck pain/occipital 
headache, and that pain associated with internal carotid artery dissection (ICAD) 
is typically upper-mid neck pain/ipsilateral front-temporal headache. 
Q: Do you think these descriptors for onset and distribution of CAD related pain 
are sufficiently evidenced for use as clinical indicators? 
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Purely based on what you have presented to us, I don’t think we can say that 
[FG2]. 
 
I don’t think so [FG3]. 
 
 
Yes. I would agree with that. You cannot tell from the location of the pain, what 
you would be dealing with [FG4]. 
 
Or the intensity of it [FG2]. 
 
I thought the description of it was vague as well. Was for the reason, if you were 
asking someone about the uniqueness of headache or that it is unlike any other, 
or its intensity, in terms of pain that is only valid for the time that they say it. It is 
not valid – it depends on their stress levels on the day, their emotions on the 
day, because it is very subjective, so I didn’t think it was very robust [FG3]. 
 
Or if you have ever had a headache before [FG1]. 
 
Yes [FG3]. 
 
 
The general opinion appears to be that no clear patterns of pain exist.  However, 
caution should be noted with this interpretation as this was part influenced by the 
literature and not entirely on participant observations as demonstrated by FG2’s 
opening comment in this section of discussion stating this response was based on the 
literature provided.  
 
4.2.2.3 Dizziness  
Dizziness is listed as a symptom of arterial pathology (e.g.  Thomas et al 2011) and 
forms part of the 5Ds And 3Ns framework.  Therefore, the following problem was read 
to the group: 
 
Problem 3: Dizziness is reported as a significant symptom potentially indicating 
serious pathology e.g. Australian guidelines 2006.  The term “dizziness” may 
encompass vertigo, presyncope, unsteadiness, and other non-specific forms of 
dizziness (Tarnutzer et al 2011).  Dizziness may be the result of a peripheral 
condition (e.g. benign paroxysmal positional vertigo, vestibular neuritis, 
Meniere’s syndrome, or postural hypotension) or a more serious central cause 
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(e.g. ischaemic stroke in brainstem or cerebellum, or tumour of posterior fossa).  
What features of dizziness and what clinical tests would aid MSK 
physiotherapists’ differential diagnosis of a peripheral versus central cause of 
dizziness? 
 
Two additional points extracted from the literature (Tarnutzer et al 2011) were read to 
the group by the researcher before inviting comments. This information was considered 
from the perspective of learning new skills to enhance the screening process. 
 
1. “Vertebrobasilar ischaemic stroke may closely mimic peripheral vestibular 
disorders, with obvious focal neurologic signs absent in greater than half of 
patients presenting with acute vestibular syndrome due to stroke” (Tarnutzer et 
al 2011 p.1025) [Researcher]. 
2. “A three-component bedside oculomotor examination – HINTS (horizontal head 
impulse test, nystagmus and test of skew) identifies stroke with high sensitivity 
and specificity in patients with acute vestibular syndrome and rules out stroke 
more effectively than early diffusion-weighted MRI” (Tarnutzer et al 2011 
p.1025) [Researcher]. 
 
Q: Could this be applied to MSK clinic screening or is it for more serious 
presentations? 
 
This topic generated several detailed responses: 
 
I see some patients referred from the ENT clinic in…(place deleted) and they 
have a dizzy clinic  which is specifically designated to see dizzy patients. And I 
would say that we have to be very careful with this as they use a whole battery 
of investigations in order to identify why the patients are dizzy, so they use prism 
glasses, caloric testing, MRIs on top of using things like Hallpike, using the 
history, to differentiate. I mean they will say for example that in BPPV that 
dizziness will last for less than a minute and always reproduced by position, so 
the history is one thing, but they use a lot of investigations on the patient before 
they make a decision that they have benign dizziness.  So I do think we have to 
be quite careful how we structure ours, whether we take on board the ability to 
assess dizziness [FG4]. 
 
I have the reverse that they do come from the consultant. They get one minute if 
they are lucky. They’re never allowed to speak then they all come down with 
disequilibrium for vestibular rehab. It doesn’t really matter about – or TMJ they 
can come down with, and that’s it. Now the starter is that they have waited a 
long time to see the consultant and then sit on our waiting list for a while, so I 
suspect that if they were going to have stroke they would have had it. So from 
  
 
102 
that point of view there is a little bit of safety in the length of time that they have 
had it.  But we do treat them and do get very good results from them, but we are 
working now with some of the audiologists, who as ….(deleted name inserted 
FG4) has said do a lot more than we do and have lot more sophisticated tests. 
But we have put together, and I have brought that today, a proforma for some 
basic testing and probably these are ones with benign dizziness, but again, 
many of the patients that come to us, I would say have not been properly 
screened. But I take your point ….(deleted name inserted FG4) that there are so 
many causes of dizziness. However, I would say that having treated for a large 
number of years now I think that once you have done that you can pick out the 
benign ones a little bit more easily. And then I do think it is case of referring on 
those that you think that you are not happy with.  But I think our waiting lists 
probably help in terms of the seriousness of it [FG1]. 
 
I think in terms of the three component bed side examination the caveat I have 
there is that is a bedside examination that these patients have been admitted so 
they have probably actually had some event and that’s why it is sensitive and 
specific. Where the patients that we see, we’re wondering is there a threat of 
pathology here or is there likelihood, so I don’t know if that is particularly 
relevant to us as MSK physiotherapists. I would need to know more [FG3]. 
 
For me the whole question of dizziness testing is the context.  If you are treating 
a patient then yes you probably do need these skills and you are probably in 
setting where you have back-up from experts and investigations. When you are 
in the MSK clinic you presumably treating for neck pain or stiffness 
predominantly, I don’t think this is appropriate [FG2]. 
 
 
In response to FG1, the researcher suggested that there is a safety net because the 
patients are referred from a consultant. This generated the following response: 
 
They don’t all come, but a large amount of them do…..But I think there is also a 
context in terms of, it is one thing to have patient sent to what is a routine physio 
list, where you have got 45 minutes, you have got time, you can think about it, 
you phone a GP.  Where it is a different context in an ESP clinic where they may 
be coming through the doors at vast rate and then you have to decide if they 
have got something serious, and they also may have been sent by the GP 
because they are not sure, so there are contexts for both. So if we see these 
patients, we give them a thorough screening and we go through all the different 
tests and try an make a decision at the end of that, which I think is quite different 
to a clinic where I don’t know how long your appointments are, but it could be 20 
minutes, half an hour, so there is context to both.  So what is appropriate for one 
setting is probably not appropriate for the next one [FG1]. 
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The researcher commented that the aim was not purely for an advanced clinic setting, 
but could be applied to a standard outpatient clinic, before further adding the following 
analysis on the tests:   
 
One test was conducted in a primary care setting indicating specificity and 
sensitivity in this environment.  However, having reviewed the tests in action 
through web-based video the most specific and sensitive test, the horizontal 
head impulse test involves high acceleration / high velocity with 20 to 30 
degrees of rotation. If a patient is presenting with neck pain or neck stiffness this 
test is likely to introduce added complications rather than assist in a screening 
process [Researcher]. 
 
One participant added agreement to this comment [FG3].  An expanded response to an 
earlier comment was added from FG1: 
 
Well I chose depending on what sort of age and co-morbidties there were, I 
would choose as what sort of tests I would apply a reasoning process to it, for 
example, I am not going to do a Hallpike, but I might do the alternate Hallpike on 
an older patient. I won’t do an Epleys’ I might send them home doing 
Brandtdaroff exercises instead, so there is a bit of reasoning, but again if you 
are trying to get something against how much reasoning there is, what level 
people are at, again it is a basic screen against a more advanced screen [FG1]. 
 
The researcher clarified that the focus of this particular process was to improve clinical 
reasoning or decision making at the early stage in identifying how serious the 
presentation is, as opposed to aiming to diagnose and provide ongoing management.  
The following extract was presented from Tarnutzner et al (2011): 
 
“Best evidence suggest that nearly two-thirds of patients with stroke lack focal 
neurologic signs that would be readily apparent to a non-neurologist and one-
third lack signs that would be readily apparent to a neurologist” (Tarnutzner et al 
(2011 p.1031) [Researcher]. 
 
The researcher suggested: 
 
Q: This statement cautions against clinicians being led into a false sense of 
security that serious pathology is not occurring and may be a case where non-
medical practitioners may not be sufficiently skilled to detect such pathology.  
The group were asked for comments on this information and if it was reasonable 
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to highlight that we (physiotherapists) are very limited in our skills to 
differentially diagnose this problem. 
 
It is, but then we run the risk of saying that every dizzy patient that walks 
through the door that we end up saying that we better not do anything with 
them. And it is getting that balance and that is the tricky bit [FG2]. 
 
There were no additional comments at this stage; therefore, the researcher added that 
the literature review provided patterns that may help in this process with the following 
identified (The researcher read the following summary information from Bhattacharryya 
et al (2008) to the group before asking a question): 
 
 Peripheral (BPPV) 
o BPPV less than one minute (also mentioned by FG4 earlier in 
discussion) 
o Relative to gravity 
o No hearing loss 
o Physical exam: vertigo and/or nystagmus from DIX-Hallpike 
 
 Otological 
o Usually hours, present at rest 
o Disabling 
o Hearing deficit likely 
o Plus or minus nausea vomiting 
 Central 
o Usually  less than thirty minutes 
o Isolated and transient 
o Aware that it maybe weeks/months pre-stroke (Summary from 
Bhattacharryya et al 2008) [Researcher]. 
 
 
Q: Do you think it would it be reasonable to put that sort of information to a 
neurology group - is there any value in us trying to use that sort of information to 
try and work out if dizziness is linked to a central or peripheral cause. Any 
thoughts on that? 
 
 
But there are so many causes of dizziness. I am thinking postural hypotension 
that could mimic, I think they will say, yes this could provide a little bit of 
guidance, but it is not going to give you any definitions or diagnosis [FG6]. 
 
I think the way the person describes their dizziness can certainly give you some 
indication as where their dizziness is coming from and what’s its cause. 
Definitely, if they are lying down and the room is spinning or if it is positional 
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lasting thirty seconds to one minute when they turn in bed. I think that can help, 
yes [FG6]. 
 
Just from my perspective of treating them for long time, the time definitely helps 
in deciding, but there is also a whole range of other factors, but for me I would 
consider the timing just in terms of how they have described it. I would agree 
[FG1]. 
 
Because we ask patients do you suffer from dizziness, and dizziness covers 
such a huge range of things, doesn’t it. And sometimes patients don’t 
understand what you are talking about dizziness. Is it light headed dizziness, is 
the room spinning, are they unsteady so helping to clarify in question of what we 
actually mean by dizziness or get the patient to clarify clearly what they are 
feeling [FG6]. 
 
I agree with that. If anything it comes back to what questions physiotherapists 
are asking with the phrasing of the questions making a difference to the weight 
of usefulness of that piece of information. So if you are going to take the point 
and put it into some sort of programme, questions that should be asked or could 
be asked in terms of risk management and as (Name deleted) did with her red 
flag book and weight them, it might be a useful question to ask that you might 
give it low weighting so this is low probability, but this increases the probability 
where if someone describes as spinning lasting for thirty minutes it might be a 
high probability. But I think the way people ask the questions is going to be the 
key thing as to how useful the answer is [FG4]. 
 
The researcher added: 
 
So if I bring this back to our current evidence base that we are using, as in 
Coman’s 5Ds and simply stating dizziness, it is just not appear to be enough 
information. We are trying fine tune some of these components. We might be 
limited with using something like the 5Ds, but can we then define it a little bit 
more that may help us, and I think that is what is coming out here.  If we can 
provide other information like position or temporal aspects it could give us better 
information [Researcher].  
 
 
There were no additional comments at this stage of the discussion. 
 
4.2.2.3.1 Nystagmus 
Nystagmus forms part of the 3Ns framework.  Patten (1998) was cited to describe 
nystagmus to the group as: 
 
  
 
106 
A sign, not a disease, with involuntary movement of the eyes (Patten 1998) 
[Researcher]. 
In addition: 
Bhattacharryya et al (2008) describe directional patterns to aid differential 
diagnosis of central versus peripheral causes of this sign [Researcher]. 
 
 The group were asked: 
 
Q:Are we sufficiently skilled to interpret this? 
I think it takes training [FG1]. 
 
I think probably not. Ok. I think we can learn to look at the Dix-Hallpike test and 
recognise normal nystagmus there, but if you read the literature there is just so 
many different types of nystagmus as to what is going on and I don’t think an 
ordinary MSK clinician, well not an ordinary one, but a highly skilled one, MSK 
clinician, can be expected to read nystagmus as they would in an expert 
neurology clinic.  Because it goes upwards, sideways, downwards, backwards 
and frontwards, you know, I mean we can say if it is there, but we can’t really 
differentiate as to what it is indicating, I don’t think [FG6]. 
 
Two agreements were noted to this statement with a further expanded response: 
 
It probably needs to be interpreted alongside other tests we wouldn’t be 
performing in any case in our clinics. So, along with other investigations [FG7]. 
 
The researcher added: 
 
Referrals may come from a safe environment, for example, specialist consultant 
after all tests completed and serious pathology excluded. However, we need to 
consider if we are presented with that patient for the first time for example 
through self referral or a GP [Researcher]. 
 
Participant FG3 added: 
 Or NHS24. 
 
Patten 1998 is a medical text on neurological differential diagnosis, which states 
that the interpretation and reporting of nystagmus is poor.  Therefore, as 
physiotherapists, recognising such limitations may be important   [Researcher]. 
 
The researcher suggested a recommendation should be made that:  
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If nystagmus is present then onward referral for specialist opinion is considered 
appropriate.  The patient may be re-accepted for further management once 
cleared from a central or serious cause [Researcher]. 
 
Q: The group were asked if this was a reasonable approach and invited 
comments on this: 
 
Approximately 5 ‘Yes’ responses or head nodding actions were received indicating 
agreement to this statement.  There were no signs or expressions noted to indicate 
disagreement.  
 
4.2.2.4. Risk factors 
Manipulation and minor trauma were included within the focus group information pack 
as a risk factor for cervical arterial problems.  Therefore, the researcher highlighted a 
recent ‘Head to Head’ discussion article “Should we abandon cervical spine 
manipulation for mechanical neck pain?” (BMJ2012;344doi: 
http://dx.doi.org/10.1136/bmj.e3679) for further reading. This article was not discussed 
within this focus group; however, one additional point was raised by the researcher on 
recognising limitations in vascular screening blood flow studies to support positional 
tests (e.g. rotation/extension).  This information was provided within the information 
pack (Appendix L): 
 
The other point that I would like to make is that within physiotherapy it is 
recognised that our vascular screening blood flow studies to support those tests 
are inconsistent or conflicting evidence [Researcher]. 
 
The group were invited to make any comments or express thoughts/opinions on this 
aspect. No responses were received. 
 
4.2.2.5 Cervical myelopathy (cord compression) 
The following problem was read to the group: 
Problem 4: It is a clinical challenge to identify cervical myelopathy (CM).  What 
signs and symptoms have been identified in this presentation that should be 
used to screen for this pathology? 
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Similar to the background problem on the 5Ds And 3Ns framework the aim of 
addressing this issue was to refine the information on these presenting features 
e.g. gait disturbances or bladder dysfunction. For example, bladder dysfunction 
is typically the basis of questioning within the subjective examination, however, 
clarification on the components considered as a dysfunction is often lacking in 
the literature as identified in chapter 2.   Therefore, increased awareness of the 
range of features that may appear within bladder dysfunction or gait 
disturbances may enhance physiotherapists clinical decision making 
[Researcher]. 
There were no additional comments at this stage. 
The researcher further presented additional information:  
Rhee et al’s (2009) prospective controlled study highlight the potential difficulty 
in identifying this pathology where: 21% (8) of 39 Cervical Myelopathy patients 
did not demonstrate a single myelopathic sign at their initial presentation. These 
patients had confirmed myelopathy with subsequent surgical intervention 
[Researcher]. 
Due to time constraints the researcher proposed to summarise main findings from the 
information pack where participants could offer thoughts/opinions as they arise. The 
Group agreed. 
4.2.2.5.1 Sexual dysfunction 
The researcher read the following: 
o Sexual dysfunction 
o It is low frequency/prevalence; subjective difficulty in penile erection or 
ejaculation. 
 
Focus group preparations revealed that a group participant [FG2] previously conducted 
PhD level research on lumbar spinal stenosis; therefore, the researcher explored this 
further by asking: 
 
 
Q: Did your research reveal any additional information on the frequency of this 
problem or indicate a requirement to include this within routine questioning? 
 
 No [FG2]. 
 
4.2.2.5.2 Bladder dysfunction 
The researcher read the following: 
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o Bladder dysfunction was identified as having two components (Sakakibara et al 
1995). 
o Irritative with subgroups; 
o Frequency, urgency, incontinence, and 
 
o Obstructive, with subgroups; 
o Hesitancy, prolongation, difficulty voiding, retention 
 
The researcher then directed the following question to FG2 before inviting group 
comments on this prompt for bladder dysfunction: 
 
Q: Were any additional findings identified in this area during your research? 
 
Nothing quantitative and it is a real problem with stenosis patients that they 
quite often are getting older [FG2]. 
 
Another participant sought clarification 
 
Going more frequent? [FG1] 
 
Yes, and quite often the men have got prostate problems. So no, nothing 
quantitative on that [FG2]. 
 
The researcher added: 
I (personal) think it is helpful to be aware that it can be any of those types of 
dysfunctions, rather than simply  stating bladder dysfunction. Would that be 
helpful to physios? [Researcher]. 
 
 
Participant FG6 responded: 
 
I think just general education about all the different causes of bladder 
dysfunction is absolutely essential because people get themselves wound up 
into so many problems about bladder dysfunction and erectile dysfunction 
problems, and I am sure that patients are sent of left, right and centre 
unnecessarily because the clinician hasn’t really understood the answer or have 
re-phrased the question wrongly.  So we definitely need clarification as to how 
they should be addressed I think [FG6]. 
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Four group members indicated agreement with this comment through nodding action 
and/or stating “Yes”.  There were no actions or expressions indicating disagreement. 
 
The researcher added that no specific information was identified on bowel dysfunction. 
Therefore, the group were asked for any additional information on bowel dysfunction.  
This generated one response: 
 
Nothing obvious [FG1]. 
 
No additional information was identified by the researcher on patterns of bowel 
dysfunction.  Similarly, no additional group comments were received. 
 
4.2.2.5.3 Gait disturbances  
The researcher read the following summary for gait disturbances: 
 
Three studies were identified in the literature with consistent findings on gait 
disturbances.  Gait disturbances were identified as having two main 
components:  
o Linear parameters with sub-groups; 
o Slow gait 
o Increased step/stride length/step width/double support 
o Decreased single limb support, and 
o Kinematic parameters with sub-groups; 
o Decreased knee flexion 
o Increased (ankle) Dorsiflexion 
o The latter 2 are suggestive of spastic gait pattern 
 
The researcher explored opinions on the breakdown component parts of gait through 
the following comment and question: 
 
As a clinician I thought this would be useful to know rather than just saying 
“have you any gait disturbances?”  I think traditionally, asking “are you tripping 
over yourself?” or, “are you moving slowly because of pain?” is not clear.  
Whereas, with this sort of information I have a better idea as to what it is I am 
assessing or asking questions to do with gait [Researcher]. 
 
Q: Would that be reasonable? 
 
  
 
111 
Participants’ expressed the visual assessment of gait was more important compared 
with questions: 
Yes, but I think it is something that is much easier to establish by assessing or 
observation. For me, I don’t ask gait questions too much. I look. I might ask 
some preliminary questions [FG2]. 
 
Again with the questions, I mean how you phrase it when you are asking the 
patient really. Are you unsteady on your feet? Do your legs giveway? Do you 
veer off to one side? You know, there are so many different connotations of this 
question. I have picked up several patients with cervical myelopathy. Two had a 
wide based spastic gait, and the other two had little shuffling type gait. And how 
do you phrase that into a question. I think looking is important here. Observation 
is the word [FG6]. 
 
So, questioning is difficult, but the actual assessment or observation is the more 
important perspective of the two [Researcher]. 
 
I think so, yes [FG6]. 
 
No additional responses were received. 
 
4.2.2.5.4 Upper motor neuron (UMN) and lower motor neuron (LMN) features 
The researcher read the following summary from the literature review to highlight two 
additional points: 
 
1. Neck pain/stiffness was not always present.  Similarly, upper/lower limb pain 
was not always present.  Therefore, patient may present with another type of 
upper limb dysfunction, which physiotherapists should consider i.e. not exclude 
cervical myelopathy prematurely [Researcher]. 
 
2. Upper limb symptoms usually occurred slightly pre-gait disturbance (Chiles 
1999), however a clinical commentary type paper not included in information 
pack reported that gait disturbance followed by fine motor disturbance (in Wang 
et al 2010).  Although it is the reverse, it suggests that it may be useful to 
consider this should both feature present e.g.  a sensory deficit alongside gait 
disturbance, regardless of order of onset may indicate myelopathic changes 
[Researcher]. 
 
Five nodding actions were noted indicating acknowledgement or approval to this 
suggestion. 
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Q: What clinical tests should be used for screening and diagnosis of 
cervical myelopathy? 
The researcher read the following summary of Cook (2007) extract: 
A range of clinical tests are used to screen for neurological conditions, such as 
cervical myelopathy (cord compression).  However, some neurological clinical 
tests (e.g. finger escape sign and clonus) have not been investigated for 
diagnostic accuracy, whilst others (e.g. the Hoffman sign, Lhermitte sign, and 
plantar response) have been investigated, but with inconsistent levels of 
methodological quality that affects their diagnostic accuracy values (summary of 
Cook et al 2007 p.1235-1236) [Researcher]. 
The researcher cited Cook et al (2007, 2011) to suggest that from the outset, 
recognition, is important that clinical tests are limited as to the information they may 
provide. Therefore, relying solely on a single test is not advisable for example due to 
low sensitivity rendering such tests as not reliable for ruling in pathologies. 
The researcher added: 
Q: Would that be a reasonable synopsis based the information that I have given 
you so far (information pack)?  So I think I would be suggesting to insert a 
footnote (into clinical chart) to physiotherapists that the cervical myelopathy 
tests are of limited value, therefore consider this in the context of your 
presentation. Is that reasonable? 
Participants indicated that they agreed with this synopsis and supported inclusion of a 
footnote into a clinical chart to inform  
Four “Yes” responses or head nodding actions were noted to indicate a general 
agreement to this statement.   
One additional response was noted: 
I think reflexes. Simple upper and lower limb reflexes are one of the most 
important physical tests. I would agree that some of the others are very operator 
dependent [FG6]. 
One additional comment was received that generated further discussion on checking 
sphincter tone in presentations of suspected cervical myelopathy: 
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You didn’t mention sphincter tone [FG2]. 
No. It was not coming up in the literature.  Are you talking about physios 
checking sphincter tone? [Researcher]. 
It is just that it is done routinely in medical practice. That is all [FG2]. 
Can I just ask… (Name deleted and inserted FG2) do your consultants do 
sphincter tone when they are looking for cervical myelopathy? [FG4]. 
If they are thinking cord problems, then yes,  they will do. But obviously more for 
cauda equina [FG2]. 
Right, but do they do it routinely [FG4]. 
They do it routinely for a neurological examination [FG2]. 
Wow. Ok [FG4]. 
No further discussion developed on this topic. 
4.2.3 Draft clinical chart 
 
A suggestion for a draft clinical chart was produced on screen (Figure 3.3 section 
3.6.3.4).  This was discussed as to how this may be developed. When asked: 
 
Q: Do you consider this initial idea as a reasonable way to progress with chart 
development? 
 
Participants indicated approval with five comments: 
 
Yes (and /or head nodding action). 
FG6 added 
It is very clear. 
 
The focus group participants were thanked for their participation and provided with an 
opportunity to add any additional information being the discussion was closed.  No 
additional information was forthcoming.  
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4.3 Phase 3: Delphi survey 
4.3.1 Pilot Delphi survey 
The pilot Delphi survey was conducted as described in Chapter 3.  This process was 
combined with early consultant feedback to inform refinement of the main Delphi survey 
following circulation of the draft clinical chart. 
 
I would consider using your Delphi to ask people what they think the red flags 
should be based on a (shortish!) list that you provide (and allowing them to add 
more). I would also try to keep the language simple and avoid neuro lingo (like 
dysarthria) that could be misinterpreted [D1]. 
 
Construction of the survey focused on three keys areas outlined below (Refer to 
Appendix Q for full Delphi Round 1 survey): 
 
1. Draft clinical chart - Feedback 
 
2. Developing list of red flags 
 
3. Any other comments? 
 
 
4.3.2 Delphi survey Round 1 (Qualitative) 
4.3.2.1 Chart feedback 
Consultants were requested to provide feedback on the draft clinical chart and were 
informed that the chart aimed to provide a 'quick reference' section with a specific list of 
key red flags. This component would be developed through the Delphi process.  The 
red flag list is accompanied by a detailed background information section in the form of 
main clinical sub-topics with drop-down menus offering  additional information designed 
to provide context for these features to assist physiotherapists' with their interpretation 
and subsequent clinical decision making. Feedback suggested a favourable response 
to the concept of the design; however, reservations were expressed with regards to its 
complexity which detracted from its usability and transfer to clinical practice: 
 
 
Having looked at it again tonight I think the chart is trying to do too many things. 
In places it is a textbook of diagnosis, in others it is trying to alert people to red 
flags.  For example, there is no need to describe hemicrania continua in a chart 
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about neck problems. If a patient has that, they will mainly have a headache 
[D1]. 
 
I think it would benefit from massive simplification targeted at the title of your 
email. What are the truly red flag symptoms associated with neck pain or neck 
problems? And are you interested in both of these things because they are a 
different set of red flags [D1]. 
 
 
May be slightly too complex.  Likely to work better in the longer term if eventual 
chart is relatively simple. Otherwise take-up and general acceptance may be 
limited [D10]. 
 
The sub-menus are comprehensive, but may contain too much information to 
make them easily useable - I might be inclined in a final version, or at least in 
the applicable version, to concentrate on main features and diagnoses, omitting 
very rare conditions. It may be of course that your intention is to make it 
complete. Is the intention to allow non-medics (physiotherapists) to identify red 
flag signs? If they are to do so and then identify a possible diagnosis, then very 
rare conditions will confuse. In symptoms and signs of cord compression, I could 
not see Lhermitte's phenomenon/sign mentioned. This is very typical in some 
patients with critical cord compression. Maybe I missed it. Central Cord 
Syndrome is very important in cervical injuries, and it is important to identify this. 
There is also a phenomenon of high cord injuries that leads to a dissociated 
sensory/motor effect due to fibre tracts that cross high in the cord and lower 
brain stem [D12]. 
I like the quick reference guide which obviously is not yet complete. I am glad 
that you have relegated cervical degenerative disease as a cause of "dizziness", 
this is a common misunderstanding in referrals I receive [D2]. 
 
I like the concept but find the chart too visually cumbersome and 'overpopulated' 
to be a simple sorting device [D5]. 
 
4.3.2.2 Developing list of red flags 
Consultants were requested to list the key red flag symptoms/signs that they consider 
to exist for neck pain or neck problems alongside which pathology the features may 
indicate e.g. cord compression.  The following categories were themed from the 
subsequent responses: 
 
 
1. Progressive pain; 
2. Cancer, infection, inflammatory arthritis/spondyloarthropathies, trauma (includes 
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risk of instability in this section); 
3. Neurological deficit; 
4. Headache (may present alongside neck pain/stiffness); 
5. Brainstem, cervical arterial, and cranial nerve dysfunctions. 
 
Participant responses from Round 1 were used to develop Round 2 and Round 3 
surveys (Refer to Appendix S for web-page version of Round 3 survey).  Responses to 
support these categories (1-5) are provided below: 
 
4.3.2.2.1 Progressive pain 
Progressive pain [D1]. 
 
New severe unremitting neck pain; Pain not responding to normal analgesics; 
severe pain on movement, or gross cervical spasm and reluctance to move 
neck at all (malignancy, instability, infection) [D12]. 
…recent acute onset neck pain failing to ease with simple measures AND 
associated with red flag neurological symptoms [D5]. 
Local pain in neck and arm nerve root pain getting worse over a week, 
disrupting sleep, worse on movement and when travelling e.g. in car, in the 
presence of Red flags ….[D6]. 
 
4.3.2.2.2 Cancer, infection, inflammatory arthritis/spondyloarthropathies, trauma 
Malaise, fever, unexplained weight loss. History of inflammatory arthritis, cancer, 
tuberculosis, immunosuppression, drug abuse, AIDS, or other infection [D1] 
 
Lymphadenopathy [D1] 
 
Severe neck pain associated with fever, sweats, lethargy, or malaise (infection) 
[D12]. 
….in the presence of Red flags are: known cancer; fever; infection; age greater 
than 40 [D6]. 
Note if: cancer; age>50 yrs; or fever/infection present [D7]. 
Neck pain: instability, neoplastic lesion/ trauma [D8]. 
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4.3.2.2.3 Headache 
…changes with posture or exertion for headache - should also mention cough 
and strain induced headache seen with Chiari malformation [D2]. 
 
Signs and symptoms of raised intracranial pressure (in capitals)  (suggests other 
site of lesion) Headache (in presence of neck pain/stiffness) with features of: 
new onset (e.g. <1 month); change in usual pattern; changes with posture or 
exertion [D7]. 
 
Headache (in presence of neck pain/stiffness) with features of: new onset(e.g. 
<1 month); change in usual pattern; changes with posture or brought on by 
exertion, cough, laugh or straining. Note caution if: cancer; age>50 yrs; or 
fever/infection present [D9]. 
 
4.3.2.2.4 Neurological 
Weakness of arms or legs…gait disturbance, clumsy or weak hands, loss of 
sexual, bladder, or bowel function. Lhermitte's sign Upper motor neuron signs in 
the lower limbs Lower motor neuron signs in the upper limbs [D1]. 
 
Most crucial are those aspects of the history that suggest spinal cord 
compromise. So Lhermitte's phenomenon, foot drop, loss of leg strength or 
bladder/bowel disturbance [D10]. 
Neurological deficit a] Radicular: Numbness, pain, paraesthesia, weakness, 
hyporeflexia in a particular dermatome b] Cord: Lhermitte's; Loss of manual 
dexterity, weakness in hands; diffuse numbness, paraesthesia - bilateral, non-
dermatomal; hyperreflexia (Hoffman's, Finger flexion/extension jerks, clonus, 
stiff gait, myoclonus); up-going plantar response; loss of proprioception [D12]. 
All new progressive unusual neurological symptoms/signs, irrespective of neck 
pain, need investigation. Bladder/Bowel/Erectile dysfunction is more common in 
lumbar disorders (cauda equina) and comparatively rare in neck disorders 
except after severe injury or in the presence of profound motor/sensory deficit in 
the limbs. Bowel and bladder dysfunction are the last features to develop in cord 
compression at a very late stage and should not be emphasised too much 
[D12]. 
Cord compression - early on patients often complain of stiffness in the legs 
(spasticity) Bladder and bowel disturbance is relatively late in cervical cord 
compression [D2]. 
 
I believe testing for hyperreflexia is more relevant than hyporeflexia (especially 
in patients who present with symptoms reminiscent of carpal tunnel syndrome) 
[D4]. 
 
Cord compression symptoms/signs (with or without neck pain/stiffness) [D6]. 
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If there is hand or arm weakness or numbness or clumsiness or gait disturbance 
I would consider that late, but clearly important. Progressive features: bilateral 
hand and/or feet pins/needles or numbness; upper or lower limbs spasticity or 
weakness; reflexes exaggerated or reduced; bladder/bowel disturbance 
(incontinence or retention); erectile dysfunction (rarely) [D6]. 
 
Signs and symptoms of myelopathy (in capitals)  Neck pain/stiffness/headache 
with cord compression symptoms/signs : a - limbs - hand weakness or 
clumsiness, gait disturbance, paraesthesia, spasticity, increased reflexes, b - 
sphincter disturbance (incontinence or retention); erectile dysfunction [D7]. 
 
…gait disturbance: cervical myelopathy upper or lower limbs spasticity or 
weakness; cervical myelopathy reflexes exaggerated cervical myelopathy 
bladder/bowel disturbance (incontinence or retention)cervical myelopathy [D8]. 
 
Cord compression symptoms/signs (with or without neck pain/stiffness): early 
features: hand weakness or clumsiness; gait disturbance progressive features: 
bilateral hand and/or feet pins/needles or numbness (need not be symmetrical ); 
upper or lower limbs spasticity or weakness; reflexes exaggerated in legs and 
reduced in arms (or exaggerated in arms too); wasting of hand muscles, 
bladder/bowel disturbance (incontinence or retention); erectile dysfunction 
(rarely) [D9]. 
 
4.3.2.2.5 Brainstem-vascular-cranial nerve 
Horners sign [D1] 
 
Secondly, those features that may indicate a vascular pathology such as arterial 
dissection in the neck (dizziness, cranial nerve symptoms etc.) but I'm not sure 
that the latter is in the remit of this study [D10]. 
In my opinion, if you include dizziness, slurred speech, double vision, horner's 
syndrome, and other cranial nerve features, every patient with almost any 
neurological symptom or condition, even with common neck pain, will be 
referred for urgent assessment, and this is not appropriate [D12]. 
Signs and symptoms of brainstem dysfunction(in capitals) (Suggests other site 
of origin) slurred speech; double or loss of vision; drooping eyelid; pulsatile 
tinnitus or sudden loss of hearing; facial numbness or weakness; taste 
disturbance; nausea/vomiting; nystagmus [D7]. 
Neck pain/stiffness/headache with brainstem symptoms/signs - may be subtle 
and typically within 1 month onset: dizziness (typically episodic and between 
>1min and <30mins duration); slurred speech; double or loss of vision; drooping 
eyelid; pulsatile tinnitus or sudden loss of hearing; unilateral limb clumsiness or 
reduced balance; facial numbness or weakness; taste disturbance; nausea ... 
nausea alone would be too non-specific I think... I'd say vomiting; nystagmus 
[D9]. 
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4.3.2.2.6 Other comments 
Could boil it down to 1. Hard neurological signs 2. Progressive pain 3. Cancer 4. 
Inflammatory arthritis [D1]. 
 
As I mentioned I think it’s a short list. For example dizziness is only a red flag in 
neck pain if the patient also has other brainstem symptoms/signs (eg double 
vision, slurred speech or unilateral limb clumsiness). It turns out that “brainstem 
symptoms and signs” are a red flag generally, and actually you can forget about 
dizziness on its own being a red flag [D1]. 
 
I think it is important to differentiate red flags that focus on C Spine and those 
which divert the search for pathology elsewhere [D7]. 
I’m partly putting this effort in to replying as I agree that knowledge of neck 
problems and how these present in neurology is often not correct among 
physios. For example, many still do “VBI tests” even though there are few 
neurologists in the UK who believe that you can produce verterbrobasilar 
ischaemia from turning your neck. Tingling down the arm is often interpreted as 
root irritation when usually it’s referred muscle pain or carpal tunnel syndrome 
(which doesn’t behave as its supposed to in the books) etc. [D1]. 
 
4.3.2.3 Intra and Inter-coder reliability 
As outlined in section 3.5.4.6 three sets of Delphi first round responses were assessed 
for intra and inter-coder reliability of coding performed by the researcher (R) and one 
research supervisor (S). Table 4.2 displays the percentage agreement and Kappa 
coefficients for inter-coder and intra-coder reliability suggesting excellent agreement for 
both.  A score of ‘0’ indicates no agreement, whilst a score of ‘1’ indicates full 
agreement between coders.  A score above 0.75 indicates excellent agreement (NVivo 
9; www.qsrinternational.com).  However, due to the limited volume of text within the 
responses the extent of coding was limited to 2-3 sentences only for each of the three 
participants selected for coding. Therefore, this significantly reduced potential for error 
meaning there was greater potential for agreement.  
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Table 4.2: Intra and inter-coder reliability analysis for Delphi 1
st
 round 
Intra-coder reliability 
Coder % Agreement Kappa coefficient 
R (repeated) 100 1 
Intra-coder reliability 
Coders % Agreement Kappa coefficient 
R and S 100 1 
R - Researcher; S - Supervisor 
 
4.3.3 Delphi survey rounds 2 and 3 
4.3.3.1 Clinical indicators and consensus levels 
As outlined in section 3.5.4.7 there are no recognised guidelines for setting a 
consensus level (Powell 2003; Keeney et al 2006).  A minimum 75% level was selected 
a priori for gauging the consensus point.  As questions were not compulsory allowances 
were factored in to accommodate missing responses.  Therefore, this was adjusted to 
require a minimum n=9 (from a total of n=11 participants) to complete a question for this 
to be considered for consensus calculation.  The consensus levels increased to a 
minimum 80% strongly agree/agree to achieve the consensus point.  Tables 4.3 to-4.7 
displays the clinical indicators achieving this consensus level.  These clinical indicators 
were selected for inclusion in a list of red flags for potential serious pathology 
presenting as, or alongside, a cervical spine musculoskeletal disorder.  The complete 
round 3 survey responses to questions with 5-point likert scale ratings, plus ‘age’ 
question, may be viewed in Appendix T.  Refer to Appendix U for round 3 descriptive 
statistics.  Raw data for rounds 2 and 3 may be viewed in Appendices V and W, 
respectively. 
 
Furthermore, the Delphi rounds 2 and 3 responses were not identifiable to consultant 
coding allocated for round 1 analysis, therefore any additional responses obtained 
during these rounds are coded as ‘NIC’ (No Identifying Code) to denote this position.  
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Table 4.3: Progressive pain (Neck and/or radicular pain. May be accompanied by headache) indicators achieving 
red flag consensus level 
 
1. Progressive pain: 
1.b. May be associated with others features (e.g. history of cancer, trauma, presence 
of hard neurological signs, suspected atlanto-axial instability or infection). 
Total responses 
n=11 
Strongly agree / Agree 90.9% 10 
 
6. Severe pain on movement; reluctance to move; gross cervical spasm or torticollis 
(cancer, infection, atlanto-axial instability). 
Total responses 
n=10 
Strongly agree / Agree 80.0% 8 
 
 
Additional comments on pain: 
In terms of pain, the most excruciating pain is most frequently encountered with 
cervical radiculopathy. With the exception of pain at rest and occipital neuralgia, 
I don't generally associate it with sinister pathologies [NIC]. 
 
 
Table 4.4: Cancer, infection, inflammatory arthritis/spondyloarthropathies, trauma indicators achieving red flag 
consensus level 
 
9.Cancer Previous history of cancer; unexplained weight loss; lymphadenopathy. 
Total responses         
n=11 
Strongly agree / Agree 90.9% 10 
 
11.Infection Malaise, fever, sweats, lethargy. 
Total responses 
n=11 
Strongly agree / Agree 81.8% 9 
 
12. Tuberculosis, immunosuppression, drug abuse, HIV/AIDS, or other (significant) 
infection. 
Total responses 
n=11 
Strongly agree / Agree 90.9% 10 
 
14.Trauma (recent onset) 
Total responses 
n=11 
Strongly agree / Agree 100% 11 
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Table 4.5: Neurological deficit (e.g. spinal cord compromise) indicators achieving red flag consensus level 
16. Quick guide Upper motor neuron symptoms/signs (in lower limbs more than upper limbs). 
Lower motor neuron symptoms/signs (in upper limbs more than lower limbs). 
 
Total responses n=11 
Strongly agree / Agree 100% 11 
 
17. Hands: clumsy/loss of dexterity or weakness. Total responses n=11 
Strongly agree / Agree 100% 11 
 
20. Loss of proprioception. Total responses n=11 
Strongly agree / Agree 81.8% 9 
 
21. Lhermitte's phenomenon / sign. Total responses n=11 
Strongly agree / Agree 100% 11 
 
22. Hyperreflexia: (Increased/exaggerated reflexes in lower limbs more than upper limbs; 
Hoffman's reflex; finger flexion-extension jerks; clonus; myoclonus/spasticity in lower limbs > 
upper limbs; upgoing plantar response). 
Total responses n=11 
Strongly agree / Agree 100% 11 
 
23. Gait disturbance e.g. stiff, slow, broad based. Total responses n=11 
Strongly agree / Agree 90.1% 10 
 
25.Very late stage Total responses n=10 
25.a. Sphincter disturbance (bladder and/or bowel) disturbance (retention or incontinence). 
Strongly agree / Agree 80.0% 8 
26.General progressive neurological deficit Any new progressive and/or unusual 
neurological symptoms/signs (irrespective of neck pain/stiffness). 
Total responses n=11 
Strongly agree / Agree 90.9% 10 
 
An additional comment was received in the neurological section: 
Physical signs too poorly done in general to be useful in assessment by most 
people. Some neurological progressive symptoms may already have reliably 
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indicated the true diagnosis and so excluded spinal pathology - it depends on 
the quality of the history [NIC]. 
 
 
Table 4.6: Headache (accompanying neck pain/stiffness) indicators achieving red flag consensus level 
30. Headache changes: Total responses n=9 
30.b. With posture or brought on by exertion, cough, laugh or straining. 
Strongly agree / Agree 100% 9 
 
31. Sudden (unexplained) onset. 
Total responses 
n=10 
Strongly agree / Agree 80.0% 8 
 
 
Headache demonstrated the most notable change in consensus levels between 
Rounds 2 and 3 (refer to 4.3.3.2). Additional comments on headache included: 
 
Headache, unless new onset, severe an unremitting, might indicate a problem 
that merits referral/investigation but I would not regard as red flag sign in relation 
to cervical pathology [NIC]. 
 
New persistent headache with evolving signs is most predictive of underlying 
pathology. Chronic severe headache is mostly primary. Need an option for 
sudden headache neck pain to cover SAH and arterial dissection (vertebral) 
[NIC]. 
 
There are many other pathological and non-pathological reasons for headache 
to be a symptom, irrespective of spinal pathology. Do not 'overload' it in this 
context [NIC]. 
 
Distinguish/separate posture and other exacerbators [NIC]. 
 
Headache suggesting more serious pathology is usually acute, severe, 
unresponsive to normal analgesics, constant and unusual to the patient. 
Progressively increasing headache over weeks is also suggestive. Chiari 
headache is specifically cough related. Raised ICP usually has a postural 
component - worse lying down and wakes the patient during the night/first thing 
in the morning [NIC]. 
 
The main type of headache that should be Ix is occipital neuralgia, signifying 
C1/2 instability or FM compaction [NIC]. 
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Table 4.7:  Brain stem, cervical arterial (occlusion/stenosis/dissection) and cranial nerve dysfunctions indicators 
achieving red flag consensus level 
33.a.ii. Slurred speech. 
Total responses 
n=10 
Strongly agree / Agree 90.0% 9 
33.a.iii. Double or loss of vision. 
Total responses 
n=10 
Strongly agree / Agree 90.0% 9 
33.a.iv. Drooping eyelid / Horner's sign. Total responses n=9 
Strongly agree / Agree 88.9% 8 
33.a.v. Pulsatile tinnitus or sudden loss of hearing. 
Total responses 
n=10 
Strongly agree / Agree 80.0% 8 
33.a.vi. Unilateral limb clumsiness or reduced balance. 
Total responses 
n=10 
Strongly agree / Agree 80.0% 8 
33.a.vii. Facial numbness or weakness. Total responses n=9 
Strongly agree / Agree 100% 9 
33.a.x. Nystagmus. 
Total responses 
n=10 
Strongly agree / Agree 90.0% 9 
 
 
This final section was accompanied by the following comments: 
I have highlighted which neurological symptoms are most worrying (Loss of 
vision, slurred speech, facial weakness, drooping eyelid) not because they 
necessarily all relate to brain stem dysfunction, but because they may suggest 
serious pathology outside the neck that justifies urgent referral/investigation. 
Blurred vision, double vision, vomiting, nystagmus, and tinnitus are not likely to 
indicate an acute decompensating chiari  that requires immediate investigation, 
but are symptoms that should be brought to the GP's attention and assessed by 
him [NIC]. 
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These are mostly worrying signs but not of cervical spine pathology (except 
rarely) [NIC]. 
 
Horner's is the main finding (often ignored) [NIC]. 
Lacks neurological clarity [NIC]. 
In relation to the possibility of dissection, Horner's is invariably present in my 
experience. What generally concerns me is the presence of abnormal 
semiology, of upper motor Neuron type [NIC]. 
 
 
One final additional comment of note perhaps summarises the complexity of this topic: 
 
Leave neurology to neurologists [NIC]. 
 
Other findings of note were three indicators achieving near consensus level (between 
70% to 79%): 
 
1. Weakness (widespread) of arms or legs. 
 
Additional comment: 
Functional (psychological) problems often present with widespread give 
way weakness and diffuse parasthesia. Focal signs are much more 
predictive of underlying pathology [NIC]. 
 
2. Lower motor neuron symptoms/signs (in upper limb more than lower limb). 
Radicular pattern in particular dermatome: Numbness; paraesthesia 
(pins/needles); weakness; hyporeflexia (reduced reflexes) in particular 
dermatome. 
 
Additional comment: 
You have to differentiate myelopathy (spinal cord compromise) from 
radiculopathy (nerve root compromise). The former requires urgent 
assessment; the latter is very common in degenerative cervical disease, 
and an isolated root problem doesn't necessarily require urgent 
assessment. The important thing is appreciating the LOWER limb 
symptoms (not pain), particularly if bilateral and related to a neck 
disorder must be due to cord compromise [NIC]. 
 
3. Taste disturbance. 
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Two additional clinical indicators of note that did not achieve either the consensus level 
or near-consensus level were dizziness and age.  Dizziness generated a number of 
detailed responses within the focus group.  However, this indicator achieved a low 
strongly agree/agree level of 40% (n=10 Mean 3.0 SD 0.94).  Similarly, Age (and 
increased risk of serious pathology occurring…..) received a split response for age > 50 
years (n=6; 54.5%) versus no age group exempt/association (n=5; 45.5%). During 
round 2, one participant stated ‘age >40 years’ as a risk.  However, in round 3 this 
option was not selected. One additional comment accompanied this section: 
 
I have reconsidered the age question and since degenerative disease becomes 
much more common with age, serious disease can probably occur in any age 
group and is unlikely to be necessarily linked with increasing age [NIC]. 
 
 
4.3.3.2. Level of agreement 
Kendall’s W (Kendall’s coefficient of concordance) ranges from 0 (no agreement) to 1 
(complete agreement).  This was calculated  for each of the five categories (outlined in 
4.3.2.2) using  IBM SPSS Statistics version 19  and demonstrated an increase in 
Kendall’s W between Rounds 2 and 3 in four out of five categories (Refer to Table 4.8).   
This indicates an increase in consensus levels between participants over these two 
rounds. The most notable change was found in the ‘Headache’ category with an 
increase from 0.13 in Round 2 to 0.63 in Round 3.  Caution should be noted in 
interpreting this calculation due to the small sample size. 
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Table 4.8: Kendall’s W (Kendall’s coefficient of concordance) and P value for Delphi survey rounds 2-3 
 
 
Categories 
 
Round 2 
 
 
Round 3 
 
P value 
 
 
K 
 
P value 
 
K 
 
Progressive pain 
 
 
0.13 
 
0.25 
 
0.02 
 
0.31 
Cancer, infection, inflammatory 
arthritis/spondyloarthropathies, trauma 
 
0.25 0.25 0.07 0.35 
Neurological 
 
0.11 0.26 0.04 0.27 
Headache 
 
0.28 0.13 0.00 0.63 
Brainstem-vascular-cranial nerve 
 
0.00 0.40 0.01 0.33 
 
P value ≤ 0.05; K= Kendall’s W (Kendall’s coefficient of concordance) 
 
 
Appendices X and Y display examples of graphical representation for Kendall’s 
coefficient of concordance for Progressive pain and Headache, respectively. 
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Chapter 5. Discussion 
 
5.1 Introduction 
The principal motivating factor behind this study design arose through development of a 
national health board’s regional spinal service (adult population) that questioned the 
diagnostic utility of red flag indicators traditionally used within physiotherapy practice for 
the screening of possible serious pathology presenting in musculoskeletal neck pain or 
neck related complaints.  A subsequent literature search identified that red flags for 
serious pathology in the cervical spine or neck pain did not receive the same level of 
attention as red flags for serious pathology in back pain.  Although some features within 
the recognised list of red flags for serious pathology in back pain (e.g. CSAG 1994) will 
relate to the whole spine, such as cancer or infection, there are however, specific 
clinical considerations to the cervical spine that creates uncertainty for physiotherapy 
practitioners’ decision making regarding clinical features and their importance relative to 
the serious nature of the clinical presentation.  There is therefore, a requirement to 
address such uncertainties that ensures vigilance and actions in the process of early 
detection of serious pathology is both measured and appropriate throughout the 
assessment and management systems. 
 
CSAG (1994) use the term serious spinal pathology to include spinal tumour, infection, 
inflammatory disease e.g. ankylosing spondylitis, structural deformity, such as scoliosis, 
and widespread neurological disorders. However, Negrini (2007) considers that the 
neck is not the back.  In relation to red flag indicators, cervical arterial dysfunction is 
one such category that would differentiate the neck from the back in terms of possible 
serious pathology.  Negrini’s (2007) editorial on new developments in neck pain 
estimates that neck pain lags approximately 20-years behind research on low back 
pain, which includes clinical behavioural differences.  Negrini (2007) calls for research 
by well trained clinicians and rehabilitation professionals in neck pain to address this 
gap.  This study design aims to contribute to this call. 
The prognostic variables or diagnostic indicators developed by CSAG (1994) for 
possible serious spinal pathology have been widely integrated into clinical practice for 
the management of low back pain. This list is displayed in Table 5.1. These clinical 
indicators are risk factors identified during the subjective examination (clinical history 
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taking) and objective examination (physical examination) and are associated with a 
higher risk of serious disorders causing low back pain compared to patients without 
these characteristics.  Further investigation may be required to exclude serious 
pathology, such as cancer, inflammatory arthritis or infection, in the presence of such 
clinical features (Greenhalgh and Selfe 2009).  
 
Table 5.1: Red flag indicators for low back pain (CSAG 1994; Greenhalgh and Selfe 2006, 2010) 
 
Red flag indicators for low back pain 
Age of onset less than 20 years or more than 55 years 
Recent history of violent trauma 
Constant progressive, non mechanical pain (no relief with bed rest) 
Thoracic pain 
Past medical history of malignant tumour 
Prolonged use of corticosteroids 
Drug abuse, immunosuppression, HIV 
Systemically unwell 
Unexplained weight loss 
Widespread neurological symptoms (including cauda equina syndrome) 
Structural deformity 
Fever 
 
With reference to specific red flags for the cervical spine, the health information website 
Patient.co.uk is a resource supplying evidence based information to patients and health 
professionals and provides a list of red flags for neck pain 
(http://www.patient.co.uk/doctor/Neck-Examination.htm).  This section ‘Neck pain 
(Cervicalgia) and Torticollis’ references the Clinical Knowledge Summaries (CKS 2009) 
as its source for this list of red flags’ (http://cks.nice.org.uk/neck-pain-cervical-
radiculopathy#!topicsummary).   CKS is a National Institute for Health and Clinical 
Excellence supported website that provides information to support clinical practice. This 
web-based resource, which has not been updated since 2009, provides a number of 
references with Binder (2007a, b) found to be the most relevant citations provided. 
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Binder (2007a, b) provides a list of red flags, which is poorly referenced.   This work has 
been adapted for use by Patient.co.uk with the following red flag list: 
 
Red flags for neck pain 
A serious underlying cause is more likely in people presenting with 
Red flags suggesting possible malignancy, infection or inflammation 
Red flags suggesting myelopathy (compression of the spinal cord) 
Red flags suggesting severe trauma/skeletal injury 
Red flags suggesting vascular insufficiency 
 
The focus group participants considered the construction of this list that divides into 
groups of pathologies, could assist physiotherapists’ clinical decision making by 
enhancing the thought process behind the pathology, as opposed to simply thinking of a 
clinical indicator in isolation.  This is a different format to the method presented in Table 
5.1, the traditional red flag list for low back pain as developed by CSAG (1994). 
 
Chapter 4 identified that the list of red flags for low back pain is integrated within 
specific cervical red flag information contained in the Patient.co.uk list summarised 
above. However, due to limited supporting evidence, questions remain on the selection 
of cervical spine clinical indicators and tests as being reliable or of sufficient detail to 
inform clinical practice.  This chapter discusses how these clinical indicators within 
specific groups of pathologies e.g. vascular insufficiency and myelopathy, relate to the 
findings from this study alongside the current evidence base.  This will include current 
physiotherapy screening processes, specifically the clinical indicators forming the 5Ds 
And 3Ns framework, neurological features, age and pain as discussed in chapter 2. 
This chapter uses Delphi participant comments to support discussion points.  As stated 
in chapter 4, the Delphi rounds 2 and 3 responses were not identifiable to consultant 
coding allocated for round 1 analysis, therefore these are coded as ‘NIC’ (No Identifying 
Code) to denote this position. 
 
Figure 5.1 displays the categories and clinical indicators identified from the Delphi 
method that achieved the consensus point.
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Figure 5.1: Cervical spine red flag categories with clinical indicators achieving Delphi consensus point 
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5.2 Clinical indicators 
5.2.1 Age 
Greenhalgh and Selfe (2009) reported this established and well recognised red flag was 
not considered as relevant by an expert panel of seven senior palliative care clinicians 
participating in a qualitative investigation of red flags for serious spinal pathology.    
Greenhalgh and Selfe (2009), however, note a weakness with their participant group 
that routinely cared for patients with a confirmed diagnosis of serious spinal pathology, 
therefore this may not be representative of the general patient population seen within a 
primary care setting.  In this current study three age options were generated by 
consultant responses: age greater than 40-years; age greater than 50-years; and, age 
has no association with the onset of serious pathology occurring naturally.  The Delphi 
3rd and final round revealed no consensus was achieved with 45.5% (n=5) supporting 
Greenhalgh and Selfe’s (2009) expert panel indicating that age was not relevant.   The 
remaining 55.5% (n=6) of selected age greater than 50-years, which follows the original 
CSAG (1994) guidance.  Given that cervical arterial pathology, such as spontaneous 
CAD (sCAD), comprising of the internal carotid artery (ICA) and vertebral artery (VA) 
can affect all age groups, but mainly affects young and middle-aged adults between the 
ages of 35-50-years (Schievink 2001; Schievink et al 1994) and the Greenhalgh and 
Selfe’s (2009) findings this suggests that caution should be used if relying on age as an 
indicator.  It would appear that age is not a clear indicator for the onset of serious 
pathology within the cervical spine. 
 
5.2.2 Pain 
Chapter 2 identified that neck pain and/or headache symptoms are the most frequent 
local symptoms of CAD (Silbert et al 1995; Savitz and Caplan 2005; Taylor and Kerry 
2005; Arnold, Cumurciuc et al 2006; Kerry and Taylor 2006; Chandra et al 2007; 
Hardmeier, Gobbi et al 2007; Morelli et al 2008; Rigamonti et al 2008; Tobin and 
Flitman 2008; Thomas et al 2011), and additionally, can be the only presenting 
symptoms (Biousse et al 1992; Biousse et al 1994; Guillon et al 1998; Arnold, 
Cumurciuc et al 2006).  Furthermore, VAD has also been reported as presenting as a 
fifth cervical nerve root (C5) radiculopathy (Arnold, Bousser et al 2006; Hardmeier, 
Haller et al 2007;). However, how does the presentation of pain within this evidence 
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base compare with CSAG’s (1994) description of constant, progressive, non-
mechanical pain, and the clinical indicators identified from this study? 
 
CSAG (1994) identify that constant progressive, non mechanical pain (no relief with bed 
rest) is a red flag indicator for serious spinal pathology. Non-mechanical pain is 
unrelated to physical activity.  The Delphi panel also identified progressive pain as a red 
flag indicator with a number of accompanying descriptors.  Rounds 2 and 3 sought to 
achieve clarity on these descriptors, such as how progressive pain may present or 
develop.   
 
Two descriptors of progressive pain achieved the consensus level: 
a) May be associated with other features e.g. (history of cancer, trauma, 
presence of objective neurological signs, suspected atlanto axial instability 
or infection); and 
b) Severe pain on movement, reluctance to move, gross cervical spasm or 
torticollis. 
 
The descriptors in (b) were suggested to indicate the presence of cancer, infection or 
atlanto-axial instability. 
 
Descriptors that did not achieve the consensus point were progressive pain: in isolation; 
progressively worse e.g. over 1-week period; not responding to simple analgesia; onset 
may be a new 1st episode of acute/sub-acute pain (e.g. following trauma or arterial 
dissection); may be acute/sub-acute on chronic pain; severe and/or unremitting; 
disrupting sleep.  However, severe and/or unremitting pain and pain with onset of new 
1st episode (e.g. trauma or cervical arterial dissection) each received 63.7% strongly 
agree/agree (n=7, mean score 3.5 SD 1.04 and 3.7 SD 1.13, respectively).  These 
scores indicate a trend towards reaching a consensus point.  Therefore, the latter two 
descriptors should be reconsidered within further studies. 
 
One participant offered additional comment indicating that, with the exception of two 
descriptors, pain in general was not a clinical indicator of serious pathology: 
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In terms of pain, the most excruciating pain is most frequently encountered with 
cervical radiculopathy. With the exception of pain at rest and occipital neuralgia, 
I don't generally associate it with sinister pathologies [NIC]. 
 
 
5.2.3 Headache 
5.2.3.1 Clinical indicators of headache achieving the consensus point 
Pain associated with occipital neuralgia was suggested to be linked with atlanto-axial 
instability and foramen magnum compaction.  
 
The main type of headache that should be Ix (investigated) is occipital neuralgia, 
signifying C1/2 instability or FM (Foramen magnum) compaction [NIC]. 
 
Williams (1977) report a case of foramen magnum impaction in a rare case of 
congenital osseous dysplasia causing basilar invagination from defective bone 
formation.  This change caused occipital headache and progressive neurological 
deterioration of cerebellar function and lower cranial nerve dysfunction.  Occipital or 
posterior neck pain with diffuse headache is considered as a main feature of vascular 
pathology of the posterior circulation system (Savitz and Caplan 2005; Rivett et al 
2006). 
 
Chiari malformation type 1 is the most frequent of the Chiari malformations (Grazzi and 
Andrasik 2012). This involves inferior displacement of the cerebellar tonsillas through 
the foramen magnum.  Most cases are congenital in origin with less frequent onset after 
birth with formations involving excessive drainage of spinal fluid due to infection, injuries 
or exposure to harmful substances.  A rare cause may be chronic sub-dural 
haematoma (Grazzi and Andrasik 2012). Robertson and Stanley (2008) report a single 
case of Chiari 1 malformation in a 25-year-old female involved in a road traffic accident 
(RTA) approximately 4-month previous to examination, but with progressively worse 
symptoms over the previous 6-weeks. 
 
Two clinical indicators within the headache section achieved the Delphi consensus 
point: 
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a) Changes with posture or brought on by exertion, cough, laugh or straining 
(100%, n=9 mean score 4.2 SD 0.4); and 
b)  Sudden (unexplained) onset (90% n=9, mean score 4.1 SD 1.0). 
 
Participant comments added: 
Chiari headache is specifically cough related. Raised ICP usually has a postural 
component - worse lying down and wakes the patient during the night/first thing 
in the morning [NIC]. 
 
New persistent headache with evolving signs is most predictive of underlying 
pathology. Chronic severe headache is mostly primary. Need an option for 
sudden headache neck pain to cover SAH and arterial dissection (vertebral) 
[NIC]. 
 
This latter comment demonstrates how the headache section was modified for round 3 
with the inclusion of ‘sudden (unexplained) onset’ following comments in round 2. This 
process allowed refinement of the clinical features that resulted in a change in 
consensus levels demonstrated by an increase in Kendall’s W from 0.13 in Round 2 to 
0.63 in Round 3.    This indicates an increase in consensus levels between participants 
over these two rounds.  
 
The Chiari 1 malformation clinical presentation may be precipitated by cough and/or 
Valsalva manoeuvre; occipital and/or sub-occipital headache; associated with 
symptoms/signs of brainstem, cerebellar and/or cervical cord dysfunction.  Evidence of 
posterior fossa dysfunction is based on at least 2 of the following: otoneurological 
symptoms (e.g. dizziness, disequilibrium, nystagmus); transient visual symptoms (e.g. 
diplopia, visual blurring); and, clinical signs of cervical cord, brainstem or lower cranial 
nerves or of ataxia or dysmetria) (Robertson and Stanley 2008; ICHD 1998 in Grazzi 
and Andrasik 2012).  Robertson and Stanley (2008) report dizziness.  However, 
dizziness is reported as a possible symptom from whiplash associated disorder.  It is 
unclear when this dizziness onset occurred in relation to the RTA reported by 
Robertson and Stanley (2008) with the original symptom being neck pain.   This article 
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is a short communication presenting magnetic resonance imaging (MRI) for this case, 
therefore lacks in-depth detail.  Cough headache is one of the most frequent headache 
forms; however, migraine and tension type is also reported (Grazzi and Andrasik 
(2012). 
 
5.2.3.2 Clinical indicators of headache not achieving the consensus point 
The Scottish Intercollegiate Guideline Network (SIGN) Guideline 107 Diagnosis and 
management of headache in adults is a national (NHS Scotland) clinical guideline 
outlined in chapter 2.   Guideline 107 states that secondary headache (i.e. headache 
caused by another condition other than a primary cause) “…should be considered in 
patients presenting with new onset headache or headache that differs from their usual 
headache” (p.9).   
 
This guideline contrasts with headache features not achieving consensus points within 
this study.  These were headache of new onset e.g. less than 1 month (20% n=2); 
severe and persistent (50% n=5); and, headache that changes from usual pattern 
(20%, n=2).  Interestingly, these features, or similar descriptors, were also included in 
comments e.g.  
 
Headache suggesting more serious pathology is usually acute, severe, 
unresponsive to normal analgesics, constant and unusual to the patient. 
Progressively increasing headache over weeks is also suggestive [NIC].  
 
 
However, these did not achieve the consensus level as seen in ‘sudden’ onset.  It 
should be noted that the comment ‘Progressively increasing…’ was received in the final 
round, therefore this is not specifically defined within the multiple choice questions.  
 
Additional comments also suggested that clinical reasoning should not be overly 
inclusive of headache features within cervical pathology.  This may explain reasons 
behind round 2 not achieving the consensus point.  This was indicated in both the chart 
feedback and rounds 2/3 comments: 
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There are many other pathological and non-pathological reasons for headache 
to be a symptom, irrespective of spinal pathology. Do not 'overload' it in this 
context [NIC]. 
 
Headache, unless new onset, severe and unremitting, might indicate a problem 
that merits referral/investigation but I would not regard as red flag sign in relation 
to cervical pathology [NIC]. 
 
During clinical chart feedback: 
……there is no need to describe hemicrania continua in a chart about neck 
problems. If a patient has that, they will mainly have a headache [D1]. 
 
These comments alongside several components of the SIGN Guideline 107 not 
achieving a Delphi consensus agreement may suggest that headache should not be 
considered in the context of neck pathology, and possibly not included within the list of 
red flag clinical indicators generated from this study.  Similarly, it may indicate that 
headache of such severity will not present at a non-medical musculoskeletal clinic. This 
latter interpretation is highly plausible; however, the overall conclusion may be too 
simplistic to separate headache from cervical spine related pathology as patients 
presenting with musculoskeletal neck pain may also complain of headache.  
 
As discussed in chapter 2 cervicogenic headaches is considered a disorder that is 
manageable by the physical therapies (Jull 1997). This disorder has been recognised 
by the International Headache Society (IHS 2004).  Part of the criteria referred to by the 
IHS is pain referred from a source in the neck and felt in one or more regions of the 
head and/or face.  Differential diagnosis of cervicogenic headache, however, can be 
difficult to separate from other causes of headache unless additional features are 
presented.  An additional problem with headache differentiation is that neurologists 
differ in their agreement of cervicogenic headache as having a nosological identity 
making the concept of cervicogenic headache controversial (Leone et al 1998; Zhou 
2008; Bogduk and Govind 2009).  This adds greater complexity to clinicians navigating 
their clinical reasoning processes when a patient presents complaining of neck pain and 
headache.   
 
It is therefore considered appropriate to include features of headache within this study.  
However, these should be restricted to key features.  The Delphi participant [D1] 
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comment during the chart feedback phase was utilised to inform development of the 
‘headache’ section within the Delphi 2nd round survey.  This included; headache 
‘accompanying neck pain/stiffness’.  This terminology was employed to indicate that a 
complaint of neck pain/stiffness should be present to help clarify that physiotherapists 
are not receiving  specific complaints of headache that are likely to present at a 
neurology clinic, except in the case of cervicogenic headache where the source of pain 
is considered to be from the neck region (IHS 2004). 
 
Chapter 2 highlighted that in relation to neck pathology the most crucial differential 
diagnosis is headache from CAD due to the heightened risk of adverse events with 
potentially near fatal consequences following manipulation (Bogduk and Govind 2009).  
In considering clinical recommendations (e.g. Rivett et al 2006; Kerry et al 2007), 
Thomas et al (2011) noted that headache was not always present or severe in either 
VBAD or ICAD subjects.  Debette, Gronsbach et al (2011) and Thomas et al (2011), 
however, both reported that neck pain was more likely in VBAD than ICAD subjects.  
Neck pain and headache are symptoms that can present at musculoskeletal clinics 
without prior attendance at a medical practitioner, or could be the reason for referral 
from the medical practitioner.   
 
Silbert et al (1995) reported  65 of ICAD patients considered their headache as ’unique’ 
but 45 did not consider a significance difference to previous experience of headache.  
This does not support Kerry and Taylor’s (2006) statement as having headache “unlike 
any other”. Silbert et al (1995) also reported that 132 from 135 ICAD patients had 
accompanying focal neurological manifestations. Only 3 had headache only, 
with/without neck or facial pain. Additionally, Silbert et al (1995) report from 135 ICAD 
patients, 35 (26%) had neck pain at time of dissection with gradual onset in 25 patients 
and sudden in 7.  Neck pain was the first symptom in only 9 patients.  Whilst it is 
possible for cervical arterial pathology to present with pain only, this appears to be in a 
small number of cases within a relatively rare condition.  Although, this condition is 
relatively rare, the outcomes unfortunately may be catastrophic to both patient and 
carer.  Debette and Leys (2009) advocate caution regarding incidence rates as CAD 
cases with reduced clinical signs may remain undiagnosed.   
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With regards to pain and cervical arterial dysfunction a review of the evidence base 
suggest there is no clear pattern of headache or neck pain and that may occur in either 
VAD or ICAD and demonstrates inconsistency in literature reporting pain presentations 
related to CAD ( e.g. Biousse et al 1994; Silbert et al 1995; Arnold, Cumurciuc et al 
2006). 
 
5.2.3.3 Differential diagnosis of arterial causes cause of pain / headache 
The literature review identified that Debette, Grond-Ginsbach et al (2011) and Thomas 
et al (2011) report neck pain is more likely in VAD, but both reports differed with regards 
to headache.   However, from a physiotherapist’s clinical perspective it is questionable if 
this information is relevant to musculoskeletal clinical decision making.  Clinical 
experience suggests the concept of differential diagnosis within cervical arterial 
pathology would be highly challenging for a physiotherapist to correctly select between 
these two arteries as the source of an underlying pathology, unless additional medical-
led advanced practice training was received.   
 
Physiotherapy literature suggests a clinical reasoning approach to identify if the arterial 
problem is ICAD or VAD in origin, such as using palpation skills for the carotid artery in 
times of suspicion (e.g. Taylor and Kerry 2010). This aspect was discussed within the 
physiotherapy focus group that indicated a mixed opinion. The differing opinions 
considered that differential diagnosis skills may be advantageous if appropriate training 
was applied versus expressions on reservations regarding concerns for the profession’s 
credibility with the medical profession on the issue of palpating the carotid artery for 
diagnostic purposes.  In the absence of such training and a need for further debate 
involving medical and non-medical musculoskeletal practitioners it appears reasonable 
to suggest that physiotherapists should focus solely on identifying the presence of a 
serious arterial pathology, rather than introducing additional complexity to the 
examination through attempts to ascertain which of the cervical arteries are in a 
dysfunctional state. 
 
It is important for the credibility of this thesis to ensure that conclusions are based on 
the combination of the focus group discussion and Delphi panel’s input through 
comments and multiple choice responses alongside the evidence base.  In the context 
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of this section key examples from the evidence base are Silbert et al’s (1995) 
identification of n=132 from 135 CAD patients had accompanying neurological 
manifestations and Savitz and Caplan (2005) reporting that vertebrobasilar ischemia 
typically presents with a collection of symptoms and signs, such as motor or oculomotor 
signs, and rarely causes only one symptom.  Therefore, it could plausibly be argued 
that a more practicable approach to considering the presentation of pain from an arterial 
pathology origin is to screen for additional local neurological features, whilst retaining 
an outside caution with pain only presentations.  This would also relegate any 
recommendations to palpate cervical arteries with the view to identifying a pathological 
state, unless such processes are advocated by the medical community.  It is important 
that physiotherapists’ progress their assessment systems based on evidence based 
practice and development to ensure wider clinical credibility is achieved and 
maintained. 
 
5.2.4 Brain stem, cervical arterial dysfunction (occlusion/stenosis/dissection) and 
cranial nerve dysfunctions 
To facilitate discussion on this section Table 5.2 displays the clinical indicators in two 
groups; achieving and not achieving the consensus point. 
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Table 5.2 Brain stem, cervical arterial dysfunction and cranial nerve dysfunctions consensus levels 
 
Brain stem, cervical arterial dysfunction (occlusion/stenosis/dissection) and cranial nerve 
dysfunctions 
 
Clinical indicator achieving consensus 
point 
  n n 
Agreement 
% 
Agreement 
 
Mean 
score 
 
SD 
Slurred speech 9 90 3.9 0.7 
Double or loss of vision 9 90 4.1 0.8 
Drooping eyelid / Horner’s sign 8 88.9 4.6 0.7 
Pulsatile tinnitus or sudden loss of hearing 8 80 4.0 0.9 
Unilateral limb clumsiness or reduced 
balance 
8 80 3.8 1.0 
Facial numbness or weakness 9 100 4.3 0.5 
Nystagmus 9 90 4.4 0.7 
 
Clinical indicator not achieving 
consensus point 
  n n 
Agreement 
% 
Agreement 
 
Mean 
score 
SD 
New or recent onset of symptoms/signs 
e.g. 1 month 
4 57.2 3.9 0.7 
Dizziness 4 40 3.0 0.9 
Taste disturbance 7 70 3.5 0.9 
Vomiting 6 60 3.5 1.0 
 
5.2.4.1 Clinical indicators achieving consensus point 
Slurred speech, double or loss of vision, drooping eyelid/Horner’s sign, pulsatile tinnitus 
or sudden loss of hearing, unilateral limb clumsiness or reduced balance, facial 
numbness or weakness, and nystagmus all achieved the consensus point within this 
study.  A recommendation within the qualitative phase of the Delphi survey was to avoid 
confusion and misinterpretation by not using neurological terminology, such as 
‘dysphasia’.  This recommendation was adopted within this section, for example Delphi 
responses included ‘slurred speech’ rather  than ‘dysphasia’, ‘double or loss of vision’ 
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rather than ‘diplopia’, ‘reduced balance’ in place of ‘ataxia’, and ‘drooping eyelid’ 
replacing ‘ptosis’.  ‘Nystagmus’ does not appear to have an obvious simplified 
alternative name.   Dysphasia, diplopia, ataxia and nystagmus form part of the 5Ds And 
3Ns framework.   
 
These features were identified within the literature review to investigate the signs and 
symptoms relative to the 5D and 3Ns framework and to ascertain if this framework is a 
reasonable clinical approach for identifying possible serious neurovascular pathology.  
For example, Thomas et al’s (2011) retrospective case control study of a younger 
patient group (<55-years) comparing cervical arterial dissection cases with non-
dissection causes of stroke identified the symptoms; visual disturbance, paraesthesia 
(face, upper and lower limb),  and signs; Unsteadiness/ataxia, weakness upper and 
lower limb; dysphasia/dysarthria/aphasia, facial palsy, ptosis (Horners sign). Thomas et 
al’s (2011) study was designed with consideration to informing clinical practice of non-
medical practitioners. 
 
5.2.4.1.1 Nystagmus 
Nystagmus forms part of the 3Ns framework and was described to the group as a sign, 
not a disease with involuntary movement of the eyes (Patten 1998).  Bhattacharryya et 
al (2008) describe directional patterns to aid differential diagnosis of central versus 
peripheral causes of this sign.  Nystagmus achieved the consensus point.  This clinical 
sign generated discussion around the physiotherapy skills level required to sufficiently 
interpret this clinical feature. 
 
Assessment of nystagmus may be performed by physiotherapists undertaking 
vestibular assessment and rehabilitation (e.g. Herdman 2007 ch.7 pp.108-124), such as 
the Dix-Hallpike manoeuvre (a positional test for the vestibular system).  As outlined in 
chapter 2, evaluation of nystagmus, however, requires a high level of interpretative 
skills.   Patten (1998 p.103) states that “…the importance of testing nystagmus correctly 
and recording the quality, direction and other features is not sufficiently appreciated, 
which can demonstrate poor clinical technique with potential failure to achieve a true 
differential diagnosis”.   
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Therefore, unless specific additional training has been undertaken, physiotherapists 
should exercise caution if attempting to interpret this sign.  Indeed, the focus group 
participants’ considered that recognising such limitations were important with onward 
referral for specialist opinion being considered appropriate. This is summarised by the 
following two participants’ comments when asked if physiotherapists are sufficiently 
skilled to interpret this.  
 
I think probably not. Ok. I think we can learn to look at the Dix-Hallpike test and 
recognise normal nystagmus there, but if you read the literature there is just so 
many different types of nystagmus as to what is going on and I don’t think an 
ordinary MSK clinician, well not an ordinary one, but a highly skilled one, MSK 
clinician, can be expected to read nystagmus as they would in an expert 
neurology clinic.  Because it goes upwards, sideways, downwards, backwards 
and frontwards, you know, I mean we can say if it is there, but we can’t really 
differentiate as to what it is indicating, I don’t think [FG6]. 
 
It probably needs to be interpreted alongside other tests we wouldn’t be 
performing in any case in our clinics…….. [FG7]. 
 
Participant FG6’s comments identifying the many different types of nystagmus is 
exemplified by Herdman (2007 p. 117) in listing the following types of vestibular 
nystagmus due to central lesions; torsional,  downbeat, upbeat, seesaw, periodic 
alternating nystagmus, and latent.  This highlights the challenges presented to non-
medical practitioners in assessing nystagmus.  It would, therefore, appear reasonable 
to recommend that a patient presenting to a musculoskeletal physiotherapy clinic with 
signs of nystagmus in the absence of a previous medical diagnosis should receive an 
onward referral for specialist opinion.  The urgency of this referral may depend on the 
presence of additional symptoms and signs.  The patient may be re-accepted for further 
physiotherapy-led management once diagnosis confirms no serious central pathology 
as the underlying cause.   
 
5.2.4.1.2 Drooping eyelid / Horner’s sign, Facial numbness or weakness, and 
pulsatile tinnitus or sudden loss of hearing 
Several clinical features out with the 5Ds And 3Ns framework were included in this 
section with subsequent consensus agreement; Drooping eyelid / Horner’s sign, Facial 
numbness or weakness, and pulsatile tinnitus or sudden loss of hearing. 
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Thomas et al (2011) additionally reported the signs of ptosis (Horner’s sign/syndrome), 
facial palsy and upper and lower limb weakness were the most common signs in ICAD 
(anterior circulation system).  This supports Baumgartner et al (2001) who identified the 
main significant local signs in ICAD without ischemic development (n=55) was Horner’s 
syndrome and lower cranial nerve palsies.  Ptosis or Horners sign/symptom or 
oculosympathetic palsy was reported in approximately 25-30% of cases (Bassi et al 
2003; Dziewas et al 2003; Lee et al 2006). 
 
Pulsatlie tinnitus is almost exclusively related to the sound of non-laminar blood flow 
transmitted to the inner ear occurring from alteration in heamodynamcis e.g arterial 
dissection, systemic disease, or local disorders within or in close proximity to the 
petrous bone (Pelkonen et al 2004).   Pulsatile tinnitus presented as a symptom in 16 
patients within a prospective study (n=136; Pelkonen et al 2004).  Similarly, Dziewas et 
al (2003) and Arnold, Bousser et al (2006) also reported tinnitus occurring in a small 
number of patients with 8 (6%) and 7 (5%), respectively.  
 
Ptosis or Horner’s sign, facial palsy and pulstaile tinnitus or sudden loss of hearing, 
however, are not included in the 5Ds And 3Ns framework.  The exclusion of these 
features suggests that this framework is not a reliable aide memoire for cervical arterial 
pathology.   The following Delphi participant adds further insight to features within this 
section: 
 
I have highlighted which neurological symptoms are most worrying (Loss of 
vision, slurred speech, facial weakness, drooping eyelid) not because they 
necessarily all relate to brain stem dysfunction, but because they may suggest 
serious pathology outside the neck that justifies urgent referral/investigation. 
Blurred vision, double vision, vomiting, nystagmus, and tinnitus are not likely to 
indicate an acute decompensating  chiari  that requires immediate investigation, 
but are symptoms that should be brought to the GP's attention and assessed by 
him [NIC]. 
 
5.2.4.2 Clinical indicators not achieving consensus point 
New or recent onset of symptoms/signs was included to reflect the evidence base 
indications of a temporal component for the onset of neurological manifestations from 
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the initial feature presenting in CAD. For example, this has been reported as a mean 
8.8 days delay in ICAD patients and mean 12-day delay in VAD patients (Silbert et al 
1995) and from several minutes to 1-month (Mas et al 1987; Biousse et al 1995).  Such 
information may assist physiotherapy clinical decision making. However, similar to the 
‘headache’ category indicator ‘new onset (e.g. less than 1 month)’, this did not achieve 
the consensus point.  This question received a low response rate of n=7 from 11 
participants. On reflection, this may be related to the placement of this question at the 
beginning of this section that refers to the onset of the symptoms/signs listed below. 
This question may have been more effective if placed at the end of this section.  
However, the intention for placement at the beginning was to set the scene for the 
remaining symptoms/signs occurring with an acute/sub-acute onset. 
The remaining questions in this category received n=9 or n=10 responses, the latter 
being the maximum return for this section.  The literature suggests that a temporal 
component could be useful within a clinical decision making framework.  Therefore, 
given the limitation for potential misinterpretation of this question or not returning to 
complete this question after viewing the subsequent indicators, it may be premature to 
dismiss this on the basis of not achieving the consensus point and warrants further 
investigation within future studies. 
Dysphagia or difficulty with swallowing did not feature within the qualitative phase of the 
Delphi survey.  Therefore, this was not included within the multiple choice rounds (2 
and 3).  Thomas et al (2011) reported that dyshpagia occurred in 8 (17%) cervical 
arterial dissection cases versus 2 (5%) non-dissection causes of stroke in a 
retrospective case control study of a younger patient group (<55-years).  Taste 
disturbance (dysgeusia), however, was included within the quantitative phase.  
Dysgeusia is not within the 5Ds And 3Ns framework.  Although taste disturbance did 
not achieve the consensus point, it did, however, achieve a near consensus level of 
70% (n=7, mean score 3.5, SD 0.7).  Therefore, further consideration should be given 
to this component. 
Nausea, which forms part of the 3Ns received a Delphi participant comment suggesting 
this feature was too vague for inclusion.  Therefore, vomiting was the recommended 
indicator for inclusion within the multiple choice, quantitative rounds 2 and 3.  Vomiting 
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did not achieve the consensus point (n=6, 60% mean score 3.5, SD 1.0).  Savitz and 
Caplan’s (2005) review paper is linked to Caplan et al’s (2004) large prospective study 
(n=407) reported vomiting as a frequent symptom of vertebrobasilar-artery occlusive 
disease.   However, Savitz and Caplan (2005) also report that such presentations 
typically presents with a collection of symptoms and signs, therefore it is questionable 
or unlikely that vomiting in this context would present to a musculoskeletal 
physiotherapy clinic.  Savitz and Caplan (2005), however, also state that dizziness and 
drop attacks are often incorrectly apportioned to posterior-circulation (vertebral artery) 
ischemia.    
5.2.4.2.1 Dizziness 
Dizziness forms part of the 5Ds And 3Ns framework as a symptom of arterial pathology 
(e.g.  Thomas et al 2011).  Dizziness is an imprecise term used to describe a variety of 
symptoms’ (Herdman 2007 p.108). The term ’dizziness’ may also encompass light 
headedness, a lack of mental clarity or frank vertigo, and is reported to be a frequent 
symptom of vertebro-basilar-artery occlusive disease (Savitz and Caplan 2005).  Savitz 
and Caplan (2005) consider that vertigo indicates dysfunction of the peripheral 
vestibular or central vestibulocerebellar system.  This is significant as Tarnutzer et al’s 
(2011) systematic review reports that vertebrobasilar ischemic stroke may closely mimic 
peripheral vestibular disorders, with obvious focal neurologic signs absent in greater 
than half of patients presenting with acute vestibular syndrome due to stroke.  
 
Herdman (2007 pp.108-110) describe the components of tempo, symptoms, and the 
circumstances of the complaint are used to help with the diagnosis of dizziness.  
‘Tempo’ refers to whether the complaint is acute (within 3-days or less) or chronic (more 
than 3-days) or spells of dizziness; ‘symptoms’ refers to the patient’s description of their 
complaint; whilst ‘circumstance’ relates to how the onset of a patient’s dizziness occurs, 
such as spontaneous, positional, or movement related onset (Herdman 2007).    
Table 5.3 lists disorders with dizziness (adapted from Herdman 2007 p.109).  This list 
highlights the complexity and challenge in differentiating a peripheral from a central 
cause of dizziness. 
 
  
 
147 
 
Table 5.3: Disorders featuring dizziness (adapted from Herdman et al 2007 p.109) 
 
Disorders 
 
Vestibular neuritis Benign paroxysmal positional vertigo 
Labyrinthitis Orthostatic hypotension 
Wallenberg’s infarct Transient ischemic attacks 
Bilateral vestibular deficit or >7 days 
 from a unilateral vestibular defect 
Migraine 
Mal de  débarquement Panic attack 
Oscillopsia Motion sickness 
Anxiety/depression Ménière’s disease 
 
Rivett et al (2006) state that dizziness was the most frequent symptom of VBI, however, 
they also advise to check for presence of neck pain or headache.   
Rivett et al (2006 p.3) recommends: 
“In every patient presenting with upper quadrant dysfunction, questioning is 
specifically directed to determine the presence of dizziness which is the most 
common presenting symptom of VBI. If dizziness is present, other symptoms 
associated with VBI should be sought…” 
Thomas et al’s (2011) retrospective case control study revealed that dizziness 
presented in only 32% (15) of total dissection cases versus 7% (3) of non-dissection 
cases.  This study is based within a specialty setting, therefore, it is difficult to 
extrapolate this prevalence to a primary care based musculoskeletal clinic.  
Bhattacharyya et al’s (2008) clinical guidelines reports that evaluation of patients 
presenting with vertigo in a non-specialty setting found that  vascular causes 
represented 3% of cases. Missed diagnosis of stroke at first medical contact within 
emergency departments is often linked to dizziness with 35% of cerebrovascular events 
in patients with any dizziness and 44% in those with isolated dizziness reported to be 
have been missed at this stage (Tarnzutzer et al 2011).  The authors add that available 
data suggests that patients with misdiagnosis are at particularly high risk of poor 
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outcomes.  This emphasises the requirement for accurate screening for potentially 
serious pathology that may present at musculoskeletal physiotherapy clinics.   
However, dizziness did not achieve the consensus point within this study (40% n=4, 
mean score 3.0, SD 0.94).  Caution should ne noted with this finding as ‘dizziness’ in 
this survey was presented as ‘Dizziness (central cause typically episodic and between 
>1min and <30min duration. Not occurring in isolation)’.  Therefore, it is unclear if it is 
‘dizziness’ or the statement within the parenthesis was the reason for not achieving the 
consensus point.  This statement was adapted from clinical practice guidelines 
developed for BPPV (Bhattacharyya et al 2008).  These guidelines include guidance on 
diagnosing and differentiating peripheral and potential central neurological causes for 
dizziness (e.g. migraine-associated vertigo, vertebrobasilar insufficiency, and 
intracranial tumors), as central causes may have more serious medical implications 
(Bhattacharyya et al 2008).  This presents a significant clinical challenge for differential 
diagnosis. 
Chapter 2 outlined that Rivett et al (2006) further suggest that symptoms of dizziness 
provoked by cervical spine causes can be differentiated from a vestibular cause by 
trunk rotation sustained and moving, whilst keeping the head steady. 
A Delphi participant made comment regarding the musculoskeletal system as a cause 
of dizziness within the draft clinical chart: 
I am glad that you have relegated cervical degenerative disease as a cause of 
"dizziness", this is a common misunderstanding in referrals I receive [D2]. 
 
From a Physician’s perspective, Post and Dickerson (2010) report that differential 
diagnosis of dizziness can be narrowed down with clinical tests, such as evaluating for 
nystagmus, Dix-Hallpike manoeuvre (a positional test for the vestibular system) and 
orthostatic blood pressure testing, but 20% of cases will remain undiagnosed beyond 
these tests. 
Vertebral-artery disease can cause transient attacks of vertigo; however, this is usually 
accompanied by other brain-stem or cerebellar symptoms (Savitz and Caplan 2005). 
This appears significantly different to Tarnutzer et al’s (2011) earlier statement that 44% 
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in those with isolated dizziness is reported to be related to a missed diagnosis of stroke 
at first medical contact within emergency departments. 
Light-headedness typically indicates presyncope related to circulatory, systemic, or 
cardiac disease rather than vertebral artery disease (Savitz and Caplan 2005).  Savitz 
and Caplan’s (2005) review following Caplan et al’s (2004) posterior circulation registry  
(n=407) observed that isolated episodes of vertigo continuing for more than three 
weeks was almost never caused by vertebrobasilar disease, and that only 7% (of 
n=407) described light-headedness.  No patients presented with light-headedness as 
an isolated symptom.  This type of information may help guide differential diagnosis at 
first point of contact.  These relatively low numbers questions the accuracy of using the 
symptom of dizziness as a primary indicator of cervical arterial pathology and perhaps 
the focus should be on a combination of symptoms/signs.  Caution, however, should be 
exercised as demonstrated by Tarnutzer et al (2011) reporting missed diagnosis at first 
medical contact: 
“Best evidence suggest that nearly two-thirds of patients with stroke lack focal 
neurologic signs that would be readily apparent to a non-neurologist and one-
third lack signs that would be readily apparent to a neurologist” (Tarnutzner et al 
2011 p.1031). 
Alongside identifying accompanying neurological symptoms/signs to the complaint of 
dizziness, perhaps this physiotherapy focus group participant’s approach in relation to 
the context or setting of the examination is equally important.  This comment was 
extracted when considering differentiating tests for dizziness: 
For me the whole question of dizziness testing is the context.  If you are treating 
a patient then yes you probably do need these skills and you are probably in 
setting where you have back-up from experts and investigations. When you are 
in the MSK clinic you presumably treating for neck pain or stiffness 
predominantly, I don’t think this is appropriate [FG2]. 
 
5.2.4.2.2 Drop attacks 
This clinical sign forms part of the 5Ds.  Binder (2007a,b) report drop attacks, especially 
when moving the neck, as a red flag for neck pain.  Similar to the origin of the 5Ds And 
3Ns framework (Coman 1986), Binder (2007 a,b) is unreferenced for inclusion of this 
sign.  Drop attacks were not identified as a feature by the consultant expert panel within 
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this study.  The 5Ds And 3Ns framework list was provided to Delphi participants in a 
‘More Info’ window within the survey as an additional opportunity for potential inclusion 
through the various comments sections.  A review of the literature identified that drop 
attacks have inappropriately been attributed to transient ischemia of the posterior 
circulation. Not a single patient in the NEMC-PCR had a drop attack as the only 
symptom (Savitz and Caplan 2005).  It would therefore appear that physiotherapists 
inappropriately check for this sign to screen for potential cervical arterial compromise.  
Patten (1998 pp.392-393) describe drop attacks as being almost exclusive to females 
and having no identifiable pathological state.  In addition, there does not appear to be 
any associated dizziness, confusion or impairment of consciousness present. 
 
The following physiotherapy focus group comments highlight the uncertainty 
surrounding the rationale behind checking for drop attacks: 
Well I would ask, what are people asking when they ask about drop attacks. 
Within the department there is a huge range of what people will actually say to 
the patient from “have you ever collapsed?” to “have you ever found yourself on 
the floor unconscious and not knowing why?” You know, it depends on how they 
establish what people say to establish that their drop attack has occurred. I don’t 
know if everyone else has had this experience with their staff or not. And 
certainly I would say there is a huge range or variation in what people are 
actually saying or asking [FG4]. 
 
I sometimes think the understanding of what a drop attack is not always 
accurate, which is in the type of questions that are asked [FG6].  
 
Therefore it would appear that drop attacks do not have sufficient clinical rationale for 
inclusion within a red flag list for the cervical spine.   
5.2.4.3 Cranial nerve testing 
SIGN guideline 107 outlines what clinical evaluation should take place in relation to 
headaches e.g. neurological testing including cranial nerve testing and fundoscopy.  
Cranial nerve testing (CNT) is advocated by a small number of physiotherapy-based 
publications on cervical arterial dysfunction (Taylor and Kerry 2010; Thomas et al 
2011). Unfortunately, clinical observation suggests that cranial nerve testing is not 
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routinely utilised within physiotherapy and fundoscopy is a medical based skill.  
Therefore, physiotherapists would benefit from additional medical guidance as to what 
specific features should be considered as being a potential indicator of serious 
pathology, relative to a musculoskeletal clinic setting.  For example, thunderclap type 
headache is a medical emergency that will not typically present at a musculoskeletal 
clinic. 
 
The focus group discussed cranial nerve testing within physiotherapy practice. Thomas 
et al (2011) recommend cranial nerve testing due to ICAD findings in their retrospective 
study.  However, symptoms and signs referred to were also present in VAD.  In 
addition, Taylor and Kerry’s (2010) masterclass type publication directed for non-
medical practitioners, also recommend conducting a simple eye exam and CNT.   
 
Two participants reported their respective locations had received training in cranial 
nerve testing, however, such testing was performed approximately ≤ 3 times per year.  
This questions knowledge and skills competency levels for such testing, which may 
impact on practitioner confidence if not performing cranial nerve testing on a regular 
basis: 
 
In my ESP clinic I have been taught to do cranial nerve testing and I do have a 
little crib sheet to help do it if I need to, and I think that is quite appropriate in 
that setting, but I probably wouldn’t expect the rest of the physio dept unless I 
have gone through that with them to be very adept at doing it, but I don’t feel 
very confident at doing it myself unless you are doing it all the time, and a lot of 
time you only need to do it when you need to clinically, so that is very rare 
actually [FG7]. 
 
A counter-argument to continue with cranial nerve testing is to perform this examination 
with a different focus to seeking diagnosis.  Perhaps the aim of performing a basic 
cranial nerve examination may be to identify the presence of features that are atypical 
of a neuromusculoskeletal presentation, suggesting the requirement for further medical 
assessment, as opposed to attempting to diagnose a specific condition.  It is vitally 
important that physiotherapists recognise any knowledge and skills limitations that may 
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exist within their clinical examination.  This is turn may support physiotherapy credibility 
with the medical profession.  One Delphi participant comment is of particular note: 
Leave neurology to neurologists [NIC]. 
 
5.3 Cancer, infection, inflammatory arthritis/spondyloarthropathies, trauma 
5.3.1 Inflammatory arthritis/spondyloarthropathies and upper cervical instability 
Table 5.4 displays the agreement levels for the section Cancer, infection, inflammatory 
arthritis / spondyloarthropathies, and trauma. 
 
Table 5.4: Agreement levels for the section Cancer, infection, inflammatory arthritis / spondyloarthropathies, 
and trauma 
Clinical Indicator 
 
n 
Agreement 
 
% 
Agreement 
 
Mean Std. Deviation 
Cancer: Previous history; 
unexplained weight loss; 
lymphadenopathy 
10 90.9 4.4 0.9 
Infection: Malaise, fever, sweats, 
lethargy 
9 81.8 3.9 1.0 
Tuberculosis, 
immunosuppression, drug 
abuse, HIV/AIDS, or other 
(significant) infection 
10 90.9 4.1 0.5 
Inflammatory 
arthritis/spondyloarthropathies 
5 50 3.4 1.0 
Trauma (recent onset) 11 100 4.4 0.5 
 
 
The most notable finding is inflammatory arthritis / spondyloarthropathies not achieving 
the consensus point (n=5, 50%) indicating that this clinical presentation was not 
considered a red flag for serious pathology within the cervical spine. 
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This is a significant finding as CSAG (1994) consider that serious spinal pathology 
includes inflammatory disease, such as ankylosing spondylitis.  Atlantoaxial dislocation 
or subluxation is a common and significant development of rheumatoid arthritis (RA) or 
ankylosing spondylitis patients with involvement of the cervical spine (Uitvlught and 
Indenbaum 1988).  Down’s syndrome is also considered as a frequent cause of 
atlantoaxial instability (Swinkels et al 1996; Cattrysse et al 1997).  Yurube et al (2011) 
conducted a 5-year prospective cohort study of cervical spine instabilities as a 
complication of RA in 21 facilities (United States of America) and reported that from 
n=267 (42.1% follow-up rate from initial n=634), 52.4% had no instability measured at 
the beginning of the study.  This decreased to 29.6% by the end of this study indicating 
that over 20% of study participants that were followed up had experienced an increase 
in measured cervical spine instability. N=11 follow-ups had received surgical 
intervention due to progression to myelopathy. 
 
Chen et al (2011) report a single case study of an 18-year old man who sustained a 
vertebral artery dissection caused by arterial compression from atlantoaxial dislocation.  
This case presented with a history of sudden severe headache, neck pain, 
unconsciousness, and irritating cough with no obvious inducing factors.  Niere and 
Torney (2004) report that bony impingement or compression of neural or vascular 
structures may occur from major instability of the cervical spine following disruption to 
the passive restraining system.  However, Chen et al (2011) report knowledge of only 
10 previous cases of arterial dissection following atlantoaxial dislocation, suggesting 
vascular compromise following atlantoaxial disruption is a rare occurrence. Similarly, 
Dickman et al (1995) report 37 from 39 patients sustaining trauma to the transverse 
atlantal ligament were neurologically intact. One patient died with the remaining patient 
presenting with mild quadriparesis. 
 
Cook et al (2005) conducted a Delphi study of physical therapists to consider identifiers 
suggestive of cervical spine instability and concluded that this is difficult to diagnose. 
Symptoms reaching highest consensus were: intolerance to prolonged static postures; 
fatigue and inability to hold head up; better with external support, including hands or 
collar; frequent need for manipulation; feeling of instability, shaking or lack of control; 
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frequent episodes of acute attacks; and sharp pain.  Occipital neuralgia was reported as 
a symptom of atlantoaxial instability within this study’s Delphi study of consultant 
neurosurgeons and neurologists: 
 
The main type of headache that should be Ix is occipital neuralgia, signifying 
C1/2 instability….[NIC]. 
 
5.3.2 Cancer, Infection and trauma 
Cancer, Infection and trauma of recent onset all achieved the consensus point.  These 
indicators are included within the CSAG (1994) list. 
 
5.3.2.1 Infection 
Recent infection is considered as a risk factor that could be a trigger for sCAD (Guillon 
et al 2003; Debette, Grond-Ginsbach et al 2011).  Both studies provide definitions of 
infection, which are very useful as a reference to the range of infections that may 
present, particularly as some may be over-looked e.g. sinusitis.  The key feature from 
these studies is the acute/subacute nature of infection alongside a clinical presentation 
suggesting potential cervical arterial compromise. Debette, Grond-Ginsbach et al 
(2011), however, consider their description to be broadly defined and occurring within 
the past week.   Guillon et al’s (2003) case control study investigates infection occurring 
within the previous 4-weeks as risk factor of sCAD (n=47) compared to a control group 
(n=52) with cerebral ischemic event unrelated to SCAD  reported that infection was 
present in 31.9% sCAD and 13.5% control subjects (crude odds ratio 3.0 95% CI 1.1-
8.2 p=0.032).  
 
Debette, Grond-Ginsbach et al (2011) consider “the presence of at least one typical 
symptom of infection in combination with fever (≥38 ºC) or the presence of at least one 
typical symptom of infection with corresponding serologic, culture or radiologic findings 
indicating an acute infection or the combination of at least 2 typical corresponding 
symptoms, infection occurring in the previous week of dissection onset” (p.1175).  
Guillon et al (2003) define infection as “symptoms within 4 weeks preceding vascular 
event and was diagnosed when with a positive history of fever (≥38 ºC), a subfebrile 
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state (37.5 to 37.9ºC), or chills, accompanied by 1 or more of the following features…” 
(p.e79), displayed in Table 5.5. 
 
Table 5.5: Clinical features contributing to the diagnosis of  infection (Adapted from Guillon et al 2003 p.e79) 
 otalgia (otitis) 
 cough with purulent sputum (upper 
respiratory tract infection such as 
tonsillitis, pharyngitis, laryngitis, 
sinusitis, bronchitis, or pneumonia if 
chest roentgenogram showed 
parenchymal consolidation) 
 headache 
 myalgia, (flu syndrome) 
 nausea, vomiting and/or diarrhea 
(gastroenteritis), 
 urinary frequency, dysuria and/or 
positive urine culture (lower urinary 
tract infection) 
 back pain with pyuria, bacteruria, or 
positive urine culture 
(pyelonephritis). 
 
 
Infection was also considered present if “....physical exam and/or laboratory studies 
performed on admission revealed sepsis, pneumonia, bacterial endocarditis, renal or 
urinary tract infection, skin or soft tissue infection, gingivitis or dental abscess, septic 
arthritis, or osteomyelitis” (Guillon et al 2003 p.e79). 
Osteomyelitis is an inflammatory condition typically affecting a single bone and caused 
by an infecting organism (McNally and Nagarajah 2010).  McNally and Nagarajah 
(2010) consider that intravenous drug abuse and immuno-compromised patients from 
HIV have presented new challenges and that bone infections from surgical 
interventions, injury, peripheral vascular disease, diabetes are increasing.  Vertebral 
osteomyelitis caused by Myobacterium tuberculosis mainly affects the thoracic spine 
(McNally and Nagarajah 2010; Cheung and Luk 2011;).  Early stages of this disease 
may be slow progressive constitutional symptoms, such as, generalized weakness, 
malaise, night sweats, fever and weight loss.  Radiculopathy or spinal cord compromise 
may occur.  In addition, spinal complications may occur years after the infection e.g. 
due to compensation from kyphotic deformity causing hyper-extension of adjacent 
levels resulting in early spinal degeneration, spinal stenosis and neurological deficits 
(Cheung and Luk 2011).  These adjacent levels could be cervical spine degeneration 
with complications such as cervical myelopathy. 
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5.3.2.2 Trauma (Recent onset) 
Trauma achieved 100% consensus (n=11) and is included within CSAG’s (1994) 
guidance.  This indicator is potentially open to large variation in interpretation as to what 
constitutes trauma.  Bandiera et al (2003) conducted a large prospective multicentre 
cohort study (10 Canadian urban academic emergency departments; 18 month, n=6265 
mean age 36.6 yrs range 16 to 97, male 50.1%) report use of the Canadian C-Spine 
rule performs better than unstructured physician judgment at detecting clinically 
important injuries with sensitivity 100% v’s 92.2% and sensitivity 44% v’s 53.9%.  The 
Canadian C-Spine rule is reported as being previously validated in a USA based study. 
This rule is for alert (Glasgow Coma Scale score=15) and stable trauma patients when 
cervical spine injury is a concern.  The Canadian C-Spine rule is outlined below 
(Bandiera et al 2003): 
 
1. “Any high risk factor that mandates radiography? 
a.  Age ≥ 65 yrs, or, Dangerous mechanism, or, paraesthesias in 
extremities. If YES – radiography 
i.  (Dangerous mechanism: Fall from height ≥ 3ft/5 stairs; Axial load 
to head, e.g. diving; High speed vehicle accident (>100km/h), 
rollover, ejection; Motorised recreational vehicles; Bicycle crash). 
2. Any low risk factor that allows safe assessment of range of motion? 
a.  Simple rear end vehicle accident, or, sitting position in department, or, 
ambulatory at any time, or, delayed onset (i.e. not immediate) neck pain, 
or, absence of midline cervical spine tenderness. If NO – Radiography. 
i.  (Simple rear end vehicle accident excludes: Pushed into 
oncoming traffic; Hit by large bus/truck; Rollover; Hit by high 
speed vehicle). 
3. Able to actively rotate neck? 
a.  45 degrees bilateral. If UNABLE: Radiography” (Bandiera et al 2003 
p.397). 
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This rule does not mention identifying risk factors for fracture e.g. osteoporosis (e.g. 
Poole et al 2009).  
5.4 Neurological deficit (e.g. cervical spondylotic myelopathy / spinal cord 
compromise) 
5.4.1 Neurological indicators for spinal cord compromise achieving consensus 
point 
Five items within the neurological section achieved 100% agreement (n=11).  These 
clinical indicators are listed in Table 5.6. In addition, gait disturbance had full participant 
response with all except one reporting strongly agree/agree response (n=10, 91%, 
mean score 4.2, SD 0.9).  
 
Table 5.6: Neurological clinical indicators achieving 100% consensus 
Clinical Indicator 
 
n 
Agreement 
 
% 
Agreement  
 
Mean Std. Deviation 
Quick guide: UMN 
symptoms/signs in LL>UL; 
LMN symptoms/signs in 
UL>LL 
11 100 4.6 0.5 
Hands: clumsy/loss of 
dexterity or weakness 
11 100 4.5 0.5 
Lhermitte's 
phenomenon/sign 
11 100 4.7 0.5 
Hyperreflexia 11 100 4.6 0.5 
General progressive 
neurological deficit 
11 100 4.5 0.7 
 
Two other clinical indicators achieved the consensus point; Loss of proprioception (n=9, 
81.8%, mean score 4.0, SD 0.9) and Sphincter disturbance (bladder and/or bowel 
retention or incontinence: n=8, 80%, mean score 4.1, SD 1.2).   
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5.4.1.1 Sphincter (bladder/bowel) and sexual dysfunction 
Bladder and bowel dysfunction generated Delphi participant comments indicating that 
this problem was a late presentation in cervical cord compression.  This is supported by 
Wang et al (2010). 
 
Bladder and bowel disturbance is relatively late in cervical cord compression 
[D2]. 
Bowel and bladder dysfunction are the last features to develop in cord 
compression at a very late stage and should not be emphasised too much 
[D12]. 
These comments informed development of the Delphi survey rounds 2 and 3 with ‘very 
late stage’ included within the descriptor.  This example highlights the benefits of 
receiving consultant level input to this project.  The inclusion/exclusion and refinement 
of the clinical descriptors enables physiotherapists to provide more informed clinical 
judgment to enhance patient care.  Whilst this project does not specifically address the 
various causes of sphincter dysfunction a physiotherapy focus group participant’s 
comment highlights a common problem faced by non-medical practitioners:  
 
I think just general education about all the different causes of bladder 
dysfunction is absolutely essential because people get themselves wound up 
into so many problems about bladder dysfunction and erectile dysfunction 
problems, and I am sure that patients are sent of left, right and centre 
unnecessarily because the clinician hasn’t really understood the answer or have 
re-phrased the question wrongly.  So we definitely need clarification as to how 
they should be addressed I think [FG6]. 
 
This supports the Researcher’s personal experience and clinical observations 
suggesting that specific detail of these features may be poorly understood by 
physiotherapists, due to generic terms being used to describe this dysfunction as 
outlined below and in chapter 2, unless advanced level or specialist training has been 
undertaken. Unfortunately, there is no empirical data to support this observation. 
However, there are examples within the evidence base that may contribute to this 
statement. 
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Bladder and/or bowel dysfunction and erectile/sexual dysfunction are signs that may 
indicate potential spinal cord compromise e.g. compression through cervical 
myelopathy (e.g. Bednarik et al 1999; Vyas et al 2004) or malignancy (Greenhalgh and 
Selfe 2003; 2009).     Similar to the 5Ds discussed earlier, in presentations that may 
include bladder dysfunction the clinician’s level of questioning may be limited to enquire 
solely on bladder dysfunction or disturbance without any clarification beyond this.   
 
Studies, in the main, reporting on cervical myelopathy tend to use generic terms such 
as, bladder or sphincter dysfunction when reporting such changes (e.g. Bednarik et al 
1999; Vyas et al 2004). These terms lack specific detail to suitably inform clinicians as 
part of their decision making processes.  This lack of specific detail may result in 
delayed diagnosis (Cook et al 2007; Meyer et al 2008).  Therefore, if physiotherapists 
become consistently more aware of the range of features that may appear within 
sphincter dysfunction then this may help earlier decision making. 
 
The detail established in this study with bladder/bowel dysfunction being a late feature 
will contribute to this decision making process. This information may then be enhanced 
through use of the evidence base as explored in chapter 2 for inclusion in the clinical 
chart to provide more detailed clinical information that underpins the main red flag list. 
For example, although the evidence has been critiqued for using generic terms, such as 
bladder/bowel dysfunction, there was however, one particular exception to this poor 
reporting on sphincter dysfunction. Sakakibaraet al (1995) describes the micturitional 
sub-groups of irritative and obstructive features.  This study could inform clinical 
practice by highlighting more specific detail.  No specific studies on bowel dysfunction 
were identified during the search. 
5.4.1.2 Lhermitte’s phenomenon/sign and upper motor neuron (spasticity) signs  
Lhermitte’s phenomenon/sign was listed by several consultants.  This clinical indicator 
is described as: 
“Consists of tingling in all 4 limbs or electric shock-like feelings down the back 
on flexing the neck if cervical cord is damaged by multiple sclerosis, cervical 
spondylosis or any other condition that distorts or inflames the cervical spinal 
cord. Reverse Lhermitte’s: hyperextension of the neck causes similar signs as 
cord may be squeezed between spondylitic bar and buckled ligaments” (Patten 
1998 p.259). 
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However, Wang et al (2010) state that Lhermitte’s sign is not specific to cervical 
spondylotic myelopathy, but rather is related to posterior column abnormalities.  Patten 
(1998) identifies multiple sclerosis as one such pathological state.  This would therefore 
indicate that physiotherapists should remain vigilant to the presence of other 
neurological pathologies out with the neurological compromise suspected from a 
degenerative spine condition. 
 
5.4.1.3 Quick guide  
The ‘quick guide’ indicator (UMN symptoms/signs in LL>UL; LMN symptoms/signs in 
UL>LL) was developed following consultant comments e.g: 
 
….Upper motor neuron signs in the lower limbs Lower motor neuron signs in the 
upper limbs [D1]. 
 
This is supported by Edwards et al (2003) who suggest that the physical examination 
may frequently reveal a mixed picture or central cord and peripheral nerve 
(radiculopathy) compromise.  Upper motor neuron findings (spasticity or ‘myelopathic 
signs’) may present in both upper and lower limbs, whereas lower motor neuron 
dysfunction will occur at the level of the cord or root compression (Edwards et al 2003; 
Wang et al 2010).  The degenerative spine condition may also present with concomitant 
myelopathic and radiculopathy features e.g. spinal stenosis or single nerve root 
compromise with origin in the lumbar spine alongside a cervical spondylotic myelopathy 
presentation (Edwards et al 2003; Wang et al 2010). The potential for mixed clinical 
presentations highlights the caution required by physiotherapists in correct 
interpretation of clinical findings that ensures more serious complications are detected.  
This red flag study will contribute to enhanced awareness of such features. 
 
Kim et al’s (2010) gait analysis study also checked for presence of: increased tendon 
reflex, ankle clonus, babinski sign (upgoing plantar response), paraesthesia, sensory 
changes, bowel/bladder symptoms.  Regression tree analysis observed upper motor 
neuron signs, such as ankle clonus and Babinski sign were important in classification of 
groups with increased signal intensity (ISI) on magnetic resonance imaging (MRI).  
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These signs, in addition to other pathologic reflexes, such as Hoffman sign, and 
inverted radial reflex are pyramidal or long tract signs consistent with cord compression 
(Edwards et al 2003).   
Hyperreflexia was developed within the Delphi rounds 2 and 3 following participant 
responses, for example:   
hyperreflexia (Hoffman's, Finger flexion/extension jerks, clonus, stiff gait, 
myoclonus); up-going plantar response; loss of proprioception [D12]. 
upper or lower limbs spasticity or weakness; reflexes exaggerated in legs and 
reduced in arms (or exaggerated in arms too) [D9]. 
 
Chapter 2 highlighted a number of studies of varying quality reporting signs of 
spasticity, for example; Chiles et al (1999; n=76) spastic gait (52: 68.4%), ankle clonus 
(25: 32.9%), Babinski reflex (31: 40.8%), hyperreflexia (58: 76.3%); and, Heffez et al 
(2004; n=270) hyperreflexia (64%), inverted radial reflex (57%), Hoffman sign (26%), 
Clonus (25%), weakness in ≥1 limb (22%). 
 
5.4.1.4 Progressive neurological deficit and hands dysfunction (clumsy/loss of 
dexterity or weakness) 
Weakness in the hands may also be described as clumsy or useless (Bednarik et al 
1999; Taylor et al 1991).   
All new progressive unusual neurological symptoms/signs, irrespective of neck 
pain, need investigation [D12].   
If there is hand or arm weakness or numbness or clumsiness or gait disturbance 
I would consider that late, but clearly important. Progressive features: bilateral 
hand and/or feet pins/needles or numbness; upper or lower limbs spasticity or 
weakness; reflexes exaggerated or reduced; bladder/bowel disturbance 
(incontinence or retention); erectile dysfunction (rarely) [D6]. 
 
This comment [D6] highlighting the late onset of hand and gait dysfunction, albeit 
remaining important, differs from Wang et al (2010) and Chiles (1999).  In addition, 
another Delphi participant’s response also considered the reverse to occur: 
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Cord compression symptoms/signs (with or without neck pain/stiffness): early 
features: hand weakness or clumsiness; gait disturbance…… [D9]. 
 
Chiles et al (1999) reported motor deficit in 152 muscle groups from n=76 patients.   
Motor deficit in the upper limbs typically occurred in the hands and triceps first. Chiles et 
al (1999) observed that upper limb symptoms usually occurred slightly before the onset 
of gait difficulties. Wang et al (2010) report that subtle gait disturbances or problems 
maintaining balance may occur in the early stage of myelopathy.  Wang et al (2010 
p.182) cite Gorter et al’s (1976) large study in which >1000 cases of cervical 
spondylotic myelopathy were reviewed with the loss of fine motor control accompanied 
by numbness was identified as following subtle gait disturbances, the most frequent 
presentation.  It is hypothesised that motor deficit occurs from anterior horn cell loss, 
rather than nerve root compression, resulting from spondylotic obstruction of spinal cord 
venous drainage (Chiles et al 1999).  Sensory deficit is a common finding in cervical 
myelopathy (e.g. Bednarik et al 1999; Chiles et al 1999).  Chiles et al (1999; n=76) 
reported upper limb sensory complaints (sensory loss, dysesthesias, paraesthesias) 
occurred in 63 (82.9%) patients, and lower limb sensory complaints 34 (44.7%). 
When considering ‘progressive neurological deficit’ the literature review identified a 
large variation in duration of symptoms that suggest a largely chronic and progressive 
presentation; however, caution should be reserved for acute or rapid deterioration of 
clinical features.  Examples of these variations in mean duration or time-range of 
features are: Vyas et al (2004) ranged from 1 to 36-months pre-surgery; Lee et al 
(2011) 4.3-months ± 4.2 months; Kuhtz-Buschbeck et al (1999) 10-months ± 3 months;   
Heffez et al (2004) 8-years (SD=6.3 years); Taylor et al (1991) Symptoms duration 1 to 
18-months (mean 9).   
5.4.1.5 Gait 
Chiles et al (1999) observed that upper limb symptoms usually occurred slightly before 
the onset of gait difficulties, whilst Wang et al (2010) report subtle gait disturbances as 
the earlier feature.  However, gait disturbances were consistently reported by the Delphi 
panel with all except one participant indicating strongly agree/agree to inclusion as a 
red flag neurological sign. 
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The physiotherapy focus group participants’ expressed the visual assessment of gait 
was more important compared with questions.  Most studies tend to use generic terms 
when reporting gait disturbances (e.g. Bednarik et al 1999; Chiles et al 1999; Kim et al 
2007).  Therefore, the literature review explored studies to help identify specific features 
of gait dysfunction that may better inform such examinations. 
 
A number of studies have investigated spatiotemporal or linear parameters and 
kinematic parameters for specific gait disturbances within this cervical myelopathy 
(Kuhtz-Buschbeck et al 1999; Kim et al 2010; Lee et al 2011). Three dimensional gait 
analysis, which provides a quantitative measurement was included in all three studies.   
Consistent findings (disturbances) were reported between these studies:   
Disturbances of linear parameters include: 
o Slow gait. 
o Decreased step/stride length  
o Increased step width and double support. 
o Decreased single limb support. 
Disturbances in kinematic parameters include: 
o Decreased maximal knee flexion (swing phase). 
o Increased ankle dorsi-flexion (swing phase). 
o Decreased plantar-flexion at push-off. 
 
These kinematic features are indicative of spasticity (Kim et al 2010). 
 
The three gait analysis studies described above are useful studies to help inform clinical 
practice to identify specific aspects of gait, rather than simply considering generic 
difficulties with this component.  More defined detail would enable clinicians to guide 
subjective questioning for any changes reported by patients and to objectively observe 
with greater knowledge. 
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5.4.2 Neurological indicators for spinal cord compromise not achieving 
consensus point 
The remaining neurological symptoms/signs achieved relatively high levels of 
agreement without meeting the consensus point.  This suggests that these features 
should not be included in a short-list of red flag indicators.  However, awareness of 
these features should remain within broader clinical decision making. Table 5.7 displays 
these indicators:  
 
Table 5.7: Neurological indicator not achieving the consensus point 
Clinical Indicator 
n 
Agreement 
 
% 
Agreement 
 
Mean Std. Deviation 
Weakness (widespread) of 
arms or legs 
7 70 3.8 1.1 
Diffuse numbness or 
paraesthesia 
7 63.7 3.5 1.1 
LMN symptoms/signs 7 70 3.6 1.2 
Very late stage: Erectile 
dysfunction (rare 
occurrence) 
6 60 3.4 1.3 
 
5.4.2.1 Weakness (widespread) of arms or legs and diffuse numbness or 
paraesthesia 
These features may occur in functional problems (e.g. Stone 2006, 2009).  However, 
caution should be exercised in the interpretation of such findings problems.  This clinical 
indicator generated an additional comment within the Delphi study:  
 
Functional (psychological) problems often present with widespread give 
way weakness and diffuse paraesthesia. Focal signs are much more 
predictive of underlying pathology [NIC]. 
 
5.4.2.2 Lower motor neuron (LMN) symptoms/signs 
LMN features also generated comments.  It would appear that the Delphi panel 
generally agrees on the components of LMN symptoms/signs, without achieving the 
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consensus point for inclusion in the red flag list.  Additional comments suggest why this 
aspect is not considered as a red flag indicator: 
 
You have to differentiate myelopathy (spinal cord compromise) from 
radiculopathy (nerve root compromise). The former requires urgent 
assessment; the latter is very common in degenerative cervical disease, 
and an isolated root problem doesn't necessarily require urgent 
assessment. The important thing is appreciating the LOWER limb 
symptoms (not pain), particularly if bilateral and related to a neck 
disorder must be due to cord compromise [NIC]. 
I believe testing for hyperreflexia is more relevant than hyporeflexia 
(especially in patients who present with symptoms reminiscent of carpal 
tunnel syndrome) [NIC]. 
 
LMN dysfunction (e.g. fasiculations and hyporeflexia or reduced reflexes) are indicative 
of a peripheral nerve compromise, for example radiculopathy (Edwards et al 2003).  
Numbness or paraesthesiae in the upper limbs from cervical spondylotic myelopathy 
origin is typically non-specific, whereas a single dermatomal distribution may be a 
radiculopathy presentation (Wang et al 2010), which as stated by a Delphi participant 
does not necessarily require an urgent assessment.  In relation to back pain, less than 
5% is attributable to true nerve root pain with only a small proportion requiring surgical 
intervention (Waddell 2004 p.11).  CSAG (1994) advise that nerve root pain usually 
arises from a single nerve root caused by disc prolapse or degenerative changes e.g. 
spinal stenosis, or scar tissue.  Similarly, pain typically follows a dermatomal distribution 
radiating distally towards the foot or toes and is worse in this distal distribution 
compared with any concomitant back pain.  This presentation does not typically require 
an urgent referral for further investigation, unless the presentation deteriorates or does 
not respond to conservative management (CSAG 1994).  
 
5.4.2.3 Erectile dysfunction 
A Delphi participant [D12] commented that bladder/bowel/erectile dysfunction is 
comparatively rare in neck disorders, except following severe injury. Therefore, these 
features should not be emphasised too much. This comment is supported by two 
studies included in chapter 2 (He et al 2006; Chiles et al 1999). He et al (2006) 
examined improvement of sexual function in male patients (Average age 56.3 years; 
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range 43-72) treated surgically for cervical spondylotic myelopathy through prospective 
follow-up. Twenty-two subjects (plus 2 unable to attend follow-up) were identified from 
753 patients diagnosed with cervical myelopathy and underlying cause was identified 
as being more likely psychogenic origin compared to reflexogenic.  This study highlights 
the low frequency of sexual dysfunction, which further supports Chiles et al (1999) in 
commenting that sexual dysfunction was relatively infrequent and usually in far-
advanced myelopathy after they identified the incidence of sexual dysfunction (5:6.6% 
men only and some inactive).   
 
Therefore, this low rate combined with the Delphi comment indicates that routine 
questioning is not required.  However, broader awareness of this outside caution for 
use in advanced level questioning may be appropriate should more information be 
needed.  
 
5.5 Implications for clinical practice 
5.5.1 Adverse events (AE) associated with physical therapies 
The literature review highlighted that identifying adverse events (AE) associated with 
treatment of neck pain in adults has been problematic due to low quality data in clinical 
trials and lack of agreement on standardised AE terminology (Carlesso et al 2010).  
Ernst’s (2007) systematic review, however, concluded that spinal manipulation was 
frequently associated with mild-moderate AE and can result in more serious events 
such as vertebral artery dissection.  This is a contentious issue as demonstrated by a 
recent ‘Head to Head’ discussion article “Should we abandon cervical spine 
manipulation for mechanical neck pain?” (BMJ2012;344doi: 
http://dx.doi.org/10.1136/bmj.e3679).  
 
Sweeney and Doody’s (2010) postal-survey of Manipulative Physiotherapists (n=127), 
based in Ireland, to determine the use of cervical spine manual treatment and to 
describe adverse events associated with these interventions reported the most serious 
adverse events were associated with more gentle non-manipulation techniques.  These 
included one TIA, one fainting, and one drop attack.  There was moderate use of 
vertebro-basilar insufficiency (VBI) functional screening tests as outlined by Rivett et al 
(2006). However, of the 26% (n=33) of respondents that experienced an adverse event, 
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24% (n=8) had conducted VBI testing, whilst 58% (n=19) did not conduct testing.  This 
questions the validity of functional screening tests (section 2.6) as outlined by Rivett et 
al (2006). 
5.5.2 Functional screening and clinical tests 
A number of blood flow studies investigating the effects of provocative testing on the 
arterial flow have produced inconsistent results (Kerry and Taylor 2008). Several 
studies have reported reduced blood flow in functional testing positions (Rivett et al 
1999; Mitchell et al 2003, 2004; Arnold et al 2004).  In contrast, several studies have 
reported no change in flow (Thiel et al 1994; Zaina et al 2003; Bowler et al 2011).  
These examples provide an indication of the inconsistency in blood flow studies and 
neurological clinical tests. Therefore physiotherapists also need to enhance awareness 
of neurological and neurovascular pathology through other methods, such as identifying 
risk factors.  
 
It is hypothesised that a mechanically induced stress on the VA causing altered blood 
flow with decreased perfusion to the brainstem will initiate VBI signs and symptoms 
(Westaway et al 2003). Thiel and Rix (2005) question the continued use of functional 
pre-manipulation testing of the cervical spine as it could cause added arterial 
compromise to an underlying vascular pathology resulting in an AE.  As stated earlier, 
screening tests should not cause further harm (Cook et al 2007). 
Provocative functional testing, as outlined by Rivett et al (2006), consists of end-of-
range cervical/neck rotation held for a minimum 10 seconds, simultaneously examining 
the eyes for nystagmus and checking for any additional symptoms.  Rivett et al (2006) 
further suggest that symptoms of dizziness provoked by cervical spine causes can be 
differentiated from a vestibular cause by trunk rotation sustained and moving, whilst 
keeping the head steady.  This current red flag study has highlighted the complexity 
associated with interpretation of nystagmus (Patten 1998 p.103) and the associated 
limitations expressed by an experienced physiotherapy focus group. Similarly, Delphi 
participants’ expressed their concern with such provocative testing and interpretation of 
dizziness as symptom: 
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I’m partly putting this effort in to replying as I agree that knowledge of neck 
problems and how these present in neurology is often not correct among 
physios. For example, many still do “VBI tests” even though there are few 
neurologists in the UK who believe that you can produce verterbrobasilar 
ischaemia from turning your neck…... [D1]. 
 
I am glad that you have relegated cervical degenerative disease as a cause of 
"dizziness", this is a common misunderstanding in referrals I receive [D2]. 
 
Furthermore, a range of clinical tests are used to screen for neurological conditions, 
such as cervical myelopathy (cord compression).  However, some neurological clinical 
tests (e.g. finger escape sign and clonus) have not been investigated for diagnostic 
accuracy, whilst others (e.g. the Hoffman sign, Lhermitte’s sign, and plantar response) 
have been investigated, but with inconsistent levels of methodological quality that 
affects their diagnostic accuracy values (Cook et al 2007, 2011). These tests have been 
identified for use by the Delphi medical panel and supported by a number of studies 
(e.g. Chiles et al 1999; Heffez et al 2004). The following is an example of a Delphi 
response:  
 
hyperreflexia (Hoffman's, Finger flexion/extension jerks, clonus, stiff gait, 
myoclonus); up-going plantar response; loss of proprioception [D12]. 
 
It is therefore important that physiotherapists recognise the limitations of such tests.  
There is, however, a knowledge shift in this area with Taylor and Kerry (2010) and Cook 
et al (2011) being physiotherapy-based publications.  Taylor and Kerry (2010) in 
particular, highlight the inconsistency in the evidence behind functional screening tests 
for VBI with such tests having poor diagnostic utility.  Taylor and Kerry (2010) and Cook 
et al (2011) are excellent examples of isolated work occurring within specific 
pathologies, however the collection of red flag screening for the cervical spine is limited.  
Similarly, the ‘5Ds And 3Ns’ framework continues to be used, albeit Taylor and Kerry 
(2010 p.86) state that “unreasoned adherence to these cardinal ‘classic’ signs and 
symptoms can, however, be misleading and result in an incomplete understanding of 
patient presentations’”.   Kerry et al (2007) state there is no support for Coman’s 5 Ds.  
Kerry and Taylor (2006, 2008), Kerry et al (2007) and Taylor and Kerry (2010) are the 
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only identified authors to question the 5Ds and 3Ns framework through a literature 
review approach. 
 
These physiotherapy ‘masterclass’ type articles provide excellent advancement in non-
medical practitioner knowledge, however, these publications are limited by; not being 
observational based studies and do not state what specific features lack sufficient 
evidence for inclusion in a red flag list, with the exception of Taylor and Kerry (2010) 
stating that dizziness does not always occur.  Therefore, the 5Ds And 3Ns framework 
continues to be used.  This creates a knowledge gap in understanding the rationale 
behind these clinical indicators. One method of addressing these areas is to engage 
with medical experts in ascertaining the importance of such features, alongside the 
evidence base that would provide further navigation towards a fuller understanding and 
improved screening process. For example, to address the continued use of dizziness 
and drop attacks as clinical indicators for serious cervical vascular pathology.  
 
5.5.3 Clinical indicators 
This study has identified poor evidence to support inclusion of drop attacks and no 
Delphi consensus was achieved for the inclusion of dizziness.  This is not to state that 
such features should be ignored; however, it may suggest that it is how these features 
are ‘weighted’ in terms of importance or relevance that may be the direction for the 
future. No studies were identified that specifically examines the 5Ds And 3Ns 
framework with engagement from both non-medical and medical personnel to seek 
opinion on these components and their relevance to non-medical practitioner clinical 
practice.  
 
Whilst red flags for musculoskeletal low back pain have been developed (e.g. CSAG 
1994) and widely accepted, a change in provision of a regional musculoskeletal service 
had given rise to the need  to include more specific red flag indicators or diagnostic 
screening for neck related pain or functional impairment.  The literature review identified 
the limitations of the references to specific red flags for the cervical spine.  For example, 
the health information website, Patient.co.uk, adaptation of Binder’s (2007 a,b) 
publications with limited references supporting the identified red flags.  However, the 
suggested red flag list provides a very useful point for development.  This current study 
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provides a platform for progression of this work, albeit with several methodological 
limitations.  
 
Figure 5.2 displays the red flag categories with subsequent clinical indicators that 
achieved the consensus point within this study.  The clinical indicators have been 
integrated with the CSAG (1994) list of red flags for back pain and incorporated into the 
draft clinical chart to display how these findings may be presented to the clinical 
community through future publication.  These clinical indicators, with appropriate 
supporting literature, have potential to be used with immediate effect to inform clinical 
decision making.  However, the draft clinical chart requires further development as part 
of an extended project to support the findings of this study. 
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Figure 5.2: Cervical spine red flag clinical indicators integrated with CSAG (1994) red flags for back pain and displayed in draft clinical chart
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5.6 Future research suggestions 
1. The clinical indicators would benefit from additional investigation to provide 
more robust evidence base for inclusion in a red flag list.  For example, few 
indicators achieved 100% consensus within this small sample size, whilst 
others narrowly failed to achieve the consensus point. This could be 
achieved initially by a focused systematic review for specific components of 
the categories identified within this study.  
2. Extend the study design to target a larger medical participation group and 
refinement of the survey questions.  The focus of any such approach should 
be medical input to inform physiotherapy clinical decision making. 
3. Greenhalgh and Selfe (2006, 2010) introduced a ‘weighting’ system for 
serious spinal pathology with a focus around the red flags developed by 
CSAG (1994).  This approach could be utilised to progress this study by 
weighting the importance of the red flag indicators identified for the cervical 
spine.   
5.7 Study limitations 
1. The SIGN methodology for conducting a literature review was adapted for 
use by a single researcher, thus limiting the breadth of critical analysis. 
2. The focus group was conducted by a single researcher, which limits the 
capacity to make extensive observational notes.  However, viewing the video 
recording soon after the focus group enhanced close working with the data.   
Stewart et al (2007) advises the transcript may not reflect the full character of 
the discussion.  Therefore, this may require supplemented material such as, 
moderator notes.  The video recording helped address this limitation. 
3. This study employed one focus group. A specific focus group study will 
typically use 3-4 groups. However, this study used a single group to inform 
development of the main Delphi survey, rather than form part of a main focus 
group approach. 
4. The consultant sample size within the Delphi survey was relatively small 
(n=11). Skulmoski et al (2007) advise that 10-15 participants from a 
homogenous group is considered acceptable for this type of post-graduate 
level study. This sample size reflects the challenges experienced in 
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recruiting expert medical level participants for this type of study.  However, 
having gained initial medical input this may facilitate future recruitment 
strategies for additional studies associated with this project. 
5.  The Delphi technique has undergone continual modifications of its concept 
and design, which makes the process of testing rigour problematic (Hasson 
and Keeney 2011). 
6. Achieving the set Delphi consensus level that enables clinically meaningful 
production of a screening process that is considered suitable to inform 
clinical practice is a challenge.  This was selected by the single researcher 
based on a similar study and guidance on conducting Delphi method 
projects.  The consensus levels for meaningful transferability is potentially 
affected by the small sample size and a number of questions were not 
completed by the full panel.  This appeared to be in areas of uncertainty e.g. 
the ‘headache’ and ‘brainstem - cervical vascular – cranial nerve dysfunction’ 
sections. However, the headache section participation improved from round 
2 to 3 with refinement of the indicators following participant feedback. 
7. Delphi methodology: Overall, it is unclear how methodological rigour should 
be established as each study design, sample and consensus process is 
different (Hasson and Keeney 2011 p.1700).  Trustworthiness is considered 
as more appropriate than reliability and validity to gauge effectiveness and 
appropriateness of a Delphi study (Hasson and Keeney 2011).  Therefore, 
the following four main strategies as outlined by Hasson and Keeney (2011 
p.1700) were adapted to establish trustworthiness: 
a. Credibility: Ongoing iteration and feedback was provided to Delphi 
participants. 
b. Dependability: The study included a representative sample of 
experts. 
c. Confirmability: A detailed description of Delphi collection and 
analyses process was maintained. 
d. Transferability: Comparing the Delphi study findings alongside the 
current evidence base helps enhance applicability of survey findings. 
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Chapter 6. Conclusion 
 
6.1 Study Overview 
Musculoskeletal physiotherapists provide assessment and treatment for pain and 
functional impairments relating to the musculoskeletal system.  Examples of such 
problems are back and neck pain.  In order to apply safe and effective treatment to 
these conditions it is vitally important that any underlying serious complaints have 
been excluded.  Prognostic variables or diagnostic indicators for possible serious 
spinal pathology, commonly known as ‘red flags’, have been developed by the 
Clinical Standards Advisory Group (CSAG1994) and widely integrated into clinical 
practice for the management of low back pain.  The intended outcome of this thesis 
was to develop a red flag screening process or equivalent clinical indicators for the 
cervical spine.  The motivating factors behind this study design arose following 
development of a musculoskeletal clinical service.  This process identified that 
screening for red flag indicators of possible serious pathology presenting in 
musculoskeletal neck pain or neck related complaints did not receive the same level 
of attention as red flags for serious pathology in back pain.  
 
The literature review identifies there is a risk of neurological/neurovascular 
pathology, such as cervical arterial dissection and cervical myelopathy, presenting 
as neck and/or head pain or functional impairment at musculoskeletal clinics. 
Currently, the extent of adverse events related to such presentations is unknown.  
Although the problem is not considered common, there is limited evidence to 
support this.  If the clinical decision making processes are not sufficient in making a 
correct early diagnosis or in identifying those patients at risk of developing an 
adverse event following manual treatment then this has potentially catastrophic 
consequences for the individual, which could result in complications such as, 
permanent gait or bladder dysfunctions and stroke, with potential for death from the 
latter example.  
 
The literature review identifies limitations and inconsistent evidence for current 
functional provocative testing and clinical tests, risk factors, and cardinal signs and 
symptoms traditionally used as a screening process by musculoskeletal therapists to 
differentially diagnose serious neurological and neurovascular pathology from 
musculoskeletal disorders.  Additionally, the review highlights the difficulties in 
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differentiating neck and head pain from non-musculoskeletal causes.  This presents 
a serious challenge for musculoskeletal physiotherapists and requires a high level of 
awareness to suspect such pathology (Thanvi et al 2005; Greenhalgh and Selfe 
2006; Kerry and Taylor 2006, 2008).  Therefore, an improved process aimed at 
detecting serious neurological and neurovascular pathology of the cervical spine 
would be of clinical value. 
 
This study contributes to the knowledge base through the mixed method study 
design aimed to combine physiotherapy and medical expert input to develop a list of 
red flag clinical indicators applicable to clinical practice that informs physiotherapy 
clinical decision making.  A list of neck related red flag clinical indicators within five 
specific categories were developed:  1. progressive pain; 2. cancer, infection, 
trauma; 3. neurological deficit (spinal cord compromise); 4. headache (associated 
with neck pain/stiffness); 5. brainstem, cervical arterial and cranial nerve 
dysfunctions.  An increase in Kendall’s W was demonstrated between Rounds 2 and 
3 in four out of five categories, indicating an increase in consensus levels between 
participants.  
 
 Whilst a short-list of clinical indicators within specific categories has been 
developed, the focus group discussion and subsequent Delphi study with consultant 
neurologists and consultant neurosurgeons has highlighted the complexity of the 
clinical features within musculoskeletal presentations.  For example, the presence of 
headaches in the context of neck complaints and the basic level of description 
attached to the descriptors in the ‘brainstem-cervical vascular-cranial nerve 
dysfunction’ section generated input to suggest that physiotherapists should not 
over-emphasise these aspects, which should be clinically assessed and managed 
by medical practitioners. 
 
An additional benefit of this study design that engages both physiotherapy and 
medical consultants is to enhance the future credibility of the former through 
engagement of the latter.  This will provide guidance to ensure that musculoskeletal 
physiotherapy screening processes develop to appropriate and effective clinical 
standards.  An example is the Delphi participant response, ‘leave neurology to 
neurologists’.  This comment is interpreted as meaning medical level, not specifically 
neurologists. The benefits of the focus group discussion part support this statement 
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through recognition of the limitations in physiotherapy based skills e.g. interpreting 
signs, such as nystagmus.  There will be, however, a number of highly skilled 
physiotherapists with such sufficient skills.  This scenario will be dependent on 
specialist settings and working closely alongside medical consultants.  In relation to 
mainstream musculoskeletal physiotherapists, these skills are likely to be limited.  
Therefore, the key aspect of this approach is for physiotherapists to have sufficient 
knowledge and skills to recognise at an early stage the potentially subtle atypical 
clinical features suggesting an underlying pathological state masquerading as, or 
presenting alongside, a cervical spine musculoskeletal presentation.  
 
Whilst this study has several methodological limitations the findings from the focus 
group discussion and subsequent Delphi survey will contribute to the understanding 
of the challenges faced by physiotherapists in screening for serious pathology as 
frontline practitioners.  This is vitally important as there is a high likelihood of 
physiotherapists increasingly becoming the first contact clinician as national services 
continue to redesign, for example self referral to physiotherapy departments without 
General Practitioner or medical consultant input.  It is therefore critical that 
musculoskeletal physiotherapy knowledge develops with support from the medical 
profession to deliver safe, effective and person-centred care in line with national 
drivers, such as the Scottish Government’s Healthcare Quality Strategy for 
NHSScotland (2010). This collaborative approach will enhance physiotherapy 
clinical credibility with the medical profession and facilitate appropriate onward 
referrals for the right person to the right place at the right time in line with the 
Healthcare Quality Strategy (2010). 
 
6.2 Progressing the research findings 
The study design was developed to have immediate clinical applicability.  Whilst 
there are limitations to this design the findings are considered to be useful to 
physiotherapists at this time. In addition to informing future project design the 
present findings will inform current practice and understanding of clinical indicators.  
The draft clinical chart requires development out with this current thesis.  Both 
physiotherapy and medical consultant feedback suggest the concept of the clinical 
chart would be a suitable vehicle to convey the findings of this project. However, 
valuable medical input recommends simplifying this platform to ensure uptake and 
usability.  
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Having identified a number of central red flag categories with respective 
components, the clinical chart is aimed at providing physiotherapists with the 
supporting knowledge base within one interactive resource.  This plan would 
address the problems of publications, such as Cook et al (2011) on cervical 
spondylotic myelopathy and Taylor and Kerry et al (2010) on cervical arterial 
dysfunction remaining separate and not easily accessible, whilst providing a detailed 
evidence base to support the clinical indicators.  The latter point is a limitation of the 
evidence base supporting the Patient.co.uk website, the health information resource 
supplying evidence based information to patients and health professionals and the 
Clinical Knowledge Summaries (2009), a resource supported previously by the 
National Institute for Health and Clinical Excellence. 
Important directions for study development are to continue with the combined 
medical and physiotherapy involvement, and to refine the clinical features through 
progression of the evidence base for the respective categories.  In addition, 
introducing a ‘weighting’ system to help inform clinicians of the importance of the 
individual clinical indicators or combination of these features would be a valuable 
feature.  For example, dizziness alone did not achieve the Delphi consensus point; 
however, dizziness in the presence of other neurological findings may alter clinical 
interpretation.  This approach could also address those clinical features that 
achieved a near consensus point. 
The combined physiotherapy and medical expert approach to this study provides a 
platform to inform the future development of physiotherapy clinical decision making 
skills for the benefits of patient safety relating to the assessment and management 
of musculoskeletal neck problems. 
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Appendix A: Clinical questions, search strategy and summary of selected 
studies 
 
Question 1. What pathologies including their signs and symptoms and risk factors should be 
considered as red flags when screening for serious pathology in neck related 
musculoskeletal disorders? 
 
Search 
strategy 
Search terms: Red flags OR serious pathology AND neck pain OR cervical spine. 
 
Search 
reduction 
Results: 172. Title checks reduced to: 4. Abstracts check reduced to 0.  
 
Additional 
search  
Additional search of medical website: patient.co.uk containing revealed 
evidenced based section with 9 references. One article contained relevant 
information, but was graded as an expert opinion, which included limited 
references. 
 
 
This article together with clinical experience was used to form the following key sub-questions: 
 
Question 2. What risk factors and signs and symptoms may indicate the presence of 
Cervical Arterial Dysfunction (CAD)?   
 
Search strategy Search terms: Risk factors AND cervical arterial dissection OR cervical artery 
atherosclerosis OR carotid artery atherosclerosis OR vertebral artery 
atherosclerosis OR carotid artery dissection OR vertebral artery dissection. 
 
Search 
reduction 
Results: 1874. Reduced by selection of academic journals192. Title checks 
reduced to 134. Full article/abstract checks 119 (including hand search): 
Selected: 36 
 
 
Study  
 
Design 
 
SIGN 
 evid. Level 
 
 
n 
 
Clinical presentation / Main findings 
Albuquerque et 
al 2011  
 
case series 3 13 
Risk: presented with craniocervical dissections 
following chiropractic manipulation.  Symptoms of 
neurological deficit, head or neck pain, or both had 
atypical onset within hours or days of 
manipulation. In this case series 31% (n=4) were 
left permanently disabled or died as a result of 
their arterial injuries. 
 
Arnold, Bousser 
et al 2006 
Prospective 
observational 
 
2+ 169 
 
 
 
Symptoms/signs: 
TIA 17 (10%), and  
Occipital head and/or neck pain alone 21 (12%)  
SAH without ischemia 3 (2%) 
cervical radiculopathy C5/C6  1 (1%). 
 
118 (88%) of 134 patients with ischemic or 
hemorrhagic symptoms had also occipital head 
and/or neck pain and 7 (5%) a pulsatile tinnitus. 
 
Arnold, Cumuric 
et al 2006 
 
Prospective case 
series 
3 20 
Risk: 
Reported a higher rate of hypercholesterolemia in 
a prospective study of 165 VAD patients compared 
to other studies.  The authors considered that 
although no control groups were used, this feature 
could not be dismissed as a significant risk factor 
in VAD. 
 
Investigated characteristics of pain as the only 
symptom of CAD. 20 from 245 consecutive cases 
diagnosed with sCAD were included.  50% had 
history of migraine (8 without and 2 with aura). 
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Arnold et al 2008 conducted a case 
control study 
2- 102 
Risk: 
Cervicocephalic artery dissection after childbirth is 
considered rare.  To determine differences 
between postpartum (childbirth within 6-weeks 
previous) and non-postpartum CAD.  A total of 102 
women <50 years (6 postpartum, 96 
nonpostpartum) from 245 female patients held on 
single centre CAD register between 1997 – 2005).  
Arnold et al (2008) concluded that post partum 
CAD patients  and associated conditions should 
be looked for in women with unusual headache 
after childbirth. All postpartum CAD patients had 
neck and or headache as the 1st symptom onset 
ranging from 7 days to 18 days after delivery.   
 
Arnold et al 2009 case control study 2+ 239 
 
control 
516 
Risk: 
There was no significant difference in other 
cardiovascular factors previously considered as a 
risk for vascular pathology: frequency of 
hypertension, diabetes, current smoking, past 
smoking and hypercholesterolemia. 
 
sCAD patients tended to be taller and have a 
lower body weight than the control group. 
 
Arnold et al 2010 prospective 2- 186 
Risk: 
compared the characteristics of consecutive 
patients with sVAD with cerebral ischaemia versus 
patients with local signs and symptoms only 
(head/neck pain, cervical spine radiculopathy) and 
concluded that older patients (mean 43.6 ±9.9 v’s 
38.6±9) and smokers were more likely to develop 
cerebral ischaemia. 
 
Arauz et al 2007  case control 2- 39 
Contro
l  
76 
Risk: 
Mild Hyperhomocysteinemia has been reported as 
a risk factor for both arterial dissection and 
ischemic stroke without dissection. 
 
Reported that high plasma concentrations of 
homocysteine and low plasma levels of folate were 
associated with an increased risk of CAD and 
concluded that in a Mexican population that 
deficiencies in nutritional status may contribute to 
the relatively high incidence of CAD in Mexico. 
 
Bassi et al 2003 
 
Prospective 
multicentre study  
2- 49 
 
 
Symptoms/signs: 
 
Headache and neck pain occurred in 32 patients 
(65.3%). 
 
Local neurological manifestations were present in 
15 patients (30.6%). 
 
Ischemic cerebral symptoms were present in 41 
patients (83.6%). 
 
36 ICAD (incl. 2 with associated VAD), 24 (66.6%) 
had headache, 10 (28.5%) had oculosympathetic 
palsy, and 27 (77.1%) had symptoms of cerebral 
ischemia. 
 
8 (16.3%) had only local symptoms. 
 
Of 13 with VAD (incl. 2 with ICAD), 9 (69.2%) had 
headache and 12 (92.3%) had symptoms of 
cerebral ischemia. Asymptomatic VAD* 
was detected in 4 patients (11.4%) during the 
evaluation of symptomatic ICAD. 
 
Baumgartner et 
al 2001  
Prospective 2+ 181 
Risk: 
Reported a statistically significant finding (p<0.05) 
in sICAD patients with ischemic events compared 
to patients without such developments. 
and Baumgartner et al 39% from n= had a history 
of smoking. 
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Benninger et al 
2009 
Case control 2+ 346 
Contro
l 100 
Risk: 
Mild Hyperhomocysteinemia has been reported as 
a risk factor for both arterial dissection and 
ischemic stroke without dissection. However the 
underlying mechanism behind this risk factor 
remains unclear and requires additional 
investigation.Hyperhomocysteinemia in SCAD 
(N=33,38%) versus healthy controls (n=23,23%; 
p=0.034). 
 
Biousse et al 
1994 
prospective series 2- 65 
Risk: 
cardiovascular risk factors were reported as  no 
difference between  ICAD patients with (n=48) or 
without pain (n=17). 
 
Caplan et al. 
2004 
 
Savitz and 
Caplan 2005  
Review article. 
Linked 
withCaplan et al 
2004 
 
Prospective 2+ 407 
Symptoms/signs: 
All patients TIA or stroke within previous 6 months. 
Coronary artery disease in 143 (35%). <1% of 
patients with vertebrobasilar ischemia had only a 
single presenting symptom or sign. 13 patients 
had hemodynamically sensitive ischemia, with 
multiple brief episodes of dizziness, veering, 
perioral paraesthesias, and diplopia. Only 7 % of  
patients described light-headedness, and none 
presented with light-headedness as an isolated 
symptom. 
No patients had a drop attack as the only 
symptom. 
 
 Chandra et al 
2007 
  
 
Retrospective  
 
 
2- 20 
 
 
 
Symptoms/signs: 
 
Most common symptom on presentation was 
headache (83% SCD, 78% SVD). A significantly 
higher incidence of nausea was reported in the 
SVD group (67% SVD vs. 33% SCD, p< 0.01). 
 
Vertebrobasilar symptoms (vertigo, dysarthria, loss 
of consciousness, or diplopia) occurred in a 
majority of patients in each group (67% SCD, 56% 
SVD) with a relatively higher rate of hemispheric 
symptoms occurring in the SCD group (33% SCD 
vs. 25% SVD). 
 
Other associated symptoms such as amaurosis 
(loss of vision 1 eye), anisocoria (unequal pupil 
size), ipsilateral facial droop, partial ipsilateral 
Horner's syndrome, and neck pain were seen to 
occur in 1/3 or fewer patients in each group. 
 
Chaves et al  
2002  
Case series 3 10  
Symptoms/signs: 
9 had a stroke (1 had an associated subarachnoid 
hemorrhage), whereas 1 patient had only TIA. 
Severe headache (usually retro-orbital, frontal 
and/or temporal) followed by contralateral 
hemiparesis was the most common initial clinical 
symptoms (80%). 
Neurological signs occurred in most pts (90%) 
immediately after headache. 
No patient had vascular risk factors or a history of 
neck or head trauma. 
 
Debette and 
Markus  2009 
systematic review / 
and a meta-analysis 
2++  
Risk: 
on genetic factors for CAD and a meta-analysis of 
association studies with a polymorphism, 
concluded that studies on genetic association with 
CAD have been underpowered.  
 
Case reports and genetic association studies on 
<20 CAD patients, or where studied in a post-hoc 
subgroup analysis were excluded.  Monogenic 
connective tissue disease is rarely associated with 
CAD.  EhlorsDahnlos syndrome is the main one; 
however, in the large majority of cases of CAD, 
there is no evidence of for a known monogenic 
disease.  However, Debette and Markus (2009) 
report that there are several arguments for 
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association of “sporadic” CAD with connective 
tissue abnormalities as part of a multifactorial 
predisposition.  A meta-analysis identified an 
overall significant association of the MTHFR 
677TT genotype and CAD (OR1.67; 95% CI, 1.21 
– 22.31). 
 
Debette, Grond-
Ginsbach et al 
2011 
Large observational  
 
2++ 946 
Symptoms/signs: 
 
1. cervical pain 
2. Headache 
3. Cerebral ischemia 
  a. Ischemic stroke 
  b. TIA 
  c. transient monocular blindness 
  d. Subarachnoid haemorrhage 
 
ICAD Vs VAD 
1. ICAD n=231 (38.7%); VAD n=212 (66%) 
p=0.001; OR(95% CI) 0.36 (O.27 to 0.48). 
 
2. ICAD n=405 (67.8%); VAD n=207 (64.5%) 
p=0.3; OR(95% CI) 1.36 (1.01 to 1.84). 
 
3. ICAD n=453 (73.2%); VAD n=295 (90.2%) 
p=0.0001 OR(95% CI) 0.32 (0.21 to 0.49). 
Risk:The following were found to have 
experienced minor mechanical trauma defined as 
not requiring a medical visit attendance at a 
hospital, within the previous 1 month: ICAD n=177 
(29.2%) and VAD (n=118 (36.5%) p=0.02 
(adjusted for univariate) OR (95% CI) 0.75 (0.56 to 
1.007) p=0.05 (adjusted for age / gender).  Major 
trauma defined as requiring a medical visit or 
attendance at a hospital did occur, but did not 
achieve significance (p=0.87 adjusted for 
age/gender). 
 
Migraine present in  221 (36.3%) ICAD and 123 
(38.1%) VAD p=0.6 OR (95% CI) = 1.09 (0.81-
1.47).   
 
Debette et al (2011 p.1175) defined infection 
”...occurring in the previous week of dissection 
onset and corresponding to the presence of at 
least one typical symptom of infection in 
combination with fever (≥38 ºC) or the presence of 
at least one typical symptom of infection with 
corresponding serologic, culture or radiologic 
findings indicating an acute infection or the 
combination of at least 2 typical corresponding 
symptoms..”,  ICAD n=131(21.7%), VAD 
n=47(14.6%) p=0.009 OR (95% CI) 1.59 (1.09-
2.31).  The authors consider this as possibly an 
overestimation of infection within the previous 
week as their definition is broad. 
 
Debette, Metso 
et al 2011 
 
 
prospective  2++ 690 
(CAD) 
and 
556 
non-
CAD 
ische
mic 
stroke 
and 
1170 
referra
nts 
 
Risk: hypertension could be a risk factor of CAD 
compared to referrants (OR 1.67; 95% CI, 1.32 to 
2.1 P=0.0001). 
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Dziewas et al 
2003 
Retrospective 2- 126 
 
Symptoms/signs: 
Major presenting complaint 
Cerebral infarction (96; 76%), Transient ischemic 
attack (15;12%);  Local signs only  (15;12%) 
Associated features 
Neck pain (73:58%), headache (57;45%, tinnitus 
(8;6%), 
Partial Horner’s syndrome (29;23%). 
Risk: 
40% CAD patients had hypercholesterolemia and 
a history of smoking. 
 
Ernst 2007  Systematic review 2++  
Risk: Manipulation of the neck, however, is 
considered as having a strong association as a 
risk factor for CAD. 
 
Ernst 2010 Systematic review 3  
Risk: to establish the numbers of fatalities 
following chiropractic intervention and reported a 
total of 26-deaths were published in the medical 
literature, but further states there is reason to 
believe that under-reporting is substantial and 
reliable incidence figures do not exist.   
 
Grond- Ginsbach 
et al 2012 
Prospective 2- 32 
Risk: To show specific factors for familial CAD.  
Nine new patients added to 23 patients from 
previous study. Mean age 38.4 yrs +/- 13.3 yrs. 
Twenty-six female (62.5%). Twelve suffered 
multiple dissections. Four recurrent dissections 
after 1 yr. Patients with familial history were 
younger (p=o.018). Conclusion: high prevalence 
multiple dissections and of longterm (>1yr) 
recurrent patients indicates specific predisposition 
for familial CAD exists. 
Gui et al 2010 
 
 
 
Prospective  2- 16  
Symptoms/signs: 
 
No history of head / neck trauma, TIA or signs of 
spinal cord ischaemia. Initial symptom headache 
in 8 (53%). 
Most (n = 14, 88%) had neurologic deficits with the 
onset of symptoms of ischemia apparent within 4 
days of onset of headache. 
13 presented with symptoms of posterior-
circulation ischemia, 1 with SAH and 2 with 
serious occipital lacerating pain. Serious 
parietooccipital pain with symptoms of posterior-
circulation ischemia were the most common 
manifestations (n = 10, 63%). 
 
Guillon et al 
2003  
Case control 2- 47 
CAD 
Contro
l 52 
Risk: 
Reported 58.3% CAD and 40% of control subject 
with cerebral ischemic event unrelated to CAD had 
baseline characteristics of oral contraceptives. 
 
Guillon et al (2003) case control study 
investigating infection as risk factor of sCAD 
(n=47) compared to a control group (n=52) with 
cerebral ischemic event unrelated to SCAD.  
Reported that infection was present in 31.9% 
sCAD and 13.5% control subjects (crude odds 
ratio 3.0 95% CI 1.1-8.2 p=0.032), concluding that 
recent infection is a risk factor and could be a 
trigger for sCAD. 
Haldeman et al 
2002 
Retrospective 2- 64 
concluded after reviewing medicoloegal (medical 
related compensation claims) cases that risk 
factors could not be identified and that dissection 
was an unpredictable event.   
Huang 2009 Retrospective 
 
 
2- 73  
 
 
Symptoms/signs: 
 
N=40 patients presenting with ischemic stroke, 22 
(55%) 
had accompanying headache and/or neck pain 
lateralized to the dissection side. 
 
All patients presenting with SAHaemorrhage or 
combined ischemia and SAH had headache. 
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4 patients with headache only, the pain described 
as intense and lateralized to the dissection side. 
 
Preceding trauma or specific activities before 
arterial dissection were found in 10 cases (13.7%). 
Prior history of hypertension was recorded in only 
12 patients (16.4%). 
Lee et al 2006 Retrospective:  2- 48 
 
 
Symptoms/signs: 
 
In CAD n=(%): Asymptomatic 3 (6); Pain 38 (80) 
Neck pain 13 (27); HA  33 (69); Horner syndrome 
12 (25); Cerebral ischemia(stroke or TIA) 32 (67); 
TIA 11 (23); Stroke  27 (56). 
 
The average annual incidence rate for CAD in 
Olmsted County was 2.6 per 100,000 population 
(95% CI, 1.86 to 3.33). The average annual 
incidence rate for CAD in the city of Rochester 
was 3.01 per 100,000 population (95% CI, 1.86 to 
3.33). 
 
Martin et al 2006 
 
observational  2- 7 
(famili
es / 15 
CAD) 
Risk: 
Genetic risk factors are thought to play a role in 
the aetiology of sCAD; however, familial CAD is 
rare.   dissections to establish if any specific 
features existed.   They concluded that familial 
CAD families are young.  Mean age (n=15, 9 
women) at first dissection was 36.2 years 
(median age 32 years, range 18-59).  Skin 
biopsies were performed on 11 patients and 
conclude that ultrastructural alterations in the 
dermal connective tissue might not be an 
important risk factor. 
Maruyama et al 
2012 
Case series 3 7 
Symptoms/signs:. 6 VAD / 1 ICAD / 1 combined 
All but 1 patient,  headache and neck pain 
were unilateral. All VAD complained of posterior 
cervical or occipital pain.  1 ICAD had temporal 
pain, and 1 patient with co-existing VAD  had 
posterior cervical pain. Acute onset in 5, 
thunderclap in 1, and 1 gradual and progressive. 
Pain severe in all cases. 5  continuous pain, 2 
intermittent pain. Quality of the pain throbbing in 5 
and constrictive in 2. Pain duration ≥1 week in 6 
patients. Suspect CAD if  intense unilateral 
posterior cervical and occipital pain or temporal 
pain. 
Miley et al 2008 
 
Review (structured 
evidence based 
clinical neurologic 
practice review) 
 
2++  
Risk: 
Conclude there is weak to moderately strong 
evidence to support causation between CMT and 
VAD and associated stroke. 
Paciaroni et al 
2006 
 
prospective study 2+ 352 
Risk: 
Examined seasonal variability. Most patients 
presented with ischemic stroke (241 / 63%), 
followed by TIA in 40 (11%), retinal ischemia in 7 
(2%), an non-ischemic in 73 (19%); 19 (5%) were 
asymptomatic spontaneous CAD.  A higher 
frequency of CAD was observed in winter (31.3%; 
95% CI; 26.5 to 36.4; p=0.021) compared to spring 
(25.5%; 95% CI; 21.1 to 30.3), and summer 
(23.5%; 95% CI; 19.3 to 28.3), and autumn 
(19.7%; 95% CI; 15.7 to 24.1).  Although there 
was seasonal pattern present, the cause in 
unclear with possible increased contribution from 
winter peaks of infection, hypertension, and aortic 
dissection.  There was no additional data to 
support this hypothesis other than observing 
season variation. 
 
Pezzini et al 
2006 
 
prospective, case-
control study 
2- 153 
non-
CAD 
153 
Risk: 
Reported a trend towards significant association 
was observed when the prevalence of 
hypertension was compared among patients with 
spontaneous CAD and control group ((26.8% v 
17%; OR 1.79; 95% CI, 0.98 to 3.27, p=0.058).    
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Contro
ls 153 
 
Mild Hyperhomocysteinemia has been reported as 
a risk factor for both arterial dissection and 
ischemic stroke without dissection. 
 
Raser et al 2011 retrospective case 
control study  
2- 38 
CAD 
Contro
l 38 
Risk: 
To investigate for association of length of styloid 
process and CAD.  The styloid process of the 
temporal bone is variable in length, angulation and 
proximity to the carotid artery. This study revealed 
no significant difference in angulation, however, 
there was a significant difference for styloid 
process being longer ipsilateral to the dissection 
than in control subjects 930.3mm v 26.6mm, 
p=0.33).  Dissection was associated with 
increasing styloid length with OR 1.08/mm (95% 
CI 1.002 to 1.17, P=0.04).  Comparing the top 
quartile of length (>31.15mm) with bottom 3 
quartiles revealed an OR for dissection of 4.0 
(95% CI 1.3 to 14.2, p=0.03).  Control subjects 
13% (n=5/38) had styloid length associated with 
risk.    Raser et al (2011) concluded that CAD is 
associated with with a longer styloid process 
suggesting that mechanical injury from the styloid 
may contribute to the pathogenesis of CAD. 
 
Rist et al 2011 
 
Systematic review 
and meta-analysis 
1+  
Risk: 
To evaluate the association between migraine or 
migraine subtypes (e.g. with aura) and CAD. Five 
case control studies included that were published 
through 2010. Pooled analysis, migraine doubled 
the risk of CAD (pooled odds ratio (OR) = 2.06, 
95% CI 1.33-3.19).  Migraine with aura showed 
slightly weaker association compared to without 
aura; however, no evidence that aura status 
modifies association between migraine and CAD 
(met-regression on aura status p=.58). 
 
Rubenstein et al 
2005 
Systematic review 2++  
Risk: 
Manipulation of the neck is considered as having a 
strong association as a risk factor for CAD. 
 
Silbert et al 1995 
 
Prospective 2- 161 
Risk: 
investigated characteristics of headaches  
consecutive symptomatic patients with 
spontaneous CAD (n=135 ICAD, n=26 VAD) 
reported a history of migraine in 24 (8%) ICAD and 
6 (23%) VAD patients.  No other statistical 
analysis presented. Medical records check and 
follow-up (letter, telephone call or clinical 
evaluation). 
 
Thomas et al 
2011 
Retrospective. Case-
control. 
 
2+  47 
(Contr
ol  43) 
 
Symptoms/signs:n=(%):control n=(%) 
Symptoms: 
Headache 38(81):22(51), neck pain 27(57):6(14), 
dizziness 15(32):3(7), visual disturbance 
16(34):12(28), paraesthesia (face 14(30):8(19); 
upper limb 16(34):20(47)/lower limb 9(19):14(33). 
 
Signs: 
Unsteadiness/ataxia26 (55%):15 (35%), weakness 
upper limb 22 (47%):32 (74%) weakness lower 
limb21 (45%):26 (60%); 
dysphasia/dysarthria/aphasia21(45%):30 (70%) 
; Facial palsy18 (38%):20 (47%);  ptosis17(36%):2 
(5%); Nausea/vomiting 13 (28%):6(14%); 
Dysphasia 8 (17%):2 (5%);  
  Drowsiness 5 (11%):1 (2%) 
 Confusion 5 (11%):6 (14%); 
Loss of consciousness 8 (17%):2 (5%) 
 
Risk: 
statistically significant association between minor 
mechanical trauma and CAD patients compared to 
a control group: 23 (64%) v’s 3(7%) OR (95% CI) 
26.67 (6.83 to 104.17) adjusted OR 25.29 (6.04 to 
105.82) p<0.000. 
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cardiovascular risk factors were not considered 
significant in a CAD group compared with age 
(<55-years) and sex matched controls of patients 
with stroke from other causes. 
 
Observed in 5 (14%) of CAD patients and 4 (9%) 
of control subjects (<55 years stroke of non-
dissection cause).  Infection had borderline 
statistical significance with CAD. 
 
Question 3.  What features of dizziness and what clinical tests would aid MSK 
physiotherapists’ differential diagnosis of a peripheral versus central cause of 
dizziness? 
 
Search strategy Dizziness AND Differential AND Diagnosis.  
 
Search 
reduction 
Research Article: 329.Title checks reduced to 30. Full article/Abstract checks 
reduced to: 12. Selected: 3. 
 
Study  Design 
SIGN 
Evid 
Level 
 
Main findings 
Bhattacharyya et al 
2008.  
Guidelines 2++ Statement 1a. Diagnosis of Posterior Canal BPPV 
Strong recommendation  
Posterior semicircular canal BPPV is diagnosed when: 
1) patients report a history of vertigo provoked by changes in 
head position relative to gravity, and when 
2) on physical examination, characteristic nystagmus is 
provoked by the Dix-Hallpike manoeuvre bringing the 
patient from an upright to supine position with the head 
turned 45 degrees to one side and neck extended 20 
degrees. 
 
2a. Differential Diagnosis of BPPV 
Clinicians should differentiate BPPV from other causes of 
imbalance, dizziness, and vertigo.  
Other causes of vertigo confused with BPPV can be divided into 
otological, neurological, and other entities. In a nonspecialty 
setting evaluation of patients presenting with vertigo, BPPV has 
been found to account for 42 percent of cases followed by 
vestibular neuritis (41%), Ménière’s disease (10%), vascular 
causes (3%), and other causes (3%).The most common 
diagnoses that require distinction from BPPV because their 
natural history, treatment, and potential for serious medical 
sequelae differ significantly. 
 
Neurological Disorders 
Key issue facing clinicians’ differentiation of vertigo between 
peripheral causes and CNS causes of vertigo. 
Several clinical features may suggest a central cause of vertigo 
rather than BPPV. 
 Nystagmus findings that more strongly suggest a 
neurological cause for vertigo, rather than a peripheral 
cause such as BPPV, include down-beating nystagmus 
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on the Dix-Hallpike manoeuvre, direction-changing 
nystagmus occurring without changes in head position 
(ie, periodic alternating nystagmus), or baseline 
nystagmus manifesting without provocative 
manoeuvres. 
Central causes of vertigo that should be differentiated from BPPV 
are migraine-associated vertigo, vertebrobasilar insufficiency, and 
intracranial tumors. 
Failure to respond to conservative management should raise 
concern that the underlying diagnosis may not be BPPV. 
Dros et al 2010.  Systematic 
review 
2++ 1. Studies on diagnosing dizziness have been conducted in highly 
selected homogenous groups of patients only. 
2. Evidence to support the diagnostic process in primary care is 
scarce. 
3. An exception is the head impulse test: +ve test diagnostic of 
peripheral vestibular dysfunction and –ve test result diagnostic of 
central peripheral dysfunction. 
Accurate evaluation of diagnostic tests should be based on the 
results of more than one study. Therefore, the authors describe 4 
tests, all targeted for neuro-otologic conditions that were 
evaluated in more than 1 study. 
a. Dix-Hallpike manoeuvre, b. Head-shaking nystagmus test, c. 
Head impulse test, and d. Vibration-induced nystagmus test. 
(weblinks provided by authors) 
Tarnutzer et al 2011.  Systematic 
review 
2++ Vertebrobasilar ischaemic stroke may closely mimic 
peripheral vestibular disorders, with obvious focal neurologic 
signs absent in >1/2 of patients presenting with acute 
vestibular syndrome due to stroke. 
A 3-component bedside oculomotor examination – HINTS 
(horizontal head impulse test, nystagmus and test of skew) 
identifies stroke with high sensitivity and specificity in 
patients with acute vestibular syndrome and rules out stroke 
more effectively than early diffusion-weighted MRI. 
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Question 4. What clinical tests, signs and symptoms of cervical myelopathy (CM)  have 
been identified in this presentation that should be used to screen for this 
pathology? 
Search strategy Cervicalspondylosis OR Cervical myelopathy AND Signs OR Symptoms OR 
Examination OR Diagnosis NOT Surgery. 
Narrow by subject major headings: Spinal Osteophytosis complications; 
Spinal Osteophytosis; Spinal Osteophytosis diagnosis; Spinal Cord 
Diseases; Spinal Cord Diseases diagnosis; 
Cervical Vertebrae pathology; Spinal Cord Compression diagnosis; Physical 
Examination; Cervical Vertebrae. 
Search 
reduction 
 
Research articles 130. Reduced to 62with title check. Full article/Abstract 
check: 50. Selected 13. 
 
Study  Study 
design 
Evid
. 
level 
Sampl
e size 
Symptoms Signs Other 
Bednarik, J., 
Kadanka, Z. and 
Vohanka, S. 
1999. Median 
nerve 
mononeuropath
y in spondylotic 
cervical 
myelopathy: 
double crush 
syndrome?  
Journal of 
Neurology, 246 
pp.544-551. 
Prospective, 
case control  
 
2- 60 Gait disturbances 
(n=56), spasticity 
and/or weakness 
of the lower and/or 
upper extremities 
(n=55), clumsy 
hand (n=13), 
sensory 
disturbance 
corresponding to 
cervical spinal cord 
involvement 
(n=37), bladder, 
bowel or sexual 
disturbances 
(n=15), Lhermitte 
sign (n=9). 
 Exclusion: other 
possible causes of 
clinical 
signs/symptoms 
(multiple sclerosis, 
motor neuron 
disease, cervical 
spinal canal and/or 
posterior fossa 
expansive lesions), 
known systemic 
disease e.g. RA  
 
CM diagnosis 
confirmed with MRI. 
Nerve conduction 
studies, EMG, and 
median nerve 
somatosensory 
evoked potentials. 
Chiles, B., 
Leonard, M., 
Choudri, H., and 
Cooper, P. 
1999. Cervical 
sponsylotic 
myelopathy: 
patterns of 
neurological 
deficit and 
recovery after 
anterior cervical 
decompression.  
Neurosurgery, 
44 (4), pp.762-
769. 
Retrospectiv
e 
(Osteophytic 
ridge 
(54:76%) or 
soft disc 
herniation 
22:29%) 
2- 
 
76 N=76 patients 
Neck pain 
(21:27.6%), upper 
extremity pain (18: 
23.7%), lower 
extremity pain 
(7:9.2%), upper 
extremity sensory 
complaints ( loss, 
dysesthesias, 
paraesthesias, 
pain) (63:82.9%), 
lower extremity 
sensory complaints 
(34:44.7%), hand 
use deterioration 
957:75%), gait 
dysfunction 
(61:80.3%), bowel 
dysfunction 
Motor deficit 
(n=152 muscle 
groups):  
Upper limb: 
Deltoid (16: 
10.5%),Biceps 
(18: 11.8%), 
Triceps (44: 
28.9%), hand 
intrinsics (86: 
56.6%) 
Lower limb: 
Iliopsoas (59: 
38.8%), 
quadriceps (40: 
26.3%), 
Authors comments: 
UE symptoms 
usually slightly 
before onset gait 
difficulties; all except 
6, had UE sensory 
complaints or 
difficulties with fine 
movements when 1st 
seen. UE sensory 
symtoms generally 
begin finger tips, 
then extend 
proximally with time, 
but rarely radicular 
distribution. Motor 
deficit (UE) usually in 
hands and triceps 
first. Hypothesised 
that this occurs fro 
anterior horn cell 
loss rather than 
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(4:5.3%), bladder 
dysfunction 
(8:10.5%), sexual 
dysfunction 
(5:6.6% men only 
and some 
inactive). 
dorsiflexion (28: 
18.4%), 
plantarflexion 
(24: 15.8%) 
Signs of 
spasticity (n=76 
patients): 
spastic gait (52: 
68.4%), ankle 
clonus (25: 
32.9%), 
Babinski reflex 
(31: 40.8%), 
hyperreflexia 
(58: 76.3%) 
nerve root 
compression – 
Anterior horn cell 
occurring from 
spondylotic 
obstruction of spinal 
cord venous 
drainage. 
Sphincter and sexual 
dysfunction relatively 
infrequent and 
usually in far-
advanced 
myelopathy. 
He, S., Hussain, 
N., Zhao, J., Fu, 
Q. and Hou, T. 
2006. 
Improvement of 
sexual function 
im male patients 
treated 
surgically for 
cervical 
spondylotic 
myelopathy. 
Shisheng. 
Spine, 31(1), 
pp.33-36. 
Prospective 
follow-up 
2+ 22 
(identified 
from 753 
CM 
patients)  
Sexual 
dysfunction 
(subjective 
difficulty in penile 
erection or 
ejaculation). All 
had normal 
function 6 months 
pre-surgery. 
Abnormal: 
reflexogenic 
erection (4) / 
psychogenic 
erection (18) 
Exclusions: No 
report of sexual 
dysfunction; Patients 
with other diseases, 
such as brain 
damage, throracic 
and lumbar spinal 
disease, peripheral 
neuropathy, 
endocrinopathy, or 
specific depression 
Heffez, D., 
Ross, R., 
Shade-Zeldow, 
Y., Kostas, K., 
Shah, S., 
Gottschalk, R., 
Elias, D., 
Shepard, A., 
Leurgans, S. 
and Moore, C. 
2004. Clinical 
evidence for 
cervical 
myelopathy due 
to Chiari 
malformation 
and spinal 
stenosis in a 
non-randomised 
group of 
patients with the 
diagnosis of 
fibromyalgia. 
European Spine 
Journal, 13 
pp.516-523. 
Prospective 
non-
randomised 
2- 
 
270 Fatigue (96%), 
Neck/back pain 
(95%), Cognitive 
impairment (92%), 
generalised 
weakness (92%), 
headache (90%), 
gait instability 
(85%), grip 
weakness (83%), 
photophobia 
(83%), hand 
clumsiness (80%), 
paraesthesiae 
(80%), irritable 
bowel syndrome 
(77%), dizziness 
(71%), numbness 
(69%), blurred 
vision or diplopia 
(65%), 
disorientation 
(54%), chronic 
nausea (40%) 
Sensory level 
(83%), 
hyperreflexia 
(64%), 
recruitment – 
inverted radial 
reflex (57%), 
absent gag 
reflex (57%), 
Romberg sign 
(28%), Hoffman 
sign (26%), 
Clonus (25%), 
impaired 
tandem walk 
(23%), 
weakness in ≥1 
limb (22%), 
impaired 
position sense 
(14%), Cranial 
nerve V (8%), 
ataxia (8%), 
nystagmus 
(6%), Cranial 
nerve X11 (4%). 
Additional: Neck 
extension/flexio
n immediate 
accentuation of 
abnormal 
pyramidal track 
findings(88% 
and 73%, 
respectively) 
Exclusion: no 
previously diagnosed 
neurological disease 
including CM (some 
had previous MRI 
identifying degree of 
stenosis and/or 
cerebellar 
tonsillarectopia, but 
not considered 
significant). 
 
Standard 
assessment: 
Multidisciplinary 
(including 
neurologist and/or 
neurosurgeon, and 
rehab team 
(PT/OT/SLT) and 
psychologist. MRI 
brain/cervical spine 
and CT cervical 
spine. 
Kim, Y., Oh, S., 
Yi, H., Kim, Y, 
Ko, Y. and Oh, 
S. Myelopathy 
caused by soft 
Retrospectiv
e 
(soft disc 
herniation) 
2- 26 Walking difficulty 
(20: 77%), 
spasticity 
(15:58%), chest 
abdominal 
Muscle atrophy 
(7:26%), 
spinothalamic 
deficits (7:26%), 
sphincter 
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cervical disc 
herniation: 
surgical results 
and prognostic 
factors. 2007. 
Journal of 
Korean 
Neurosurgerical 
Society, 42 
pp.441-445. 
discomfort 
(15:58%), hand 
numbness 
(11:42%), radicular 
pain (9:35%) 
disturbance 
(5:19%), central 
cord syndrome 
(4:15%). 
Kim C., Yoo, J., 
Lee, S., Lee, D. 
and Rhim, S. 
2010. Gait 
analysis for 
evaluating the 
relationship 
between 
increased signal 
intensity on T2 –
weighted 
magnetic 
resonance 
imaging and gait 
function in 
cervical 
spondylotic 
myelopathy. 
Archives of 
Physical and 
Medical 
Rehabilitation, 
91 pp.1587-92. 
Retrospectiv
e 
comparative 
– gait 
analysis 
laboratory 
2+ 36  Examination als 
o included: neck 
pain, increased 
tendon reflex, 
ankle clonus, 
babinski sign, 
paraesthesia, 
sensory 
changes, 
bowel/bladder 
symptoms 
Three dimensional 
gait analysis: linear 
parameters - step 
width, gait velocity, 
cadence (step rate 
per minute), step 
length, stride length 
(distance between 
both feet), step 
length (distance 
between contact 
point same foot), 
stance time (single 
foot), and double 
support time (both 
feet); Kinematic data 
– pelvis, hip, knee, 
ankle angles.  
Exclusions: unable 
to walk; other 
diseases that could 
affect walking e.g. 
stroke, traumatic 
brain injury,, or 
myelitis; previous 
cervical or lumbar 
surgery.  
Kuhtz-
Buschbeck, J., 
Jöhnk, K., 
Mäder, S., 
Stolze, H. and 
Mehdorn, M. 
1999. Analysis 
of gait in 
cervical 
myelopathy. 
Gait and 
Posture, 9 
pp.184-189. 
Case control 
(n=14) 
2+ 26 Additional: 
Radiculoapthy in 
upper limbs (9), 
Sensory symtoms 
(paraesthesia) 
affecting legs 3, 
sphincter 
dysfunction 2 (not 
specified). 
Upper motor 
Neuron 
involvement 
included a mild 
increase of leg 
muscle tone 
(0.9 ± 0.3 
Ashworth 
scale).  
Pre-surgery: 
significantly 
reduced gait 
velocity and 
step length, 
prolonged 
double support, 
increased step 
width and 
reduced ankle 
jtplantarflexion. 
Hip and knee no 
difference to 
controls. 
Gait recorded on 
walkway (13-m) and 
treadmill. 
 
Three dimensional 
gait analysis: 
spatiotemporal gait 
parameters – stance, 
swing, double 
support phase 
duration, cadence 
(step rate per 
minute);Kinematic 
parameters - Joint 
angles – hip, knee, 
ankle.  
 
Exclusions: other 
neurological 
disorders, or 
orthopaedic lower 
limb joints that could 
alter gait. 
Lee, J., Lee, S. 
and Seo, I. 
2011. The 
characteristics 
of gait 
disturbance and 
Prospective 
case control  
 
 
2+ 
38 Leg muscle tone in 
all CM patients 
was increased (1 
to 1+ Ashworth 
scale). 
Graded levels of 
compression: 
garde 0 – no 
impingement on 
spinal cord, 
garde 1 – some 
Three dimensional 
gait analysis: linear 
parameters - step 
width, gait velocity, 
cadence (step rate 
per minute), step 
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its relationship 
with posterior 
tibial 
somatosensory 
evoked 
potentials in 
patients with 
cervical 
myelopathy. 
Spine, 36 (8), 
pp.E524-E530. 
Control 
group n=36 
(no 
significant 
difference 
impingement, 
but deformity on 
spinal cord is 
absent or 
minimal, grade 
2 – evident 
deformity of 
spinal cord with 
an obviously 
reduced cross-
sectional area, 
and, grade 3 – 
grade 2 and 
high signal 
intensity area 
within the spinal 
cord. Grade 2 or 
3 at minimum 1 
level considerd 
as positive MRI 
sign indicative 
of CM. 
Patients also 
divided into 2 
groups related 
to posterior 
tibial 
somatosensory 
evoked 
potentials. 
Abnormal 
PTSEP  results 
in 20 patients of 
CM group 
(52.6%) 
length, stride length 
(distance between 
both feet), step 
length (distance 
between contact 
point same foot), 
stance time 9single 
foot), and double 
support time (both 
feet); Kinematic data 
– hip, knee, ankle 
jtROM.  
Six trails of 10-m 
walkway. Posterior 
tibialsomato-sensory 
evoked potentials  
 
Exclusions: previous 
CM surgery, other 
neurological 
disorders, coexisting 
peripheral 
neuropthay, or 
orthopaedic lower 
limb joints that could 
alter gait. 
Sakakibara, R., 
Hattori, T., Tojo, 
M., Yamanishi, 
T., Yasuda, K. 
and Hirayama, 
K. 1995. The 
location of the 
paths 
subserving 
micturition: 
studies in 
patients with 
cervical 
myelopathy. 
Journal of the 
Autonomic 
Nervous 
System, 55 
pp.165-168. 
Prospective 2+ 95 
(identifed 
from 128 
CM 
patients) 
Micturitional 
symptoms:irritativ
e (diurnal or 
nocturnal urinary 
frequency; 
sensation of 
urgency or 
incontinence) 61 / 
obstructive (urinary 
hesitation, 
prolongation, 
difficulty of voiding 
and urinary 
retention) 71. 
(urinary 
incontinence 25 / 
urinary retention 
22) 
Relationship of 
urodynamic 
studies (residual 
volume, water 
cystometry and 
simulataneous 
sphincter EMG) 
alongside 
neurological 
examination 
(disturbed deep 
sensation of 
lower 
extremities (55) 
– position and 
vibration, 
disturbed 
superficial 
sensation (63) 
of lower body 
including 
perineal area – 
pin prick, and 
pyramidal signs 
(96) – 
weakness and 
hyperreflexia of 
lower 
extremities and 
Babinski 
Exclusions: No 
report of 
micturitionalsymtoms
; drug treatment 
influencing lower 
urinary tract function; 
or prostate 
hypertrophy.  
Taylor, J., 
Johnston, R. 
and Caird, F. 
1991. Surgical 
treatment of 
cervical 
spondylotic 
myelopathy in 
Retrospectiv
e 
 
2- 17 Paraesthesiae in 
hands and upper 
limbs, often 
assymetrical 
distribution (16), 
Weak hands (11. 
Four commented 
clumsy and 
Reflex changes 
in both upper 
and lower 
(generally 
hyperreflexia in 
lower limbs, 
with brisk or 
diminished 
Coexisting medical 
conditions were 
common: ischemic 
heart disease (5), 
significant RA/OA (5, 
4 of which with 
arthroplasties). 
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elderly patients. 
Age and 
Ageing, 20 
pp.407-412. 
useless), 
deterioration in gait 
(11), neck pain (5), 
prone to falls 
(4),sphincter 
disturbance (1). 
 
 
upper limb 
depending on 
level of lesion), 
weakness of 
hands and 
upper limbs 
(14), Reduced 
power lower 
limb, associated 
with spasticity 
(13), impairment 
of pin prick 
sensation in 
hands and 
upper limb (12), 
lower limb (10), 
sever 
proprioceptive 
loss in legs (1).  
Additional: only 
4 patients 
mobile without 
any aid, upper 
limb function 
independence 
(2) 
The authors 
considered 
presenting signs and 
symptoms (not co-
morbities) were 
similar to those in 
younger patients. 
Vyas, K., 
Banerji, D., 
Behari, S., Jain, 
S. and 
Chabra,D. 2004. 
C3-4 level 
cervical 
spondylotic 
myelopathy. 
Neurology India, 
52 (2), pp.215-
219. 
Prospective 2-- 
 
14 
(identified 
from 137 
CM 
patients) 
Not specified All 14 had 
pyramidal signs; 
13 sensory 
involvement; 5 
posterior 
column 
involvement; 3 
distal hand 
muscle wasting; 
3 sphincteric 
dysfunction. 
No additional 
specific detail 
presented. 
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Cook , C., 
Wilhelm, M., 
Cook, A., 
Petrosino, C. 
and Isaacs, 
R. 2011. 
Clinical tests 
for screening 
and 
diagnosis of 
cervical spine 
myelopathy: 
a systematic 
review. 
Journal of 
Manipulative 
and 
Physiological 
Therapeutics, 
34, pp.539-
546. 
Systematic 
review 
1- 12 
studies  
        
Reviewer comments: Well conducted systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines.  All studies assessed using Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool.  No RCT’s within 
studies and authors acknowledge that not many studies met their inclusion criteria, which is outlined and appears appropriate; therefore 
the process relied heavily on hand searches. All studies double assessed and no authors assessed any of their own previous work.  
Nonetheless, this paper is a good collection of the clinical tests commonly used for screening for CM and highlights the generally low-
moderate quality of studies assessing the clinical utility of such testing.  These tests demonstrated high levels of specificity and low 
levels of sensitivity (see additional comments below). The authors have sub-divided into 3 categories of tests: 1. associated with gait or 
balance analysis; 2. associated with upper motor neuron or “pathological” signs; and, 3. associated with deep tendon reflexes. 
Permission has been gained to reproduce Cook et al’s (2011) tables 1-4 and descriptions/positive findings summary within this 
presentation to help inform readers.  These are presented below.  The authors recommend further evaluation of these tests and 
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exploration of clustered findings. Tests with low sensitivity are unlikely to identify the condition early in the exam (cannot rule it out) and 
may result in a false negative. Thus clinicians may apply treatment techniques under false assumptions of safety, which may further 
compromise the spinal cord. 
 
 
Tables 1-4  
 
TableI.Diagnostic accuracy of test findings associated with gait or balance analysis    
Study  Reliability  Sensitivity  Specificity  LR+  LR-  QUADAS Score (0-14)  
 
Abnormally wide-based gait, ataxia, or spastic gait  
 
    
 
Cook et al38 
  
NT 19 (14-24)                94 (91-97) 3.4 (1.6-7.3) 0.85 (0.78-0.94) 10 
 
Static or dynamic Rhomberg sign  
 
     
Kiely et al39*  NT  NT  NT NT 100 NT NT 2 
       
NT: not tested; * Confidence intervals were not reported in the article    
Adapted with permission from Cook et al (2011) 
Authors comments: Unable to pool results as QUADAS <10. Both tests very specific. Both tests were evaluated by 1 author only. 
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Table 3. Diagnostic accuracy of test findings associated with deep tendon reflex changes   
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Study  Reliability  Sensitivity  Specificity  LR+  LR-  QUADAS Score (0-14)  
Biceps or triceps hyperreflexia      
Cook et al36 89% Agreement 44 (28-59) 71 (59-82) 1.5 (0.7-3.4) 0.8 (0.5-1.2) 12 
Cook et al38 NT 18 (13-22) 96 (93-96) 4.8 (2.0-11.7) 0.85 (0.79-0.93) 7 
Suprapatellar reflex       
Cook et ae6 84% Agreement 56 (39-72) 33 (22-46) 0.8 (0.5-1.3) 1.3 (0.6-2.8) 12 
Cook et al38 NT 22 (17-25) 97 (94-99) 6.9 (2.8-17.5) 0.81 (0.76-0.89) 7 
Achilles tendon hyperreflexia      
Cook et al38 NT 15 (11-17) 98 (96-99) 7.8 (2.5-25.4) 0.87 (0.84-0.93) 7 
Rhee et al42*  NT 26 81 1.37 0.91 6 
Infrapatellar reflex       
Chikuda et al44 NT 94 (88-97) NT NA NA 9 
Rhee et al42*  NT 33 76 1.37 0.88 6 
Authors comments: 4 studies. Measures appear very specific and diagnostic. I low quality study (Chikuda et al) indicated infrapatellar reflex as sensitive. Unable to pool results (only 1with  QUADAS 
>10). 
 
Adapted with permission from Cook et al (2011) 
 
 
Table 4 Clustered findings for diagnosis of CSM38 
  
Study  Reliability  
Sensitivity (95% 
Cl) 
Specificity (95% Cl) LR+ (95% Cl) LR- (95% Cl) QUADAS Score (0-14)  
Cook et al38 (I of 5 positive test 
results) 
NT 
 
0.94 (0.89-0.97) 
 
0.31 (0.27-0.32) 1.4 (1.2-1.4) 0.18 (0.12-0.42) 7 
Cook et al38 (2 of 5   positive 
test results)  0.39 (0.33-0.46) 
NT 
0.39 (0.33-0.46) 
 
0.88 (0.84-0.92) 3.3 (2.1-5.5) 0.63 (0.59-0.79) 7 
Cook et al38 (3 of 5 positive test 
results) 
NT 
0.19 (90.15-0.20) 
 
0.99 (0.97-0.99) 30.9 (5.5-181.8) 0.81 (0.79-0.87)       7 
Cook et al38 (4 of 5 positive test 
results) 
NT 
0.09 (0.06-0.09) 
 
1.0 (0.98-1.0) Inf (3.9-Int) 0.91 (0.90-0.95) 7 
Five tests are included in the rule: (I) gait deviation, (2) +Hoffinann test, (3) inverted supinator sign, (4) +Babinski test, and (5) age more than 45 years. The associated posttest 
probability values are based on a pretest probability of 35%.  
Authors comments: 1 low quality study clustered test findings. Diagnostically, failure of a =ve finding in 1 of 5 tests resulted in strong screening combination yielding a 
sensitivity of 0.94 and LR- of 0.18.  A finding that included 3 o5 +ve tests results yielded an LR+ OF 30.9 (95% ci=5.5-181.8) and a post-test probability of 94%. 
Adapted with permission from Cook et al (2011) 
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Table 5. Test Descriptions and Positive Findings   
Test Description  Positive Finding  
Gait abnormality The examiner asks the patient to ambulate while the examiner 
observes from different angles.   
Wide based gait, 
spastic gait, or ataxia, 
all typically 
symmetrical  
Staic or Dynamic 
Rhomberg Sign 
Static: With the patient in standing, instruct the patient to stand with 
their feet together, eyes closed, and hands by his or her side. Dynamic: 
same position as static but with a light external moment applied to the 
patient.  
Balance disruption  
 
Hoffman’s Sign With the patient in sitting or standing, the examiner stabilizes the 
middle finger just proximal to the distal interphalangeal joint and cradles 
the patient's hand. The examiner then either nips the patient's fingernail 
between his or her thumb and index finger, or flicks the middle 
fingernail with the examiner's fingernail.  
Adduction of the thumb 
and flexion of the 
fingers  
 
Babinski’s Sign With the patient in supine and the foot held in neutral by the examiner, 
the examiner applies stimulation with the blunt end of a reflex hammer 
to the plantar aspect of the foot (laterally to medial from heel to 
metatarsal). 
 
Lhermitte’s Sign With the patient in sitting or supine, the patient is instructed to flex the 
neck with emphasis on lower cervical flexion. Some examiners have 
advocated use of hyperextension to produce Lhermitte's response. 
Query the patient for "electrical-type" response during flexion or 
extension.  
 
An "electrical-type" 
sensation in the 
midline and 
occasionally into the 
extremities during 
flexion  
Clonus This technique can be applied to either the ankle or wrist. With the 
patient in supine or sitting, the examiner takes up slack of the wrist into 
extension or the ankle into dorsiflexion. The examiner then applies a 
quick overpressure with maintained pressure.  
Repeated beats of 3 or 
greater 
Gonda-Allen Sign With the patient in supine, the examiner provides a forceful downward 
stretch or snaps the distal phalanx of the 2nd or 4th toe. The examiner 
may also press on the toe nail, twist the toe, and hold for a few 
seconds.  
The extensor toe sign 
(great toe extension) 
Similar to positive 
Babinski's sign  
Allen-Checkley Sign 
 
With the patient in supine, the examiner provides a sharp upward flick 
of the 2nd toe or pressure over the distal aspect or ball of the toe.  
The extensor toe sign 
Inverted Supinator 
Sign   
With the patient in sitting, the examiner places the patient's forearm in 
slight pronation on his or her forearm to ensure relaxation. The 
examiner applies a series of quick strikes near the styloid process of 
the radius at the attachment of the brachioradialis and the tendon.  
 
Finger flexion or slight 
elbow extension 
Finger Escape Sign 
 
 
With the patient seated, the patient is asked to flex both elbows to 90° 
and keep them at his or her side. The forearms ar then pronated and all 
fingers are adducted. 
Inability of the patient 
to maintain adduction 
of the 5th digit which 
will start to drift in an 
ulnar and volar 
direction. 
 
Hand Withdrawal Reflex With the patient in either sitting or standing, the examiner grasps the 
patient's palm and strikes the dorsum of the patient's hand with a reflex 
hammer.  
 
Crossed Upgoing Toe 
Sign (Cut sign) 
With the patient in supine, the examiner passively raises the opposite 
limb into hip flexion. The examiner then instructs the patient to hold the 
leg in flexion. The examiner applies a downward force against the leg. 
The examiner needs to visually inspect the opposite great toe.  
Upgoing toe sign of 
great toe of the 
opposite toe  
Biceps or Triceps 
Hyperreflexia 
Biceps: With the patient in sitting, the examiner slightly supinates the 
patient's forearm and places it on his or her own forearm. The 
examiner's thumb is then placed on the patient's bicep tendon and is 
struck with quick strikes of a reflex hammer. Triceps: With the patient in 
sitting,  the patient's shoulder is elevated to 90° with the elbow 
passively flexed to 90°. The examiner's thumb is placed over the distal 
aspect of the patient's triceps tendon and a series of quick strikes is 
applied with a reflex hammer to the back of the examiner's thumb.  
Brisk, exaggerated 
finding or hyperreflexia 
Suprapatellar Reflex With the patient seated and his or her feet off the ground, the examiner 
applies quick strikes of the reflex hammer to the suprapatellar tendon. 
Brisk, exaggerated 
finding or hyperreflexia 
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with hip flexion or knee 
extension  
Achilles Tendon 
Hyperreflexia 
With the patient seated and his or her feet off the ground, the examiner 
uses a reflex hammer to either strike the Achilles tendon itself or use 
the plantar strike technique. If the reflex is absent, ask the patient to 
plantarflex the foot, tightly close the eyes and pull their clasped hand 
apart just prior to striking. 
Brisk, exaggerated 
finding or hyperreflexia 
Infrapatellar reflex With the patient seated and the his or her feet off the ground, the 
clinician uses a reflex hammer to deliver quick strikes to the 
infrapatellar tendon 
Brisk, exaggerated 
finding or hyperreflexia 
Adapted with permission from Cook et al (2011) 
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Study  Study 
design  
Evid. 
Level 
Sample 
size 
Population 
characteristics  
Index 
Test 
Reference 
Test 
Reliability Sensitivity Specificity QUADAS 
Score (0-
14) 
Outcome 
Numasawa, N., 
Ono, A., Wada, 
K., Yamasaki, 
Y., Yokoyama, 
T., Aburakawa, 
S., Takeuchi, 
K., Kumagai, 
G., Kudo, H., 
Umeda, T., 
Nakaji, S. and 
Toh, S. 2012. 
Simple foot 
tapping test as 
a quantitative 
objective 
assessment of 
cervical 
myelopathy. 
Spine, 37(2), 
pp.108-103 
Cohort 2++ 252 (126 
tested 
pre-post 
op). 
 
Control 
group 
n=792 
CM group: Male 
(166: 65.9%), female 
(86: 34.1%) Mean 
age 64.8 years 
(male range 32-84; 
female 43-82). 
 
Control group: 
Male (279 (35.2%), 
female (513: 64.8%). 
Mean age 57.5 
years (male range 
20-83; female 21-83) 
 
 
Foot 
tapping 
test 
(FTT) 
 
Grip and 
release test 
(see Cook et al 
2011 
description). 
 
Functional 
lower limb 
measure: 
modified 
Japanese 
Orthopaedic 
Association 
Lower 
Extremity 
(JOALE) 
FTT: right 
side (r=0.934, 
p<0.0001); 
left side 
(r=0.899, 
p<0.0001). 
 
50 each from 
CM and 
control group 
tested 
randomly x 2 
to identify 
immediate 
test-retest 
reliability. 
  12 CM group: 
FTT mean 
value 
23.8±7.2 
FTT scores 
improved by 
surgery. 
Control group: 
FTT mean 
value 
31.3±6.5. FTT 
strongly 
correlated 
with JOALE 
(r=0.696, 
P<0.0001) 
and correlated 
with grip 
/release test 
(r=0.571, 
P<0.0001). 
Test description: Foot tapping test (FTT): Participant seated on a chair with comfortable posture (hips and knees at approx 90º. The value of FTT was measured bilaterally by having sole 
of the foot tap as many times as possible for 10 seconds while keeping the heel in contact with the floor. The mean no. of times was adopted for the data analysis.  (slowness of foot 
tapping is a phenomenon  that reflects upper motor neuron weakness with cerebral or spinal cord disorders (p.106). 
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Appendix B: South East Scotland Research Ethics Service letter 
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Appendix C: NHS Borders Research and Governance Committee letter 
 
NHS Borders  
Research Administration 
Clinical Governance 
 
Clinical Office 
Borders General Hospital 
Melrose 
Roxburghshire TD6 9BS 
 
Telephone   01896 826719 
Fax                01896 826040 
www.nhsborders.org.uk 
 
 Mr Colin Redmond 
2 Cranston Road 
Lauder 
TD2 6TU 
T
D
2
 
6
T
U 
 
 
Date 17th March 2012 
  
Our Ref     SE46 
 
Enquiries to     
Extension   
Email research.governance@borders.scot.nhs.uk 
 
 
Dear Mr Redmond 
 
Red flag screening for serious pathology presenting in cervical spine musculoskeletal 
disorders 
 
Thank you for sending details of your study to NHS Borders. Given that ethics has 
deemed your study an evaluation, your study does not require R&D 
Management approval. However, it has been noted by our Research 
Governance Committee.  
 
You may proceed with your study in the NHS Borders area. We ask that you 
inform the R&D Office when the study is completed. 
 
May I take this opportunity to wish you every success with your project. Please do 
not hesitate to contact the R&D Office should you require any further assistance. 
 
 
Yours sincerely 
 
 
Name deleted for thesis 
Associate Medical Director (Clinical Governance) 
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For Office Use Only 
Ref. Number  
Assigned 
Reviewers 
 
Recommendation  
Outcome   
 
 
APPLICATION FOR ETHICAL APPROVAL 
FOR A RESEARCH PROJECT 2011/12 
 
This is an application form for ethical approval to undertake a piece of research.  Ethical 
approval must be gained for any piece of research to be undertaken by any student or 
member of staff of QMU.  Approval must also be gained by any external researcher who 
wishes to use Queen Margaret students or staff as participants in their research. 
 
Please note, before any requests for volunteers can be distributed, through the moderator 
service, or externally, this form MUST be submitted (completed, with signatures) to the 
Secretary to the Research Ethics Panel. 
 
You should read QMU’s chapter on “Research Ethics: Regulations, Procedures, and 
Guidelines” before completing the form.  This is available at:  
http://www.qmu.ac.uk/quality/rs/default.htm 
Hard copies are available from the Secretary to the Research Ethics Panel. 
 
The person who completes this form (the applicant) will normally be the Principal Investigator 
(in the case of staff research) or the student (in the case of student research).  In other cases 
of collaborative research, e.g. an undergraduate group project, one member should be given 
responsibility for applying for ethical approval.  For class exercises involving research, the 
module coordinator should complete the application and secure approval. 
 
The completed form should be typed rather than handwritten. Electronic signatures should 
be used and the form should be submitted electronically wherever possible. 
 
Applicant details 
 
1. Researcher’s name: Colin Redmond 
 
2. Researcher’s contact email address: 09001905@qmu.ac.uk 
 
3. Category of researcher (please tick and enter title of programme of study as 
appropriate): 
QMU undergraduate student  
Title of programme:  
QMU postgraduate student – taught degree  
Title of programme:  
QMU postgraduate student – research degree (Professional Doctorate)  
QMU staff member – research degree  
Appendix D: Application for Ethical Approval Queen Margaret University 
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4. School: Health Sciences 
 
5. Division: Dietetics, Nutrition, Biological Sciences, Physiotherapy, Podiatry and 
Radiography 
 
6. Name of Supervisor or Director of Studies (if applicable): Dr Fiona Macmillan; 2
nd
 
supervisor Dr Jan Gill 
 
7. Names and affiliations of all other researcher who will be working on the project: 
 
 
Research details 
 
8. Title of study: Red flag screening for serious pathology presenting in cervical spine 
musculoskeletal disorders. 
 
9. Expected start date: March 2012 
 
10. Expected end date: June 2013 
11. Details of any financial support for the project from outside QMU: NHS National 
Education Scotland (NES) is contributing up to £200.00 towards focus group expenses.  
NES and NHS Borders have additionally contributed funds towards academic fees 
2011/12. 
 
12. Please detail the aims and objectives of this study (max. 400 words) 
 
 
 
 
 
 
QMU staff member – other research  
Other (please specify)  
Research aim and objectives  
Aim 
The overarching aim of the study is to formulate a red flag screening algorithm for clinical indicators 
of possible serious cervical spine related pathology presenting as, or alongside, a musculoskeletal 
disorder. 
 
Objectives 
 1. Conduct a detailed literature review that will be used to develop materials for a focus group.  
 
 2. Facilitate a focus group (physiotherapists) prioritising the research literature review main findings 
(from a musculoskeletal physiotherapy perspective) for inclusion in a red flag screening tool. This 
will also reveal areas of consensus and lack of consensus in preparation for presenting material in a 
Delphi process. 
 
3. Construct and implement a Delphi survey with medical experts where iterative exploration of the 
findings formulated from 1 and 2 will allow these to be refined. 
 
4. Formulate final draft cervical spine red flag screening algorithm suitable for use in a clinical 
setting. 
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Methodology 
 
13. Research procedures to be used: please tick all that apply. 
 
 Tick if 
applicable 
Questionnaires (please attach copies of all questionnaires to be 
used) 
 
 
 (part of 
phase 2 and will 
be developed 
following phase 
1) 
Interviews (please attach summary of topics to be explored) 
 
 
Focus groups (please attach summary of topics to be explored / 
copies of materials to be used) 
 
 
 
Experimental / Laboratory techniques (please include full details 
under question 14) 
 
 
Use of email / internet as a means of data collection (please include 
full details under question 14) 
 
 
 
Use of questionnaires / other materials that are subject to copyright 
(please include full details under question 14 and confirm that the 
materials have been / will be purchased for your use) 
 
 
Use of biomedical procedures to obtain blood or tissue samples 
(please include full details under question 14 and include subject 
area risk assessment forms, where appropriate) 
 
Other technique / procedure (please include full details under 
question 14) 
 
 
 
14. Briefly outline the nature of the research and the methods and procedures to be 
used (max. 400 words).  
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15. Does your research include the use of people as participants? Please delete as 
appropriate.  Yes  
Methodology 
Introduction 
The study’s aim to inform clinical practice by developing a clinical screening algorithm will be 
created through a 2-phase process that follows a literature review: Phase 1 -Physiotherapy 
focus group that informs phase 2; Phase 2 - Delphi survey of medical experts.   This process 
seeks to achieve aclinical consensus on main clinical features, subjective questioning and 
subsequent actions or tests to enhance early detection of serious pathologies presenting as, or 
alongside, a musculoskeletal disorder.  The Delphi technique is considered as a suitable 
method to gain a consensus where there is incomplete knowledge or uncertainty in clinical 
issues.  
 
Phase 1: Focus group 
Participants: Approximately 6-10 UK based physiotherapists (Recruitment process - refer to 
Appendix K).  
Procedure and Data Analysis: The Principal Investigator (PI) will circulate the topics for 
discussion and summary of the key components of the literature review to the group 
participants (Refer to example Appendix A).  The focus group will be conducted within QMU 
(subject to gaining permission).  This will combine attendance for locally based (within South-
Central Scotland) and video link for participants out with this location.  A transcript will be 
compiled. Thematic content will be established.  This will be used to prioritise clinical sections 
for inclusion in a screening algorithm and formulate accompanying questions for inclusion in 
phase 2 round 1.  
 
Phase 2: Delphi study (including pilot study) 
Pilot Delphi study:  To assist reliability or consistency in the interpretation of the questions, 
the 1
st
 round questions will undergo a pilot phase.  The questions will be submitted to three 
medical practitioners using the same procedure as outlined below (Recruitment process - refer 
to Appendix L). The purpose is to explore respondents’ interpretations of the questions 
achieved through follow-up discussion with the PI. The questions will be amended accordingly 
for the main study. 
 
Main Delphi study participants: Consultant neurologists.Neurologists are medical specialists 
in the relevant areas (e.g. cervical arterial dysfunction and cervical myelopathy). A sample 
number between 10-15 participants is considered appropriate (Recruitment process - refer to 
Appendix M).  
Procedure and data analysis: An internet based survey system 
http://www.survey.bris.ac.uk/ will be used as the data collection system over 3 rounds.   
Round 1 will consist of a small (<5) number of initial short questions to obtain demographic 
data, followed by a number of questions based on presented non-sensitive information 
obtained from the literature review and focus group. 
Main Delphi study: Main study round 1 data will undergo a thematic content analysis and 
subsequently used to inform the survey content in round 2.  Inter-coder reliability will be 
checked by the PI and one research supervisor coding the same response data from 3 
randomly selected transcripts.  This will provide verification of the content analysis. Intra-coder 
reliability will be checked by the PI coding 3 randomly selected transcripts on two separate 
occasions with a minimum of 2-days a part. Rounds 2 and 3 data analysis will utilise a 
quantitative approach. 
Non-respondents: Email reminders will be sent on two occasions after each round (after 2 and 
3 weeks, respectively). 
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16. Does your research include the experimental use of live animals? Please delete as 
appropriate.  No 
 
17. Does your research involve experimenting on plant or animal matter, or inorganic 
matter? Please delete as appropriate.  No 
 
18. Does your research include the analysis of documents, or of material in non-print media, 
other than those which are freely available for public access? Please delete as 
appropriate.  No  
 
19. If you answered ‘Yes’ to question 18, give a description of the material you intend to 
use.  Describe its ownership, your rights of access to it, the permissions required to 
access it and any ways in which personal identities might be revealed or personal 
information might be disclosed.  Describe any measures you will take to safeguard the 
anonymity of sources, where this is relevant: 
 
 
20. Will any restriction be placed on the publication of results? Please delete as appropriate.  
No    
 
21. If you answered ‘Yes’ to question 20, give details and provide a reasoned justification 
for the restrictions. (See Research Ethics Guidelines Section 2, paragraph 7) 
 
 
22. Will anyone except the named researchers have access to the data collected? Please 
delete as appropriate.  No    
 
23. Please give details of how and where data will be stored, and how long it will be retained 
for before being destroyed. (See Research Ethics Guidelines Section 1, paragraph 
2.4.1) 
 
 
 
24. Please highlight what you see as the most important ethical issues this study raises (eg. 
adverse physical or psychological reactions; addressing a sensitive topic area; risk of 
loss of confidentiality; other ethical issue. If you do not think this study raises any ethical 
issues, please explain why). 
 
The main ethical issue is to prevent loss of participant confidentiality.  However, the 
encrypted information systems offer the best available measure against this loss 
occurring. The Delphi survey participants will also be informed that their identity will 
be withheld from other participants.  This is to ensure that an individual’s responses 
will not be influenced directly by another participant.  Due to the nature of the focus 
group this aspect is not possible, therefore all participants will be introduced. 
However, the focus group data will also be stored in the same encrypted systems 
and names replaced by coder identifiers.  
This text box will expand as required. 
This text box will expand as required. 
Data will be stored on NHS encrypted information systems (memory stick, laptop and health board’s 
network) and in accordance with NHS Borders Data Protection Policy (2006), which incorporates the 
Data Protection Act 1998.  In accordance with QMU Code of Research Practice recommendations 
all data will be stored for 5-years post completion of the study 
(http://www.qmu.ac.uk/research_knowledge/docs/Code%20of%20Practice-
Aug%202011.doc Appendix A). 
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25. If you have identified any ethical issues associated with this study, please explain how 
the potential benefits of the research outweigh any potential harms (eg. by benefiting 
participants; by improving research skills; other potential benefit). 
 
 
 
Protection for the Researcher 
 
26. Will the researcher be at risk of sustaining either physical or psychological harm as a 
result of the research? Please delete as appropriate.  No    
 
27. If you answered ‘Yes’ to question 26, please give details of potential risks and the 
precautions which will be taken to protect the researcher. 
 
 
Research Involving Human Participants 
You should only complete this section if you have indicated above that your research 
will involve human participants. 
 
28. Please indicate the total number of participants you intend to recruit for this study from 
each participant group: 
 
Participant Group Please state total 
number 
QMU students  
QMU staff  
Members of the public from outside QMU  
NHS patients  
NHS employees 
Refer to Appendix N: (NHS) Research Ethics Service letter – 
confirming NHS ethical review is not required. 
20-30 (additional Delphi 
participants  will be 
accepted if volunteers 
are forthcoming) 
Children (under 18 years of age)  
People in custody  
People with communication or learning difficulties  
People with mental health issues  
People engaged in illegal activities (eg. illegal drug use)  
Other (please specify):  
* Please declare in section 32 where the participant group may necessitate the need for 
standard or enhanced disclosure check 
 
 
 
 
Participant responses are their own professional opinions on clinical topics that are 
considered important to developing a clinical screening process, as opposed to opinions on 
clinically sensitive patient information.  Participant opinions on the research topics are 
considered as non-sensitive with no greater risk than discussing such non-sensitive 
information during a formal or informal meeting that could take place as part of an individual’s 
professional role.  The developed screening process will be used to promote patient safety 
through early identification of potentially serious pathology presenting in musculoskeletal 
disorders.  This benefit is considered to significantly outweigh any potential harm. 
This text box will expand as required. 
 
 
 219 
 
29. Please state any inclusion or exclusion criteria to be used. (See Research Ethics 
Guidelines Section 1, paragraph 2.4) 
 
 
 
30. Please give details of how participants will be recruited: 
 
 
31. Please describe how informed consent will be obtained from participants. (See Research 
Ethics Guidelines Section 1, paragraphs 2.1.2 – 2.1.5) 
 
 
32. Ethical Principles incorporated into the study (please tick as applicable): 
 
 Tick as 
applicable 
Will participants be offered a written explanation of the research?   
 
 
 
Will participants be offered an oral explanation of the research? (Applicant added: 
opportunity offered via participant information sheets – Appendices B-D). 
 
 
 
Will participants sign a consent form? (Applicant added: Refer to section 31.  
Focus group participants will provide consent by responding through 
personalised work email; and, Delphi participants’ consent will be gained by 
accessing the web-based survey).  
 
 
 
Will oral consent be obtained from participants? 
 
 
Will participants be offered the opportunity to decline to take part? 
 
 
 
Will participants be informed that participation is voluntary?  
Inclusion criteria: 
Focus group – Physiotherapist plus one of the following; clinical/academic staff with 
publications in relevant areas; consultant level; senior specialist spinal role; or lecturer in 
spinal component of post-graduate MSc in Neuromusculoskeletal Physiotherapy/Manual 
Therapy. 
Pilot Delphi Study – NHS Borders medical practitioner at Consultant or GP level 
Delphi survey - Consultant neurologist and/or neurologists with publications in relevant 
areas. 
No added exclusion criteria. 
Focus group:Physiotherapists – Refer to Appendix K 
Pilot Delphi study: NHS Borders Medical Practitioners - Refer to Appendix L 
Main Delphi study: Consultant neurologists - Refer to Appendix M 
 
Focus group:Refer to Appendix E. Participants will be instructed to ‘Please copy /paste 
this completed form to your work email address and return to the researcher’s 
university email address’.  This method is adapted from the procedure outlined below in 
the Main Delphi study.  
Pilot Delphi study: Refer to Appendix F (as Main Delphi study below) 
Main Delphi study:Refer to Appendix G. Participants will be informed that clicking the 
web link to online data collection tool http://www.survey.bris.ac.uk/ will be considered as 
gaining informed consent.  Participants will be informed of this procedure. This process has 
been used in a published Delphi survey. 
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  
Will participants be offered the opportunity to withdraw at any stage without giving a 
reason? 
 
 
 
Will independent expert advice be available if required? 
 
 
 
Will participants be informed that there may be no benefit to them in taking part? 
 
 
 
Will participants be guaranteed confidentiality?  
 
 
 
Will participants be guaranteed anonymity? (Applicant added: Delphi survey 
participants will be anonymous to all except the Principal Investigator. Due to 
the format of the focus group, participants will be introduced to one another. 
However, for the purpose of all reporting, group participants will be assigned a 
coder identifier.  In the event of achieving future journal publication, 
participants may be offered the opportunity to be ‘acknowledged’.  Further 
consent will be gained if this opportunity arises). 
 
 
 
 
Will the participant group necessitate a standard or enhanced disclosure check?  
Will the provisions of the Data Protection Act be met? 
 
 
 
Has safe data storage been secured? 
 
 
 
Will the researcher(s) be free to publish the findings of the research? 
 
 
If the research involves deception, will an explanation be offered following 
participation? 
 
If the research involves questionnaires, will the participants be informed that they may 
omit items they do not wish to answer? 
 
 
If the research involves interviews, will the participants be informed that they do not 
have to answer questions, and do not have to give an explanation for this? 
 
 
Will participants be offered any payment or reward, beyond reimbursement of out-of-
pocket expenses? 
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33. Risk Assessment 
 
 
 
School / Division: 
 
Health Sciences / 
Dietetics, Nutrition, 
Biological Sciences, 
Physiotherapy, 
Podiatry and 
Radiography 
 
Location: QMU / NHS Borders Date 08/02/2012 
Assessed by: 
 
 C Redmond Job Title: Prof Doc student /  
Principal Spinal 
Physiotherapist 
Signature  
Activity / Task: 
 
Prof Doc Research Total Number exposed to risk 20-30 Review Date  
 
 
 
Ref 
no. Hazards 
People at risk Likelihood Severity 
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M
a
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r 
F
a
ta
l 
Total risk 
Existing control 
measures A
d
e
q
u
a
te
 
c
o
n
tr
o
ls
? 
1. Focus group participants: 
dominant character effect – 
offends other participants. 
6-
10 
      
 
   
 
    2 Explain ground rules re. 
Professional conduct i.e. 
respect of different 
 
Reference: Red flag screening for serious pathology presenting in cervical spine musculoskeletal disorders. 
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perspectives, ‘one voice 
at a time’, can withdraw 
at anytime without 
reason. 
2. Loss of participant 
confidentiality. 
20-
30 
            1 Data secured within 
NHS encrypted systems 
and adherence to 
principles of Data 
Protection Act (1988). 
 
3. Availability of respondents to 
participate is significantly 
poorer than expected / there 
is a higher than expected 
drop out rate. 
  
 
          3 Focus group: ensure 
potential focus group 
participants confirm their 
acceptance or rejection 
of invitation.  Approach 
additional participants if 
suitable numbers not 
achieved. 
Continue recruitment 
strategy of Delphi phase 
until sufficient numbers 
achieved. Include all 
respondents (in excess 
of basic number 
required) in Delphi 
phase, if inclusion 
criteria are met.  
 
 
4. Respondents become 
unavailable for focus group or 
withdraw from Delphi survey 
  
 
          3 Risk minimised by 
interim communication 
with respondents 
between recruitment 
and focus group date, 
and throughout the 
Delphi survey with 
feedback. 
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5. Data lost due to network 
malfunction 
  
 
          3 Principal Investigator to 
make daily backups of 
project information.  
 
6. Unable to access workstation 
due to property damage/theft 
             1 Principal Investigator will 
be able to access back-
up project material from 
multiple sites. 
 
7. Maintaining contact with 
participants 
             1 Principal Investigator’s 
email, plus alternative 
email, address and two 
telephone numbers will 
be issued to participants 
should they wish to 
discuss any aspect of 
the study. 
 
8. Complaints procedure              1 QMU Code of Research 
Practice will be followed.  
In the first instance the 
issue should be 
addressed to the 
Principal Investigator, 
supported by the 
research supervisor. If 
the complaint can not 
easily be resolved in a 
timely manner, the QMU 
escalation procedure will 
be employed. 
 
Risk value (RV) 1 2 3 4 1 2 3 4   
Total risk = Likelihood (RV) x Severity (RV) Total risk of 1 – 4 = ‘L’, low risk Total risk of 6 – 9 = ‘M’, medium risk Total risk of 12 – 16 = ‘H’, high risk 
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Remedial action required 
Ref 
no. 
Action required Target date Action by: Date completed 
1.  
 
 
 
 
 
 
 
 
 
2.  
 
 
 
 
 
 
 
 
 
3.  
 
 
 
 
 
 
 
 
 
4.  
 
 
 
 
 
 
 
5.  
 
 
 
 
 
 
 
 
 
Reference: 
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Declarations 
 
34. Having completed all the relevant items of this form and, if appropriate, having 
attached the Information Sheet and Consent Form plus any other relevant 
documentation as indicated below, complete the statement below. 
 
 I have read Queen Margaret University’s document on “Research Ethics: 
Regulations, Procedures, and Guidelines”.  
 
 In my view this research is: 
 
See Research Ethics Guidelines Section 6 Please 
tick 
Non-invasive  
Minor invasive using an established procedure at QMU  
Minor invasive using a NEW procedure at QMU  
Major invasive  
 
 I request Ethical Approval for the research described in this application. 
 
Name (if you have an electronic signature please include it here) 
 
 
 
    Colin Redmond___   Date ___08/02/2012____ 
 
Documents enclosed with application: 
 
Document Enclosed 
(please 
tick) 
Not 
applicable 
(please 
tick) 
Copy of consent form(s)   
Copy of information sheet(s)   
Sample questionnaire   
Example interview questions   
Copy of proposed recruitment advert(s)   
Letters of support from any external organisations 
involved in the research 
  
Evidence of disclosure check   
Division risk assessment documentation   
Any other documentation (please detail below)   
Risk Assessment   
NHS Research Ethics Service letter   
See appendices list next page   
 
------- 
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Appendices         Page 
 
Appendix A: Focus group and Delphi survey outline construction plan 16 
Appendix B: Participant information sheet – Focus Group   20 
Appendix C: Participant information sheet – Pilot Delphi Study 23 
Appendix D: Participant information sheet – Delphi Study   26 
Appendix E: Focus group participant consent form    29 
Appendix F: Pilot Delphi study participant consent form   30 
Appendix G: Main Delphi participant consent form    31 
Appendix H: Research call to Physiotherapists (Focus group)  32 
Appendix I: Research call for Medical Practitioners (Pilot study)  33 
Appendix J: Research call for Consultant Neurologists (Delphi)  34 
Appendix K: Focus group participant recruitment process   35 
Appendix L: Pilot Delphi study - participant recruitment process   36 
Appendix M: Delphi study participant recruitment process   37 
Appendix N: (NHS) Research Ethics Service letter    38 
 
35.If you are a student, show the completed form to your supervisor/Director of Studies 
and ask them to sign the statement below. If you are a member of staff, sign the 
statement below yourself. 
 
 I am the supervisor/Director of Studies for this research.  
 
 In my view this research is: 
 
See Research Ethics Guidelines Section 6 Please 
tick 
Non-invasive √ 
Minor invasive using an established procedure at QMU  
Minor invasive using a NEW procedure at QMU  
Major invasive  
 
  I have read this application and I approve it. 
 
Name (if you have an electronic signature please include it here) 
 
 ____Dr Fiona S Macmillan_______________  Date 13
th
 Feb 2012_________ 
 
------- 
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36. For all applicants, send the completed form to your Head of Division or Head of 
Research Centre or, if you are an external researcher, submit the completed form to the 
Secretary to the QMU Research Ethics Panel.  You should not proceed with any 
aspect of your research which involves the use of participants, or the use of data 
which is not in the public domain, until you have been granted Ethical Approval.   
 
FOR COMPLETION BY THE HEAD OF DIVISION/HEAD OF RESEARCH CENTRE 
Either 
 
I refer this application back to the applicant for the following reason(s): 
 
 
 
 
 
Name (if you have an electronic signature please include it here) 
 
 
_______________________________________        Head of Division / Research 
Centre 
 
Date ______________ 
 
 
Please return the form to the applicant. 
 
Or 
 
Please tick one of the alternatives below and delete the others. 
 
    I refer this application to the QMU Research Ethics Panel. 
 
    I find this application acceptable and an application for Ethical Approval should now 
be  
   submitted to a relevant external committee. 
 
    I grant Ethical Approval for this research. 
 
 
 
 
 
Name (if you have an electronic signature please include it here) 
 
 
_______________________________________        Head of Division / Research 
Centre 
 
Date ______________ 
 
Please send one copy of this form to the applicant and one copy to the Secretary 
to the Research Ethics Panel, Quality Enhancement Unit, Registry. 
Date application returned: __________________
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Appendix E: Queen Margaret University Student project release form (ethical 
approval) 
 
DIVISION OF DIETETICS, NUTRITION, BIOLOGICAL SCIENCES, PHYSIOTHERAPY, PODIATRY and 
RADIOGRAPHY 
STUDENT PROJECT RELEASE FORM 
This form is designed to notify each student of the DivREC response to individual 
Dissertation Proposals.  A copy of the form will also be retained by the Committee to 
record each decision and to monitor resource requirements.  StudentsPlease complete a – 
d below 
a. PROJECT TITLE: _Red flag screening for serious pathology presenting in cervical 
spine musculoskeletal disorders._ 
 
b. STUDENT(S): ____Colin Redmond____________________________________ 
 
c. SUPERVISOR: __ Dr Fiona Macmillan; 2nd supervisor Dr Jan 
Gill________________________ 
 
d. SITE FOR DATA COLLECTION ____NHS Borders_________________________ 
(if not QMU state where) 
e.     APPROXIMATE DATES FOR DATA COLLECTION __March 2012 – June 
2012___________________ 
 
All students should refer to Committee Response below and Comments overleaf 
 
COMMITTEE RESPONSE 
Decision  / X Date 
1. Project proposal and Ethical approval granted   
2. Proceed with minor modifications to the project 
proposal (as noted in response overleaf) 
 ASAP 
3. Resubmit revised proposal by (insert date………)   
4. Resubmit revised ethics by (insert date ………)   
5. Submit for further ethics scrutiny (QMU / external)   
6. Project documentation incomplete    
 
Please note – you can not proceed to dissertation unless response box 1 or boxes 1 and 2  
ticked  
        
GENERAL COMMENTS: 
 
This project has been granted ethical approval provided some minor changes are made 
and the DivREC committee informed by letter that these changes have been made. 
 
 
 
 
This form will only be signed by Head of Division once project and ethical approval 
granted 
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Signature DiVREC member :__Dr Derek Santos___ DATE__15/03/2012__ 
 
SIGNATURE OF HEAD OF DIVISION: _______L Flynn________________     
 DATE: __16.3.12_____ 
Submission 1    Date __/__/__ 
Submission 2    Date __/__/__ 
Submission 3    Date __/__/__ 
STUDENT TO COMPLETE sections i. – v. on submission 
ISSUES ADDRESSED Student complete 
this column 
COMMITTEE 
RESPONSE 
ACTION (state 
whether for student / 
supervisor) 
i. Subjects    
Number of subjects  N= ok None 
QMU students or other? 
(Please state) 
 ok None 
ii.  Access to QMU 
facilities 
   
?which labs / rooms  
(if known) 
 N/A N/A 
?when is access required 
(dates and/or times) 
 N/A N/A 
iii.  Training 
requirements 
   
Technician support 
required 
 Yes / No / NA N/A N/A 
Supervisor to provide 
training 
Yes / No /NA N/A N/A 
iv. Equipment 
requirement 
   
state precise equipment 
requirements 
 ok None 
v. Costs     
(eg reprographics / 
postage / consumables) 
 ok Student 
 
DivREC representative to complete sections vi. – xv, after proposal scrutiny 
  RESPONSE ACTION 
REQUIRED 
vi.Recruitment 
Procedure (any advert 
should be included by 
student) 
 Need to add where 
interview tapes 
will be stored, who 
will have access to 
theses and when 
they will be 
destroyed. 
Student  
vii. Intervention / 
Investigation 
Procedure 
 ok None 
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viii.  Outcome 
measures 
 
 ok None 
ix. Risk Assessment 
completed 
 ok None 
x. Safety concerns 
(COSSH etc) 
 
 ok None 
xi.  Information sheet 
 
 Focus group 
information leaflet 
– need to add 
information on 
storage, handling 
and maintaining 
confidentiality of 
tape recordings. 
Pilot Delphi 
information leaflet 
– “why have I 
been chosen?” 
rephrase 1st 
sentence of the 
paragraph. 
Delphi survey 
information leaflet 
– “what will 
happen if I take 
part?” renumber 
paragraphs as 1 -
4. 
Student  
xii. Consent Form 
 
 Consent forms 
add participant 
name and date to 
these forms in 
appendix F and G. 
 
xiii. Independent 
advisor 
 
 ok None 
xiv. Feasibility 
 
 ok None 
xv. Other issues 
 
 
 
 Appendix H 
paragraph starting 
“Whilst red flags 
….” Remove “is” 
after needed in last 
sentence of this 
paragraph. 
Student 
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Appendix F: Request letter 1 for ethical approval for minor amendments 
        2 Cranston Road 
        Lauder 
TD2 6TU 
 
2nd July 2012 
 
Dr Derek Santos 
DivREC Member 
Division of Dietetics, Biological Sciences, 
Physiotherapy, Podiatry and Radiography 
Queen Margaret University 
Edinburgh 
EH21 6UU 
 
Dear Dr Santos 
 
Professional Doctorate Research Study - Red flag screening for serious 
pathology presenting in cervical spine musculoskeletal disorders: 
Amendment to Recruitment Process 
 
Further to my letter of 21/03/12 informing you of the minor changes as 
requested by the DivREC student project release form (16/3/12) for the 
above project, I would like to inform you of the following planned expansion 
to my recruitment process for the main Delphi study phase: 
 
1. Approach individual health boards to recruit medical consultants.   
 
2. Our local consultant neurologist has recommended expanding my 
recruitment call to include consultant neurosurgeons.  My original 
inclusion criterion was limited to consultant neurologists. 
 
3. Contact the Society of British Neurological Surgeons and Irish Institute 
of Clinical Neuroscience to request circulation of research call for 
participants to their respective membership. 
 
I have included my amended Delphi study research call for medical 
consultants. 
 
I hope the expanded recruitment process meets with your considered 
approval. The project methodology remains unchanged. 
 
Yours sincerely 
 
 
Colin Redmond 
Prof Doc Student 09001905 
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Appendix G: Request letter 2 for ethical approval for minor amendments 
         2 Cranston Road  
Lauder  
TD2 6TU  
16th October 2012 
Dr Derek Santos  
DivREC Member  
Division of Dietetics, Biological Sciences,  
Physiotherapy, Podiatry and Radiography  
Queen Margaret University  
Edinburgh  
EH21 6UU  
 
Dear Dr Santos  
 
Professional Doctorate Research Study - Red flag screening for serious 
pathology presenting in cervical spine musculoskeletal disorders: 
Amendment to Recruitment Process  
 
Further to my letter of 21/03/12 and 02/07/2012 informing you of the minor changes 
as requested by the DivREC student project release form (16/3/12) for the above 
project, I would like to inform you of the following planned expansion to my 
recruitment process for the main Delphi study phase:  
 
1. Approach individual health boards to recruit medical consultants (previously 
stated in letter 02/07/2012). Clarification - This will also require contacting individual 
consultants e.g. with a view to circulating research call for participants within their 
health boards (Scotland initially. North England if needed) or if identified through 
publications as having a specialist interest in the subject matter1.  
 
2. Letter dated 02/07/2012 stated: Contact the Society of British Neurological 
Surgeons and Irish Institute of Clinical Neuroscience to request circulation of 
research call for participants to their respective membership. This option has not 
been used to date; however, this strategy should be extended to include the Scottish 
Association of Neurological Sciences and the British Association for the Study of 
Headaches. These organisations include the same target professional groups of 
consultant neurosurgeons and consultant neurologists.  
 
I hope the expanded recruitment process meets with your considered approval. The 
project methodology remains unchanged.  
 
Yours sincerely  
 
 
 
 
Colin Redmond  
Prof Doc Student 09001905  
 
 
1.Gordon, T. 1994. The delphi method. Futures research methodolgy, AC/UNC Milennium Project 
[online]. Available from: http://www.gerenciamento.ufba.br/Downloads/delphi%20(1).pdf [Accessed 
October 01 2011]. 
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Appendix H: Ethical approval letter to minor amendments 
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Appendix I: Focus group recruitment call information 
 
Dear Colleague 
Would you like to help develop a red flag screening tool for musculoskeletal neck pain and 
headache?  
 
I would like to invite you to participate in a focus group alongside other leading UK based 
physiotherapists.  The group will consist of approximately 6 – 10 participants through video link or 
attendance (Edinburgh). 
Provisional date/time: Wednesday 27th June 2012 1.45pm - 3.45pm. 
Why?  
• To promote early detection of potentially serious pathology mimicking as a cervical spine 
musculoskeletal disorder. 
• To reduce the risk of adverse events, e.g. transient ischaemic attacks and stroke, occurring from 
physical treatments. 
• Adverse events of this nature have been reported in international peer-reviewed literature. 
• It is vitally important that any underlying serious complaints have been excluded in order to 
apply safe and effective physical treatment. 
 
My name is Colin Redmond.  My professional role is Principal Spinal Physiotherapist with NHS 
Borders and I am currently undertaking a Professional Doctorate programme with Queen 
Margaret University, Edinburgh.  This research forms part of my Professional Doctorate 
studies.  During the redevelopment of a regional spinal service it became apparent that some 
clinical indicators used by the physical therapy professions to identify potentially serious 
pathology presenting as, or alongside, a cervical spine musculoskeletal disorder were not 
reliable.   
 
Whilst red flags for musculoskeletal low back pain have been developed  and widely accepted, 
there is a need  to review more specific red flag indicators or diagnostic screening for 
neck  related pain or functional impairment.  Your help is needed to enhance safe practice. 
 
This research project combines a physiotherapy focus group and a Delphi survey (see 
information sheet) with medical experts (consultant neurologists) to develop an evidence-based 
screening tool for serious pathology in cervical spine musculoskeletal disorders.  Some initial 
literature summaries prepared by me will be provided. 
 
If you would like to become involved or receive a more detailed information sheet, please contact 
me: email 09001905@qmu.ac.uk or Colin.Redmond@borders.scot.nhs.uk or telephone: 01896 
827004. Thank you. 
  
 
Appendix J: Participant Information Sheet – Focus Group 
Study Title 
 
Red flag screening for serious pathology presenting in cervical spine 
musculoskeletal disorders  
 
You are invited to take part in a research project that aims to improve physiotherapy red 
flag screening for serious pathology in cervical spine musculoskeletal disorders.  Before 
you decide it is important for you to understand why the research is being undertaken 
and what it will involve.  Please take time to read the following information.  Take time to 
decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
What is the purpose of the study? 
The study is being carried out to establish a red flag screening process for serious 
pathology presenting as, or alongside, a cervical spine musculoskeletal disorder, which 
can be used by physiotherapists, but additionally will inform chiropractic osteopathy, and 
general practitioners’ practice. This could enhance early detection of potentially serious 
pathology and enable safer practice.  Clinical experience supported by a literature 
review has identified a knowledge gap and inconsistencies in screening for neurological 
and neurovascular pathology.  Red flag screening in low back pain has received 
significant attention by researchers; however specific questions and testing for the 
cervical spine remain inconsistent e.g. cervical arterial dissection has been reported 
following manipulation, but screening processes to reduce the potential of adverse 
incidents occurring remains unclear.  Similarly, there is inconsistent evidence to support 
the diagnostic accuracy of clinical tests for signs of cord compression myelopathy.  This 
study is looking to establish a screening process through the combination of literature 
review, focus group with leading physiotherapists, and a Delphi method with consultant 
neurologists that will be used to inform clinical practice and contribute to the evidence 
base for future research.  Main findings from the literature review will be forwarded in 
advance to focus group participants. The combination of literature review and focus 
group discussion will be used to inform the Delphi phase.  The Delphi technique is an 
iterative process used to collate expert opinion over a series of sequential rounds, which 
are interspersed by feedback from the previous round and is considered as a suitable 
method to gain a consensus where there is incomplete knowledge or uncertainty in 
clinical issues. 
 
Why have you been selected? 
You have been offered the opportunity to participate in this study as your expertise as a 
physiotherapist with relevant expertise is considered as highly valuable in contributing to 
the knowledge base that will inform clinical practice.  Participants are being recruited 
from physiotherapists of: consultant level, specialist spinal roles, those with relevant 
peer-reviewed published papers, or MSc neuromusculoskeletal / manual therapy (post-
graduate) level educators. 
 
Do I have to take part? 
No. It is up to you to decide whether or not you take part.  However, in addition to help 
progress clinical practice, the study also offers an excellent professional development 
opportunity. Your clinical expertise is considered as very valuable to the study.  Consent 
to participate in the study will be gained through email.  If you decide to take part you 
are still free to withdraw at any time and without giving a reason.   
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What will happen to me if I take part? 
By agreeing to take part in the study you will participate in a focus group with other UK 
based physiotherapists, however, you should not feel obliged to participate in all aspects 
of the discussion.  The discussion will be conducted through a combination of video link 
or attendance at Queen Margaret University, Edinburgh.  In preparation for the focus 
group you will receive a summary of the literature review that will part inform the 
discussion.  The aim of the focus group is to identify key components for inclusion in a 
red flag screening process and discuss any main inconsistencies in the literature.  
Points for consideration may be: clinical features, risk factors, screening questions, and 
clinical tests related to screening for potentially serious neurological/neurovascular 
pathologies.  The focus group discussion will be recorded.  This information will be 
analysed by the principal investigator and combined with the evidence based literature 
review to develop a draft screening process to use in a Delphi phase of the study.   The 
focus group is expected to last approximately 1 ½ - 2 hours and you are requested to 
ensure that you have relevant local authority / permission to participate in the study. 
 
What are the risks of taking part? 
There is no identifiable risk of taking part in this study. 
 
What if something goes wrong? 
This study is considered as low risk.  Regardless of this, if you wish to complain, or have 
any concerns about any aspect of the way you have been approached or treated during 
the course of this study, you may raise this concern directly with the principal 
investigator who will follow Queen Margaret University, Edinburgh complaint escalation 
procedure.  Alternatively, you are free to contact the Independent Advisor. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you will be kept strictly confidential and managed 
in accordance with the Data Protection Act (1998).  The group discussion will be 
recorded on an .mp4 file and downloaded and transferred from the secure JANET 
server (videolink) to a secure NHS encrypted information systems by an information 
systems expert from Queen Margaret University.  Thereafter, the file will be handled by 
the principal investigator. This recording will be destroyed after being transcribed for 
analysis. You will then be assigned a study number which is linked to your name and 
stored in NHS encrypted information systems. Any information which leaves the NHS 
information system will have your name and contact details removed so that you cannot 
be recognised from it. 
 
What will happen to the results of the research study? 
The results of this study will be used to present a thesis that will be submitted as part 
fulfilment of a Professional Doctorate in Health and Social Sciences at Queen Margaret 
University, Edinburgh.  The results will also be used to publish and present the findings 
of the research in a relevant journal and conference to inform clinical practice that 
promotes patient safety.  However you will not be identified in any report or publication, 
unless you provide additional consent to do so.  
 
The results will be submitted in a thesis format in June 2013 and you can obtain a 
summary from the principal investigator (details at the end of this sheet). 
 
Who is organising and funding the research? 
The study is being organised by the principal investigator who is completing the 
research as part of a higher academic degree as outlined above.  Queen Margaret 
University, Edinburgh has approved the study and some time and financial support for 
this research has been obtained from NHS Borders and NHS Education for Scotland. 
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Who has reviewed the study? 
The study protocol has been reviewed and conduct of the study has achieved Queen 
Margaret University, Edinburgh ethical approval.  Recent changes to NHS Governance 
Arrangements for Research Ethics Committees states that additional NHS approval is 
not required.  However, South East Scotland Research Ethics Service (NHS) has been 
informed of the study. 
 
Contact for further information 
If you would like any further information about this study please ask the Principal 
Investigator:  Colin Redmond 
 
Address:  Physiotherapy Department 
   Borders General Hospital 
Melrose 
TD6 9BS 
 
University email / work telephone: 09001905@qmu.ac.uk   01896 827004/826548 
 
Alternative: Work email: Colin.Redmond@borders.scot.nhs.uk 
 
 
If you have questions relating to any aspect of the study that you would like independent 
advice on, you will be able to speak to. 
 
Independent Advisor:  Professor James M Scobbie 
    Director, CASL (Clinical Audiology, Speech and  
    Language) Research Centre 
    Queen Margaret University 
    Edinburgh 
    EH21 6UU 
 
Email     JScobbie@qmu.ac.uk 
Telephone   0131 474 0000 (state name of person) 
 
 
If you decide to take part in this study, please retain a copy of the information sheet for 
your own records and thank you for taking part in this project. 
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Red flag screening for serious pathology presenting in cervical spine 
musculoskeletal disorders 
 
I have read and understood the information sheet and this consent form.  I have had an 
opportunity to ask questions about my participation. 
 
I understand that the focus group will be recorded. 
 
I understand that I am under no obligation to take part in this study. 
 
I understand that I have the right to withdraw from this study at any stage without giving 
any reason. 
 
I have permission from my employer to participate in this study. 
 
I agree to participate in this study and understand that returning this form to the 
researcher’s university email address, using my personalised work email address will be 
considered as providing informed consent.  
 
 
Name of participant:   
 
Date:    
 
Please copy /paste this completed form to your work email address and return to 
the researcher’s university email address.  Thank you. 
 
Contact details of the researcher 
 
Name of researcher: Colin Redmond 
 
Address:  Physiotherapy Department 
   Borders General Hospital 
Melrose 
TD6 9BS 
 
University email / work telephone: 09001905@qmu.ac.uk   01896 827004/826548 
 
Alternative work email: Colin.Redmond@borders.scot.nhs.uk 
 
Appendix K: Focus group consent form 
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Appendix L: Focus group information pack (part-presented only) 
 
 
 
 
 
 
 
 
 
 
Professional Doctorate in Health and Social Sciences 
 
 
Research Project 
 
 
Red flag screening for serious pathology presenting in cervical 
spine musculoskeletal disorders  
 
 
 
Focus Group Information Pack 
 
Wednesday 27
th
 June 2012 
13.45 
 
Facilitator: Colin Redmond MSc MMACP MCSP 
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Introduction  
This information pack primarily consists of a range of literature summaries designed to 
inform participants in preparation for a focus group that forms part of this research 
project.  The study design aims to review and develop our current red flag screening 
processes for potential serious pathology presenting as, or alongside, musculoskeletal  
cervical spine and headache presentations.  There are examples of excellent clinical 
development, specifically, cervical arterial dysfunction (e.g. Taylor and Kerry 2010; 
Kerry et al 2008; Kerry and Taylor 2009; 2006; ongoing IFOMPT project).  This project 
does not aim to replace such examples, but to contribute to their development, consider 
other areas of clinical uncertainty, and combine these clinical areas to sit within one 
cervical spine red flag screening system for ease of access.  Due to the broad spectrum 
of pathologies that could potentially present alongside cervical spine disorders it is 
outwith the scope of this discussion group to review all areas.  Therefore, the focus 
group discussion and information pack will primarily focus within cervical arterial 
dysfunction, headache, dizziness, and cervical myelopathy.  Where applicable, other 
pathologies may be explored, and a later section identifies some additional 
considerations. 
 
This document provides initial information on the focus group outline, grading quality of 
literature, current status on red flags, before progressing to section 4 that contains a 
number of problems/questions with accompanying literature for your consideration.  I 
appreciate that you are very busy professionals; therefore, you are not expected to 
dissect all the literature.  It is recommended that you initially read to page 13, and then 
consider the individual problems/questions contained within section 4. It is advisable not 
to attempt section 4 in one sitting, but to split your allocated time accordingly.  The 
reader can then explore any statistics in more detail, as required, or simply consider 
how some of the information may be used in musculoskeletal clinical settings. 
 
Thank you for agreeing to participate in the group discussion.  As an experienced 
clinician, your expertise is considered as highly valuable. You will be familiar with some 
of the work contained within this document, but equally, I hope you have the benefit of 
gaining new knowledge within these subject areas.  Similarly, if you have relevant 
articles to contribute to the project, this would also be greatly appreciated. 
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Technical Glossary 
Abbreviations 
AE  Adverse events 
CAD  Cervical Arterial Dissection 
CADy  Cervical Arterial Dysfunction 
ICA  Internal Carotid Artery 
ICAD   Internal Carotid Artery Dissection 
PI  Principal Investigator 
sICAD  spontaneous Internal Carotid Artery Dissection 
SCD  spontaneous Internal Carotid Artery Dissection 
sVAD  spontaneous Vertebral Artery Dissection 
SVD  spontaneous Vertebral Artery Dissection 
VA  Vertebral Artery 
VAD  Vertebral Artery Dissection 
VBI   Vertebrobasilar Insufficiency  
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1. Focus group outline construction plan  
 
Focus group  
Duration: 1.5 – 2 hours 
Preliminaries 
 Introduction (facilitator)  
 Discussion procedures 
 Reminders: 
o Participants can withdraw at any time without reason 
o Discussion is recorded for post-analysis 
 Outline problem / reason for group discussion 
 Introductions (group) 
Topics for Discussion 
As part of the focus group preparations participants have received a series of literature 
summaries to help inform discussion. The summaries relate to clinical areas where 
literature on specific clinical topics is considered inconsistent to aspects of current 
clinical practice:  
 What groups of serious clinical pathologies should be included within red flag 
screening for cervical spine musculoskeletal presentations? 
 For each group - What main clinical indicators are suggestive of this clinical 
group? 
 What questions should be asked to help identify or explore the presence of 
these pathologies? 
 What clinical tests (not further investigations) should be utilised to help identify 
these pathologies? 
 Do you have any suggested formats for the presentation of a red flag screening 
process / algorithm? 
 Do you have any additional questions that you feel should be addressed by the 
expert medical panel?  
Delphi Survey – web-based survey 
The Delphi phase will be constructed following completion of the focus group.  The 
anticipated format will consist of a draft clinical chart/algorithm accompanied by a series 
of open ended questions, similar to the above outline, to address any clinical areas that 
remain uncertain. The initial literature review has identified the areas of cervical arterial 
dissection/dysfunction, including associated symptoms of headache and dizziness, and 
cervical myelopathy where most clinical uncertainty remains. 
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2. Literature review – grading evidence 
 
Where applicable, evidence has been graded (single reviewer) using the Scottish 
Intercollegiate Guidelines Network (SIGN) process for grading evidence. 
 
2.1 SIGN Guidelines: Key to evidence statements and grades of 
recommendations adapted from 
http://www.sign.ac.uk/guidelines/fulltext/50/index.html 
 
LEVELS OF EVIDENCE  
1++ High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low 
risk of bias 
1+ Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias 
1 - Meta-analyses, systematic reviews, or RCTs with a high risk of bias 
2++ High quality systematic reviews of case control or cohort studies 
High quality case control or cohort studies with a very low risk of confounding or bias 
and a high probability that the relationship is causal 
2+ Well conducted case control or cohort studies with a low risk of confounding or bias 
and a moderate probability that the relationship is causal 
2 - Case control or cohort studies with a high risk of confounding or bias and a 
significant risk that the relationship is not causal 
3 Non-analytic studies, e.g. case reports, case series 
4 Expert opinion 
 
GRADES OF RECOMMENDATION 
Note: The grade of recommendation relates to the strength of the evidence on which the 
recommendation is based. It does not reflect the clinical importance of the 
recommendation. 
A: At least one meta-analysis, systematic review, or RCT rated as 1++, 
and directly applicable to the target population; or 
A body of evidence consisting principally of studies rated as 1+, directly applicable to 
the target population and demonstrating overall consistency of results 
B: A body of evidence including studies rated as 2++, directly applicable to the target 
population, and demonstrating overall consistency of results; or 
Extrapolated evidence from studies rated as 1++ or 1+ 
C: A body of evidence including studies rated as 2+, 
directly applicable to the target population and demonstrating overall consistency of 
Results; or extrapolated evidence from studies rated as 2++D 
D: Evidence level 3 or 4; or extrapolated evidence from studies rated as 2+ 
GOOD PRACTICE POINTS 
√ Recommended best practice based on the clinical experience of the guideline 
development group. 
 
 
References not provided within summaries are located in the reference section. 
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2.2 Statistical terminology 
Some key statistical terms have been provided as a refresher to assist evaluation of 
literature.  
Odds ratio (OR):  The odds of an event are the probability of occurrence over the 
probability of non-occurrence.  OR is used to compare if the probability of an occurrence 
is the same for two groups. A value of 1 indicates that the occurrence is equally likely in 
both groups. An OR value >1 indicates that the event is more likely in the first group. A 
value of <1 indicates that that the event is less likely in the first group (Altman et al 2006; 
Munro 2001). 
Positive likelihood ratio (LR+): The ratio of a positive test result of the people with the 
pathology to a positive test result in people without the pathology (Cook et al 2011). 
Negative likelihood ratio (LR-):The ratio of a negative test result of the people with the 
pathology to a negative test result in people without the pathology (Cook et al 2011). 
Jaeschke et al (1994 in Cook et al 2011) provides guidance: LR+ should be ≥5 to 
moderately influence post-test probability and clinical decision making. LR- should be 
≤0.20. Small influences in post-test probability involve LR+ of ≥2.0 and LR- of ≤0.50. 
Sensitivity: percentage of positive tests in individuals with the pathology. Tests with low 
sensitivity are not likely to identify the condition early in an examination (Cook et al 
2011.   
Specificity: percentage of a negative test result in individuals without the pathology 
(Cook et al 2011).  
 
Confidence intervals (95%CI): Most studies estimate a quantity or risk. The CI is a 
range that is 95% confident it includes the true value. CI reveals the precision of an 
estimate.  A wide CI points to lack of information, whether the difference is statistically 
significant or not, and is a warning against over interpreting results from small studies 
(Altman et al 2006). 
Altman, D.G., Machin, D., Bryant, T.N. and Gardner, M.J. (ed.) 2006. Statistics With 
Confidence (2
nd
 ed.) Bristol: BMJ. 
Munro. B. 2001. Statistical methods for health care research. 4
th
 ed. Philadelphia: 
Lippincott.
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3. Current status on ‘Red flags’ 
 
3.1 The Clinical Standards Advisory Group (1994 in Greenhalgh and Selfe 2006) red 
flag list (below) was developed for low back pain.  In addition, Greenhalgh and Selfe 
(2010, 2006) have provided a weighted flag structure to assist gauging the clinician’s  
index of suspicion of potential serious pathology.  This list does not provide sufficient 
information for the cervical spine:  
1. Age of onset <20 or >55 years. 
2. Violent trauma 
3. Constant, progressive, non-mechanical pain. 
4. Thoracic pain. 
5. PMH of carcinoma 
6. Systemic steroids. 
7. Drug abuse, HIV. 
8. Systemically unwell. 
9. Weight loss. 
10. Persistent severe restriction of lumbar flexion. 
11. Widespread neurology 
12. Structural deformity. 
 
With reference to specific red flags for the cervical spine, the health information website 
Patient.co.uk, which  reports itself as “one of the most trusted medical resources in the 
UK, supplying evidence based information on a wide range of medical and health topics 
to patients and health professionals”,  provides a list of red flags for neck pain.  A 
section on ‘cervical radiculopathy’ cites the Clinical Knowledge Summaries (CKS: Jan 
2009) as it’s source.   CKS  is a National Institute for Health and Clinical Excellence site 
(no longer maintained: http://www.cks.nhs.uk/neck_pain_cervical_radiculopathy. 
Follow link for red flags), and provides a number of references.  Binder (2007) is the 
most relevant reference. This article provides a poorly referenced list of red flags.  
 
Patient.co.uk provides the following red flag list, which the reviewer considers as a 
reasonable group (http://www.patient.co.uk/doctor/Cervical-Disc-Protrusion-and-
Lesions.htm). However, are the tests and clinical indicators reliable or of sufficient detail 
to inform clinical practice? 
 
Red flags for neck pain 
“A serious underlying cause is more likely in people presenting with: 
 New symptoms before the age of 20 years or after the age of 55 years. 
 Weakness involving more than one myotome or loss of sensation involving more 
than one dermatome. 
 Intractable or increasing pain. 
Red flags suggesting possible malignancy, infection or inflammation: 
 Fever 
 Unexplained loss of weight 
 History of inflammatory arthritis 
 History of malignancy, drug abuse, tuberculosis, AIDS, or other infection 
 Immunosuppression 
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 Pain that is increasing, unremitting and/or disturbs sleep 
 Lymphadenopathy 
 Exquisite localised tenderness over a vertebral body 
Red flags suggesting myelopathy (compression of the spinal cord): 
 Insidious progression 
 Gait disturbance; clumsy or weak hands; loss of sexual/bladder/bowel function 
 Lhermitte's sign (flexing the neck causes electric shock-like sensations that 
extend down the spine and shoot into the limbs) 
 Upper motor Neuron signs in the lower limbs (Babinski's sign — up-going plantar 
reflex, hyperreflexia, clonus, spasticity) 
 Lower motor Neuron signs in the upper limbs (atrophy, hyporeflexia) 
 Variable sensory changes (loss of vibration and joint position sense more 
evident in the hands than in the feet) 
Red flags suggesting severe trauma/skeletal injury: 
 History of trauma 
 Previous neck surgery 
 Osteoporosis or risk factors for osteoporosis 
 Increasing and/or unremitting pain 
Red flags suggesting vascular insufficiency: 
 Dizziness and blackouts (restriction of vertebral artery) on movement, especially 
on extension of the neck with upward gaze 
 Dizziness, drop attacks” 
 
Current status on red flags for headaches (SIGN guidelines) is contained in 
section 4. 
 
3.2 Cochrane library: 2 publications on red flag screening on lumbar spine.  No 
reviews on cervical spine. 
 
 
3.3 Traditional physiotherapy screening 
3.3.1 ‘Classical’ cardinal signs and symptoms (Vascular and spinal cord) 
Rivett et al (Australian guidelines - 2006 p.3) recommends: 
 
 “In every patient presenting with upper quadrant dysfunction, questioning is 
specifically directed to determine the presence of dizziness which is the most 
common presenting symptom of VBI. If dizziness is present, other symptoms 
associated with VBI should be sought…” 
 
No references are provided to support these cardinal signs and symptoms, which is a 
similar list referred to by Kerry and Taylor (2006 p.244-245) as “Classically, signs and 
symptoms related to hindbrain ischaemia are considered as the “5 Ds and 3Ns” of 
Coman (Coman 1986).  This list is Dizziness (vertigo, giddiness, lightheadedness), Drop 
attacks, Diplopia, Dysarthria, Dysphagia (+ hoarseness/hiccups), Ataxia, Nausea, 
Nystagmus, Numbness (unilateral).  Coman’s (1986) list of cardinal signs and symptoms 
is not referenced.  However, unreasoned adherence to this list may result in an 
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incomplete understanding of the patient’s presentation (Taylor and Kerry 2010; Kerry 
and Taylor 2009; 2006; Kerry et al 2008), and in a commissioned report, Kerry et al 
(2007) state there is no support for Coman’s 5 Ds.   
 
Patten (1998) suggests “differential diagnosis of brainstem disease is complicated by a 
specific feature of symptomatology – all common symptoms e.g. diplopia, dysarthria, 
vertigo, nausea and vomiting are by their very nature acute” p.171-2.  This highlights the 
difficulty physiotherapists face in clinic when these questions are asked i.e. how relevant 
are they when we perform our screening, specifically relative to duration of onset and 
what pathology is indicated? 
Thiel and Rix (2005) also produce a list using the “5D’s and 3N’s framework” whilst 
stating ‘adapted from Sturzenegger (1993) Saeed et al (2000)’.  These references are 
omitted from Thiel and Rix’s (2005) reference list.  However, these papers cited are 
small studies with patients presenting at neurological units with stroke. Other than one 
patient presenting with recurrent TIAs, signs and symptoms, such as the 5D’s and 3 N’s 
framework mainly formed part of the presenting features i.e. at development of stroke 
rather than early warning signs.  Additionally, in referring to a variation of this framework 
Greenhalgh and Selfe (2006) cite Magarey et al (2004) who in-turn cite Grad and Baloh 
(1989 cited by Clendaniel 2000).  Greenhalgh and Selfe (2006) also cite Grant (1994) 
regarding a variety of signs and symptoms resulting from vertebrobasilar dysfunction.  
Grant (1994) cites Williams and Wilson (1962). Therefore, it is questionable whether the 
5D and 3N framework is an appropriate screening process in neck pain/headache 
presenting at musculoskeletal clinical setting.  Taylor and Kerry (2010), Kerry and Taylor 
(2009; 2006) and Kerry et al (2008; 2007), are the only authors to question the 5Ds and 
3Ns framework through a literature review approach.  
The clinical features of myelopathy can overlap with a radiculopathy problem and spinal 
cord pathologies, such as multiple sclerosis and amyotrophic lateral sclerosis may have 
similar presenting signs and symptoms that may include upper and lower motor neuron 
signs, pain, paraesthesia, functional impairment (Cook et al 2007).  This presents a 
significant challenge to practitioners to ensure correct differential diagnosis is obtained 
with subsequent selection of safe management strategies. 
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3.2 Problem: Terminology “CAD” 
Medical literature and some physiotherapy articles e.g. Thomas et al (2011) use the 
acronym of “CAD” to represent cervical arterial dissection, which mainly occurs in a 
younger population.  This pathology does not include atherosclerotic causes of stroke, 
although there can be some overlap. In contrast, Taylor and Kerry (2010), Kerry and 
Taylor (2009, 2006), and Kerry et al (2008) use the same acronym to represent cervical 
arterial dysfunction, which encompasses the anatomical and pathological spectrum of 
events.  Such pathologies may be “…transient mechanical occlusions, dissections 
(intimal tearing), to frank atherosclerotic thromboembolic events leading to stroke” (Kerry 
and Taylor 2009 p.378).  These pathologies may include “…the posterior system 
(vertebrobasilar) supplying blood to the hindbrain the anterior arterial system (internal 
carotid arteries) supplying blood to the cerebral hemispheres and eye…”(Kerry and 
Taylor 2009 p.378). 
 
Identifying this distinction in terminology assists our evaluation of research.  An example 
is Thomas et al (2011) who question Kerry et al’s (2008) recommendation of including a 
vascular risk assessment of patients prior to therapeutic management of neck 
dysfunction.  The reviewer’s personal opinion is that this debate is arising due to 
considering two different interpretations of vascular pathology i.e. one is focusing on 
very specific problem (dissection), whereas Kerry et al’s (2008) emphasis is on the 
spectrum of vascular events.  Therefore, for the purpose of this literature pack the 
following terms will be used: 
Cervical arterial dissection (CAD) 
Cervical arterial dysfunction (CADy) 
 
From personal experience, the clinical reasoning or screening process should 
encompass the dysfunction approach, as clinicians’ primary interest at the initial stage is 
to identify risk or exclude a potentially serious vascular event occurring, regardless of 
the underlying pathology e.g. dissecting artery versus an atherosclerotic occlusion.   
 
Additional: Kerry and Taylor (2006) p.249 “In addition to the early signs, it is important to 
be aware of signs and symptoms related to cerebral and retinal ischemia. It is unlikely 
that a patient with full stage cerebral ischemic stroke will present to the manual 
therapist, but the more subtle presentation of retinal ischemia might, which makes 
simple eye examination a key part of the assessment”.  Cerebral or retinal ischemia 
includes ischemic stroke, TIA, or transient monocular blindness (Debette et al 2011).  
Thomas et al (2011) consider that more appropriate therapeutic risk management can 
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be applied if individuals with intrinsically enhanced risk of dissection can be more readily 
identified (refer to discussion point section 4.4.3. Risk factors: Cardiovascular). 
 
 
3.3 Pain (Vascular) 
Neck pain and/or headache symptoms are the most frequent local symptoms of CAD 
(Thomas et al 2011; Morelli et al 2008; Rigamonti et al 2008; Tobin and Flitman 2008; 
Hardmeier et al 2007a; Arnold et al 2006a; Taylor and Kerry 2006, 2005; Savitz and 
Caplan 2005; Silbert et al 1995), and additionally, can be the only presenting symptoms 
(Arnold et al 2006a; Guillon et al 1998; Biousse et al 1994; Biousse et al 1992).  
Furthermore, VAD has also been reported as presenting as a fifth cervical nerve root 
(C5) radiculopathy (Hardmeier et al 2007b).  Note, Rivett et al (2006) stated that 
dizziness was the most frequent symptom. However, they also advise to check for 
presence of neck pain or headache. 
 
For VBI, Rivett et al (2006 p.3) cite Haldeman et al (2002) and Krespi et al (2002) to add 
that pain is “Specifically, sudden, severe, sharp pain located in the ipsilateral postero-
superior region of the neck and occiput and for which there is no past history should be 
regarded as suspicious”.  This does not include ICAD. Acute onset neck pain/headache 
and has been described as “unlike any other” (Taylor and Kerry 2010; Kerry and Taylor 
2009; 2006; Kerry et al 2008), but are these patterns, distributions and descriptions 
definitive in CAD or are they the severe end of the headache spectrum? This problem is 
explored in section 4. Neck pain and headache are symptoms that may present in 
patient presentations at musculoskeletal clinics without prior attendance at a medical 
practitioner, or could be the reason for referral from the medical practitioner. 
 
3.4 Pain (cervicogenic headache) 
Cervicogenic headache is considered a disorder that is manageable by the physical 
therapies (Jull 1997). This disorder has been recognised by the International Headache 
Society (IHS 2004).  Part of the criteria referred to by the IHS is pain referred from a 
source in the neck and felt in one or more regions of the head and/or face.  Differential 
diagnosis of cervicogenic headache, however, can be difficult to separate from other 
causes of headache unless additional features are presented.   Some physiotherapy 
studies have attempted to address this differential diagnosis problem by comparing 
examination findings in headaches groups of cervicogenic and migraine with aura, and 
asymptomatic controls and have identified upper cervical spine mechanical dysfunction 
(Ogince et al 2007; Zito et al 2006).   The most crucial differential diagnosis is headache 
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from CAD due to the heightened risk of adverse events with potentially near fatal 
consequences following manipulation (Bogduk and Govind 2009).   
 
An additional problem with headache differentiation is that neurologists differ in their 
agreement of cervicogenic headache as having a nosological identity making the 
concept of cervicogenic headache controversial (Bogduk and Govind 2009; Zhou 2008; 
Leone et al 1998).  This adds greater complexity to clinicians navigating their clinical 
reasoning processes when presented with patient complaining of neck pain and 
headache.   
 
The publications in section 3 referring to signs and symptoms, such the ‘5Ds and 3Ns 
framework’, myelopathy and headache presentations highlights the difficulty therapists 
face in clinic when considering differential diagnosis.  This creates the question of what 
subjective and objective procedures should musculoskeletal practitioners use to support 
awareness of detecting more subtle aspects of neurological change in order to prevent 
occurrences of an adverse event?  
 
 
The following sections contain a number of clinical problems based on section 3.  
The problems focus on areas where the reviewer considers that most clinical 
uncertainty exists.  These problems are cervical arterial dysfunction with 
associated symptoms of headache and dizziness, and cervical myelopathy.  The 
problem areas are accompanied by literature summaries in various formats to 
help inform participants.  The selection of literature is from the best identified 
literature following guidance from the SIGN methodology.  Single-case studies are 
excluded within the main problems.  Case series of minimum n= 5 have been 
selected, where literature is limited.  Any review literature is a systematic process 
or accompanies another study (e.g Caplan et al 2005), unless otherwise indicated 
by appropriate SIGN grading.
  
 
4. Clinical problems with accompanying literature 
 
 
Problem 4.1: What signs and symptoms indicate the presence of CADy?  Studies appear to be based in neurological centres; therefore it is questionable 
as to how relevant the findings are to MSK clinics?  Admission to neurological centres indicates significant progression of an arterial event. Taylor and 
Kerry (2010 masterclass) provide excellent information on CADy from a manual therapy perspective.  However, the following studies highlight the 
difficulty in identifying features relevant to MSK clinics. Other than single case reports, there are no identifiable studies within MSK settings (excluding 
adverse events based reports) 
Study  Study design Evid. level Sample size Population 
characteristics 
Clinical 
presentation 
statistics 
 
Debette et al (21). 
2011b. Differential 
features of carotid and 
vertebral artery 
dissections. The 
CADISP study. 
Neurology, 77: 1174-
1181. 
Large 
observational  
(20 centres, 9 
countries 2004-
2009) 
2++ ICAD n=619 
VAD n=327 
ICAD: age 
45.7±9.6 yrs 
Women n=245 
(39.6%) 
VAD: age 
41.1±9.6 yrs 
Women n=245 
(39.6%) 
 
 
1. cervical pain 
2. Headache 
3. Cerebral ischemia 
  a. Ischemic stroke 
  b. TIA 
  c. transient 
monocular blindness 
  d. Subarachnoid 
haemorrhage 
 
ICAD Vs VAD 
1. ICAD n=231 (38.7%); VAD n=212 
(66%) p=0.001; OR(95% CI) 0.36 (O.27 
to 0.48). 
 
2. ICAD n=405 (67.8%); VAD n=207 
(64.5%) p=0.3; OR(95% CI) 1.36 (1.01 
to 1.84). 
 
3. ICAD n=453 (73.2%); VAD n=295 
(90.2%) p=0.0001 OR(95% CI) 0.32 
(0.21 to 0.49). 
Reviewer comments: This report forms part of the large multicentre Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) study.  Excellent 
large study with this report presenting differential features of carotid and vertebral artery dissections.  Unfortunately, does not offer specific detail on 
aspects of the pain presentation or ischemic signs.  This study is presented to highlight the difficulty in establishing patterns of presenting features to 
assist MSK practitioners.  Neck pain is more likely in VAD, headache more likely in ICAD, but does this matter from a clinical perspective i.e. can we 
differentiate between the two and would it alter your management? 
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Study  Study design Evid. 
level 
Sample size Population 
characteristics 
Clinical presentation 
 
Thomas, L., Rivett,D., 
Attia, J., Parsons, M., 
Levi, C. 2011. Risk 
factors and clinical 
features of 
craniocervical arterial 
dissections. Manual 
Therapy, 16: 351-356 
Retrospective. 
Case-control. 
 
Database 
records 1998-
2009 
2+ All under age 55 
yrs. 
 
Total dissection 
subjects n = 47 
Males n=27 
 
Control subjects 
n = 43 (clinico-
radiological 
diagnosis of 
stroke from non-
dissection cause) 
Males n=22 
 
Dissection age 
37.6±10 
Males n=27 
 
Control age 
43.6±7.3 
Symptoms/signs:n=(%):control n=(%) 
 
“Symptoms: 
Headache 38(81):22(51), neck pain 27(57):6(14), dizziness 
15(32):3(7), visual disturbance 16(34):12(28), paraesthesia 
(face 14(30):8(19); upper limb 16(34):20(47)/lower limb 
9(19):14(33). 
 
Signs: 
Unsteadiness/ataxia26 (55%):15 (35%), weakness upper 
limb 22 (47%):32 (74%) weakness lower limb21 (45%):26 
(60%); dysphasia/dysarthria/aphasia21(45%):30 (70%) 
; Facial palsy18 (38%):20 (47%);  ptosis17(36%):2 (5%); 
Nausea/vomiting 13 (28%):6(14%); Dysphasia 8 (17%):2 
(5%);  
  Drowsiness 5 (11%):1 (2%) 
 Confusion 5 (11%):6 (14%); 
Loss of consciousness 8 (17%):2 (5%)”  (p.355) 
 
Authors’ general comments:“Considering (clinical recommendations e.g Rivett et al 2006; Kerry et al 2007), …headache not always present or severe in either 
VBAD or ICAD subjects, although was more common in VBAD (85%) and ICAD (75%) subjects than controls (51%)” p.355.(Reviewer comments: this latter 
point differs to Debette et al (2011) headache in ICAD > VAD). Similarly, neck pain and dizziness more likely in VBAD than ICAD subjects or controls. 
Dizziness present in only 52% VBAD cases, yet often stressed as primary clinical indicator of vertebrobasilar flow insufficiency. The presence or absence of 
nystagmus rarely recorded, although other visual disturbances were reported. Ataxia or balance problems were fairly common in VBAD group (67%). 
Recommend beingaware of in assessment of neck pain or headache and perhaps consider formal testing of balance more routinely. Similarly findings for 
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ICAD suggest it may be appropriate to perform a focused cranial nerve examination (e.g. for facial palsy or ptosis) if specific symptoms are reported in the 
history or signs are evident on casual observation.(reviewer comments: cranial nerve testing recommended elsewhere (e.g. Taylor and Kerry 2010: 
masterclass article). Do participants or your departmental colleagues currently consider balance testing in neck pain/headache? 
Limitations of retrospective studies: medical records not always detailed and it is acknowledged that negative responses to questions in the history may not 
always be recorded. Details of blood results and radiological imaging were sometimes limited.  
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Problem No. 4.4   Pre-manipulative screening, including provocative positional 
tests for vascular pathology, does not identify all patients at risk of an adverse 
event from therapeutic intervention.  Therefore, other factors, such as 
identifying risk factors should be identified to assist in process.   
Unfortunately, there is inconsistency in the literature regarding what risk 
factors should be considered for subjective screening of CADy.   
 
 
4.4.1 Theoretical modelling 
Thomas et al (2011) consider that a consensus has not been achieved on definitive 
risk factors for CAD.  Additionally, there is inconsistent evidence between studies 
investigating risk factors for CAD (Thomas et al 2011; Kerry et al 2008). 
 
Taylor and Kerry (2010) consider CAD to be intrinsically linked to two inter-related 
principles of an underlying pathology (including atherosclerosis) and mechanical 
forces. Other features linking to underlying pathology or risk have been suggested 
as: genetic (e.g. connective tissue disorders, fibromuscular dysplasia (non-
inflammatory disease of medium sized arteries), or family history) and environmental 
origins (e.g. major and minor trauma, infections, smoking, hypertension, oral 
contraceptives, iatrogenic causes such as, surgery or medical intervention) are also 
considered a risk (Debette and Leys 2009; Thanvi et al 2005). 
 
Risk ratio – Kerry et al  (2008) conclude that the actual risk cannot be determined 
from the available evidence and as a result, advise that clinicians should consider 
risk based on their clinical reasoning including assessment of the patient relative to 
their particular situation at a particular time 
 
 
In an attempt to aid understanding and clinical reasoning of the pathogenesis of 
CAD Rubinstein et al (2006) present a theoretical model that outline four major risk 
categories of CAD: 1) genetic predisposition/underlying familial disorder; 2) 
environmental exposure e.g. infection, oral contraceptive; 3) trivial trauma e.g. 
normal neck movements, sports injury, neck manipulation; and 4) common risk 
factors associated with atherosclerosis.  Rubinstein et al (2006) propose that a 
genetic predisposition must be present, plus an additional necessary trigger for a 
CAD event to occur.  They argue that a CAD is highly unlikely in an otherwise 
healthy individual free from this combination of factors.  In a thorough review 
focusing on sCAD Debette and Leys (2009) concluded that studies on genetic 
association with CAD have been underpowered.   
 
The difficulties with studies investigating risk factors and presentations are that 
patients with local signs only (e.g. pain) or with minor cerebral or retinal ischemia 
changes may not be detected dependent on where and how they are managed 
(Debette et al 2011). 
 
4.4.2 Manual therapies and minor trauma (note this is the subject of a current 
academic discussion in the BMJ) 
Debette et al (2011a) observational study 2004-2009 20 centres in 9 countries 
observed 946 consecutive patients in with CAD (n=619 ICAD and n=327 VAD).  The 
following were found to have experienced minor mechanical trauma defined as not 
requiring a medical visit attendance at a hospital, within the previous 1 month: ICAD 
n=177 (29.2%) and VAD (n=118 (36.5%) p=0.02 (adjusted for univariate) OR (95% 
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CI) 0.75 (0.56 to 1.007) p=0.05 (adjusted for age / gender).  Major trauma defined 
as requiring a medical visit or attendance at a hospital did occur, but did not achieve 
significance (p=0.87 adjusted for age/gender).  No specific detail of traumas type is 
provided.  Thomas et al (2011) found a statistically significant association between 
minor mechanical trauma and CAD patients compared to a control group: 23 (64%) 
v’s 3(7%) OR (95% CI) 26.67 (6.83 to 104.17) adjusted OR 25.29 (6.04 to 105.82) 
p<0.000. The minor trauma occurred within the previous 3-weeks and included 
manual therapy (chiropractic, osteopathy, physiotherapy, massage) to the neck; 
however, what type and extent of therapy was not recorded. 
 
Miley et al (2008) conducted a detailed structured evidence based clinical neurologic 
practice review to address the question “Does cervical manipulative therapy cause 
vertebral arterial dissection and subsequent ischemic stroke?” and conclude there is 
weak to moderately strong evidence to support causation between CMT and VAD 
and associated stroke.  Detailed search strategies are provided, which was reduced 
to 26 highest levels of evidence publications: 3 case-control studies, 8 prospective 
and retrospective case series, 4 illustrative case reports, 1 survey, 1 systematic 
review of observational research, 5 reviews, and 4 opinion and expert commentary 
pieces.  A cross reference was conducted with this reviewer’s search results, which 
revealed the same main studies. 
 
Ernst (2010) conducted a systematic review with no time limit to establish the 
numbers of fatalities following chiropractic intervention and reported a total of 26-
deaths were published in the medical literature, but further states there is reason to 
believe that under-reporting is substantial and reliable incidence figures do not exist.  
Albuquerque et al (2011) reported a case-series of 13 patients (8 male, mean age 
44 , range 30-73 years) extracted from a prospective endovascular database who 
presented with craniocervical dissections following chiropractic manipulation.  
Symptoms of neurological deficit, head or neck pain, or both had atypical onset 
within hours or days of manipulation. In this case series 31% (n=4) were left 
permanently disabled or died as a result of their arterial injuries. 
 
Haldeman et al (2002) concluded after reviewing 64-medicoloegal (medical related 
compensation claims) cases that risk factors could not be identified and that 
dissection was an unpredictable event.  Manipulation of the neck, however, is 
considered as having a strong association as a risk factor for CAD (Ernst 2007; 
Rubenstein et al 2005).   Murphy (2010) offers a commentary to provide a balanced 
view of cervical manipulation and arterial dissections and suggests that the 
relationships is not causal, but that patients often seek chiropractic intervention for 
some initial symptoms of dissection in progress that may proceed to stroke following 
manipulation.  Ernst (2010), however, reports that even taking this argument into 
consideration, causality is at least likely, which alongside the limited evidence to 
support the effectiveness of chiropractic manipulation this makes the risk-benefit 
balance for chiropractic manipulation less positive. 
 
Rubinstein et al (2006) acknowledge that based on poor methodological processes 
identified in a systematic review (Rubinstein et al 2005), the true risk of CAD to the 
population remains unknown. Therefore, if manipulation could be a contributing 
factor, as opposed to a principal cause of CAD, the problem of identifying a 
young/middle aged person at risk from CAD still remains.  This provides a 
challenging problem to clinicians – how do we identify these patients? 
(Thesis note: due to the size of full information pack this is not included within thesis appendices) 
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Appendix M: Draft Clinical Chart 
 
Electronic version - Embedded pdf. 
 
 
 
 
Hard copy – refer to CD inside rear cover. 
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Appendix N: Research call for Consultant Neurologists and Consultant 
Neurosurgeons 
 
Red flag screening for serious pathology presenting in cervical spine 
musculoskeletal disorders 
 
Dear Consultant  
 
Would you like to help develop a red flag screening tool for musculoskeletal neck 
pain and headache?  
 
Why? 
 To promote early detection of potentially serious pathology mimicking or presenting 
alongside a cervical spine musculoskeletal disorder. 
 To reduce the risk of delayed diagnosis, for example, cervical myelopathy, or adverse 
events, such as transient ischaemic attacks and stroke occurring from physical 
treatments (e.g. manipulation). 
 Delayed diagnosis or adverse events of this nature have been reported in international 
peer-reviewed medical literature. 
 It is vitally important that any underlying serious complaints have been excluded in order 
to apply safe and effective physical treatment. 
 
Consultant neurologist and neurosurgeon expertise is needed to help address some 
uncertainty relating to clinical indicators and tests for serious pathology that may mimic or be a 
deteriorating cervical spine musculoskeletal problem. 
 
My name is Colin Redmond.  My professional role is Principal Spinal Physiotherapist with NHS 
Borders and I am currently undertaking a Professional Doctorate programme with Queen 
Margaret University, Edinburgh.  This research forms part of my Professional Doctorate studies.  
During the redevelopment of a regional spinal service it became apparent that some clinical 
indicators used by the physical therapy professions to identify potentially serious pathology 
presenting as a musculoskeletal disorder were not reliable.  Musculoskeletal practitioners 
(physiotherapists, chiropractors, osteopaths) provide assessment and treatment for pain and 
functional impairments relating to neck pain and headache.  Your help is needed to enhance 
safe practice. 
 
This research project combines a focus group with leading UK physiotherapists and a Delphi 
survey with medical experts (consultant neurologists/neurosurgeons) to develop an 
evidence-based screening process for serious pathology in cervical spine musculoskeletal 
disorders.  A draft clinical screening chart will be provided for your comments alongside 
some open questions to address any remaining clinical uncertainties. There will be 3 rounds 
of on-line survey (October and December 2012 and January/February 2013) aimed at achieving a 
clinical consensus.  
 
Your participation will be highly valued.  If you would like to become involved or receive a 
more detailed information sheet, please contact me: email 09001905@qmu.ac.uk or 
Colin.Redmond@borders.scot.nhs.uk, or telephone: 01896 827004.  
 
Thank you. 
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Appendix O: Participant Information Sheet – Delphi Survey 
Study Title 
 
Red flag screening for serious pathology presenting in cervical spine 
musculoskeletal disorders  
 
You are invited to take part in a research project that aims to improve physiotherapy red 
flag screening for serious pathology in cervical spine musculoskeletal disorders.  Before 
you decide it is important for you to understand why the research is being undertaken 
and what it will involve.  Please take time to read the following information.  Take time to 
decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
What is the purpose of the study? 
The study is being carried out to establish a red flag screening process for serious 
pathology presenting as, or alongside, a cervical spine musculoskeletal disorder, which 
can be used by physiotherapists, but additionally will inform chiropractic, osteopathy, 
and general practitioners’. This could enhance early detection of potentially serious 
pathology and enable safer practice.  Clinical experience supported by a literature 
review has identified a knowledge gap and inconsistencies in screening for neurological 
and neurovascular pathology.  Red flag screening in low back pain has received 
significant attention by researchers; however specific questions and testing for the 
cervical spine remain inconsistent e.g. cervical arterial dissection has been reported 
following manipulation, but screening processes to reduce the potential of adverse 
incidents occurring remains unclear.  Similarly, there is inconsistent evidence to support 
the diagnostic accuracy of clinical tests for signs of cord compression myelopathy.  This 
study is looking to establish a screening process through the combination of literature 
review, focus group with leading physiotherapists, and a Delphi method with consultant 
neurologists and consultant neurosurgeons that will be used to inform clinical practice 
and contribute to the evidence base for future research.  The Delphi technique is 
considered as a suitable method to gain a consensus where there is incomplete 
knowledge or uncertainty in clinical issues.   
 
Why have you been chosen? 
You have been invited to participate in this study as your expertise as a consultant 
neurologist or consultant neurosurgeon is considered as highly valuable in contributing 
to the knowledge base that will inform clinical practice aimed at early detection of 
potentially serious neurological and neurovascular pathology presenting as, or 
alongside, a cervical spine musculoskeletal disorder. 
 
Do I have to take part? 
No. It is up to you to decide whether or not you take part.  However, in addition to help 
progress clinical practice, the study also offers an excellent professional development 
opportunity.  Your clinical expertise is considered as very valuable to the study.  
Informed consent will be considered as gained by your decision to access the web-
based survey tool (http://www.survey.bris.ac.uk/), at the beginning of the study.  If you 
decide to take part you are still free to withdraw at any time and without giving a reason. 
 
What will happen to me if I take part? 
1. By agreeing to take part in this study you will be forwarded a draft clinical chart 
and web link to round 1 of the Delphi survey.  There will be a small number of 
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demographic questions to complete at the beginning.  You will then be asked for 
your opinions on the presented information through open questions; however, 
you are free to omit items if you do not wish to answer. The draft red flag chart 
contains information on clinical features, risk factors, and clinical tests related to 
screening for potentially serious pathology, including neurological/neurovascular 
conditions.  This information is collated from an evidence based literature review 
and physiotherapy focus group consisting of leading UK based physiotherapists 
(physiotherapy consultant level expertise, specialist spinal role, those with 
relevant peer-reviewed published papers, or MSc post-graduate level 
educators). Round 1 is anticipated to last approximately 15 minutes after initial 
viewing of the draft chart and will be complete when you press the ‘continue’ 
button on the main questions page. 
2. The information is analysed in preparation for round 2. 
3. Approximately 4-6-weeks from completing round 1 you will receive round 2 
questionnaire via emailed web link.  Round 2 will be a series of statements 
devised from the collective round 1 response that has been analysed into 
themes.  You will be asked to give your level of agreement and disagreement 
based on a 5-point likert scale.  There will also be an opportunity to provide 
added information if you feel it is appropriate or clarify a response.  
4. Round 3 will follow a similar process to round 2 that will aim to achieve a 
consensus on the red flag screening process. Rounds 2 and 3 are anticipated to 
last approximately 10 minutes each.  
 
What are the risks of taking part? 
There is no identifiable risk of taking part in this study. 
 
What if something goes wrong? 
This study is considered as low risk.  Regardless of this, if you wish to complain, or have 
any concerns about any aspect of the way you have been approached or treated during 
the course of this study, you may raise this concern directly with the Principal 
Investigator who will follow Queen Margaret University, Edinburgh complaint escalation 
procedure.  Alternatively, you are free to contact the Independent Advisor. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you will be kept strictly confidential and managed 
in accordance with the Data Protection Act (1998).  You will be assigned a study number 
which is linked to your name and stored in NHS encrypted information systems. Any 
information which leaves the NHS information system will have your name and contact 
details removed so that you cannot be recognised from it. 
 
What will happen to the results of the research study? 
The results of this study will be used to present a thesis that will be submitted as part 
fulfilment of a Professional Doctorate in Health and Social Sciences at Queen Margaret 
University, Edinburgh.  The results will also be used to publish and present the findings 
of the research in a relevant journal and conference to inform clinical practice that 
promotes patient safety.  However you will not be identified in any report or publication, 
unless you provide additional consent to do so.  
 
The results will be submitted in a thesis format in June 2013 and you can obtain a 
summary from the Principal Investigator (details at the end of this sheet). 
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Who is organising and funding the research? 
The study is being organised by the Principal Investigator who is completing the 
research as part of a higher academic degree as outlined above.  Queen Margaret 
University, Edinburgh has approved the study and some time and financial support for 
this research has been obtained from NHS Borders and NHS Education for Scotland. 
 
Who has reviewed the study? 
The study protocol has been reviewed and conduct of the study has achieved Queen 
Margaret University, Edinburgh ethical approval.  Recent changes to NHS Governance 
Arrangements for Research Ethics Committees states that additional NHS approval is 
not required.  However, South East Scotland Research Ethics Service (NHS) has been 
informed of the study. 
 
Contact for further information 
Should you want any further information about this study please ask the Principal 
Investigator:  Colin Redmond 
 
Address:  Physiotherapy Department 
   Borders General Hospital 
Melrose 
TD6 9BS 
 
University email / work telephone: 09001905@qmu.ac.uk   01896 827004/826548 
 
Alternative: Work email: Colin.Redmond@borders.scot.nhs.uk 
 
 
If you have questions relating to any aspect of the study that you would like independent 
advice on, you will be able to speak to (to be inserted). 
 
Independent Advisor:  Professor James M Scobbie 
    Director, CASL (Clinical Audiology, Speech and  
    Language) Research Centre 
    Queen Margaret University 
    Edinburgh 
    EH21 6UU 
 
Email     JScobbie@qmu.ac.uk 
Telephone   0131 474 0000 (state name of person) 
If you decide to take part in this study, please retain a copy of the information sheet for 
your own records and thank you for taking part in this project. 
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Appendix P: Delphi survey participant consent (page1) 
Welcome 
Welcome to the Delphi survey for the project 'Red flag screening for serious pathology 
presenting in cervical spine musculoskeletal disorders'.  
 
The survey is completed anonymously, can be saved part way through and is 
anticipated to take around 15 minutes to complete after viewing the draft red flag chart. 
 
Data Protection 
All data collected in this survey will be held anonymously and securely. No personal 
data is asked for or retained. 
 
Cookies, personal data stored by your Web browser, are not used in this survey. 
 
Consent 
I have read and understood the information sheet and have had an opportunity to ask 
questions about my participation. 
 
I understand that I am under no obligation to take part in this study. 
 
I understand that I have the right to withdraw from this study at any stage without giving 
any reason. 
 
I agree to participate in this study and understand that by clicking the 'continue' button to 
the next page will be considered as providing informed consent. 
 
Thank you for participating in this project. 
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Appendix Q: Round 1 Delphi Survey 
The initial questions about you are mandatory (except 3a). The remaining questions 
are optional; however, your input to the 2 main questions (4 & 5) is considered as 
highly valuable, regardless of the extent of your response. All questions are 
contained on this page to allow ease of viewing between your responses. 
 
Note that once you have clicked on the CONTINUE button your answers are 
submitted and you can not return to review or amend this page. 
Page 2 of 3 
About you 
1.  Are you a consultant neurologist or consultant neurosurgeon?  
neurologist neurosurgeon  
2.  How many years have you been qualified as a consultant?  
less than 5 years  
5-9 years  
10-19 years  
20 years or more  
 
3.  Which professional setting(s) do you work in?  
(select all that apply) 
NHS   Independent or private healthcare   Academia   Research    
Other (please specify): 
 
 
a. If two or more settings are selected, which of these best represents your main work 
environment?  (Optional) 
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b. Which geographic region/country is your main base located in (e.g. South East Scotland)?  
 
 
Draft clinical chart - Feedback 
This section relates to your feedback on the draft chart. Your feedback will be used to inform 
the editing process to achieve a simpler and user friendly chart with a specific focus on red 
flags.  
 
4.  Do you have any initial comments on the draft clinical chart as a tool to help 
identify red flags in neck pain and neck problems? See 'More Info'. 
 
Considerations may include your thoughts on the relevance of the sub-topics 
information, including tests or actions, and their inclusion/exclusion in the 
chart.  (Optional) 
(Thesis note: Question 4 ‘More info’ appeared on clicking button) 
Question 4 ‘More Info’ The chart intends to provide a 'quick reference' section with 
a specific list of key red flags. The more detailed background information is designed 
to provide context for these features that will assist Physiotherapists' with their 
interpretation and subsequent clinical decision making.  
 
More 
info 
 
Developing list of red flags 
This section aims to develop a brief red flag list as previously outlined - A starter list is 
provided below for your development: 
 
5.  Please list the key red flag symptoms/signs that you consider to exist for neck pain or neck 
problems. Your list should include what the symptom/sign is likely to indicate e.g. cord 
compression. 
 
Starter list of red flags for your development (copy & paste is available for editing 
purposes if required) 
 
Neck pain/stiffness/headache with brainstem symptoms/signs - may be subtle and 
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typically within 1 month onset: 
dizziness (typically episodic and between >1min and <30mins duration); slurred speech; 
double or loss of vision; drooping eyelid; pulsatile tinnitus or sudden loss of hearing; unilateral 
limb clumsiness or reduced balance; facial numbness or weakness; taste disturbance; 
nausea/vomiting; nystagmus. 
 
Headache (in presence of neck pain/stiffness) with features of: 
new onset(e.g. <1 month); change in usual pattern; changes with posture or exertion. Note if: 
cancer; age>50 yrs;or fever/infection present. 
 
Cord compression symptoms/signs (with or without neck pain/stiffness: 
early features: hand weakness or clumsiness; gait disturbance 
progressive features: bilateral hand and/or feet pins/needles or numbness; upper or lower 
limbs spasticity or weakness; reflexes exaggerated or reduced; bladder/bowel disturbance 
(incontinence or retention); erectile dysfunction (rarely). 
 
 (Optional) 
 
Any other comments? 
6.  Please add any further comments you may have about the red flag screening process 
that has not been covered above.  (Optional) 
Thank you very much for completing this survey.                 Page 3 of 3 
Participants' responses will now be analysed and arranged into a series of themed short 
statements. These statements will be presented in round 2 using a 5-point likert scale format. 
This process aims to establish a consensus on the red flags to help develop the draft chart and 
improve our clinical decision making for earlier diagnosis of serious pathology.  
Thank you for your participation. 
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Appendix R: Clinical scenario reminder for final round 
 
 
 Patient attends non-medical musculoskeletal clinic (e.g. Physiotherapy -
 typically received by GP referral or by self referral with no previous GP 
contact). 
 
 They complain of: 
  neck pain/stiffness (that may or may not have headache 
alongside their complaint); and / or upper limb dysfunction 
(e.g. pain, weakness, pins/needles/numbness, or reduced 
function - any combination of these). This occurs. 
 
 When assessing the patient - Physiotherapist needs to expand their level of 
enquiry to screen for any underlying serious pathology that may be linked to 
their symptoms/signs.  This enhanced enquiry may reveal additional 
symptoms/signs or other pathologies as outlined in the survey (developed 
from 1st round). 
 
 With consultant input, we can improve this enhanced enquiry 
and understanding of how relevant these symptoms/signs and additional 
pathologies are, and when to raise our level of concern to seek 
additional medical opinion.   
 
 Any consultant consensus on agreement / disagreement will help physios 
etc. achieve better focus on the relevant screening process and will part-
inform our future development.  
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Appendix S: Delphi survey final round 
Cervical spine red flags 3 (Final) 
Page 1 of 3 
Welcome 
Welcome to the Delphi survey 3rd (final) round for the project 'Red flag 
screening for serious pathology presenting in cervical spine musculoskeletal 
disorders'.  
 
The survey is completed anonymously, can be saved part way through and is 
anticipated to take around 10-15 minutes to complete the questions.  
 
The Delphi survey design is a re-run of the 2nd round with several minor 
modifications to help with clarity of information and is accompanied by the 2nd 
round results.  
 
You are asked to simply re-rate your level of agreement/disagreement 
(5-point likert scale) on all clinical features (except Q10) for inclusion of 
the various components to guide clinical screening. 
 
The additional comments option after each section has been retained should you 
wish to clarify or add any information. 
 
Please note: All 2nd round additional comments have been saved to 
inform the full analysis, including the clinical groups listed on page 2. 
 
Thank you for participating in the final phase of this project. 
 
 
Cervical spine red flags 3 (Final) 
Page 2 of 3 
Red flag features 
The clinical groups are presented in no particular order and may be combined at 
a later stage once clinical features are agreed. 
 
1. Progressive pain 
2. Cancer, infection, inflammatory arthritis/spondyloarthropathies, trauma (also 
risk of instability in this section) 
3. Neurological deficit  
4. Headache (may present alongside neck pain/stiffness) 
5. Brainstem, cervical arterial, and cranial nerve dysfunctions  
 
All groups are contained on this page to allow ease of viewing between your 
responses. 
 
Note: Physiotherapists are increasingly aware to consider clusters of 
symptoms/signs indicating a raised index of suspicion for serious pathology, 
rather than acting prematurely on each individual feature in isolation. 
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Note: Once you have clicked on the CONTINUE button your answers are 
submitted and you are unable to return to review or amend this page. 
 
Please remember to consider your level of agreement/disagreement for 
inclusion of the features in the list of red flags and to complete each 
question. Please select "No opinion" if there is uncertainty regarding 
level of agreement/disagreement. 
 
1. Progressive Pain (Neck and/or radicular pain. May be 
accompanied by headache). 
1.  Progressive pain:  
a.  May be in isolation (i.e. not accomapnied or associated with others features e.g. 
history of cancer, trauma, presence of hard neurological signs, suspected atlanto-
axial instability or infection).  
Strongly agree Agree No opinion Disagree Strongly disagree  
b.  May be associated with others features (e.g. history of cancer, trauma, 
presence of hard neurological signs, suspected atlanto-axial instability or infection).  
Strongly agree Agree No opinion Disagree Strongly disagree  
 
2.  If pain is progressively worse (e.g. over past week).  
Strongly agree Agree No opinion Disagree Strongly disagree  
3.  Pain not responding to simple measures (e.g. normal analgesics).  
Strongly agree Agree No opinion Disagree Strongly disagree  
4.  Onset: 
a.  May be a new 1st episode of acute/subacute pain onset (e.g. onset immediately 
following trauma or present for hours to 1-month for arterial dissection).  
Strongly agree Agree No opinion Disagree Strongly disagree  
b.  May be an acute/subacute aggravation on chronic pain.  
Strongly agree Agree No opinion Disagree Strongly disagree  
 
5.  Description: Severe and/or unremitting. 
 
Note caution: Description is not definitive - May be sharp or dull; localised or 
139314 109790033 139547
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diffuse/no specific distribution; moderate or severe.  
Strongly agree Agree No opinion Disagree Strongly disagree  
6.  Severe pain on movement; reluctance to move; gross cervical spasm or torticollis 
(cancer, infection, atlanto-axial instability).  
Strongly agree Agree No opinion Disagree Strongly disagree  
7.  Disrupting sleep (does not ease with adjusting sleep position e.g. pillow).  
Strongly agree Agree No opinion Disagree Strongly disagree  
8.  Any other comments on this section?  
 
2. Cancer, infection, inflammatory arthritis/spondyloarthropathies, 
trauma 
Note: Risk of upper cervical spine instability occurring as a progression of such 
pathologies  
9.  Cancer 
Previous history of cancer; unexplained weight loss; lymphadenopathy.  
Strongly agree Agree No opinion Disagree Strongly disagree  
10.  Age and risk (The consultant panel have provided 3 options): 
 
What age group do you think should be used as an indicator of increased risk of 
serious pathology occurring naturally e.g. cancer? Additional consideration could be 
given to other pathologies e.g. cervical arterial dissection.  
Age greater than 40 years Age greater than 50 years No age group 
association (no age group is exempt)  
Other (please specify):    
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11.  Infection 
Malaise, fever, sweats, lethargy.  
Strongly agree Agree No opinion Disagree Strongly disagree  
12.  Tuberculosis, immunosuppression, drug abuse, HIV/AIDS, or other (significant) 
infection. 
Strongly agree Agree No opinion Disagree Strongly disagree  
13.  Inflammatory arthritis/spondyloarthropathies 
Strongly agree Agree No opinion Disagree Strongly disagree  
14.  Trauma (recent onset) 
Strongly agree Agree No opinion Disagree Strongly disagree  
15.  Any other comments on this section?  
 
3. Neurological deficit (e.g. spinal cord compromise) 
 
16.  Quick guide 
Upper motor neuron symptoms/signs (in lower limbs more than upper limbs). 
Lower motor neuron symptoms/signs (in upper limbs more than lower limbs). 
Strongly agree Agree No opinion Disagree Strongly disagree  
17.  Hands: clumsy/loss of dexterity or weakness.  
Strongly agree Agree No opinion Disagree Strongly disagree  
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18.  Weakness (widespread) of arms or legs.  
Strongly agree Agree No opinion Disagree Strongly disagree  
19.  Diffuse numbness or paraesthesia (pins/needles).  
Strongly agree Agree No opinion Disagree Strongly disagree  
20.  Loss of proprioception.  
Strongly agree Agree No opinion Disagree Strongly disagree  
21.  Lhermitte's phenomenon / sign.  
Strongly agree Agree No opinion Disagree Strongly disagree  
22.  Hyperreflexia: 
(Increased/exaggerated reflexes in lower limbs more than upper limbs; Hoffman's 
reflex; finger flexion-extension jerks; clonus; myoclonus/spasticity in lower limbs > 
upper limbs; upgoing plantar response). 
Strongly agree Agree No opinion Disagree Strongly disagree  
Other (please specify):  
   
23.  Gait disturbance 
e.g. stiff, slow, broad based.  
Strongly agree Agree No opinion Disagree Strongly disagree  
24.  Lower motor neuron symptoms/signs (in upper limb more than lower limb). 
 
Radicular pattern in particular dermatome: Numbness; paraesthesia (pins/needles); 
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weakness; hyporeflexia (reduced reflexes) in particular dermatome.  
Strongly agree Agree No opinion Disagree Strongly disagree  
25.  Very late stage 
a.  Sphincter disturbance (bladder and/or bowel) disturbance (retention or 
incontinence). 
 
Strongly agree Agree No opinion Disagree Strongly disagree  
b.  Erectile dysfunction (rare occurrence).  
Strongly agree Agree No opinion Disagree Strongly disagree  
 
26.  General progressive neurological deficit 
 
Any new progressive and/or unusual neurological symptoms/signs (irrespective of neck 
pain/stiffness).  
Strongly agree Agree No opinion Disagree Strongly disagree  
27.  Any other comments on this section?  
 
4. Headache (accompanying neck pain/stiffness) 
Headache may be reported at musculsoskeletal clinics alongside neck pain/stiffness. 
Other possible sites of lesion should be considered e.g. Cervical arterial 
dissection/dysfunction; Chiari 1 malformation; raised intracranial pressure; instability 
(e.g. occipital neuralgia) if the following features present:  
28.  New onset (e.g. less than 1 month).  
Strongly agree Agree No opinion Disagree Strongly disagree  
29.  Severe and persistent. 
 
Note caution: May have no definitive distribution (e.g. local (such as occipital), or 
diffuse), description (e.g. sharp or dull) or intensity (e.g. moderate or severe).  
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Strongly agree Agree No opinion Disagree Strongly disagree  
30.  Headache changes:  
a.  In usual pattern.  
Strongly agree Agree No opinion Disagree Strongly disagree  
b.  With posture or brought on by exertion, cough, laugh or straining. 
 
Strongly agree Agree No opinion Disagree Strongly disagree  
 
31.  Sudden (unexplained) onset.  
Strongly agree Agree No opinion Disagree Strongly disagree  
32.  Any other comments on this section?  
 
5. Brain stem, cervical arterial (occlusion/stenosis/dissection) and 
cranial nerve dysfunctions  
Low level evidence suggests that subtle symptoms/signs of these other origins of 
pathology may present at musculoskeletal clinics alongside neck pain/headache before 
progressive deterioration. 
 
This section presents most clinical uncertainty for non-medical practitioners see 
'More Info' 
33. Symptoms/signs outlined below should raise concern if: New or 
recent onset (e.g. within 1 month). 
 
Caution - symptoms/signs may be subtle if presenting at musculoskeletal 
clinics.  
(Thesis note: Question 33 More info. The following text appears when button 
pressed) 
Physiotherapists have traditionally used the acronym '5Ds And 3Ns' (Dizziness, diplopia, 
dysphagia, dysphasia, drop attacks, ataxia, nystagmus, numbness, nausea) for recognition of 
cervical arterial pathology. The 5Ds origin is an unreferenced book chapter (1986) and the A & 
3Ns parts being added at later stages. There is limited research to support this acronym. 
However, it is possible that some features may present at musculoskeletal clinics 
(Physiotherapy, chiropractic, osteopathy). 
 
In addition, observational studies of cervical arterial pathology are generally conducted at 
More 
info 
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neurological centres where the focus may not be on early features, making it more difficult to 
inform physiotherapy practice.  
 
Strongly agree Agree No opinion Disagree Strongly disagree  
 
 
 
i. Dizziness (Central cause typically episodic and between >1min and <30mins 
duration. Not occurring in isolation).  
Strongly agree Agree No opinion Disagree Strongly disagree  
ii. Slurred speech.  
Strongly agree Agree No opinion Disagree Strongly disagree  
iii. Double or loss of vision.  
 
Strongly agree Agree No opinion Disagree Strongly disagree  
iv. Drooping eyelid / Horner's sign.  
Strongly agree Agree No opinion Disagree Strongly disagree  
v. Pulsatile tinnitus or sudden loss of hearing.  
Strongly agree Agree No opinion Disagree Strongly disagree  
vi. Unilateral limb clumsiness or reduced balance.  
Strongly agree Agree No opinion Disagree Strongly disagree  
vii. Facial numbness or weakness.  
Strongly agree Agree No opinion Disagree Strongly disagree  
viii. Taste disturbance.  
Strongly agree Agree No opinion Disagree Strongly disagree  
ix. Vomiting (Stronger indicator than nausea).  
Strongly agree Agree No opinion Disagree Strongly disagree  
x. Nystagmus. 
 
Strongly agree Agree No opinion Disagree Strongly disagree  
 
 
34.  Any other comments on this section?  
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Lastly - Any other general comments? 
35.  Please add any further comments you may have about the red flag screening process 
that has not been covered above.  
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Cervical spine red flags 3 (Final) 
Page 3 of 3 
Thank you very much for completing the final survey of this 
project. 
The consultant panel's collective responses will now be analysed and re-
presented in a similar format that accompanied this survey. 
 
This Delphi study aims to establish a consensus on the red flags to help 
improve our clinical decision making for earlier diagnosis of serious 
pathology and to inform future projects.  
 
Thank you for your highly valued support to this project. 
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Appendix T: Delphi survey Round 3 results in graph representation 
Boxes shaded red indicate clinical indicators meeting consensus point 80% 
Boxes shaded orange indicate clinical indicators achieving 70-79% based on minimum 
n=9 responses per indicator.  This suggests borderline agreement. 
Section 1: 1. Progressive Pain (Neck and/or radicular pain. May be accompanied by headache). 
1. Progressive pain: 
1.a. May be in isolation (i.e. not accomapnied or associated with others features e.g. history of 
cancer, trauma, presence of hard neurological signs, suspected atlanto-axial instability or infection). 
Strongly agree:  9.1% 1 
Agree:  45.5% 5 
No opinion:  9.1% 1 
Disagree:  36.4% 4 
Strongly disagree:  0.0% 0 
1.b. May be associated with others features (e.g. history of cancer, trauma, presence of hard 
neurological signs, suspected atlanto-axial instability or infection). 
Strongly agree:  54.5% 6 
Agree:  36.4% 4 
No opinion:  9.1% 1 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
2. If pain is progressively worse (e.g. over past week). 
Strongly agree:  0.0% 0 
Agree:  36.4% 4 
No opinion:  18.2% 2 
Disagree:  45.5% 5 
Strongly disagree:  0.0% 0 
 
3. Pain not responding to simple measures (e.g. normal analgesics). 
Strongly agree:  0.0% 0 
Agree:  27.3% 3 
No opinion:  27.3% 3 
Disagree:  36.4% 4 
Strongly disagree:  9.1% 1 
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4. Onset: 
4.a. May be a new 1st episode of acute/subacute pain onset (e.g. onset immediately following 
trauma or present for hours to 1-month for arterial dissection). 
Strongly agree:  18.2% 2 
Agree:  45.5% 5 
No opinion:  9.1% 1 
Disagree:  27.3% 3 
Strongly disagree:  0.0% 0 
4.b. May be an acute/subacute aggravation on chronic pain. 
Strongly agree:  0.0% 0 
Agree:  36.4% 4 
No opinion:  9.1% 1 
Disagree:  45.5% 5 
Strongly disagree:  9.1% 1 
 
5. Description: Severe and/or unremitting. Note caution: Description is not definitive - May be 
sharp or dull; localised or diffuse/no specific distribution; moderate or severe. 
Strongly agree:  9.1% 1 
Agree:  54.5% 6 
No opinion:  9.1% 1 
Disagree:  27.3% 3 
Strongly disagree:  0.0% 0 
 
6. Severe pain on movement; reluctance to move; gross cervical spasm or torticollis (cancer, 
infection, atlanto-axial instability). 
Strongly agree:  30.0% 3 
Agree:  50.0% 5 
No opinion:  10.0% 1 
Disagree:  10.0% 1 
Strongly disagree:  0.0% 0 
 
7. Disrupting sleep (does not ease with adjusting sleep position e.g. pillow). 
Strongly agree:  9.1% 1 
Agree:  27.3% 3 
No opinion:  9.1% 1 
Disagree:  54.5% 6 
Strongly disagree:  0.0% 0 
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Section 2: 2. Cancer, infection, inflammatory arthritis/spondyloarthropathies, trauma 
9.Cancer Previous history of cancer; unexplained weight loss; lymphadenopathy. 
Strongly agree:  54.5% 6 
Agree:  36.4% 4 
No opinion:  0.0% 0 
Disagree:  9.1% 1 
Strongly disagree:  0.0% 0 
 
10. Age and risk (The consultant panel have provided 3 options): What age group do you think 
should be used as an indicator of increased risk of serious pathology occurring naturally e.g. cancer? 
Additional consideration could be given to other pathologies e.g. cervical arterial dissection. 
Age greater than 40 
years:  
0.0% 0 
Age greater than 50 
years:  
54.5% 6 
No age group 
association (no age 
group is exempt): 
 45.5% 5 
 
11.Infection Malaise, fever, sweats, lethargy. 
Strongly agree:  27.3% 3 
Agree:  54.5% 6 
No opinion:  0.0% 0 
Disagree:  18.2% 2 
Strongly disagree:  0.0% 0 
 
12. Tuberculosis, immunosuppression, drug abuse, HIV/AIDS, or other (significant) infection. 
Strongly agree:  18.2% 2 
Agree: 
 
72.7% 8 
No opinion:  9.1% 1 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
13.Inflammatory arthritis/spondyloarthropathies 
Strongly agree:  10.0% 1 
Agree:  40.0% 4 
No opinion:  30.0% 3 
Disagree:  20.0% 2 
Strongly disagree:  0.0% 0 
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14.Trauma (recent onset) 
Strongly agree:  45.5% 5 
Agree:  54.5% 6 
No opinion:  0.0% 0 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
 
Section 3: 3. Neurological deficit (e.g. spinal cord compromise) 
16. Quick guide Upper motor neuron symptoms/signs (in lower limbs more than upper limbs). Lower 
motor neuron symptoms/signs (in upper limbs more than lower limbs). 
Strongly agree:  54.5% 6 
Agree:  45.5% 5 
No opinion:  0.0% 0 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
17. Hands: clumsy/loss of dexterity or weakness. 
Strongly agree:  45.5% 5 
Agree:  54.5% 6 
No opinion:  0.0% 0 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
18. Weakness (widespread) of arms or legs. 
Strongly agree:  30.0% 3 
Agree:  40.0% 4 
No opinion:  10.0% 1 
Disagree:  20.0% 2 
Strongly disagree:  0.0% 0 
 
19. Diffuse numbness or paraesthesia (pins/needles). 
Strongly agree:  18.2% 2 
Agree:  45.5% 5 
No opinion:  9.1% 1 
Disagree:  27.3% 3 
Strongly disagree:  0.0% 0 
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20. Loss of proprioception. 
Strongly agree:  27.3% 3 
Agree:  54.5% 6 
No opinion:  9.1% 1 
Disagree:  9.1% 1 
Strongly disagree:  0.0% 0 
 
21. Lhermitte's phenomenon / sign. 
Strongly agree: 
 
72.7% 8 
Agree:  27.3% 3 
No opinion:  0.0% 0 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
22. Hyperreflexia: (Increased/exaggerated reflexes in lower limbs more than upper limbs; Hoffman's 
reflex; finger flexion-extension jerks; clonus; myoclonus/spasticity in lower limbs > upper limbs; 
upgoing plantar response). 
Strongly agree:  54.5% 6 
Agree:  45.5% 5 
No opinion:  0.0% 0 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
23. Gait disturbance e.g. stiff, slow, broad based. 
Strongly agree:  45.5% 5 
Agree:  45.5% 5 
No opinion:  0.0% 0 
Disagree:  9.1% 1 
Strongly disagree:  0.0% 0 
 
24. Lower motor neuron symptoms/signs (in upper limb more than lower limb). Radicular pattern in 
particular dermatome: Numbness; paraesthesia (pins/needles); weakness; hyporeflexia (reduced 
reflexes) in particular dermatome. 
Strongly agree:  20.0% 2 
Agree:  50.0% 5 
No opinion:  0.0% 0 
Disagree:  30.0% 3 
Strongly disagree:  0.0% 0 
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25.Very late stage 
25.a. Sphincter disturbance (bladder and/or bowel) disturbance (retention or incontinence). 
Strongly agree:  50.0% 5 
Agree:  30.0% 3 
No opinion:  0.0% 0 
Disagree:  20.0% 2 
Strongly disagree:  0.0% 0 
25.b. Erectile dysfunction (rare occurrence). 
Strongly agree:  20.0% 2 
Agree:  40.0% 4 
No opinion:  0.0% 0 
Disagree:  40.0% 4 
Strongly disagree:  0.0% 0 
 
26.General progressive neurological deficit Any new progressive and/or unusual neurological 
symptoms/signs (irrespective of neck pain/stiffness). 
Strongly agree:  54.5% 6 
Agree:  36.4% 4 
No opinion:  9.1% 1 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
283 
Section 4: 4. Headache (accompanying neck pain/stiffness) 
28. New onset (e.g. less than 1 month). 
Strongly agree:  0.0% 0 
Agree:  20.0% 2 
No opinion:  30.0% 3 
Disagree:  50.0% 5 
Strongly disagree:  0.0% 0 
 
 
29. Severe and persistent. Note caution: May have no definitive distribution (e.g. local (such as 
occipital), or diffuse), description (e.g. sharp or dull) or intensity (e.g. moderate or severe). 
Strongly agree:  0.0% 0 
Agree:  50.0% 5 
No opinion:  10.0% 1 
Disagree:  40.0% 4 
Strongly disagree:  0.0% 0 
 
30. Headache changes: 
30.a. In usual pattern. 
Strongly agree:  0.0% 0 
Agree:  20.0% 2 
No opinion:  20.0% 2 
Disagree:  60.0% 6 
Strongly disagree:  0.0% 0 
30.b. With posture or brought on by exertion, cough, laugh or straining. 
Strongly agree:  22.2% 2 
Agree: 
 
77.8% 7 
No opinion:  0.0% 0 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
31. Sudden (unexplained) onset. 
Strongly agree:  40.0% 4 
Agree:  40.0% 4 
No opinion:  10.0% 1 
Disagree:  10.0% 1 
Strongly disagree:  0.0% 0 
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Section 5: 5. Brain stem, cervical arterial (occlusion/stenosis/dissection) and cranial nerve dysfunctions 
33. Symptoms/signs outlined below should raise concern if: New or recent onset (e.g. within 1 
month). Caution - symptoms/signs may be subtle if presenting at musculoskeletal clinics. 
Strongly agree:  14.3% 1 
Agree:  42.9% 3 
No opinion:  42.9% 3 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
33.a. 
33.a.i. Dizziness (Central cause typically episodic and between >1min and <30mins duration. Not 
occurring in isolation). 
Strongly agree:  0.0% 0 
Agree:  40.0% 4 
No opinion:  20.0% 2 
Disagree:  40.0% 4 
Strongly disagree:  0.0% 0 
33.a.ii. Slurred speech. 
Strongly agree:  10.0% 1 
Agree: 
 
80.0% 8 
No opinion:  0.0% 0 
Disagree:  10.0% 1 
Strongly disagree:  0.0% 0 
33.a.iii. Double or loss of vision. 
Strongly agree:  30.0% 3 
Agree:  60.0% 6 
No opinion:  0.0% 0 
Disagree:  10.0% 1 
Strongly disagree:  0.0% 0 
33.a.iv. Drooping eyelid / Horner's sign. 
Strongly agree:  66.7% 6 
Agree:  22.2% 2 
No opinion:  11.1% 1 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
 
33.a.v. Pulsatile tinnitus or sudden loss of hearing. 
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Strongly agree:  30.0% 3 
Agree:  50.0% 5 
No opinion:  10.0% 1 
Disagree:  10.0% 1 
Strongly disagree:  0.0% 0 
33.a.vi. Unilateral limb clumsiness or reduced balance. 
Strongly agree:  20.0% 2 
Agree:  60.0% 6 
No opinion:  0.0% 0 
Disagree:  20.0% 2 
Strongly disagree:  0.0% 0 
33.a.vii. Facial numbness or weakness. 
Strongly agree:  33.3% 3 
Agree:  66.7% 6 
No opinion:  0.0% 0 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
33.a.viii. Taste disturbance. 
Strongly agree:  0.0% 0 
Agree: 
 
70.0% 7 
No opinion:  10.0% 1 
Disagree:  20.0% 2 
Strongly disagree:  0.0% 0 
33.a.ix. Vomiting (Stronger indicator than nausea). 
Strongly agree:  10.0% 1 
Agree:  50.0% 5 
No opinion:  20.0% 2 
Disagree:  20.0% 2 
Strongly disagree:  0.0% 0 
33.a.x. Nystagmus. 
Strongly agree:  50.0% 5 
Agree:  40.0% 4 
No opinion:  10.0% 1 
Disagree:  0.0% 0 
Strongly disagree:  0.0% 0 
  286 
 
Appendix U: Descriptive statistics Delphi survey Round 3 
 
Descriptive Statistics Delphi Round 3 
Clinical Indicator N Minimum Maximum Mean Std. Deviation 
Progressive pain in isolation 11 2 5 3.27 1.104 
Progressive pain associated 
with other features e.g. history 
of cancer 
11 3 5 4.45 .688 
Pain is progressively worse e.g. 
over past week 
11 2 4 2.91 .944 
Pain not responding to simple 
analgesia 
11 1 4 2.73 1.009 
Pain may be new 1st episode of 
acute/sub-acute onset 
11 2 5 3.55 1.128 
Pain may be an acute/subacute 
aggravation on chronic pain 
11 1 4 2.73 1.104 
Severe and/or unremitting pain 11 2 5 3.45 1.036 
Severe pain on movement 10 2 5 4.00 .943 
Pain disrupting sleep (does not 
ease with adjusting position) 
11 2 5 2.91 1.136 
 
5=Strongly Agree; 4= Agree; 3=No Opinion; 2=Disagree; 1=Strongly Disagree 
 
Clinical Indicator N Minimum Maximum Mean Std. Deviation 
Cancer: Previous history; 
unexplained weight loss; 
lymphadenopathy 
11 2 5 4.36 .924 
Age as an indicator of increased 
risk of serious pathology 
occurring naturally 
10 1.00 2.00 1.4000 .51640 
Infection: Malaise, fever, 
sweats, lethargy 
11 2 5 3.91 1.044 
Tuberculosis, 
immunosuppression, drug 
abuse, HIV/AIDS, or other 
(significant) infection 
11 3 5 4.09 .539 
Inflammatory 
arthritis/spondyloarthropathies 
10 2 5 3.40 .966 
Trauma (recent onset) 10 4 5 4.40 .516 
 
5=Strongly Agree; 4= Agree; 3=No Opinion; 2=Disagree; 1=Strongly Disagree 
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Descriptive Statistics Delphi Round 3 
 
Clinical Indicator N Minimum Maximum Mean Std. Deviation 
Quick guide: UMN 
symptoms/signs in LL>UL; 
LMN symptoms/signs in 
UL>LL 
11 4 5 4.55 .522 
Hands: clumsy/loss of 
dexterity or weakness 
11 4 5 4.45 .522 
Weakness (widespread) of 
arms or legs 
10 2 5 3.80 1.135 
Diffuse numbness or 
paraesthesia 
11 2 5 3.55 1.128 
Loss of proprioception 11 2 5 4.00 .894 
Lhermitte's 
phenomenon/sign 
11 4 5 4.73 .467 
Hyperreflexia 11 4 5 4.55 .522 
Gait disturbance 11 2 5 4.18 .874 
LMN symptoms/signs 10 2 5 3.60 1.174 
Very late stage: Sphincter 
disturbance (bladder and/or 
bowel retention or 
incontinence) 
10 2 5 4.10 1.197 
Very late stage: Erectile 
dysfunction (rare 
occurrence) 
10 2 5 3.40 1.265 
General progressive 
neurological deficit 
11 3 5 4.45 .688 
 
5=Strongly Agree; 4= Agree; 3=No Opinion; 2=Disagree; 1=Strongly Disagree 
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Descriptive Statistics Delphi Round 3 
 
Clinical Indicator N Minimum Maximum Mean Std. Deviation 
Headache: new onset (e.g. less 
than 1-month) 
10 2 4 2.70 .823 
Headcahe: severe and 
persistent 
10 2 4 3.10 .994 
Headache: changes in usual 
pattern 
10 2 4 2.60 .843 
Headache: changes with 
posture or brought on by 
exertion, cough, laugh or 
straining 
9 4 5 4.22 .441 
Headache: sudden 
(unexplained) onset 
10 2 5 4.10 .994 
 
New or recent onset (e.g. within 
1-month) of the following 
symptoms/signs 7 
 
 
3 
 
 
5 
 
 
3.86 
 
 
.900 
Dizziness (central cause 
typically episodic and between 
>1min and <30min duration. Not 
occurring in isolation) 
10 2 4 3.00 .943 
Slurred speech 10 2 5 3.90 .738 
Double or loss of vision 10 2 5 4.10 .876 
Drooping eyelid / Horner's sign 9 3 5 4.56 .726 
Pulstaile tinnitus or sudden loss 
of hearing 
10 2 5 4.00 .943 
Unilateral limb clumsiness or 
reduced balance 
10 2 5 3.80 1.033 
Facial numbness or weakness 9 4 5 4.33 .500 
Taste disturbance 10 2 4 3.50 .850 
Vomiting (stronger indicator 
than nausea) 
10 2 5 3.50 .972 
Nystagmus 10 3 5 4.40 .699 
 
5=Strongly Agree; 4= Agree; 3=No Opinion; 2=Disagree; 1=Strongly Disagree
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Appendix V: Raw data Delphi survey Round 2 
 
 
 
 
Delphi Round 2: Question numbers (1-33) and responses (1-5) 
 
 
 
 
P 
1 2 3 4 5 6 7 9 10 11 12 13 14 16 17 18 19 20 21 22 23 24 
25
a 
25
b 26 28 29 30 33 
33
a1 
33
a2 
33 
a3 
33
a4 
33
a5 
33
a6 
33
a7 
33
a8 
33 
a9 
 
3
3
a
1
0 
 
                                       
 
                            
           
 
1 1 1 1 1 1 1 1 4 2 4 5 5 4 1 5 4 2 5 5 0 4 1 4  4  1 1 
           
2 4 4 2 4 4 5 2 5 1 4 5 4 5 5 5 5 4 4 5 5 5 4 5  4 2 2 2  2 4 4 4 4 4 5 4 2 5 
3 4 3 3 3 4 4 4 4 2 4 2 4 4 4 4 4 4 4 4 4 2 4 4 4 4 2 3 4 5 4 5 5 5 5 5 5 3 5 5 
4 3 2 2 2 2 4 4 5 1 4 4 4 5 5 5 5 4 4 5 5 5 4 5  5 4 4 4  4 4 5 5 5 5 4 4 4 5 
5 4 3 3 4 2 4 4 5 1 4 5 4 4 5 4 4 4 4 5 5 5 4 5 4 5 4 4 4 4 4 5 5 5 5 5 5 4 5 5 
6 3 2 2 3 2 2 4 4 2 5 5 2 5 5 5 5 5 5 5 5 5 2 4 4 5 3 3 4  3 5 5 5 3 4 4 3 4 5 
7 4 2 4 4 4 4 3 5 2 4 4 4 4 5 5 5 5 5 5 5 5 4 5 4 4 2 2 4 4 3 5 4 4 3 4 4 3 4 4 
8 4 1 2 2 4 5 2 5 1 5 4 2 4 4 4 5 2 4 5 5 2 2 5  5 2 5 2  2 5 5 5 2 4 5 3 2 2 
9 5 4 4 5 4 4 5 4 1 4 5 4 5 4 4 5 5 4 5 5 4 4 5 4 5 4 5 4 3 3 4 4 3 4 4 5 5 4 5 
10 5 4 4 3 5 4 4 5 0 4 4 3 4 4 4 4 4 3 3 4 4 3 4  4 3 4 3 4 3 4 4 3 4 4 4 4 3 4 
11 4 4 2 4 4 2 2 5 1 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 3 2 4 
                                        
 
P = Participant numbers 1-11  Responses: 5=Strongly Agree; 4= Agree; 3=No Opinion; 2=Disagree; 1=Strongly Disagree
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Appendix W: Raw data Delphi survey Round 3 
 
 
 
Delphi Round 3: Question numbers (1-33) and responses (1-5) 
 
 
 
 
P 1a 
1
b 2 3 4a 
4
b 5 6 7 9 10 11 12 13 14 16 17 18 19 20 21 22 23 24 
25
a 
25
b 26 28 29 
30
a 
30
b 31 33 
33
a1 
33
a2 
33
a3 
33
a4 
33
a5 
33
a6 
33
a7 
33
a8 
33
a9 
33
a1
0 
 
                                           
                                            
1 4 5 2 1 2 1 4  2 5 1 4 5 5 4 5 5 5 3 5 5 5 4 4 4 4 5                 
2 5 5 4 4 5 4 5 5 2 5 2 5 4 4 5 5 5 5 5 5 5 5 5 4 5 2 5 2 4 2 4 4  2 2 2  5 5 5 2 4 5 
3 2 4 2 2 2 2 2 4 4 4 2 4 4 4 5 5 4 4 4 4 5 4 4 2  4 4 2 2 2 4 5  2 4 4 5 4 4 4 4 2 4 
4 4 4 4 2 4 2 4 5 2 5 1 5 5 4 5 5 4  5 4 5 5 5 4 5 4 5 4 4 2 5 5 4 4 5 5 5 5 4 4 4 5 5 
5 2 4 2 4 4 2 2 2 3 4 1 2 4 3 4 5 5 2 2 3 5 5 5 2 2 2 5 2 2 2  2 3 3 4 4 5 3 4 4 4 4 5 
6 4 5 3 2 4 4 4 5 2 4 2 5 3   4 5 4 4 5 5 4 4 2 5 5 5 2 4 3 4 5 5 2 4 5 5 5 4 5 4 3 3 
7 2 5 4 3 5 4 4 4 5 5 1 4 4 3 5 4 4 3 2 2 4 5 4 4 4  5 3 4 2 4 4 4 4 4 5 3 4 2 4 4 4 5 
8 4 4 4 4 4 4 4 4 2 5 1 4 4 2 4 4 4 2 2 4 4 4 4 4 4 4 4 4 4 4 4 4 5 3 4 4 4 4 4 4 4 4 4 
9 2 5 3 3 3 3 4 4 4 5 1 4 4 3 4 5 5 5 4 4 5 5 5 5 5 5 3 3 3 3 5 5 3 4 4 4 5 4 5 5 3 3 5 
10 4 3 2 3 2 2 3 3 4 2 2 2 4 2 4 4 4 4 4 4 4 4 2  2 2 4 2 2 2 4 3 3 2 4 4 4 2 2  2 2 4 
11 3 5 2 2 4 2 2 4 2 4 2 4 4 4 4 4 4 4 4 4 5 4 4 5 5 2 4 3 2 4 4 4  4 4 4 5 4 4 4 4 4 4 
 
 
P = Participant number         5=Strongly Agree; 4= Agree; 3=No Opinion; 2=Disagree; 1=Strongly Disagree
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Appendix X: Graphical representation of Kendall’s Coefficient of Concordance for Progressive Pain 
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Appendix Y: Graphical representation of Kendall’s Coefficient of Concordance for Headache 
 
